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Abstract 
The objective of this study was to study and investigate the efficacy and 
pharmacotoxicity of some trypanocidal: CymelarsanR, quinapyramine and 
homidium bromide, and also oxytetracycline at single and multiple dosages, in 
addition to their pharamcotoxicity of interaction of each other. A trial for the 
treatment of T. evansi with Cymelarsan supplemented with zinc and copper was 
also conducted. Parasitological, clinical and pathological investigations were also 
made. Drugs under experimentation were also studied for their residual status. The 
study consisted of 10 experiments conducted in 380 Nubian goats and 65 camels 
(Camels dromedarius), divided randomly into different groups of both sexes each 
of ten goats and five camels. Three groups were defined as control groups such as 
uninfected, untreated group, infected with T. evansi or T. vivax were also used. 
The infection was done first in 5 albino rats in both sexes, and then the animals 
were infected after many passages with rats’ blood each experiment was taken 
from 79-86 days. These ten experiments targeted:  
(1) Toxicity and efficacy of CymelarsanR in goats infected with T. evansi at single 
and multiple doses.  
(2) Toxicity and efficacy of oxytetracycline in goats infected with T. evansi and 
given single and multiple dosages of oxytetracycline.                                               
(3) Efficacy and clinicopathological effects of Cymelarsan and oxytetracycline in 
goats infected with T. evansi      
(4) Clinicopathological effects and efficacy of Cymelarsan in Nubian goats 
infected with T. evansi, supplemented with zinc and copper.  
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(5) Toxicity and efficacy of quinapyramine in goats infected with T. evansi 
(6) Toxicity and efficacy of ethidium bromide in goats infected with T. vivax 
(7) Efficacy and clinicopathological effects of quinapyramine and ethidium 
bromide combination in goats infected with T. evansi or T. vivax 
(8) Toxicity and efficacy of Cymelarsan in camels (Camelus dromedaries) 
naturally infected with T. evansi and given single and multiple dosages of 
Cymelarsan 
(9) Toxicity and efficacy of oxytetracycline in camels (Camelus dromedaries) 
infected with T. evansi and given single and multiple dosages of oxytetracycline 
(10) Efficacy and clinicopathological effects of Cymelarsan and oxytetracycline in 
camels (Camelus dromedaries) infected with T. evansi. 
Various parameters pertaining to existence or removal of parasites from blood as 
well as survival or death and the experimental animals have been recorded with 
respect to the drug given alone singular or in combination.  
Liver impression smears indicated parasitaemia in the different experimental 
groups. 
A number of clinical signs were observed in goats in different groups with respect 
to hypothermia and various manifestations and thriftiness or posture and state of 
health.  
Post treatment all goats dosed with Cymelarsan showed swelling at injection site 
which disappeared after 1-2 days in a few goats but never in other majority of the 
groups. Severity of the clinical signs developed with the high dosing of the drugs. 
Some goats showed decrease in body temperature, respiratory rate, pulse rate, 
body weight and blood pressure, others showed severe signs, including 
lacrimation, nasal discharge, shivering, and pyrexia, loss of appetite, keratitis, 
diarrhoea, weak respiration and pulse rate. Some camels exhibited crying sounds 
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and restlessness with episodes of diarrhoea whereas in goats most prevalent 
lesions were congestion, oedema and haemorrhage and frothing at the mouth plus 
necrosis of livers and kidneys in addition to nephritis, gastritis, enteritis, peritonitis 
and hydroperitoneum, spleenomegaly, and orchitis post infection. Post treatment 
these signs disappeared in some groups while in other groups they remained with 
different severities. Similar observations were made with respect to 
histopathological findings pre and post dosing. 
Minor effects were noticed with respect to haematocrit parameters and minerals 
and enzymatic activity. 
Residues of Cymelarsan were measured by determination of arsenic. The residue 
of Cymelarsan, OTC and quinapyramine was measured in serum, organs (liver, 
kidney, heart, lung, spleen, cerebellum, cerebrum, fat, site of injection, leg muscle, 
uterus, ovary and testis), bile and urine. Generally the drug concentration 
increased when the dose is increased.  
The residual status of Cymelarsan, quinapyramine and OTC was studied and 
relevant data obtained. Serum arsenic (for Cymelarsan) values were monitored 
under the various circumstances. Kinetics of these drugs was studied with respect 
to different manipulations. 
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  ﺍﻷﻁﺭﻭﺤﺔ ﻤﻠﺨﺹ
) ﺩﺭﺍﺴﺔ ﺩﻭﺍﺌﻴﺔ ﻭﺴﻤﻴﺔ ﺒﻌﺽ ﻤﻀﺎﺩﺍﺕ ﻤﺭﺽ ﺍﻟﻨﻭﻡ: ﻫﺩﻓﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻟﻲ
 ﻲﺒﺭﻭﻤﻴﺩﻭﻜﺫﻟﻙ ﺍﻷﻭﻜﺴﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ، ﺍﻟﻜﻭﻴﻨﺎﺒﺎﻴﺭﺍﻤﻴﻥ، ﺍﻟﻬﻭﻤﻴﺩﻴﻡ 
 ﻋﻼﺠﻴﺔ ﺠﺭﻋﺎﺕ ﺔﺘﺘﺭﺍﺴﺎﻴﻜﻠﻴﻥ، ﺜﻡ ﺍﻟﺘﺩﺍﺨل ﺒﻴﻥ ﻫﺫﺓ ﺍﻷﺩﻭﻴﺔ ﻭﻜﺫﻟﻙ ﺩﺭﺍﺴ
ﻤﺨﺘﻠﻔﺔ ﻤﻥ ﺍﻷﺩﻭﻴﺔ ﻗﻴﺩ ﺍﻟﺒﺤﺙ ، ﻭﻤﺤﺎﻭﻟﺔ ﺍﻟﻌﻼﺝ ﺒﺩﻭﺍﺀ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻤﻌﻀﺩﺍﹰ 
ﺒﺠﺭﻋﺎﺕ ﻤﺘﺘﺎﺒﻌﺔﻜﻤﺎ ﺃﺠﺭﻴﺕ ﺩﺭﺍﺴﺔ ﺘﺭﺴﺒﺎﺕ ﻫﺫﺓ ﺍﻷﺩﻭﻴﺔ ، ﺒﺎﻟﺯﻨﻙ ﻭﺍﻟﻨﺤﺎﺱ
  .ﻓﻲ ﺍﻨﺴﺠﺔ ﺍﺠﺴﺎﻡ ﺤﻴﻭﺍﻨﺎﺕ ﺍﻟﺘﺠﺎﺭﺏ
 ﺘﺠﺎﺭﺏ ﺘﺭﺍﻭﺤﺕ ﻓﺘﺭﺓ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﻭﺍﺤﺩﺓ ﺒﻴﻥ 01ﻤﻠﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻠﻰ ﺍﺸﺘ
 ﺭﺃﺴﺎ ﻤﻥ 56 ﺭﺃﺴﺎ ﻤﻥ ﺍﻟﻤﺎﻋﺯ ﺍﻟﻨﻭﺒﻲ ﻭ083 ﻴﻭﻡ،ﻤﺴﺘﺨﺩﻤﻴﻥ ﻋﺩﺩ 68-97
ﻗﺴﻤﺕ ﻫﺫﺓ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﻋﻠﻰ ﻤﺠﻤﻭﻋﺎﺕ . ﺍﻹﺒل ﻭﺤﻴﺩﺓ ﺍﻟﺴﻨﺎﻡ ﻤﻥ ﺍﻟﺠﻨﺴﻴﻥ
 5 ﺭﺃﺱ ﻤﻥ ﺍﻟﻤﺎﻋﺯ ﺍﻟﻨﻭﺒﻲ ﺃﻭ01ﻋﺸﻭﺍﺌﻴﺎ ﺍﺤﺘﻭﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻭﺍﺤﺩﻩ ﻋﻠﻰ 
ﺒل ﻭ ﺘﺭﻜﺕ ﻤﺠﻤﻭﻋﺘﺎﻥ ﺒﺎﻋﺘﺒﺎﺭﻫﻤﺎﻤﺠﻤﻭﻋﺘﻲ ﺘﺤﻜﻡ ﺤﺴﺏ ﺭﺃﺱ ﻤﻥ ﺍﻹ
ﺍﻟﻤﺠﻤﻭﻋﺔ ) ﺒﺭﻭﺘﻭﻜﻭل ﺍﻟﺘﺠﺎﺭﺏ ﺍﻟﻤﻌﻤﻠﻴﺔ ﺇﺤﺩﺍﻫﻤﺎ ﻤﻌﺩﻴﺔ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ 
ﺍﻟﻤﺠﻤﻭﻋﺔ ) ﻤﻥ ﺍﻟﻨﻭﻋﻴﻥ ﻭﺍﻷﺨﺭﻯ ﺒﻁﻔﻴل ﺍﻟﻔﻴﻔﺎﻜﺱ ﺩﻭﻥ ﻋﻼﺝ ( ﺍﻟﻤﻭﺠﺒﺔ
  (.ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺴﺎﻟﺒﺔ) ﺃﻤﺎ ﺍﻟﺜﺎﻨﻴﺔ ﻓﻠﻡ ﺘﺼﺏ ﺒﻌﺩﻭﻯ ﺃﻭ ﺘﻌﺎﻟﺞ ( ﺍﻟﻤﻭﺠﺒﺔ
 ﻓﺌﺭﺍﻥ ﻤﻥ ﻓﺌﺭﺍﻥ ﺍﻷﻟﺒﻴﻨﻭ ﺍﻟﺒﻴﻀﺎﺀ ﻭﺒﻌﺩ ﺍﻟﺘﻤﺭﻴﺭ 5 ﺃﻭﻻﹰ ﻓﻲ ﺘﻡ ﺤﻘﻥ ﺍﻟﻁﻔﻴل
ﻓﻲ ﻋﺩﺩ ﻤﻥ ﺍﻟﻔﺌﺭﺍﻥ ﺘﻡ ﺤﻘﻥ ﺍﻟﻤﺎﻋﺯ ﺍﻟﻨﻭﺒﻲ ﺒﺩﻡ ﺍﻟﻔﺌﺭﺍﻥ ﺤﺎﻤﻠﺔ ﺍﻟﻌﺩﻭﻯ ﺒﺠﺭﻋﺔ 
ﻤﻥ ﺍﻟﻁﻔﻴل ﻭﻜﺎﻨﺕ ﺍﻟﺘﺠﺎﺭﺏ ﺍﻟﻌﺸﺭ 015 x5 ﻤل ﺍﺤﺘﻭﺕ ﻋﻠﻰ 57.0ﻤﻘﺩﺍﺭﻫﺎ 
  -:ﻜﺎﻵﺘﻲ
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 ﺍﻟﻨﻭﺒﻲ  ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﺩﻭﺍﺀ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻓﻲ ﺍﻟﻤﺎﻋﺯ-: ﺍﻟﺘﺠﺭﺒﺔ ﺍﻷﻭﻟﻰ
  .ﺍﻟﻤﺼﺎﺏ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ ﺒﺠﺭﻋﺎﺕ ﺃﺤﺎﺩﻴﺔ ﺃﻭ ﻤﻜﺭﺭﺓ
 ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﺩﻭﺍﺀ ﺍﻷﻭﻜﺴﻲ ﺘﺘﺭﺍﺴﺎﻴﻜﻠﻴﻥ ﻓﻲ ﺍﻟﻤﺎﻋﺯ -:ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻨﻴﺔ
  .ﺍﻟﻨﻭﺒﻲ ﺍﻟﻤﺼﺎﺏ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ ﺒﺠﺭﻋﺎﺕ ﺃﺤﺎﺩﻴﺔ ﺃﻭ ﻤﻜﺭﺭﺓ
ﺃﺜﺭ ﺩﻭﺍﺀ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻭﺍﻷﻭﻜﺴﻲ ﺘﺘﺭﺍﺴﺎﻴﻜﻠﻴﻥ ﻤﻌﺎﹰ ﻓﻲ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻟﺜﺔ
  .ﻤل ﻟﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ ﻋﻼﺠﻴﺎﺍﻟﻤﺎﻋﺯ ﺍﻟﺤﺎ
ﻋﻼﺠﻴﺔ ﺍﺜﺭ ﺩﻭﺍﺀ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻤﻌﻀﺩﺍﹰ ﺒﺎﻟﺯﻨﻙ ﻭﺍﻟﻨﺤﺎﺱ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺭﺍﺒﻌﺔ
  .ﻓﻲ ﺍﻟﻤﺎﻋﺯ ﺍﻟﺤﺎﻤل ﻟﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ
ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﻭﺩﻭﺍﺀ ﺍﻟﻜﻭﻴﻨﺎﺒﺎﻴﺭﺍﻤﻴﻥ ﻓﻲ ﺍﻟﻤﺎﻋﺯ ﺍﻟﻤﺼﺎﺏ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺨﺎﻤﺴﺔ
  .ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ
ﻭﻤﻴﺩﻴﻡ ﺒﺭﻭﻤﻴﺩ ﻓﻲ ﺍﻟﻤﺎﻋﺯ ﺍﻟﻤﺼﺎﺏ ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﺩﻭﺍﺀ ﺍﻟﻬ: ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺴﺎﺩﺴﺔ
  .ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ
ﺴﻤﻴﺔ ﻭ ﻋﻼﺠﻴﺔ ﺩﻭﺍﺌﻲ ﺍﻟﻜﻭﻴﻨﺎﺒﺎﻴﺭﺍﻤﻴﻥ ﻤﻌﺎﹰ ﻓﻲ ﺍﻟﻤﺎﻋﺯ :ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺴﺎﺒﻌﺔ
  .ﺍﻟﻤﺼﺎﺏ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ ﺃﻭ ﺍﻟﻔﻴﻔﺎﻜﺱ
ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﺩﻭﺍﺀ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻓﻲ ﺍﻹﺒل ﻭﺤﻴﺩﺓ ﺍﻟﺴﻨﺎﻡ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺜﺎﻤﻨﺔ
  .ﺒﺠﺭﻋﺎﺕ ﺃﺤﺎﺩﻴﺔ ﺃﻭ ﻤﻜﺭﺭﺓﺍﻟﻤﻌﺩﻴﺔ ﻁﺒﻴﻌﻴﺎﹰ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ 
ﺴﻤﻴﺔ ﻭﻋﻼﺠﻴﺔ ﺩﻭﺍﺀ ﺍﻷﻭﻜﺴﻲ ﺘﺘﺭﺍﺴﺎﻴﻜﻠﻴﻥ ﻓﻲ ﺍﻹﺒل ﻭﺤﻴﺩﺓ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﺘﺎﺴﻌﺔ
  .ﺍﻟﺴﻨﺎﻡ ﺍﻟﻤﺼﺎﺒﺔ ﻁﺒﻴﻌﻴﺎﹰ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱ ﺒﺠﺭﻋﺎﺕ ﺃﺤﺎﺩﻴﺔ ﺃﻭ ﻤﻜﺭﺭﺓ
ﻋﻼﺠﻴﺔ ﺩﻭﺍﺌﻲ ﺍﻟﺴﺎﻴﻤﻼﺭﺴﺎﻥ ﻭﺍﻷﻭﻜﺴﻲ ﺘﺘﺭﺍﺴﺎﻴﻜﻠﻴﻥ ﻤﻌﺎﹰ : ﺍﻟﺘﺠﺭﺒﺔ ﺍﻟﻌﺎﺸﺭﺓ
  .ﺔ ﻁﺒﻴﻌﻴﺎﹰ ﺒﻁﻔﻴل ﺍﻻﻴﻔﺎﻨﺯﺍﻱﻓﻲ ﺍﻹﺒل ﻭﺤﻴﺩﺓ ﺍﻟﺴﻨﺎﻡ ﻭﺍﻟﻤﺼﺎﺒ
 ﺘﻡ ﺍﻟﻜﺸﻑ ﻋﻥ ﺘﻭﺍﺠﺩ ﺍﻟﻁﻔﻴل ﻓﻲ ﺍﻟﺩﻡ ﺍﻟﻁﺭﻓﻲ ﺒﻌﺩﺩ ﻤﻥ ﺍﻻﺨﺘﺒﺎﺭﺍﺕ ﻜﻤﺎ ﺘﻡ 
  ﺍﻟﻜﺸﻑ ﻋﻨﺔ ﺒﺎﺨﺘﺒﺎﺭﺓ ﻓﻲ ﺍﻟﻤﺴﺤﺔ ﺍﻟﻜﺒﺩﻴﺔ ﺍﻟﻤﻀﻐﻭﻁﺔ 
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INTRODUCTION 
Camels (Camelus dromedarius) play an important role in arid and semi-arid 
zones where they are used by pastoral societies as a source of meat, milk and, for 
drought and transport purposes (Shwarts and Dioli,1992).  
In Sudan, the one-humped camel (Camelus dromedarius) plays an 
important role in the national income and constitutes   a major   proportion   of 
foreign currency revenue. Sudanese camels are affected by three major diseases 
namely mange (Jereb), internal helminthiasis mainly haemonchosis (Holaa), and 
trypanosomosis (Guffar). The latter is the most important health problem of all 
(Wilson, 1984).  
The goat is one of the small-domesticated ruminants, which have served mankind 
since early times and longer than cattle and sheep. In the Sudan people keep goats 
for several purposes including food. Goats need mainly natural grazing, at low 
cost management and they are a form of investment (meat and milk products) but 
the  productivity of goats will be low if they are not kept healthy. 
Trypanosomosis (Surra) encompasses about 9 – 10 million square 
kilometers of Savannah area (Atang, 1982) and is widespread in East Africa 
(Ethiopia, Sudan, Somalia, and Kenya) and West Africa (Chad, Mali, Mauritania, 
and Niger). It has also been described in the Middle East, India and Asia (Wilson, 
1984). The disease is well known by camel’s herder but not far small ruminants 
(Rötcher and Heising1980). 
T.vivax causes the most important form of trypanosomosis of cattle in West 
Africa, Sahel and Sudan zones of territories of Chad. Niger, Mali, Northern 
Senegal and Northern Nigeria which are relatively free of Tsetse. The cattle 
migrate yearly south into Guinea zone which were heavily infested with Tsetse 
flies, also in East Africa cause infection and disease but the course is mild(Anosa 
and Isoun, 1976). 
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ElKarib, (1961) reported that only sheep showed clinical episodes of the disease 
with loss of weight and abortion during 220 days after inoculation of T. evansi 
(strain isolated from dairy camels) in sheep and goats.  
There is little information about the distribution and the economic importance of 
the disease caused by the T. congolense in small ruminants. The infection and the 
disease, however, are known to occur in both West and East Africa. Pecaud, 
(1909and1910) recorded a 1.3% incidence of infection by the T. congolense, T. 
vivax and T. evansi in a large number of animals. In a more recent but much 
smaller survey, 13.8%were infected with either T. congolense or T. vivax (Kramer, 
1966). Mornet, (1954) considered that goats and sheep made up 4% of all the 
animals infected with T. congolense. Lewis, (1949) reported that goats can be 
infected if kept close to infected cattle.   
Yesufu, (1975) exposed pregnant female rates infected with T. brucei, T. 
congolense, T. gambiense to various stresses and noted a high rate of abortion and 
two litter survived, also Ige and Amdou observed that infection with T. vivax, T. 
congolense, T. brucei brucei and mixed infection had a severe effect on the 
fertility of the cattle.    
The pathology of animal trypanosomosis was summarized  in more details by 
Ikede, (1975)   although the disease caused by the various species of trypanosomes 
has certain features in common, the types and mechanisms of injury done to the 
host may vary considerably with the species.                                                                                          
Human sleeping sickness influences physical, sexual maturity and 
academic performance of children (Khonde et al., 1997).  
Control of the vector is not feasible and the production of vaccine is still remote 
due to the problem of antigenic variation. Thus chemotherapy is the only method 
available for controlling trypanosomosis in camels and other animals (Bujon, 
1990). Treatment in camels is dependent on one of two drugs suramin and 
quinapyramine (Bujon, 1990). However, suramin has become less effective (Gad-
el Mwla and Fayed, 1979). In addition, suramin has disadvantages related to its 
route of administration (Zelleake et al., 1989) and quinpyramine sulphate is no 
larger available from the original manufacturer. On the other hand isometamidium 
chloride (samorin) only removes the parasites from the blood -stream for 21 hours 
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followed by relapse. And causes some serious adverse effects (Ali et al., 1986). 
Diminazine aceturate (Berenil) was found to be toxic at a dse of 10 or 20 mg/kg in 
camels (Leach and Robert, (1981). 
Mwambu, (1975)re-evauted the value of ethidium for the treatment of T. brucei 
subgroup infection  in cattle and concluded that the use of this drug as  a curative 
in T.  brucei infection of cattle should be restricted. Ethidium bromide was 
recorded as carcinogenic and mutagenic drug. 
 Extensive use of these compounds led to the appearance of drug resistance, 
which is becoming more widespread (Leach and Robert, 1981). This drug 
resistance poses a great problem (Mahmoud and Gray, 1980, Bujon, 1990) thus 
highlighting the need for newer trypanocidal drugs (Bujon, 1990). 
Since 1961 no additional drugs for use against animal trypanosomosis have gone 
beyond the experimental stage. Drug esistance between diamidines and 
isometamidium group seems to exsist (Finelle, 1975) . 
Cymelarsan® is a new trypanocide for treatment of camel trypanosomosis 
presented in the market by Rhône Mérieux – France and is indicated for the 
treatment of acute, sub-acute and chronic T. evansi infections, which are resistant 
to other drugs (Bujon, 1990). 
Trypanosomosis may sometimes be associated with other infections such as 
internal parasites and bacterial infection. Of the commonly used antibiotics, a 
tetracycline group is a board spectrum intoxic, bacterio-static, have effect against 
virus, mycoplasma, protozoa of blood (Thielirea, Anaplasma) (Giovani and 
warren, 1983), and have high concentration in the kidney, spleen, lung and liver 
(Bywater et al., 1991). 
It is well known that the vast majority of livestock in the Sudan are kept 
under extensive systems of husbandry pasturolists.  Accordingly under such 
extensive systems one would expect that mineral nutrition problem would been in 
countered since nomadic cares don't stay in any one place for a long time where 
mineral deficiency areas would be expected and also areas of adequacy and 
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toxicity also would be expected however, mineral nutrition problem in nomadic 
herds and great in addition, the tremendous physical extension of nomadic 
movement may lead to even more salt losses through increased sweating, 
micturition, defecation and other avenues of minerals escape of the animals body. 
In addition these herds expose environmental factors that stressed the camels 
through starvation, lack of water, prevalence of diseases and management of the 
lack of trace element which aggregate the stimulation. 
At the recommended dose Cymelarsan® has been shown to be well 
tolerated (Bujon, 1990 and Fairouz, 2000). It is well known that drug combined is 
used mainly to over come resistance or any undesirable side effects. Drugs are 
often given in combination with potentially   beneficial or adverse effect results. 
When two drugs are given together, their effects may be additive, the final being 
the sum of the individual effects. Alternatively, the interaction may be synergistic, 
the effect then being greater when two drugs are given together than one would 
expect from their effect when given alone (Girdwood, 1979). Interaction may be 
the result of pharmacokinetic (absorption, distribution, metabolism and excretion), 
pharmacodynamic (antagonism, additive interaction, synergism and potential) 
changes or a combination of both (Bentram and Anthony, 1993). The combination 
Cymelarsan® OTC gave best results in infected T. evansi Nubian goats, with 
correction of the haemogram, and some biochemical changes such as liver 
enzymes, thyroxin and progesterone levels were more quickly revealed with 
combined action than in Cymelarsan® alone (Fairouz, 2000).  
This study describes the efficacy, toxicity, drug interaction and residues of 
some trypanocidal drugs in infected goats and camels of the Sudan. Thus, the main 
objectives of this study are: 
1- A trial to use Cymelarsan against T. evansi in Nubian goats. 
2- To study pharamcotoxicity of some trypanocidal drugs CymelarsanR, 
quinapyramine and homidium bromide. 
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3- To study the pharamcotoxicity of oxytetracycline at different doses. 
4- To study the pharamcotoxicity of interaction between these drugs at 
different doses. 
5-  To study the efficacy of different doses of the above mentioned drugs.  
6- A trial for the treatment of infected goats with Cymelarsan 
supplemented with zinc and copper. 
7- A trial for intermittent treatment of infected camels and goats with the 
above mentioned drugs. 
8- To study the residual effects of the drugs experimented with, in tissue, 
urine, serum and bile of camels and goats. 
   
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
                                LITERATURE REVIEW    
1.1Classification  
As described by Soulsby, (1982): 
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Phylum Protozoa 
Subphylum Sarcomastigophora 
Super class Mastigophora 
Class  Zoomasigophorea 
Order  Kinetoplastida 
Suborder Trpanosomatida 
Family  Trypanosomatidae 
Genus   Trpanosoma 
Subgenus Pycnomas Nanomas Duttonella Trypanozoon  
Species suis congolense simiae  vivax  brucei 
Subspecies     vivax   uniforme   viennei      
                   brucei  rhodesiense  gambesiense  equiperdum  equinum   
evansi 
        
1.2Description of trypanosomes 
Trypanosomes are microscopic elongated unicellular flagellates. They 
move forwards with the help of a single flagellum, which arises from the 
flagella pocket, near the kinetoplast that is situated at the posterior end of the 
cell. They are obligate parasites, which multiply in the body fluids, 
especially blood stream and tissue fluid of the vertebrate host, and live in the 
digestive tract of the invertebrate host, which is generally a biting fly 
(Solusby, 1982). 
1.3 Trypanosomosis in Africa  
In Africa, the disease occurs in 37 countries extending over one third 
of the continent and covered about 9 – 10 million square kilometers of 
Savannah area (Atang, 1982). An estimated 50 million cattle constituting 
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30% of Africa total cattle are exposed to the risk of infection (FAO, WHO, 
and OIE, (1982) – Muarray and Gray, 1984). The sleeping sickness is found 
only in Sub-Saharan Africa (WHO, 1998).Trypanosomosis in camels (Surra) 
is widespread in East Africa (Ethiopia, Sudan, Somalia, and Kenya) and 
West Africa (Chad, Mali, Mauritania, and Niger). It has also been described 
in the Middle East, India and Asia (Wilson, 1984). 
1.3Transmission of trypanosomes 
There are three major types of transmission of trypanosomes: 
1- Cyclical transmission: Is restricted to Glossina species only. 
2- Mechanical transmission: Materialized by two means firstly biting insect (Uilenberg, 
1998) e.g Tabanids, Stomoxys and tsetse flies themselves (Jordon, 1974), secondly by 
latrogenic means, these caused by the careless operators and one induced 
involuntarily by operators using unhygienic procedures, such as contaminated 
instruments like surgical instrument and needle (Uilenberg, 1998). 
3- Transmission by other means: 
a) Carnivores were reported to be infected with T. evansi and T. burcei by ingesting 
meat or organs from infected animals, as long as these are still sufficiently fresh 
to contain live trypanosomes (penetration through the mucous membranes). 
b) Transmission of T. evansi in Latin American by the bites of vampire bats is 
common. 
c) Congenital transmission from the mother to the offspring, either through 
placenta, while the foetus still in the uterus or when bleeding occurs during birth. 
d) Venereal transmission is the normal means by which dourine of equines, caused 
by T. equiperdum is propagated (Uilenberg, 1998). 
Tryanosoma evansi belongs to the brucei group of trypanosomes and 
is morphologically identical with the long slender form of the polymorphic 
tsetse transmitted T. brucei (Soulsby, 1982). It has been reported to be 
transmitted mechanically with body fluids from camel to camel by a number 
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of haematophagus biting flies: Tabanus, Stomoxys and Haematobia. The 
transmission of T. evansi and T. equiperdum in horses and cattle in South 
America by the bite of vampire bat was described by Hoare (1939 and 
1967). 
1.4 Trypanosomosis outside the tsetse belt in Africa 
Wells (1972) stressed that the occurrence of T. vivax in areas where 
tsetse flies are absent is widely attributed to mechanical transmission. Ford 
(1964and 1972) found that, in Rhodesia T. congolense culminated in cattle 
adjacent to the tsetse area whereas T. vivax was found in areas further. The 
same result was found in Uganda (Ford and Cliford, 1968) and in Nigeria 
(Folkers and Jones, 1966). 
1.5 Trypanosomosis in the Sudan 
In Sudan, trypanosomosis has been recognized as an important disease 
of livestock since 1904 when it was recorded that 87 cattle were sick of 
trypanosomosis when they came to Khartoum from Upper Nile province 
(Annual Veterinary Department). In 1908 Dr. Wenyon reported the disease 
in camels in Bahr Elgazal province. In 1914cattle trypanosomosis caused by 
T. perccorum, T. brucei and T. cazalboui in Southern provinces and camel 
trypanosomosis to be widespread throughout the Northern Sudan, high 
mortality   in equines, cattle and camels due to T. brucei in Bahr ElGazal 
Province was reported by the Wellcome Tropical Research Laboratories in 
Khartoum as T. sudanese. (Elkarib, 1961). In the study of Kheir et al.1992 
along Sudan Ethiopian border in an area from Khor Yabous (lat.9o 45  long 
43o 10 ) in the South to River Setit in the North included areas of Rivers 
Rashad, Dinder, the Blue Nile and Kurmuk district T.congolense, T. brucei 
and T.vivax were found. Five strains from T.vivax isolated from Sennar 
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(Blue Nile State), Gedid (40km from Khartoum state), Jabal Awlia(50km 
from Khartoum State) and from Soba(20km from Khartoum State) and they 
were infective to white mice(Abdoon et al.,2001). 
Bovine trypanosomaisis is mainly a problem of mechanical 
transmission by the genera tabanids, stomoxys and possibly others. The 
main cattle-rearing zone lies north of the tsetse zone, in Bahr El Gazal, 
Darfur, Kordofan, Upper Nile and the Blue Nile province (Elkarib, 1961). T. 
congolense occurs throughout, and in areas just north of the tsetse zone. It 
may also occur in areas farther north. T. vivax occurs in the tsetse zone and 
extends farther north than T. congolense east from parallel 15th north on the 
east T. brucei affects cattle in the tsetse zone and possibly immediately north 
of it and in the latter case it is probably of tsetse origin.  Outside the tsetse 
zone T. congolense is widespread in Bor, Central Nuer Province and 
Malakal district of the Upper Nile province. T. brucei is commoly found in 
tsetse areas and T. vivax outside the tsetse zone. (Elkarib, 1961). 
1.6 Trypanosomosis outside the tsetse belt in the Sudan 
Ismail and Shomain (1975) reported the presence of T. vivax in 
Damazin (Blue Nile). Homeida, (1993) recorded T. vivax in Sennar, Kosti 
and El Deuim. Surveys conducted in South Darfour area along Bhar El Arab 
site the tsetse fringe and in South Kordfan revealed that the species of 
trypanosomes prevalent to be T. vivax, T. brucei and T. conglense (Hall et 
al., 1990) T. evansi was recorded in camels comming from El Gadarif State 
(Eastern Sudan) to El-Mwelh market (Khartoum State) (Fairouz, 2000).  
1.7Distribution of the vectors 
Lewis made a first major review of the tsetse fly problem in the Sudan 
in 1949, and studied the genus Glossina as a full description. The various 
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species of tsetse in the Sudan, Glossina fuscipes fuscipes together with G. 
moristans were found east of the Nile in the Sudan Blue Nile area around 
Kurmuk district. G. tachiniodes, G. palidipes, G. longipennis, G. 
fuscipleuris and G. fusca fusca. In addition to the four mentioned above. 
Records and maps of tsetse flies and their distribution in the Sudan are well 
documented (Elkarib, 1961and Razig and Yagi, 1973) and changes in fly 
belt with a northward spread beyond the previously was noted (Yagi and 
Abdel Razig, 1972). Two distinct zones are recognized viz the tsetse fly 
zone and tsetse free zone. The tsetse zone covers an area of about 
90.000square miles, which lies south of a diagonal line extending from the 
point on the western border at 10o north parallel to a point on the Southern 
border at 32o longititude. 
Tsetse infested area in Sudan, where owner’s spend the dry season, is estimated at 
250.000 km2in South Western Sudan(Razig and Yagi,1973), Jur narrow(Yagi and Razig, 
1972). 
Lewis, (1954) reported seventy species of tabanidae flies and Yagi (1968) added four 
species, Atylotus agrestis, A. fuscipes, T. taeniola, T. sufis, T. biguttatus, T. gratus, 
philoliche magretti, Ancala latipes and A.africana were the main species known in Sudan 
((Razig and Yagi,1975 and Khier and Majid, 1999). 
Mechanical transmission by tabanids and their contribution to the seasonal outbreaks to 
of T. evansi infections are well outlined (Yagi and Abdel Razig, 1972; Mahmoud and 
Gray, 1980). Results of surveys on tsetse and trypanosomal infection and their rates in 
Darfour, Kordofan, Eastern Region, and Central and Southern Sudan were reported (Hall 
et al., 1983 and 1984). 
A camel normally live immediately north of the cattle zone and biting flies chiefly 
tabanids and the zone where this combination exists extends from 15th north parallel on 
the west to 18th north parallel on the east. North of these line camels exist but no flies 
occur and south of the cattle zone flies are abundant but normally no camels live there 
(Elkarib, 1961) and it was between lat. 13o-18oN in (Kheir et al., 1999) report.    
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Southern Darfur province is situated on the northern edge of the main African tsetse belt 
and was first surveyed by Yagi and Abdel Razig (1972) who captured tsetse north of 
these assumed limits. The seasonality of tsetse catches at Radom on the Bahr ElArab(9o 
47N, 24o  47E) and female tabanids at the provincial capital Nyala (12o 02 N, 24o 
53E), at Radom and at Qoz Dango up to about 10o 15 N, a line from Birka Khadra to 
Fereidi to Gileizan were determined by examination of monthly records. The greater 
densities are found in the Souh-west of the province particularly along and south of the 
Wadi Umbelasha. Flies were not found around the area of umm Dafog nor at several 
camps southwards along the Wadi Khadra until Birka Khadra. (Hall, et al1984) 
Tabanids have long been considered as pests of cattle in Sudan 
(Lewis, 1953). In southern Darfur the tsetse fly as a vector of tryanosomosis 
it is more important than tabanids (Lewis, 1953). 
Bovine trypanosomaisis is mainly a problem of mechanical 
transmission by the genera tabanids, stomoxys and possibly others. The 
main cattle-rearing zone lies north of the tsetse zone, in Bahr El Gazal, 
Darfur, Kordofan, Upper Nile and the Blue Nile province (Elkarib, 1961). T. 
congolense occurs throughout, and in areas just north of, the tsetse zone. It 
may also occur in areas further north. T. vivax occurs in the tsetse zone and 
extends further north than T. congolense east from parallel 15th north on the 
east T. brucei affects cattle in the tsetse zone and possibly immediately north 
of it and in the later case it is probably of tsetse origin.  Out side the tsetse 
zone T. congolense widespread in Bor, Central Nuer Province and Malakal 
district of the Upper Nile province. T. brucei is commoly found in tsetse 
areas and T. vivax outside the tsetse zone. (Elkarib, 1961). 
In the study of Kheir et al.(1992and1995) along Sudan Ethiopian 
border in an area from Khor Yabous (lat.9o 45 long 43o 10) in the South 
to River Setit in the North included areas of Rivers Rashad, Dinder, the Blue 
Nile and Kurmuk district, in this survey G. morsitans and G. fuscipes were 
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found except in North El-Kurmuk and the Bank of the Blue Nile Dinder, 
Rashad and Setit River. Also Tabanus taeniola, T. gratus, T. biguttatus, A. 
agrestis and A. fuscipes were found. 
No pathogenic species were detected in several hundered specimens 
of blood samples examined but only a few nonpathogenic species were seen. 
(Elkarib, 1961). 
Lewis (1954) reported two species of Stomoxys in Sudan S. cacitrans 
and S. nigra. The peak of this fly coincides with high trypanosomosis 
incidences (Mohamed et al., 1989 and Mohamed, 1989).). They are three 
speices of Haematobia. The Hippoboscidae is wide spread in the Sudan but 
not well studied(Kheir and Majid, 1999). 
1.8Imoprtance of the animals in Sudan 
Sudan has an immense animal wealth, which satisfies all local needs of meat and 
produces an export surplus constituting 20% of foreign currency earnings. It satisfies 
80% of total milk needs in Sudan. (AOAD, 1992). 
 In the Sudan people are dependent on animals as a first source of food, milk and foreign 
currency.   
The population of the livestock in the Sudan was 128.523.000 animals (3.342.000 head of 
camels, 41.485.000head of goats, 48.136.000 head of sheep and 39.479.000 head of cattle 
and 370.056.000 head of poultry). (MARF, 2002). The greater number was found in Blue 
Nile state (11.642.942 head of animals), then Western of Darfur state (10.753.521 head of 
animals) and Southern Darfur state (10.155.074head of animals)(MARF, 2001). 
The exported livestock was (155.710.000 head of camels, 53.164.000 head of goats, 
160.263.800 head of sheep and 2.655.000 head of cattle), the exported of meat was (6.6 
ton of camels, 353.8 ton of goats, 347.1ton of sheep and 7113.8 ton of cattle)(MARF, 
2002). The production from meat was 1628 ton, 7298ton of milk, 60 ton of fish, 18ton of 
poultry meat, 22 ton of eggs and 60 ton of hide and skin.(MARF,2002). The gross 
domestic product was 16088S.D at constant prices of 1981-1982(MARF, 2002). It is well 
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known that diseases have a negative influence of feed intake, growth rate and body gain, 
production and feed conversion efficiency. 
1.9The economy of trypanosomosis  
The habitat of the dromedary camel is Northern Africa (The 
Mediterranean) the Sahelian States of West Africa, Sudan, Ethiopia, Somalia 
and Northern Kenya (Wilson, 1984). The camel has been used as a pack 
animal by Northern Arabian tribes since 3000 BP; the South Arabian tribes 
used it as a source of milk. 
In general terms, the camel is considered as an animal of the tropics 
but, much of the present day normal range is extra-tropical. World total of 
15 million camels about 20% spread thinly over a vast area not found within 
the tropics (Wilson, 1984). Somalia and Sudan contain about 50% of all old 
world Camelidae and 55% of all dromedaries. In Africa these countries 
account for 70% of camels, while Ethiopia, Chad and Kenya contain a 
further 12.5%. Apart from these countries Mauritania, Niger and Mali has 
important camel populations (as de Maghreb countries) (FAO, 1978). Sudan 
has the second largest number of camels in the world and almost 1.5 million 
km2 of territory suitable primarily or solely for their raising. The proximate 
southern limit suitable for breeding is about 14oN in the west (in Darfur and 
Kordofan) and about 16oN in the east. Seasonal movements take camels 
considerably to the south of these limits, in ever increasing number and over 
longer distances. The common classification of camels is into riding and 
pack types. It should be remembered that camels are the basis of the family 
economy over very large areas and for a considerable number of people 
(Wilson, 1984). They are most important as a source of meat, for human 
consumption, source of milk and for export. Economically, and probably 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
ecologically a family might do better to sell protein (meal) and fat and buy 
in exchange energy (grain) to fulfill its annual food needs, hides, wool, hair 
and work (Wilson, 1984). In modern world, after some 40 to 50 centuries of 
domestication, the camel seems to be an anachronism. 
Trypanosomosis is by far the most important protozoan disease of 
camels and is probably the most important health problem of all. The 
chronic form of the disease is a more common than the acute. The acute 
form commonly affects the adults. Real immunity is never acquired although 
premmunity may be attained through dams. An infection level of 20% in 
areas where the disease occurs is not uncommon and up to 70% is common. 
Death may reach 3%, declining milk production; abortion and chronic 
poor condition are the classic symptoms of the disease in camels (Wilson, 
1984). An estimated 50 million cattle constituting 30% Africa total cattle are 
exposed to the risk of infection (FAO, WHO, OIE, 1982 and Murray and 
Gray, 1984). Due to this wide spread incidence of this disease, Africa 
produces about 70% less animal proteins per hectare than Europe (ILRAD, 
1987).  
Wild animals can also be infected with trypanosomes but generally 
adversely they do not suffer from it. They serve instead as reservoirs as the 
source of infection. Goats and sheep become infected with various species of 
pathogenic trypanosomes when kept close to infected cattle (Lewis, 1949) or 
to infected camels (ElKarib,1961). 
There are direct and indirect impacts on trypanosomosis in Africa. 
The direct impacts are aggregated into three groups: impacts on livestock 
productivity, impacts of migration and settlement and impacts on livestock 
management. The indirect impacts are aggregated into four groups: crop 
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production, land use, ecosystem structure and function and human welfare. 
Animal trypanosomosis has serious economic consequences including the 
loss of meat and milk protein to the population, a subsequent demand for 
imports of dairy products, further potential export earnings. Agricultural 
communities are denied the benefits of draught animals, in addition the 
concentration of cattle as a result of overgrazing and subsequent erosion. 
There are also the costs of treatment and planning, execution and evaluation 
of vector control program (Uilenberg, 1998). In Sub-Saharan Africa for 
example, in addition to the enormous direct losses, more than US $ 20 
million are spent per annum on trypanocides, accounting for 44% of the total 
expenditure in veterinary drugs (Solano et al., 1999).                                    
1.10Trypanosomosis in different animals  
The parasite T.evansi causes Guffar in camels, commonly known as Surra(Wilson, 1984) 
Nagana in livestock mainly cattle,sheep and goats is caused by T. vivax, T. congolense 
and T. brucei. T. equiperdum causes dourine and T. equinum causes mal de caderas. 
(Soulsby, 1982) 
1.10.1Trypanosomosis in camels 
 In camels Trypanosoma evansi causes a disease known as Guffar in 
Sudan. Commonly the disease is known as Surra, can result in infection rates 
of 20%, in affected areas. In some instances infection may be as high as 70% 
have been detected (Wilson, 1984). The disease in camels is usually chronic, 
and is characterized by recurrent pyrexia and anaemia. In T. evansi- infected 
camels an   acute form is also reported (Bujon, 1990).  
1.10.2Trypanosomosis in goats and sheep 
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The disease in small ruminants is caused by the T. congolense. 
Infection and disease, however, are known to occur in both West and East 
Africa. Pecaud,(1909 ; 1910)recorded a 1.3% incidence of infection by the 
T. congolense, T. vivax and T. evansi in a large number of animals. In a more 
recent but much smaller survey, 13.8%were infected with either T. 
congolense or T. vivax (Kramer, 1966). Mornet, (1954) considered that goats 
and sheep made up 4% of all the animals infected with T. congolense. 
Lewis, (1949) reported that goats could be infected when kept close to 
infected cattle. None of 381 blood smears and none of the 187 sera (109 
goats, 78 sheep) were positive in south Mauritania (Jacquiet et al, 1993).                          
There is no detailed information on the distribution of the disease in small 
ruminant (Bruce et al, 1910). In Africa, about 9-10 million km2 is Savannah  
(Atang, 1982).  
There are reports on the incidence of infection in sheep with T. 
congolense, T. vivax and T. Brucei of 2.5 % (Pecaud,1910), 
10.4%(Delonoe,1914) and17%(Krampitz,1970)respectively.                          
1.10.3Trypanosomosis in cattle 
 Pathogenic species affecting cattle are Trypanosoma congolense (T. 
congolense) and T. vivax and they have a significant impact on cattle 
production. The landmass of Africa, south of the Sahara, over which tsetse 
flies are distributed, and which is virtually devoid of cattle because of 
trypanosomosis, is about 4million square miles. It is estimated that if this 
area is reformed, 125 million cattle could be raised, and this would be more 
than double the present cattle population of Africa. T. congolense produces 
the most important form of animal trypanosomosis in East Africa, T. vivax 
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causes trypanosomosis in West Africa. (Wilson et al, 1963). Natural 
infections with T.brucei are common, and an incidence of 20 to 30% has 
been reported in West Africa in both zebu and humpless cattle. Infections 
are usually mixed with T. congolense and T. vivax, which are present in 
larger numbers than T. brucei. Cattle can naturally be infected with T. 
rhodesiense (Onyango et al, 1966), T. gambiense was less infective than 
either T. brucei or T. rhodensiense (Kleine and Fischer 1911) and with T. 
evansi in South America, India and South East Asia (Atange,1982).  
1.10.5Trypanosomosis in wild animals 
Wild animals can also be infected with trypanosomes but generally; 
they do not suffer from the disease. They serve as the source (reservoir) of 
infection from which the trypanosomes are transmitted to the domestic 
animals by several species of tsetse flies and by other biting insects 
(Atange,1982).  
1.10.6Trypanosomosis in other animals 
There are very few descriptions of either infection or disease in the 
horse (Hornby,1952).   
West African donkeys and horses make up 8% of the animals infected 
with T. congolense and 10% with T. vivax (Mornet, 1954). T. brucei causes 
an important and severe disease, which is considered to make up 48% 
(Mornet, 1954) , T. evansi in horses in South America, India and South East 
Asia (Atang,1982). T. evansi effects in Asia and horses and domestic buffalo 
in South America, India and South East Asia (Atang,1982). 
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Mornet, (1954) reported that dogs and cats make up 2% of the animals 
infected with T. congolense. No reports exist about natural infection with T. 
vivax (MacFie, 1913) and 48% with T. brucei (Mornet, 1954). 
No record of natural infection in monkeys (Bruce et al, 1910) but can 
be infected with T. brucei (Bruce et al, 1911). 
In rodents, infection with T. brucei and T. rhodesiense was different 
from that of T. gambiense and no natural infection with the other species. 
(Andrews et al,1927). 
1.10.7Infection with mixed species 
Mixed infections by T. congolense, T. vivax and T. brucei are very 
common in cattle than in other species. (Mettam, 1933 ; 1934) 
1.10.8Trypansomosis in human (Human sleeping sickness) 
There are two subspecies of T. brucei, which cause chronic sleeping 
sickness in West and Central Africa T. brucei rhodesiense, which causes 
acute sleeping sickness in East Africa and T.brucei gambiense. They are 
transmitted to humans by the various species of Glossina (tsetse). Molyneux 
et al. (1984) indicated that, in the sleeping sickness the disease was 
characterized by three stages, the chancre in the primary lesion of the site of 
the infection seldom in T. b. gambiense disease(stage one), 
haematolymphatic and meningoencephalitic stage(stage two) and the 
severity of the pathological lesions that arise during the haematolymphatic 
stage (e.g. aneamia, immunodepression and IgM and IgG 
hypermglobulinaemia) only partly correlates with the level of parasitaemia 
(stage three)( WHO,1998).  
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Sleeping sickness was first recorded from Nimuli in 1915. Different 
areas in Southern Sudan were known as endemic foci. It had been 
predominantly of the Gambian type and has always been maintained by the 
palpalis group of flies particularly G. fuscipes, the major vector of T. b. 
gambiense (Hutchinson, 1975; Snow, 1983).  
The sleeping sickness is found only in Sub-Saharan Africa between 
latitudes 14oN and 25oS, within the limits of the geographical distribution of 
the tsetse. There are around 200 discrete endemic foci in 36 countries so, 60 
million people are at risk with an estimate of 300000 new cases each year 
(WHO, 1998). 
 
 
1.11Diagnosis of Trypanosomosis 
1.11.1 Parasitological examination 
1.11.1.1 Microscopic examination 
There are four methods of microscopic examination of trypansomosis: 
viz examination of : 
1-fresh drop of blood under cover slip (wet mount). 
 2-stained thin  
3-thick blood film  
4-centrifuged deposits (Killick-Kendrick, 1968). 
1.11.1.2 Microhaematocrit centrifugation (m-HCT) technique 
Capillary tube centrifugation or microhaematocrit centrifugation (m-
HCT) was described by Woo (1970) as a rapid and reliable method when 
parasitaemia was low. It was satisfactory for T. brucei subgroup, while it 
was not sensitive for T. congolense (Walker, 1972). 
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1.11.1.3 Aspiration technique 
Lymph node aspirate and cerebrospinal fluid examination are widely 
used in the diagnosis of human African trypanosomosis at a magnification of 
10x40. Examination of the cerebrospinal fluid is used to determine the stage 
of the disease. Parasites can sometimes be seen in the cerebrospinal fluid. 
Examination of the deposits after a single centrifugation increases the 
likelihood of finding trypanosomes but the double centrifugation technique 
is substantially more sensitive (WHO, 1998). 
1.11.1.4 Biological examination 
Inoculation of animals especially rodents was of some diagnostic 
value.  
1.11.1.5 Biochemical tests 
There are two types of tests first one for animals trypanosomosis this 
chemical tests depend on increased serum globulin and it is used for T. 
evansi infection they are include the mercuric chloride test (MCT) (Bennett 
and Kenny, 1929), the formol-gel test (FGT) (Plantureux, 1923) and the 
thymol turbidity test (TTT) (Abdel Gaaffar, 1960).  
Second one for sleeping sickness, they are including the dye binding 
protein assay (WHO, 1998) for the second stage infection of human African 
trypanosomosis, which is characterized by an increase in protein content of 
the cerebrospinal fluid. Lejon et al. (1999) detected light subunit 
neurofilament (NFL) and glial fibrillary acidic protein (GFAP) in 
cerebrospinal fluid of patients infected with T. b. gambiense. 
1.11.1.6 Serological tests 
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Serological test or diagnosis is of great help when few parasites are 
present in the body fluid of infected host (WHO, 1979). It is assessing the 
level of circulation antigen and/or antibodies including complement fixation 
test (CFT) (Schoening, 1924 and Sabanshiev, 1973), indirect 
haemoaglutination test (Jatkr and Singh, 1971), precipitation test, latex 
fixation test (Mohamoud and Kreier, 1972), indirect immunofluorescent 
antibody test, enzyme linked immunosorbent assay, capillary tube 
agglutination and indirect immunoflurescent antibody (Sabanshiev, 1973; 
Wilson, 1969 ; 1979).   
Parasite DNA detection technique, has a high sensitivity and 
specificity when coupled with amplification of the DNA by the polymerase 
chain reaction (PCR) it is used for research purposes only at present (WHO, 
1998). 
1.12 The pathogenesis of trypansomosis 
The success of the trypanosomes as pathogens is due to their ability to 
undergo antigenic variation; this enables them to establish persistent 
infection by evading host immunoresponse (Solusby, 1982). 
 The prepatent period is 3 – 5 days in T. evansi-infected goats (De-Villa et al., 1991) 2 – 
30days Elmalik, (1983) 4 – 9 days Fairouz, (2000) in T. evansi infected goats and 4-5 
days in T. vivax (Kyewalabye et al,1988). In both goat and cattle infected with T. vivax 
parasitaemia was detected 6-7 days after inoculation with 1x105 but not in T. congolense 
infection (Maxie et al., 1979). 
Olaho et al. (1996) noticed pyrexia in goats infected with T. evansi, 
also, (Elamin 1980, Elmalik 1983, De-Villa et al. 1991 and Fairouz, 2000). 
 In infection of goats with T. evansi loss of body weight were noticed Elmalik (1983), 
Mutayoba et al. (1989), Negeranwa et al. (1993) and Fairouz (2000).  
Amodu and Ige, (1975) elucidated the mechanism of development of anaemia in rabbits 
experimentally infected with T. brucei and concluded that the anaemia is possibly a  
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result of an auto reaction together with anaemia and specific organ damage, a wider range 
of immunological abnormalities appear to character the pathology of the disease. 
Pyrexia, inappetance, respiratory and pulse rate and anaemia were 
observed in trypanosomosis T. evansi infected goats (Elamin, 1980). 
Emaciation, rapid loss of body condition, scrotal swelling, kertitis, nervous 
signs followed by prostration and death was observed in goats infected with 
T. evansi (De-Villa et al., 1991 and Fairouz, 2000). In addition muscle 
wasting, lethargy and paleness of mucous membranes was observed in 
Olaho et al. (1996) Lacrimation, shivering, weakness, diarrhea, weak 
respiratory and pulse rate and in some animals muscle spasm, neck back 
position, nasal discharges and nervous signs followed by death  while others 
animals showed nasal discharge and loss of hair. (Fairouz, 2000). 
(Elamin, 1980) noticed haemorrhages and congestion in the lungs, 
liver, spleen, kidney and brain of infected T. evansi goats. The pericardial 
sac contained straw coloured fluid and pulmonary emphysema and 
congestion were seen in some infected groups. 
Yesufu, (1975) exposed pregnant female rates infected with T. brucei, T. congolense, T. 
gambiense to various stresses and noted a high rate of abortion and only two litter 
survived, also Amdou and Ige, (1975) observed that infection with T. vivax, T. 
congolense, T. brucei brucei and mixed infection had a severe effect on the fertility of the 
cattle. 
West Africa Dwarf goats were allotted to a diet of Lucerne pellets or a 
diet of chopped grass straw, and infected with T. vivax, caused an increased 
weight of the liver and prescapular lymph nodes in animals from both feed 
treatments, but lymph nodes were more enlarged in infected animals that had 
been fed Lucerne (Dam et al., 1998b). 
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Enlargement of lymph nodes, spleen, liver and oedema of the lung, 
kidneys, flabby heart, accumulation of sero-sanguineous fluid in the 
peritoneal, thoracic cavity, and pleura and intestinal-mucosa oedematous 
brain, brain congestion and meningial petechiation was observed in T. evansi 
infected goats (Olaho et al., 1996). Fairouz (2000) studied T. evansi infected 
goats treated with Cymelarsan®, Cymelarsan® -OTC treated goats. 
Enlargement of spleen, kidneys lymph nodes oedema in lungs and kidneys, 
flabby heart, petechial haemorrhage on the serosa, pleura, and intestine, 
congestion in brain, emaciation and serous atrophy of fat, hydropericardium, 
pseudocys were observed in the infected group. , In addition multifocal 
encephalitis, pesudocysts in the cortex of cerebral and cerebellum, whereas, 
it was absent post-treatment. 
Focal degeneration of the myocardial fibers and haemorrhage were 
seen, liver congestion, mononuclear wall infiltration especially around blood 
vessels, Cytoplasmic fatty vacculation of the centrilobular hepatocyte, 
deposits of haemosidrin in the hepatic sinusoids and red pulp and 
haemorrhage, mononuclear cell infiltration was more prominent in the 
interstitial tissue of the kidney, increase in the number of endothelial cells 
and mild cellularity in the renal glomeruli, haemorrhage, degeneration of 
cells of the proximal convoluted tubules, and its human contained 
desquamated epithelial cells, lung congestion and increase in the number of 
endothelial cells of alveoli were observed in Elamin (1980) on T. evansi 
infected goats. No apparent structural damage in the thyroid gland observed 
in T. conglense infected cattle (Abebe and Eley, 1992). In female goats the 
thyroids glands were extensively degenerated and atrophied (Mutoyoba et 
al., 1988). 
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Negeranwa et al. (1993) studied the histological changes in goats 
infected with T. evansi and found lymphatic tissue hyperplasia, muscular 
atrophy focal necrosis foci in the liver, kidney, spleen and lungs and also 
bronchopnumonia. There was a decrease of lymphocytes in lymphatic 
tissues, destruction of hepatocytes. Infiltration by inflammatory cells was 
been in the liver, spleen and kidney.  
The pathology of T. vivax in East African goats Frisian cattle showed major changes in 
the lymph nodes, spleen, eyes, pituitary gland, testicles and heart(Masake, 1980). 
 
T. vivax infected cattle showed fever, increased in heart rate, anorexia, emaciation, 
elevation of body temperature, anaemia, leukopeniaand thrombocytopenia(Maxie et al, 
1979). 
The acute form of T. vivax infection in mice was characterized fibrin thrombus formation 
in the blood vessels of heart, lung, spleen and brain.(Anosa and Isoun,1976). 
Anaemia, muscle mass atrophy, generalized oedema and petechial to ecchymotic 
haemorrhages, swollen oedematous lymph nodes, oedema in lung, spleen, proliferative 
interstitial pneumonia and lobular pneumonia, were seen, hyperplasia of the bone 
marrow, localized extra medulary hemopoiesis, haemosiderosis in various organs, and 
monoclear cell infiltration in the heart and skeletal muscle were observed (Anosa and 
Isoun, 1976). 
Increase in blood plasma volumes and decrease in RBC and PCV values indicating 
anaemia were observed in T vivax-infected goat and sheep (Anosa and Isoun, 1976). 
T. vivax and T. congolense infection caused significant fall in Hb, PCV and RBC values 
and slight reduction in WBC(Ugochukwu, 1986). 
Certain indigenous breeds of cattle in west and Central Africa can also 
better tolerate exposure to trypanosomosis (Murray et al., 1982). There is 
also evidence for similar breeds in East Africa e.g Orma boran (Njogu et al., 
1985). These 
 naturally resistant (trypanotolerant) livestock breads offer a potential 
means for improving agricultural productivity in tsetse -infested areas of 
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Africa. It has been shown both in field and experimentally, that 
trypanotolerant cattle are capable to varying extent of resisting the 
pathogenic effects of trypanosomosis (Murray et al., 1982), they remain 
productive despite the infection and often spontaneously recover from 
infections.  There is another breed of cattle from West Africa, the N’Dama, 
which is known to be naturally resistant to effects of trypanosomosis (Paling 
et al., 1987). Even under field conditions trypanotolerant livestock can be 
productive under trypanosome challenge depending on nutrition status 
(ILCA, 1979). 
Serum potassium level was decreased in camels infected with T. 
evansi (Anosa, 1988b) and also in infected T. evansi goats. (Fairouz, 2000) 
while no changes recorded in serum sodium level were seen post infection 
(Anosa, 1988b, Otsile et al., 1991 ; Fairouz, 2000). 
The serum calcium was normal in acute T. rhodesiense infection of 
mice, but reduced in T. evansi infection of camels and buffalo calves and 
during relapse in T. congolense in cattle (Anosa, 1988b) and decrease in T. 
evansi infected goats (Elamin, 1980 and Fairouz, 2000).  
The serum phosphorus was decreased in T. evansi infection of camels 
and goats (Fairouz, 2000). T. congolense infection of cattle and it was 
normal in T. rhodesiense infection of mice and T. evansi infection of buffalo 
calves (Anosa, 1988b). 
A depletion of zinc and copper values was obtained in six New 
Zealand white rabbits infected with T. b. brucei. Also, in T. evansi infected 
goats.  
Plasma levels of iron and zinc were measured in T. vivax and T. 
congolense infected goats. They declined post-infection the reduction being 
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much less pronounced as compared with the values found with, bacterial 
pyrogen – induced fever (Amole et al., 1990 and Fairouz, 2000). 
 
The serum protein   was increased in infected sheep and goats post-
infection (Anosa, 1988b) in infection goats. Igbokwe and Mohammed 
(1992) and Fairouz, (2000) whereas, (Elamin 1980, Arusni et al. 1989, Kalu-
Au et al., 1989) and Otsile et al. (1991) observed decrease in infected goats.  
The serum albumin was decreased in infected sheep and goats (Anosa 
and Isoun, 1976, Arunsi et al., 1989; Anosa 1988b; Kalu-Au et al., 1989; 
Fairouz, (2000) study. 
Serum globulin levels were increased post-treatment in infected goats 
(Igbokwe and Mohammed, 1992; Dam et al., 1998a) and in infected sheep 
and goats (Anosa, 1988b). However, it was decreased post-infection (Kalu-
Au et al., 1989; Arunsi et al., 1989; Otsile et al., 1991 and Fairouz, 2000). 
Raina et al. (1988) observed in 24 male buffalo calves infected with T. 
evansi, blood urea nitrogen values were significantly increased in one group 
and decreased in the two other infected groups, also in goats subjected to 
restricted feeding regimen of pelleted Lucerne and infected with T. vivax 
(Dam et al., 1997). It was lower In infected goats with T. vivax (Dam et al., 
1998a), and with T. evansi (Fairouz, 2000). 
In T. brucei infected goats no significant changes were seen in the 
serum creatinine  (Igbokwe and Kohammed, 1992). In goats infected with T. 
vivax serum creatinine concentration was higher in grass straw fed than in 
Lucerne fed animals, infected animals had a lower creatinine levels post-
infection (Dam et al., 1998a). In infected T. evansi goats it was lower in 
Cymelarsan® and Cymelarsan® OTC treated groups (Fairouz, 2000).       
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In T. evansi infected goats they positive for ketone bodies test 
(Fairouz, 2000).  
The serum alkaline phosphatase was increased in T. cruzi infected 
dogs (Barr-s et al., 1986), also, in T. evansi infected goats (Fairouz, 2000). 
The serum bilirubin concentration in T. evansi infected goats was increased 
post-treatment with Cymelarsan and Cymelarsan-OTC(Fairouz, 2000). 
The serum aspairtate amino transferase (AST) and alanine amino 
transferase (ALT) activities was increased post-infection in infected donkeys 
(Aliyu et al., 1997), and in infected T. evansi goats (Fairouz, 2000). 
Infection with T. congolense in cattle caused hypothyrodism (Abebe and 
Eley, 1992), also, infection with T. vivax in goats (Dam et al., 1998a) and in 
infected T. evansi goats (Fairouz, 2000).  
The serum progesterone was lower in ewes infected with T. 
congolense (Osaer et al., 1998) and in infected T. evansi goats (Fairouz, 
2000). 
The leukocytes counts were normal pre, post infection (Elamin, 1980; 
Elmalik, 1983; Damayanti et al., 1994); were reduced in infected cattle 
(Naylor, 1971b). In Moulton and Sollod (1976) study it was increased early 
in infection in calves, also in Fairouz, (2000) study in infected T. evansi 
goats. 
The basophils and eosinophils cells disappeared post-infection in 
infected goats (De-Villa et al., 1991 and Fairouz, 2000). Monocytes levels 
showed little change post-infection (Naylor, 1971b; De-Villa et al., 1991) 
two groups of five showed monocyts post-infection with T. evansi in goats 
(Fairouz, 2000). Lymphocytes disappeared from the circulation post-
infection (De-Villa et al., 1991) it was decreased during the infection 
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(Fairouz, 2000). Neutrophils count were depressed (Naylor, 1971a) whereas, 
De-Villa et al. (1991) observed sudden increase, also increase were seen in 
Fairouz, (2000)  
In infected T. evansi goats there was a greater reduction in RBC 
counts (Elmalik, 1983; De-Villa et al., 1991; Fairouz, 2000). 
There was a drop in PCV values in goats post-infection (De-Villa et 
al., 1991; Negeranwa et al., 1993; Elamin, 1980; Elmalik, 1983, Mutayoba 
et al., 1989; Dam et al., 1998b and Fairouz, 2000). 
There was a decline in Hb levels post-infection (Naylor, 1971a; 
Elamin, 1980; Damayanti et al., 1994 ; Fairouz, 2000). 
 No clear difference in Mean corpuscular volume (MCV) was 
observed between infected and control buffaloes (Damyanti et al., 1994). 
Whereas, there was a decrease in MCV post-infection in buffalo calves 
infected with T. evansi (Raina et al., 1988 ; Fairouz, 2000).  
 No changes were observed in Mean corpuscular haemoglobin (MCH) 
post-infection in infected T. evansi buffaloes (Damayanti et al., 1994). It was 
decreased in infected T. congolense cattle (Naylor, 1971a) and infected T. 
evansi buffalo calves (Raina et al., 1988). But it was increased in T. evansi 
infected goats (Elamin, 1980 and Fairouz, 2000). Mean corpuscular 
haemoglobin concentration (MCHC) was normal infected T. evansi 
buffaloes calves (Raina et al., 1988).  
1.13 Drugs  
Parasitic protozoa are responsible for a wide range of diseases in both 
animals and man, diseases which are of world importance but are difficult to 
eliminate as these are frequently transmitted by ticks, tsetse flies and 
tabanids which abide in many of the under developed parts of the world. 
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Wide ranging research for new drugs in the area of protozoa control, apart 
from coccidiosis, is inhibited by the absence of any financial incentive 
without WHO or FAO financial support it is difficult for pharmaceutical 
companies to justify the very large research effort that is necessary to 
support both the basic research and the large-scale field trials. In addition the 
drugs used in the field of trypanosoma, babesia and histomonas control are 
frequently chemically unrelated.  
Generally four groups of antitrypanosome were used: Dimidines compounds (Diminazine 
aceturate -Berenil, phenanmidine, isothionate, stilbomidine and pentamidine), 
Aminophenanthridium compounds (homidium bromide, homidium chloride and isometamidium 
chloride), quinapyramine compounds (quinapyramine chloride, quinapyramine sulphate and 
quinapyramine prosalt (chloride and sulphate)) and others compounds (Suramin, Samorine, 
Nitrovinylfuran, some arsenical compounds (Melarsorpol and Cymelarsan) and antipyrtic agents). 
(Bywater et.al. 1991). 
 
 
1.13.1Chemotherapy of trypanosomosis 
Chemotherapy is the treatment of disease by the use of chemical drugs. Such drugs are 
curative. They disrupt or block one or more of the vital processes which are essential to 
the invading micro-orgnism. Certain compounds have specific effects on some enzyme 
system or block essential metabolic pathway, but the exact way in which they work is 
often not known or only incompletely understood, and this is true of most of the 
trypanocides (chemotherapeutic drugs which kill trypanosomes or inhibit their 
develoment). 
Chemotherapeutic drugs are toxic to the trypanosome, because they 
interfere with one or more of its vital processes. An ideal drug is one which 
kills the parasite but, at the same time, causes no or minimal harm to host 
cells. The toxicity of drugs differs in different species of the animals.  
The application of antitrypanosomal drugs has been the mainstay of 
controlling animal trypanosomosis since the early 1950s (Kinabo, 1993). It 
is important to release that drugs alone will not treat trypanosomosis. 
Trypanosomosis overwhelm the immune system of the host, they are 
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immune suppressive. Chemotherapy, by stopping the multiplication of the 
trypanosomes helps the immune system to overcome the infection. 
Treatment will be more effective in well-fed and rested animals, in which 
the immune system is not adversely affected by stress and lack of food. The 
management of African animal trypanosomosis (AAT) at farmer’s level has 
been predominately dependent on the use of the trypanocidal drugs 
(Diminazine, Homidium and Isometamidium). It is estimated that, about 35 
million doses per year are used in Africa to cure the disease (Geerts, 
Holmes, 1997). 
There is another problem in the treatment of animal trypanosomosis, 
because of the variety of domestic livestock, which are susceptible to 
trypanosome infection and the diversity of trypanosome species, which are 
pathogenic to animals of economic importance. 
The problems of chemotherapy and chemopropylaxis are even more 
complicated and formidable than human trypanosomosis (Muligan, 1970). 
Other complimentary measures aimed at tsetse eradication using insecticides 
have been successful only to a limited extent. Despite the fact that 
chemotherapy is the major means of disease controls.  
Development of new anti-trypanosomal drugs have been more or less 
static over the last three decades, due to lack of interest by the 
pharmaceutical industry to invest into research and development of anti-
trypanosomal drugs (Gutteridge, 1985). Consequently, this has been a major 
stimulus to intensive research into the few existing drugs. It is well known 
that developing an effective drug for chemotherapy of protozoan infections 
and particularly effective against T. brucei evansi, is a difficult task 
(Bourdichon and Zhang, 1999). Trpanosoma evansi is an economically 
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important; infection affecting a variety of domestic animals such as horses, 
cattle and camels (Lun et al., 1993). 
1.13.2Quinapryamine (Antrycide) 
It has activity in vitro and in vivo against T. evansi, T. congolense, T. 
simiae, T. equinum and T. equiperdum and T. vivax. (Leach and Roberts, 
1981). 
1.13.2.1Chemistry and mode of action 
 It is available as the chloride and as methyl sulphate, the latter being 
quickly absorbed and the chloride slowly absorbed from sites of injection. It 
was introduced in the 1950s for field use as a therapeutic (Antrycide 
sulphateR) and prophylactic drug (Antrycide prosaltR) for animal 
trypansomosis chemistry.It is 4 – amino – 6(2 – amino – 6 – 
methylquinoline – 1, 1 di - metho) (methyl sulphate) (C19H28N6O6S2, 
molecular weight 532.6) (Curd and Davey, 1950). Quinapyramine inhibits 
the groth and cell division (Alexander, 1985). 
Its local name in Sudan (Eljazy) and (Elroby) for quinapyramine 
chloride and quinapyramine sulphate respectively. 
1.13.2.2Adverse effects and toxicity 
Severe and immediate general reaction resulting in collapse is of 
common occurrence when the drug is administered to horses; these 
symptoms usually subside after a short time but are sometimes fatal 
(Mulligan, 1970). It is advisable a suitable antidote at hand and to divide the 
amount of the drug into two or three equal doses at six hourly intervals 
subcutaneous, at different sites. This will also reduce the tendency to abscess 
formation at the injection site (Mulligan, 1970). 
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Quite severe and sometimes fatal general reaction may sometimes be 
seen in dogs with doses in excess of 4.5 mg/kg (Mulligan, 1970). However, 
due to the development of drug resistance, the drug was withdrawn from the 
market in many parts of Africa in the 1970s, in cattle trypanosomosis and is 
associated with cross resistance to the other entire trypanocidal drugs in use 
(Uilenberg, 1998). It is now produced for treatment of surra in camels and 
horses, where there is resistance of T. evansi to suramin. 
1.13.3Amino Phenanthridium compounds 
1.13.3.1Homidium bromide (Ethidium)                             
1.13.3.1.1Chemistry and mode of action 
It is known as Ethidium bromide (Homidium bromide) and is 3,8 diamino – 5 ethyl – 6 
phynyl – phenantheridium bromide. It is dark purple, almost odourless crystalline or 
amorphus powder with persistent bitter taste and is available as the bromide salt. Solution 
is stable for several days at 20oC. And it must be difficult in hot or boiling water, but this 
practical disadvantage was overcome by the use of the chloride salt of the drug 
(NovidiumR), which is soluble in cold water. It’s mode of action not understood; the 
compounds are fixed by the trypanosomes in small amounts. This small amount inhibits 
the factor required for division of the trypansomal cytoplasm. When the store of this 
factor has been exhausted, the trypanosomes cease to multiply and disappear. They are 
active mainly against T. congolense and T. vivax (Alexander, 1985). Its local name in 
Sudan is Alhabba Alhamraa. It has been used primarily as a curative drug in cattle, 
intramuscular injection was advised by the manufactures (Bailey, 1967). On the basis of 
trials in the Sudan, Kenya, Tanganyika and Nigeria against T. congolense and T. vivax a 
therapeutic dose of 1.0 gm/kg was recommended (Leach and Ropers, 1981). Kalu et al. 
(1983) observed complete disappearance of trypanosome from the blood 3days after 
treatment with homidium bromide. 
Mwambu, (1975) re-evaluated the value of ethidium for the treated of T. brucei subgroup 
infection in cattle and concluded that the use of this drug as  a curative in T.  brucei 
infection of cattle should be restricted. 
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De-Deken et al. (1989) have reported success in protecting rabbits for more than 300 
days against seven challenges of T. congolense use a slow release device implanted 
subcutaneously, this finding suggests that the commonly used drug products, lack 
prolonged prophylactic activity because the active principle, homidium is rapidly 
eliminated from the body, should this field it will undoubtedly be widely accepted in 
many areas with a yearlong high incidence of trypanosomosis (Kinabo, 1993). The period 
of protection recorded in South West Kenya was 4 – 6 weeks over twelve months 
(Stevenson et al., 1995).  
Infected Zebu cattle with T. vivax and T. congolense and treated 12th week post infection 
with Novidium and slaughtered for histological evidence of healing of the genital lesions 
( Sekoni, 1990). 
1.13.3.1.2Adverse effect and toxicity 
Sings of acute toxicity were reported in several countries such as 
photosensitivity, necrosis and sloughing of extensive areas of unpigmented 
skin, followed by death. Severe local reaction can result from subcutaneous 
injection, so that deep intramuscular route should be used, when local 
swellings and allergic reaction were observed. Dividing the dose between 
two sites may also reduce the local reaction in the horse (Stephen, 1963). 
1.13.3.2Isometamidium chloride (Samorin) 
It is used against T. brucei, T. vivax, and T. congolense. It shows its effect after latent 
period of trypanosome division. Also it is used for prophylaxis for six to eight months 
(Alexander,1985). Kalu et al. (1983) observed complete disappearance of trypanosome 
from the blood 3days after treatment with samorin. It causes weight loss in poorly 
nourished cattle if administered at short months intervals. 
1.13.4The Diamidines They are as equally effective trypanocide in vitro thus 
demolishing the hypothesis of trypanocidal activity being related to hypoglycaemia. They 
are not well absorbed from the gut. The toxic effect is attributed to involving the CNS. It 
has been used against T. congolense and T. vivax (Alexander, 1985). Kalu et al. 1983 
observed complete disappearance of trypanosome from the blood 3days after treatment 
with berenil. Cattle treated with diminazine aceturate after several isometamidium 
treatments suffer from hepatic damage and may even die. 
The diminazine aceturate in Sudan is known as Berenil. 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
1.13.5Suramin  
It is a polyanionic drug that has been used for Africa trypanosomosis before CNS 
involvment. It causes skin rashes, gastrointestinal distress, and neurological 
complications. (Bentram and Anthony, 1993). It is known as Naganol in Sudan and used 
against T. evansi, T. brucei, T. equinum and T. equiperdum. It shows its effect after latent 
period of trypanosome division. Also it used for prophylaxis for six months (Alexander, 
1985).  
1.13.6 Use of arsenical compound in veterinary medicines and as a 
trypanocide 
The first widely used member of the Melaminyl Thioarsentie family 
was Arosbal® as a combination of melarsenoxide and dimercaptol BAL (for 
British Anti Lewisite), MeIB or Melarsorpol was invented in (1949) by Dr. 
Friedheim presented as a solution in propylene glycol for strict intravenous 
perfusion. The product is very effective on phase 1 human sleeping sickness, 
when the parasite multiply in lymph fluid or blood, at a dose of 10 
mg/kg/four days. In the same family he invented in (1963) a water soluble 
product used by intramuscular injection Trimelarsan® MelW. This product 
had a relative short commercial use and Arsobal® remained as the only 
arsenical used for about 50 years. None of the products were developed for 
veterinary medicine. Melasony potassium (MelW), has also been 
synthesized, but showed little improvement over MelB. Treatment of the 
cerebral stage of trypanosomosis has relied primarily on the melamino 
phenylarsine melarsorpol (Mel B) (Friedheim, 1949). Mel B induced 
encephalopathy (Pepin and Milord, 1991; Friedheim and Distefano, 1989), 
thrombophlebitis (Apted, 1970). In 1985, in the same family (Melaminyl 
Thioarsenite) Friedheim discovered a combination of melarsenoxide and 
cysteamine, the product was named Cymelarsan® (MelCy) (Bujon, 1990). 
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Melasamine hydrochloride (MelCy) is very effective against T. brucei, T. 
evansi and T. equiperdum in camels, buffalo, cattle, pigs, goats and in vitro 
(Lun et al., 1991; Otsulya et al., 1992). Also, it is effective against 
diminazine aceturate resistant T. brucei and T. evansi (Zhang et al., 1992). It 
is more effective than MelW (Zweygarth, and Kaminsky, 1990) this result 
has an important for the use of Mel Cy as a therapeutic agent and it is 
theorized melarsenoxide is the active form of all melamine-phenyl arsine 
and that it acts by binding trypanosomal thiols, such as trypanothione 
(Fairlamb et al., 1989; Zweygrath et al., 1992).  
However, melarsenoxide is generally considered to be too toxic for 
direct administration (Friedheim, 1989) and is therefore, administrated as 
less toxic dithiol conjugates. These compounds must first convert to 
melarsenoxide to have direct. MelCy, which more readily converted than 
MelB and MelW to melarsen solution, might be expected to have greater 
activity (Bradley and Fairlamb, 1994b). Pentavalent melarsen is much less 
active than trivalent melarsenoxide (Fairlamb et al., 1992). Because it enters 
the CNS it is the drug of choice in African sleeping sickness. It causes 
gastrointestinal irritation thus it is given parenterally and it has caused a 
reactive encephalopathy that may be fatal.(Bentram and Anthony, 1993). 
1.13.6.1 Cymelarsan® 
This is based on a trypanocide launched nearly 30 years ago, its an 
arsenical, patented in (1985), discovered by Friedheim. It is introduced to 
the market by Rhône, Mérièux – (France). It is a combination of 
Melarsenoxide and cysteamine. It is related to the drug Arsobal®, which is 
the only treatment available for the late-stage sleeping sickness in human. It 
is a new compound from a group that has not previously been used against 
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animal trypanosomosis. The product is a white powder highly soluble in 
water. It is described chemically as: bis (aminoethyl thio – 4 melamino 
phenyl arsine dihydrochloride), used as an aqueous solution at 0.5%prepared 
at the time of use, it is presented as a sterile freeze – dried powder, (Bujon, 
1990). It is very good in both local and general tolerance (Bujon, 1990), 
injectable I.M. or S.C and a very effective (more than the two predecessors) 
on parasites of the T. brucei group. Its qualities merit its development as a 
trypanocide in veterinary medicine (Code No. RM110) with a curative dose 
as a single treatment and at a rate of 0.25 to 0.5 mg/kg, against 
trypanosomosis especially T. evansi infection which are resistant to other 
drugs commonly used in the field, vis Quinapyramine and suramin (Raynaud 
et al., 1989a, b and Bujon, 1990). 
1.13.6.1.1 Chemistry  
The drug was made by conjugation of one equivalent of 
melarsenoxide and two equivalents of cysteamine. Immediately after it has 
been dissolved in water, it exists as a mixture in equilibrium containing 
Cymelarsan® (Mel Cy) 43%, which had lost one cysteamine moiety 1.24% 
melarsenoxide 38% and free cysteamine. Small amounts, 2% of the 
oxidation products derived from the last two components also form 
cysteamine and sodium melarsen. On incubation at room temperature, the 
Mel CY content decreased steadily, associated with an increase in arsenical 
agent melarsenoxide, oxide and sodium melarsan. (Bujon, 1990) 
1.13.6.1.1.2Characteristics  
Cymelarsan® has a rapid trypanocidal activity. Trypanosomes are destroyed within a few 
hours; it achieves a peak plasma concentration by about 15 min. post-injection, 
irrespective of the route of injection, after which plasma levels decline rapidly. The 
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absolute bioavailability is a 100% when given by the intramuscular route. In view of the 
short duration of trypanocidal levels in plasma, Cymelarsan® should not be regarded as a 
therapeutic product that has no preventive or long acting effect. After injection, complete 
recovery occurs rapidly (Bujon, 1990). The bioequivalence of the S/C and I/M routes was 
studied in infected dromedary, the area under the curve for I/M route was 12% greater 
than that for S/C route, no significant difference between the pharmacokinetics of the 
routs  of administration or the different formula. (Toutain, 1991). 
1.13.6.1.1.3Mode of action 
Cymelarsan® inhibits the metabolism of trypanothion reductase 
(TTR), an enzyme which is present in the parasite and absent from the host 
(Chouchane and Snow, 2001); Bujon, 1990). In 1909 Paul Ehrlich first 
proposed that trivalent arsenical compounds exert their lethal effect against 
trypansomes and spirochetes by chemical reaction with sulphahydral groups. 
However, the first definitive evidence in favour of this theory was obtained 
by Voegtline et al. (1923) observing that arsenicals had a propensity to 
combine more avidly with vicinal dithiols than with simple monothiols 
ultimately leading to development of 2, 3-dimercaptopropanol [British Anti 
Lewisite (BAL)] as an antidote to the arsenical nerve gases subsequently 
(Friedheim, 1949) used this compound in the development of MelB although 
the mode of action of the trivalent arsenical drugs such as melarsen oxide 
and melarsorpol remains to be determined.  
One primary effect of exposing trypanosomes to these compounds is 
the formation of stable MelT (Fairlamb et al., 1989) between melarsenoxide 
and the unique intracelular dithiol, dihydro trypanthione (Fairlamb et al., 
1985) the other dithiol found in most organisms is dihydrolipomaide, which 
along with dihydrolipomaide dehydrogenase forms part of the exo-
decarboxylase complexes for pyruvate and ketoglutarate in mammalian 
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cells. These two enzymes are absent from long-slender blood stream forms 
of T. brucei (Fairlamb et al., 1989). Therefore, dihydrolipomaide 
dehydrogenase has never been seriously considered as possible target for 
arsenical drugs. However, this organism does in fact contain significant 
amounts of dihydrolipomaide dehydrogenase, which has an unusual 
localization in plasma membrane (Fairlamb et al., 1992). This enzyme and 
its substrate may be involved in the transport of maltose in the cell. 
(Richarm, 1985 ; Fairlamb et al., 1992) hypothesized that D, L-
dihydrolipomaide and D, L-dihydrolipoic acid react to form stable 
complexes with melarsen oxide. These complexes are 10 fold less stable 
than that found in trypanocidal drugs melarsorpol and trimelarsen, but 500 
fold more stable than the complex formed between melarsen oxide and 
dihydrotrypanothione.  
Arsenical resistant strain of T. brucei was found to contain 
significantly less lipoic acid than the sensitive strain. However, since the 
enzyme dihydrolipomaide dehydrogenase, dose not appear to be a target for 
inhibition, its substrate, lipoic acid, could be involved in either the 
mechanism of uptake or being the ultimate target for the drug (Fairlamb et 
al., 1992). 
1.13.6.1.1.4Safety  
At the recommended dose, Cymelarsan® has been shown to be well tolerated, (Bujon, 
1990 and Fairouz, 2000). No adverse systemic effects were observed and only a slight, 
transient local reaction like a tennis ball at the site of injection was seen in a small 
number of animals. This transient local reaction resolves in a few days. Cymelarsan® is 
safe for target animals. RM 110 was rapidly and completely absorbed after S/C injection 
24h. when 0.1, 0.15, 0.2 or 0.3 mg/kg was injected in Morocco dromedaries. (Toutain, 
1991). 
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It must be stored in dry cool place. It has been shown not to be 
mutagenic, teratogenic or embryotoxic by standard procedures. It can be 
used in animals in poor condition or in pregnant females (Bujon, 1990). 
1.13.6.1.1.5Toxicity and adverse effects                                                                    
General toxicity with a maximum tolerated dose in the range of 3-4 
mg/kg gave a large safety margin when therapeutic dose is used (Bujon, 
1990). 3.75 mg/kg induced a significant necrosis of the tissue of the point at 
inoculation whether the injection was subcutaneous or intramuscularly 
(Tagerkagan and Clair 1989). Often a depot of drug is formed at the site of 
the injection where it is retained and slowly released into circulation to 
maintain a concentration in the blood at a level at which no trypanosome can 
exist. Other drugs are not maintained in the form of such a local depot, but 
are found loosely attached to blood proteins and become slowly available to 
act the parasite. 
Necrosis at the site of injection was also reported in buffaloes treated 
with 3.0 mg/kg Cymelarsan®, in order to avoid problem, dosages 1 – 2 
mg/kg were recommended (Lun et al., 1991).  
In human, avoid contact of the product with the mucus membrane 
especially the ocular mucous (Bujon, 1990). 
The comparison the kinetics between camel and other species at doses 
of 1 – 0.2 or 0.3 mg/kg and for the two routes of administration (I/M and 
I/V)was made. The absolute bioavailability was 70 – 80% in camels, from 0 
to 10 hours kinetic were similar in all species. Trypanocidal activity was 
apparently higher in horses than in cattle or camels, which are equivalent 
(Raynaud et al., 1989a). 
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1.13.6.1.1.6Residues 
The product has a short half-life in the animals, and the toxicological profile or a residue 
is low. The proposed withdrawal time for meat, milk and edible tissue is provisionally 
recommended at 2 weeks (Raynaud et al., 1989b). Cymelarsan® has a short-life in horses 
and monkeys and the toxicological profile or residues is low (Raynaud et al., 1989b).  
Seven infected camels in Kenya were treated with 0/25 mg/kg of Cymelarsan I/M and 
slaughtered either 7days, 14 or 21, residues of total arsenic were noted in fat, liver and 
kidney all results of assay for total As were less than 2mg/kg, no residues were observed 
in plasma, but were observed on 4 occasions in milk on one camel, in 3 occasions in one 
camel, no residues in one camel, seven days after treatment no residues of As were 
observed in the milk of any treated camel.(Sones, 1991). Also Rahman et al., (2001) 
mentioned that about 1/3 of total tubewells in Bangladish contained arsenic on average of 
500µg/l also Mir Misbahuddin and Kamaluddin, (2002) found that water of some 
tubewells contains 1500µg/l of arsenic and people are drinking that As contaminated 
water unknowingly and recommended that one should be careful to prescribed Zn 
supplementation unless   he is in sure   that the patient is not taking As at the same time 
1.13.6.1.1.7Use of Cymelarsan® infected animals 
No trypanosomes were detected by any of the method in either of the 
groups of camels treated with 0.3 mg/kg or 0.6 mg/kg (Zelleake et al., 
1989). All parasites disappear within 3 – 24 hours after injection with a dose 
of 0.625 mg/kg and 1.25 mg/kg, in infected camels none relapsed for more 
than 65 days (Tagerkagan et al., 1989). Musa,(1990)  and Musa et al., 
(1990) used the recommended dose of 0.25 mg/kg with 100% efficiency to 
cure the disease in infected camels. 
Cymelarsan® eliminates T. evansi, T. equiperdum and T. equinm in 
acute and sub acute or chromic infection. Therapeutic dose of 0.25 – 0.5 
mg/kg gives safety margin in the range of x6 to x2 times, with few or no 
local reaction I.M. 
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 Evidence from parasitological and serological assay confirmed the 
effectiveness of Cymelarsan® for the treatment of T. evansi infection of 
Friesian Holstein cattle. The infection appeared to be eliminated most 
effectively when the drug was administrated intramuscularly at dose 
between 0.50 and 0.70 mg/kg. Cymelarsan® cleared T. evansi population and 
resistant to suramin from the circulation within 24 hours after treatment 
(Payne et al., 1994b). All infected T. evansi buffaloes treated with a single 
dose of 0.5 to 3.5 mg/kg were cured and no relapses could be observed with 
one to three years, at a dose of 0.25 mg/kg, relapse occurred in two out of 
four treated buffalo within two months after treatment, indicating that the 
lowest effective dosage to treat T. evansi in buffalo might be between 0.25 to 
0.50 mg/kg (Lun et al., 1991). Goats infected with T. evansi were cured after 
a single injection of 0.3 mg/kg Cymelarsan® and above (Zewygarth et al., 
1992 and Fairouz, 2000). In contrast, all animals infected with the least 
sensitive stock of T. brucei and subsequently treated with one I.M injection 
of Cymelarsan® at 0.625 or 2.5 mg/kg parasitaemic between 11 to 17 days 
after treatment, and lower dose of 0.037, 0.075 and 0.17 mg/kg did not 
provide a cure (Zewygarth et al., 1992). Two – four 0.5 – 2.0 mg/kg 
Cymelarsan® could cure the mice the infected with T. evansi and T. 
equiperdum (Zhang et al., 1992). 
1.13.6.1.1.8Antigen and antibody level 
Olaho et al., (1992) reported that antigen detection could be used to 
evaluate the success of therapeutic trials when trypanosome detection tests 
fail to pick patent infection. In 14 infected camels treated with Cymelarsan®, 
0.5 mg/kg and 1.2 mg/kg, thereafter, no trypanosomal antigen could be 
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detected in the animals, while two out of three camels treated with 0.4 mg/kg 
showed no trypanosomal antigen by day 90 post-treatment. However, there 
was evidence of trypanosomal antigen in camels treated with 0.2 mg/kg and 
untreated positive controls, 90 day post-treatment. Antibody levels were still 
high in all 14 camels, 90 day post-treatment.   
In anther group of 55 field camels, of which 47 were parasite-positive 
and 8 negative, trypanosomal antigens could not be detected in 42 of the 
camels, 28 and 49 days post-treatment with quinapyramine prosalt. 
However, antigen levels were still high in five parasite-positive camels, 48 
days post-treatment. 
1.13.7 Other trypanocidal drugs 
1.13.7.1Antirovinylfuran          
It has trypanocidal activity when given by mouth in mice infected with T. rohesiense 
intramusclar single injection had prophylactic properties. It inhibits various nucleic acid 
and carbohydrate metabolic pathways (Alexender, 1985). 
1.13.7.2The effect of antipyretic agents  
Flurbiprofen (1 mg/kg) i.v twice daily inhibited the febrile reactions during the acute 
phase of T. congolense or T. brucei infections. Again parasitaemia of a progressive type 
could be observed during drug treatment. All infected T. congolese goats treated with 
flubriprofen died. However, a number of the T. brucei infected goats treated with the 
drug survived, this was also the case during long-standing trypanosome infections.  
Suprofen, an antipyretic agent, which is less potent than flurbiprofen, induced 
parasitaemia of a progressive type as compared with the control when tested in T. vivax 
infected goats.  
Treatment of T. vivax infected goats with sodium salicylate or flunixine meglumine only 
had a partial inhibitory effect upon the febrile reactions, no effect upon the number of 
circulating trypanosomes could be seen. Both flurbiprofen and suprofen induce a 
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progressive increase in the number of circulating trypanosomes, which often terminated 
in early death (Newton,1974). 
1.13.7.3Nitrofurazone derivative 
It inhibits the unique enzyme trypanothione reductase. It has an effect 
on mucocutaneous leishmaniasis. It causes severe toxicity, including 
allergies, gastrointestinal irritation, and central nervous system (CNS) 
(Alexander,1985) 
1.13.8Tetracyclines group 
The tetracyclines were discovered as a result of a search for 
antibiotics active against a wider range of bacteria than penicillin. They are 
bacteriostatic acting on the bacterial ribosome and they have a chelating 
action in binding the metallic ions, calcium, magnesium and manganese. 
They also inhibit a number of essential enzyme systems. It is found in the 
market in the form of an odourless, yellow base, insoluble in water, soluble 
in hydrochloride. Solutions lose their activity in a few days. They inhibit a 
wider range of Gram-positive and negative bacteria and act against certain 
protozoa such the Anaplasma, Mycoplasma spp. and also act against, 
Reckettsia and Theileria. They may be given by mouth and take 3-4 days to 
be excreted. (Alexander, 1985) 
 
 
1.13.8.1 Oxtetracycline (OTC) 
1.13.8.1.1 Isolation and synthesis 
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This broad spectrum antibiotic has been isolated from a culture of 
Strepomyces reimosus. It could be obtained by extracting the culture filtrate 
with BuOH and then extracting the organism phase with dilute mineral 
where an aqueous extract obtained. Purification is carried out by 
chromatography on an alumina column followed by repetitive solvent and 
dilute acid extractions. Final purification is done by dissolving in dilute acid 
and then neutralization to give crystals of the dehydrated form of the 
antibiotic known.(A non, 1985). 
1.13.8.1.2 Characteristics 
The free antibiotic sodium salt and hydrochloride are all soluble in 
polar organic solvents. The dehydrate is laevorotatory with specific rotation 
of [α]D25 – 196.6oC) (0.9, 0.1 N – HCl) and [α]D25 – 2.1 (oC(0.9, 0.1 N - 
NaOH) among the crystalline salts and derivatives that have been prepared 
are the hydrochloride, which form (CH3OH, m.p 208 – 213oC, [α]25D + 
214oC CH3OH) and the sodium salt as lemon-yellow crystals from CH3OH. 
The latter decomposes in aqueous solution at room temperature and the acid 
salt hydrolyses slowly in solution above pH 1.0 to yield crystal of OTC 
(Glasby, 1978). 
1.13.8.1.3 Chemistry 
The tetracycline antibiotics differ from each other as a result of 
differing molecules or atoms being attached to R1, R2 and R3 positions as 
noted in Fig. 2. However, relatively few modifications can be made on the 
structure without loss of antibacterial activity (Giovani et al., 1983). It is 
named chemically: 4 – (dimethylamino) – 1, 4, 49, 5, 59, 6, 11, 129 – 
octahydro – 3, 5, 6, 10, 12, 12a – hexahydroxy – 6 – methyl – 1, 11 – dioxo 
– 2 – nepthacene carboxamide (Anon, 1985). 
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1.13.8.1.4 Mode of action 
Oxytetracycline is indicated for the treatment and control of a wide 
range of bacterial infections caused by, or associated with OTC – sensitive 
organisms, a large number of gram positive (Farca and Nebbia, 1984; A non, 
1985) and Gram negative bacteria (A non, 1985) certain large viruses, 
rickettsiae, protozoa and chlamydia are sensitive to OTC (A non, 1985). 
Also, it is effective against certain species of Mycoplasma such as M. 
gallinarum and M. orginini, and against theileriosis (Mishra et al., 1983). 
Tetracyclines block protein synthesis by the organism (Dineen, 1980). 
1.13.8.1.5 Absorption and excretion     
Giovani et al. (1983) found tetracycline groups in significant amounts 
in the bile of most animals after treatment with tetracycline. It can be 
excreted by hepatic cells into bile and eventually pass into the intestines. A 
cycle (enterohepatic) can result in which the drug is continually re absorbed 
from the intestines after biliary secretion until enough of the drug passes 
through the liver to render it sufficiently water soluble for urinary excretion 
(Giovani et al., 1983 and Bywater et al., 1991). 
Varma and Paul (1983) reported a very slow rate of absorption of OTC-LA   from I/M 
site and the drug remains ionised over the entire pH range. The slow absorption of the 
drug from I/M site as well the delayed appearance of the drug in milk as compared to 
plasma may be chiefly attributed to the greater ionized fraction of the drug at pH of the 
body fluids, since it is the unionized fraction of a drug that usually passes across a cell 
membrane. 
All tetracyclines including OTC-LA   form a stable calcium complex in any bone-
forming tissue. A decrease in the fibula growth rate has been observed in premature 
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infants given oral tetracycline in dosages of 25 mg/kg every 6h this reaction was shown 
to be reversible when the drug was discontinued. (Pfizer, 2005). OTC-LA   and its salts 
are readily absorbed orally and are 10-40% bound to plasma proteins. Between 40-70% is 
excreted unchanged in the urine via glomerular filtration. A serum half life of 6-10 h. has 
been reported for OTC-LA   in patients with normal renal function. (Pfizer, 2005). 
Tetracyclines as a class, are widely distributed in the body, including to the heart, kidney, 
lungs, muscle, pleural fluid, bronchial secretions, sputum, bile, saliva, urine, synovial 
fluid, ascetic fluid, and aqueous and vitreous humor. Only small quantities of tetracycline 
and oxytetracycline are distributed to the CSF and therapeutic levels may not be attain-
able. (Susan and Donald2003-2005). 
 While all tetracyclines distribute to the prostate and eye, doxycycline or minocycline 
penetrate better into these and most other tissues. Tetracyclines cross the placenta, enter 
fetal circulation and are distributed into milk. The volume of distribution of oxytetracy-
cline is approximately 2.1 L/kg in small animals, 1.4 L/kg in horses, and 0.8 L/kg in 
cattle and the amount of plasma protein binding is about 10-40% for oxytetracycline. 
(Susan and Donald2003-2005). 
 All tetracyclines readily distributed to most body fluids, including bile, sinus secretions, 
and synovial, pleural, ascitic, and gingival crevicular fluids. Cerebrospinal fluid (CSF) 
concentrations vary and may achieve 10 to 25% of plasma concentrations following 
parenteral administration. Concentrations in gingival crevicular fluid may be three to 
seven times the serum concentrations. Tetracyclines tend to localize in bone, liver, 
spleen, tumors, and teeth; tetracyclines also cross the placenta and distribute into breast 
milk. (Ziv and Suliman, 1974, Susan and Donald 2003-2005; Pfizer, 2005). 
1.13.8.1.6 Safety 
Oxytetracycline is safe in the recommended doses of 15 – 50 mg/kg 
but must be given in divided doses (Varma and Paul, 1983; Davey et al., 
1985 and Radwan et al., 1989). 
1.13.8.1.7The half-life and the long-acting formulation          
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In Xia et al. (1983) study on OTC-IA (long acting) as compared OTC-
C the half-life is 6 hours, after I.V and I.M injection.  
The long-acting formulation was an effective way to administer OTC 
and remove the need for repeated daily treatment (Toutain and Raynaud, 
1983). The long-acting formulation gave a lower serum concentration and 
showed longer half-life as compared with conventional formulation (Davey 
et al., 1985). In buffaloes the half-life after I.V was shorter than after I.M 
administration – (Varma and Paul, 1983). The half-life was shorter after 
conventional preparation than in long acting preparation when OTC 10 
mg/kg L.A preparation and 20 mg/kg OTC-C at the therapeutic levels is 
given (Luthman and Jacobsson, 1982). OTC suspended in milk replacer was 
responsible for low serum concentration whereas the greater absorption form 
glucose glycine electrolyte solution was responsible for improved uptake of 
antibiotic. This was observed in Palmer et al. (1983) study when OTC was 
suspended in milk replacer, water or glucose glycin electrolyte solution 
given orally to 64 calves. Bertzalf et al. (1982) observed that OTC when 
administered I.V attained concentrations in the wall of the uterus of the cow, 
equivalent to its plasma concentration.  
The long-acting formulation gave a lower serum concentration and 
showed longer half-life as opposed to the conventional formulation (Davey 
et al., 1985) OTC given intraperitoneal 250, 500, 1000 mg/6 weeks daily to 
ewes infected with Brucella melitensis, after 16 weeks they were Brucella 
free with 52, 69 and 100, respectively (Radwan et al., 1989). 
1.13.8.1.9Adverse effects and toxicity 
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Drug concentration may accumulate in developing bones, teeth and 
other organs of the young, since their detoxification enzyme systems are not 
fully developed (Alexander, 1985).  
Gross et al. (1981) observed that, OTC causes increase in pulmonary 
arterial pulse and decreased in heart rate, pulmonic and systemic resistance 
were increased and no direct effect on the left ventricular contractility was 
observed also glossitis, diarrhoea, idiosyncrasy and photodynamic reactions 
were observed in rabbits when administered orally at dose of 10-
100mg/kg/day for 20 days there were regeneration of blood cells, 
proliferation and maturation of bone marrow elements, together with atrophy 
of the gastric and intestinal mucosa and dystrophic changes in the kidney, 
liver and myocardium. 
The toxic effect is observed in the gastrointestinal tract, producing 
diarrhea, nausea and vomiting. The degradation product of tetracyclines 
namely epianhydrot and unhydrot are toxic. The degradation can result from 
improper storage. Also, it may produce symptoms of acute proteinuria, 
glycosuria and acidosis. The inclusion of lactose in oral tetracycline capsules 
prevents this decomposition (Cluff, 1980). 
1.13.8.1.12The residues 
Residues of OTC may therefore be expected in milk, milk products, 
and meat products of livestock. With help of pharmacokinetic research in 
target animals and toxicological investigation, it is possible to establish 
(qualitatively and quantitatively) what residues are present in milk and meat 
after several intervals of time and what amounts of residue may be 
acceptable in milk or meat. The toxicicological investigation includes a long 
list of toxicity tests like biotransformation, mutagenicity, neurotoxicity 
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…etc, for establishment of the quantitative toxicity. Special investigations 
involve establishment of acceptable drug residues in milk and meat and 
these involve pharmacokintic, teratogenicity and mutagenicity tests.  
Pharmacokintic research might give the information needed with 
respect to the interval needed pertaining non-detectable residues and the 
required information about the profile of the metabolites. Teratogenicity 
tests on the other hand will point to the non-toxic levels, being the most 
sensitive to toxicological criteria. Mutogenicity tests which address potential 
quantitative toxic profile of substances make it possible to establish an 
acceptable daily intake for the consumer of food products of animal origin 
(Koenen-Dierick,  et al., 1995). 
Bywater et al., (1971) mentioned that the lowest therapeutic serum concentration is 
considered to be 0.5 µg/ml while Salte, (1982) mentioned that this limit of serum 
concentration was mentioned for about 48hr after I/M injection of OTC-LA in cattle. Xia 
et al., (1983) mentioned that I/Mm injection of OTC-LA resulted in plasma concentration 
with big values after 6-8 hr with100%, bioavailability about 60% of the dose was 
excreted in the urine during the first week and plasma concentration above 0.5µg/ml was 
mentioned for approximately 60 hr indicating normal effect of OTC-LA. The maximum 
allowable tolerance for OTC-LA   in cattle is 6ppm in the liver and 2ppm in muscle tissue 
(FDA, 2003). 
If residues are found, serious economic sanctions may follow at great 
cost to the livestock producer (Mercer et al.,1978). In addition, public health 
regulatory authorities usually legally define withdrawal times and limitation 
for use of certifiable antibacterial in food-producing animals. Once again the 
presence of disease process can substantially alter the normally accepted 
withdrawal times. 
The elimination half-life of oxytetracycline is approximately 4-6 hours in dogs and cats, 
4.3 - 9.7 hours in cattle, 10.5 hours in horses, 6.7 hours in swine, and 3.6 hours in sheep 
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and in high concentrations, tetracyclines can also inhibit protein synthesis by mammalian 
cells. (Susan and Donald, 2003-2005). 
In the committee for veterinary medical products (CVMP) of the European Agency for 
the evaluation of medicinal products (EAEMP,1995) evaluated OTC-LA   in the past an 
established an acceptable daily intake (ADI) of 0-0.003 mg/kg bw based on the human 
gut flora. Based on this ADI and taking into account the typical residue distribution of 
OTC-LA   in tissues, the following maximum residue limits (MRLs) established by 36th 
joint FAO/WHO expert committee on food additive (JECFA) were adopted: kidney 600  
µg/kg, liver 300  µg/kg, eggs 200  µg/kg, muscle 100  µg/kg and milk  µ100 g/kg. It was 
concluded that the antimicrobial potency of chlortetracycline and tetracycline is 
comparable to that of OTC-LA, the JECFA established a group ADI of 0-3 µg/kg bw for 
OTC-LA, tetracycline and chlortetracycline alone or in combination, the highest levels 
are in the kidneys and liver but, they are not detectable in fat to any great extent. For the 
complete recovery compounds, the 4-epimers of OTC-LA, tetracycline and 
chlortetracycline, have to determine. The 4-empires of the compounds occur in samples 
and are formed during sample preparation. The 4-empires are in equilibrium with the 
parent compound. Therefore, the marker residue is the sum of the parent drug and its 4-
empires (EAEMP, 1995). 
Suitable and well validated HPLC methods are available which can be used in the 
surveillance of residues of tetracycline, OTC-LA   and chlortetracycline in tissues of 
cattle, sheep, pig, turkey, trout, carp, and in milk and eggs. This method takes into 
account the 4-empiers of OTC-LA, tetracycline and chlortetracycline. (EAEMP,1995). 
1.13.8.1.13 Use of OTC in production animals             
Because of their relatively low toxicity, tetracyclines have been used 
extensively as animal feed additives in animal production due to their 
stability in dry form. When administered in the feed at the onset of clinical 
signs at a dose of 15 mg/kg reduces the symptoms but does not prevent the 
development of lesion (Betts and Campbell, 1956). 
Larson and Stowe (1981) studied OTC residues when injected I.V at 
dose of 10 mg/kg to 3 horses, after 4 hours mean concentration of OTC of 
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kidney tissue, in lung, plasma and diluted bronchial fluid, respectively. In 
lung, OTC concentration was high enough for cambering bacterial 
infections. In infected T. evansi goats and negative-control Fairouz, (2000) 
observed that OTC late the death of goats when compared with untreated 
control and the goats had gained a high body weight. 
1.13.9 Drug resistance  
Malaria, Trypanosomosis, Lieshmaniasis and Amoebiasis are the most 
serious of the diseases caused by protozoa. Satisfactory drugs exist for all 
these diseases. However, there is increasing evidence of resistance to most 
of the drugs used to  cure trypanosomosis in Africa where, in an area of 
nearly four million square miles South of the Sahra Desert, many millions of 
people are affected either in health or by the illness of their animals. The 
disease is confined to under developed areas, and is complicated by under 
nutrition. (Adrien, 1973). 
One of the major problems in the chemotherapy and 
chemoprophylaxis of animal trypanosomsis is resistance to trypanocides 
(Joshua, 1988). Repeated passage (83) through mice treated with sub-
therapeutic concentration of Cymelarsan® induced complete resistance in the 
subclones whether they were derived from very sensitive or more resistant to 
the compound. During induction of resistance to Cymelarsan®, T. evansi 
subclones develop cross-resistance to both berenil and pentamidine. Berenil 
resistant clones display two different types of resistance: 
1- Single drug resistance demonstrated by those that remained 
sensitive to Cymelarsan.            
2- Cross-resistance (Zhang et al., 1992). 
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The relapse of the T. brucei in mice after treatment was attributed to 
trypanosomes in the brain beyond the action of tryanocides, and which 
subsequently replicate and reinvade the circulation (Jennings and Gray, 
1983). Mice infected with T. evansi were cured with lower doses of 
Cymelarsan® if treated early, (< 24 hours post-infection) than if treated late 
(< 48 hours post-infection) (Dennings et al., 1989). This implies failure of 
treatment or prevention, and if no other active drugs are available the animal 
has to rely on its immune defenses alone to combat the disease (Uilenberge, 
1998). In trypanosome strain to survive, despite the administration of drug 
given in doses equal to higher than, those usually recommended (El Rayah, 
1997). 
Drug resistance was found to develop, when trypanosomes were 
exposed to sub-curative doses of trypanocidale (El Rayah and El Malik, 
1990). 
The usefulness of isometmedium has been greatly reduced due to 
widespread resistance over the years (Scott and Pegram, 1974), but it has 
remained essentially a curative drug in the field despite claims that the drug 
has some prophylactic properties (Dolan et al., 1990). 
 
1.13.10 the combined action of the drugs 
1.13.10.1 The interactions of tetracyclines 
Interactions are due to the displacement of drugs like barbiturates from plasma proteins 
by other drugs, such as phenylbutazone and doxycycline. A problem is to differentiate 
disease effects from drug effect, e.g. in nephrotoxicosis by oxytetracycline during 
azotemin or to identify the drug involved in behavioral reactions, e.g. egg restiveness due 
to predinsolone and metoclopramide. 
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Fatal shock and odema were reported after a second injection of neomycin, OTC, 
trimethoprim sulphadimethoxine 3-6 days. Dyspnoea and recumbency following 
intrauterine administration of polymixin and OTC for 15 days after calving. In heifers by 
ptyalism and blooding, for 6 hr, 30 min following chlorotetracycline and bullocks by 
dyspnoea and pulmonary odema (within 2 min following I.v OTC and phenylbutazone). 
1.13.10.2Combination chemotherapy possibilities in 
trypanosomosis 
Some infectious diseases are routinely treated with drug combinations 
(Keiser et al., 2001). Trypanosomosis may sometimes be associated with 
other parasites such as hemonchus and bacteria (Bywater et al., 1983). 
Additional studies investigated the susceptibility of T. brucei infections to 
diminazine aceturate in combination therapy with non-steroidal anti-
inflammatory drugs and lithium chloride (Abatan, 1991). The effect of 
combination of calcium antagonists with standard trypanocidal against T. 
evansi was described (Anene et al., 1996). One drug may damage 
macromolecules and the other inhibits the availability of precursors for 
synthesis (diamidine plus cordycepin), drugs, which bind to DNA, appear to 
be of the kinds which are expected to be synergetic. The demonstration 
specific inhibitors of RNA synthesis are powerfully trypanocidal 
(Williamson and Scott-finnigan, 1975), may indicate a potential source of 
ancillary agents, which if not too toxic might be used to reinforce existing 
drugs. In certain instance a combination of drug may prove to be toxic 
whereas either may be used safely if administered alone. Some compounds 
used at the correct dosages are non-toxic, but are excreted so slowly from 
the organism that repeated administration at relatively short intervals may 
result in accumulation until a level is reached which will result in the 
appearance of toxicity. 
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Synergetic effects with less active drugs have produced lightened 
activity and showed inhibited drug- resistance development, so for this 
approach has not been looked at extensively trypanosomosis, a part from the 
prophylactic suramin complexes, the demonstration of potentiative 
synergism between suramin and tryparsamide (Williamson, 1966; 
Williamson ;Scott-Finnigan, 1975; Gill, 1971).  
Complexes of suramin with cationic drugs especially quinapyramine 
have been found to be more effective in prophylaxis than suramin alone but 
such complexes have not been widely acceptable for field use because of the 
high cost of the complex formulations and the severe tissue reaction that 
occur in the injection sites (Williamson, 1970 and Willamson et al., 1982). It 
is unclear whether the improved prophylactic activity is due to 
pharmacodynamic or pharmacokinetic factor, which is now suramin have 
been shown to be synergistic with a number of drugs, including 
trypansamide, puromycin, and diminazine aceturate (Willamson et al., 
1982). More studies on the synergistic activity seem justified considering the 
potential of Cymelarsan® and oxytetracycline combination. It was the best 
treatment of T. evansi infection in Sudanese Nubian goats. (Fairouz, 2000). 
1.13.10.3 Use of Cymelarsan and OTC in normal animals         
In Nubian goats infected with T. evansi, Fairouz, (2000) studied the effect of Cymelarsan 
and OTC intramuscularly and found that Leucocytes numbers, lymphocytes were increased after 
injection of the combination, monocytes appeared at 1 – 3% but neutrophils were decreased. The 
serum sodium, potassium, calcium, phosphorus, total protein, albumin, globulin, urea, creatinine, 
thyroxin, progesterone, bilirubin concentration and alanine amino transferase, aspirate amino 
transferase and alkaline phosphatase activities were increased after injection with combination. 
The ketone bodies were negative to the test except one animal in day one after injection with the 
combination.  
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1Animals  
The study was done in two species of animals:  
2.1.1 Nubian Goats 
2.1.2 Camels (Camelus dromedarius) 
2.2Adaptation period of goats 
Three hundred and eighty five (175) Nubian goats, 8 – 10 month old, weighing 9-10 kg, 
and of both sexes were purchased from Sheikh Abu Zeed Market (Omdurman -Khartoum 
State). Animals were housed in pens at the College of Animal Production and Veterinary 
Medicine – Sudan University-Hillat Koko. Each animal was fed daily on green forage 
consisting of 3kg Lucerne (Medicaqo sativa), 1.5 kg sorghum (Sorghum vulgar) and 2 kg 
millets (Pearl millet) one time weekly as a concentrate, and with free access to water.  
The goats were kept for 14 days before commencement of the study for acclimatization. 
General health examinations were done daily and samples of urine; faeces, blood and 
serum were taken for determination of normal base-line data. The goats, giving abnormal 
data were excluded.  
Twenty goats were chosen randomly, divided into two groups each of ten. Group (1) was 
uninfected-untreated (control negative group), while group 2 was infected-untreated 
(control positive group). The remaining animals were infected either with T. evansi or T. 
vivax and were used in ten experiments each experiment was divided into groups, each 
group consisted of 10 goats.   
2.3 Parasite and infection  
Two species of the parasite were used for precipitating the infection in 
goats excepting group 1: 
2.3.1 Trypanosoma evansi (T.evansi) 
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Albino rats of two month old, weighing 250gm, were inoculated intraperitoneal with 
0.2ml camel’s blood containing 3-5 parasite/field, (These camels were infected naturally 
with Trypanosoma evansi strain Gad trip (1) which was obtained from El Gadarif State, 
Eastern Sudan) when parasitaemia developed in rats, each goat (except goats in group 1) 
was injected intravenously with 0.75 ml   rat's blood containing 5 x 105 organisms. The 
parasites were activated by adding phosphate glucose solution (PGS) buffer before 
inoculation. 
2.3.2 Trypanosoma vivax (T. vivax) 
Trypanosoma vivax obtained from Western Sudan (Gebeesh town), the strain being 
designated as vivax west (1). It was inoculated in goat intravenously using 0.5ml 
containing 2.3 parasites/field till parasitaemia developed. Experimental goats each goat 
injected with 0.75ml-inoculated goat's blood intravenously which contained 5 x 105 
organisms. Before inoculation activation of the parasites was made by adding PGS 
buffer. 
2.4 Drugs used 
1- Cymelarsan® 0.25mg/kg(Rhône – Mérieux – France). 
2- Oxyteracycline (Remacyline®) 20mg/kg(Coophavet – France). 
3- Quinapyramine (Trypanil®) 5mg/kg (Agropharm – U.K). 
4- Homidium Bromide (Ethidium®) 1mg/kg (Laprovet – France). 
Each animal in each experiment was subjected to the following investigations: 
a/ Clinical examination:  
Which included body temperature (oC), body weight (kg), respiratory rate 
(movement/min.), pulse rate (pulse/min.) and blood pressure(mmHg) and 
were examined daily. 
b/ The efficacy of the drugs is determined by the detection of the parasites daily in 
peripheral blood with thin or thick smears,  or whole blood by wet films and 
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buffy coat technique from the whole blood and, also with liver impression 
smears. 
The detection of the parasite by the above methods was done daily until the animals died 
or slaughtered. 
 
c/Blood analysis:  
Blood from jugular vein was withdrawn in two plain test vacutainers one containing 
anticoagulant and used for examination of complete haemogram,  packed 
cell volume (PCV), haemoglobin (Hb), red blood cell count(RBC), white 
blood cell count(WBC), differential WBC count, reticulocytes count, 
platelets count in addition to calculation of blood indices (MCV, MCH, 
MCHC  ). Tubes contain no anticoagulant were left to clot, centrifuged at 
3000rpm for examination, sera collected and kept at -20oC until analyzed for 
the activity of glutamic oxalocetic transaminase (GOT), glutamic pyruvic 
transaminase (GPT), alkaline phosphatase (ALP), lactate dehydrogenase 
(LDH), creatine kinase (CK), pyruvate kinase (PK), succinate 
dehydrogenase (SDH), amylase and lipase  and for the concentrations of 
sodium, potassium, chloride, calcium, phosphorus, magnesium, manganese, 
zinc, copper, iron, arsenic, urea, creatinine, total protein, albumin, globulin, 
total cholesterol, glucose, triglycerides and  phospholipids. 
d/Pathology:   
Animal that have died or slaughtered underwent immediately: post mortem examination 
and findings were recorded. Specimens of heart, brain, kidney, spleen, liver, 
lung, colon, small intestine, ovary, testis, thyroid gland, and muscle, site of 
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injection, nerve, tendon, spinal cord and tongue were taken and fixed in 10% 
formal saline for histopathology.  
e/ Residues: 
 Other specimens of heart, brain, kidney, spleen liver, lung, ovary, testis, muscle and site 
of injection, were kept in plastic containers kept in a deep freezer for 
determination of residues of Cymelarsan, oxytetracycline and 
quinapyramine after the withdrawal period 14, 21,28 days respectively in 
slaughtered animals two goats/week or one camel/week or after death.  
2.5 Experimental design of goats 
Ten procedures were conducted: 
 
2.5.1 Experiment 1: Toxicity and efficacy of Cymelarsan® in goats infected with T. 
evansi 
Two experiments were conducted: 
2.5.1.1 Single-dose experiment 
Each goat in groups 3, 4,5and 6 was given single intramuscular (I/M) dose of 
CymelarsanR® at the rate of 0.125 mg/kg (half-therapeutic dose), 0.25 mg/kg (therapeutic 
dose), 0.625 mg/kg (two and half times the therapeutic dose), 1.25 mg/ml (five-times the 
therapeutic dose) respectively. 
2.5.1.1.2 Multiple-dose experiment.  
Each goat in groups 7and 8 was given intramuscularly (I/M) a dose of Cymelarsan® at 
rate of 0.125 mg/kg (half-therapeutic dose) twice/week for two weeks, 0.125 mg/kg (half-
therapeutic dose) daily for 8 days, respectively. Goats in groups 9and 10 were each given 
the drug (I/M) at the rate of 0.25 mg/kg (therapeutic dose) twice/week for two weeks and 
0.25 mg/kg (therapeutic dose) daily for 8 days respectively. 
Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive, respectively 
2.5.1.2 Experiment 2: Toxicity and efficacy of oxytetracycline in goats infected with 
T. evansi 
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 Two experimental procedures were conducted: 
2.5.1.2.1 Single dose experiment 
Each goat in group 3, 4, and 5 was given the single (I/M) dose of the drug at the rate of 
20 mg/kg(therapeutic dose), 50mg/kg (two and half therapeutic dose), and 
100mg/kg(five-therapeutic dose) respectively.  
Goats in group 6 were each given the drug weekly at dose rate of 200 mg/ml for three 
weeks intramuscularly. 
2.5.1.2.2 Multiple dose experiment.  
Each goat in groups 7and 8 was given the drug intramuscularly (I/M) at dose rate of 20 
mg/kg (therapeutic dose) twice/ week for two weeks or repeated daily for 8 days 
respectively. 
Goats in-groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively. 
2.5.1.3Experiment 3: Clinicopathological effect and efficacy of Cymelarsan® and 
oxytetracycline   in goats infected with T.evansi.  
Goats in groups 3and 4 were each given single intramuscular dose of CymelarsanR at the 
rate of 0.125 mg/kg (half therapeutic dose) followed by single intramuscular dose of 
oxytetracycline at rate of 10 mg/kg (half therapeutic dose) while goats in group (4) were 
also each given single intramuscular dose of CymelarsanR 0.125 mg/kg (half therapeutic 
dose) followed by single dose of oxytetracycline (intramuscular I/M) at rate of 50mg/kg 
(two and half therapeutic dose). Group(5) was given Cymelarsan 0.125 mg/kg (half 
therapeutic dose) followed by oxytetracycline 20 mg/kg (therapeutic dose) 
intramuscularly twice/week for two weeks. Group (6 ) was given the drugs similar to 
group (5), but daily for 8 days. 
Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively 
2.5.1.4 Experiment 4: Clinicopathological effect and efficacy of Cymelarsan® in 
goats infected with T.evansi supplemented with     zinc & copper.  
Zinc (98%) and copper (98%) (The British Drug Houses Ltd. BDH-Laboratory 
Chemicals Division. Poole- England) were dissolved in distilled water with (1g in 
100ml distilled water). Goats in group (3) were each given a single intramuscular dose 
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of Cymelarsan at the rate of 0.125 mg/kg,  goats in group (4 ) were each given a single 
intramuscular dose of Cymelarsan at the rate of 0.125 mg/kg followed by zinc (12 
µmol/l) intramuscular and copper (1g in 100ml distilled water) orally. While goats of 
group (5) was given Cymelarsan at the rate of 0.125 mg/kg the same dose daily and 
goats in group (6) were each given a single intramuscular dose of Cymelarsan at the rate 
of 0.125 mg/kg followed by zinc (12 µmol/l) intramuscular and copper (1g in 100ml 
distilled water) orally daily for 8 days.   
 Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively. 
 
 
2.5.1.5 Experiment 5: Efficacy and toxicity of quinapyramine in goats infected with 
T. evansi: 
Two experimental procedures were conducted: 
2.5.1.5.1 Single dose:  
Each goat in groups 3, 4, 5and 6 was given single intramuscular doses of quinapyramine 
at the rate of, 5mg/ kg (therapeutic dose), 10 mg/ kg (two and half-therapeutic dose), 
25mg/ kg (five-therapeutic dose) and 50mg/kg(ten therapeutic dose) respectively.  
2.5.1.5.2 Multiple doses:  
Each goat in groups 7 and 8 was given the drug intramuscular at the rate of 5 mg/ kg 
(therapeutic dose) weekly for three successive weeks or daily for 8 days 
respectively. 
Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively 
2.5.1.6 Experiment 6: Toxicity and efficacy of Homidium bromide in goats infected 
with T. vivax: 
Two experimental procedures were conducted: 
2.5.1.6.1 Single dose:  
Each goat in groups 3,4and 5 was given single intramuscular dose of homidium bromide 
at the rate of 1 mg/ kg (therapeutic dose), 2.5 mg/ kg (two and half therapeutic dose) and 
with 5 mg/ kg (five-therapeutic dose) respectively. 
2.5.1.6.2 Multiple doses:  
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Goats in groups 6and 7 were given the drug at the rate of 1mg/ kg (therapeutic dose) 
weekly for three successive weeks and 1 mg/ kg (therapeutic dose) daily for 8days 
respectively. 
Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively 
2.5.1.7Experiment 7: Clinicopathological effect and efficacy of quinapyramine and 
homidium bromide interaction in goats infected with T.vivax or T. 
evansi 
a/ T. evansi infection 
Each goat in group 3 was given single intramuscular dose of 
quinapyramine at the rate of 5 mg/ kg (therapeutic dose) followed by 1 mg/ 
kg of homidium bromide (therapeutic dose) while, goats in group 4 were 
each given single intramuscular dose of quinapyramine at 12.5 mg/kg (two 
and half-therapeutic dose) followed by 1mg/ml (therapeutic dose) of 
homidium bromide.   
b /T. vivax infection  
Each goat in groups 5 and 6 was given 5mg/ kg (therapeutic dose) of 
quinapyramine followed by 1mg/ml (therapeutic dose) of homidium 
bromide, 5 mg/kg (therapeutic dose) of quinapyramine followed by 2.5 mg/ 
kg (two half-therapeutic doses) of homidium bromide respectively. 
Goats in groups 1 and 2 were not given the drug but used as control negative and control 
positive respectively. 
2.5.2 Camels (Camelus dromedarius) 
Sixty one- humped camels (Camelus dromedarius) 1 – 3 years-old, of both sexes 
weighing (250-300 kg) were obtained from El Gadarif State and were stabled in 
Elmewelh Market pens (Omdurman-Khartoum State). Each camel was fed daily on 4kg 
Lucerne (Medicaqo sativa), 3.5millets (Pearl millet) and 2.5kg sorghum (Sorghum 
vulgare); with free access to water. The camels were kept for 14 days before the study 
was commenced for acclimatization. General health examinations were done such as 
urine, faeces, blood and serum samples taken for analysis to determine normal base-line 
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data. The camels, recording abnormal data, were eliminated from the study. All 
experimental animals chosen were clinically healthy giving data with normal ranges for 
all parameters. They were divided randomly into three experiments, each experiment 
consisting of groups of 5 camels each. 
Ten camels were chosen randomly and divided into two groups, each of five. Group 1 
was uninfected-untreated (control negative group), while group 2 was infected-untreated 
(control positive group). The remaining animals were infected with T. evansi naturally as 
they came from a trypanosomosis region (El Gadarif State-Eastern Sudan). They were 
used in three experiments each experiment being divided into groups, group consisted of 
5 camels each.   
Three experimental procedures were conducted: 
 2.5.2.1 Experiment 1: Efficacy of Cymelarsan® in camels infected with T. evansi 
Each camel in group 3 and 4 was given a single intramuscularly dose of the drug at the 
rate of, 0.25 mg/ kg (therapeutic dose), and 0.6125 mg/ kg (two and half-therapeutic 
dose), respectively. Camels in group 5 were each given a single dose of Cymelarsan at 
rate of 0.125mg/ kg (half-therapeutic dose) weekly for three successive weeks  
Camels in groups 1 were used as un- infected-untreated (control negative), while camels 
in group 2 were infected-untreated (control positive). 
2.5.2.2 Experiment 2: Toxicity and efficacy of Oxytetracycline in camels infected 
with T. evansi: 
 Two experimental procedures were conducted: 
2.5.2.2.1 Single doses experiment   
Each camel in group 3, 4 and5 was given a single intramuscular dose of the drug at the 
rate of 20 mg/ kg (therapeutic dose), 50mg/kg (two and half therapeutic dose), and 100 
mg/ kg (five-therapeutic dose) respectively.  
2.5.2.2.2 Multiple doses 
Each camel in groups 6 and 7 was given the drug intramuscularly at the rate of 20 mg/ml 
(therapeutic dose) twice /week for two weeks or repeated daily for 8days respectively. 
Camels in groups 1 were used as un- infected-untreated (control negative), while camels 
in group 2 were infected-untreated (control positive). 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
2.5.2.3Experiment 3: Clinicopathological effect and efficacy of Cymelarsan and 
oxytetracycline interaction in camels infected with T.evansi:  
Each camel in group 3 was given single intramuscular dose of CymelarsanR at the rate of 
0.250mg/ kg (therapeutic dose) followed by 20 mg/ kg of oxytetracycline, (therapeutic 
dose) while animals in group 4 were given a single intramuscular dose of Cymelarsan® at 
0.125 mg/ kg (half therapeutic dose) followed by oxytetracycline at 50 mg/ kg (two and 
half therapeutic dose). A single dose of Cymelarsan® at 0.125 mg/ kg (half-therapeutic 
dose) followed by a single intramuscular dose of oxytetracycline at 100mg/ kg (five 
therapeutic) were given to each camel in the groups. 
Camels in group 1 were used as un- infected-untreated (control negative), while camels in 
group 2 were infected-untreated (control positive). 
2.6Collection and preservation of samples 
A weekly slaughter program for survival animals studied after the cessation of the drugs 
in Cymelarsan 14 days, 21 days in oxytetracycline and 28 day in ethidium 
and quinapyramine.  Urine samples were collected from urinary bladder, bile 
from the gall bladder after the death or slaughter (two animals/week) of the 
animals in plain containers (Wols – U.K) and were preserved under -20oC 
until use. Specimens  (5-7mm) for histopathology were taken from heart, 
brain, kidney, spleen liver, lung, colon, small intestine, ovary, testes, thyroid 
gland, muscle, site of injection, nerve, tendon, spinal cord and tongue. Two 
specimens were taken one (9g) from heart, brain, kidney, spleen, liver, lung, 
ovary, testis, muscle, site of injection for the determination of residues of the 
drugs and were preserved under -205C until use.  
2.7 Postmortem changes and Histopathology  
At necropsy, animals were examined for postmortem lesions and specimens (5 – 7 mm), 
of heart, brain, kidney, spleen liver, lung, colon, small intestine, ovary, 
testes, thyroid gland, muscle, site of injection, nerve, tendon, spinal cord and 
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tongue were fixed in 10% formal saline, according to (Carleton, 1976; 
Culling, 1974).  
2.8 Methods 
2.8.1 Clinical examination  
2.8.1.1Clinical signs were closely observed daily and recorded regularly.   
2.8.1.2 Body temperature (BT) 
Rectal temperature was obtained daily by using a Digital Thermometer (Astro 
Temperature, Marshall, Elec.).  (Kelly, 1986). 
2.8.1.3 Body weight (BW) 
Body weight was measured twice a week by the Poked Balance (Original Rebüre – 
Germany) (Kelly, 1986). 
2.8.1.4 Respiratory rate (RR) 
 Respiratory rate was done daily by counting the movements of the nose per second 
(Kelly, 1986). 
2.8.1.5 Blood pressure rate (BPR) 
Blood pressure rate was measured twice a week using Electronic Apparatus (Digital 
Blood Pressure Meter, Seinex Electronics Ltd. Jenny Mount Court, North 
Derby Street Belfast BT IS 3HN – UK). 
Principle 
Blood pressure is a measurement of the force of blood flowing against resistance along 
the walls of arteries. Arterial blood pressure is constantly changing during the course of 
the cardiac cycle. The highest pressure in the cycle is called the systolic blood pressure; 
the lowest is the diastolic pressure; both pressure readings are necessary to enable 
evaluation of status of blood pressure. World Health Organization (WHO) has established 
standards for assessment of high and low blood pressure. (MHSS, 1971). 
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Procedure 
Wrap the cuff around the left femur; turn the power and adjust the zero in one second the 
cuff pressurizes after the zero displayed on the display window and when the 
pressurization is complete, the (heart mark) will appear indicating that measurement is in 
progress. 
Calculation 
Read from the display window as systolic pressure/diastolic pressure. 
2.8.1.6 Pulse rate 
Pulse rate of the femoral artery was measured using Electronic Apparatus (Digital Blood 
Pressure Meter, Seinex Electronics Ltd. Jenny Mount Court, North Derby 
Street Belfast BT IS 3HN – UK). 
Principle 
Pulse rate is a measurement of the force of blood flowing against resistance along the 
walls of arteries. World Health Organization (WHO) has established standards for 
assessment of pulse rate. (MHSS, 1971). 
Procedure 
Wrap the cuff around the left femur; turn the power and adjust the zero . in one second 
the cuff pressurizes after the zero displayed on the display window and when the 
pressurization is complete, the (heart mark) will appear indicating that measurement is in 
progress. 
Calculation 
Read from the display window as pulse rate puls/min. 
2.9 Parasitological methods 
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The parasitological methods are done to detect the parasites T. evansi 
and T. vivax in blood (peripheral or whole blood) or liver tissues in rats, 
goats and camels in the daily using different techniques: 
2.9.1 Wet blood film    
A drop of blood was taken from the ear vein on a glass slide covered 
with cover slip and examined under light microscope (CH20- Olympus 
Germany) using 10 x 40 of magnification (Soulsby, 1982). 
2.9.2 Thin film 
A drop of blood was spread on a glass slide fixed with methanol 70 % 
and stained with Giemas’s stain then the slide was examined under light 
microscope (CH20- Olympus Germany) using an oil immersion lens 10 x 
100 (Soulsby, 1982). 
2.9.3 Thick film 
A drop of blood was spread as a thick smear on a glass slide, stained 
with leishman’s stain, and examined under light microscope (CH20- 
Olympus Germany) using 10 x 40 magnification (Soulsby, 1982). 
2.9.4Buffy coat technique 
Samples of blood were taken at the every three days post infection for 
15 days, then 1 hour, 3hours post-treatment, 24 hours, 3 days, 7, 14, 21, 28, 
35, 42 and/or 49 days post-treatment).A centrifuge capillary tube (Becton 
and sons- France) was filled with ear vein blood and centrifuged at 5000rpm. 
The tube was broken in a buffy coat area and squeezed on glass slides to 
prepare a wet smear and examined under light microscope (CH20- Olympus 
Germany) using 10 x 40 magnification (Soulsby, 1982). 
2.9.5 Liver impression smears 
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This method was done after death or slaughter of the animals.  The specimens of the liver 
(3-5mm) were pressed between two slides then a drop of distilled water was 
added and examined under the microscope as described by Soulsby, (1982). 
2.10 Collection of the blood  
Animals were bled from the jugular vein (at the first day after 
infection, and then three days post infection then 1 hour, 3hours post-
treatment, 24 hours, 3 days, 7, 14, 21, 28, 35, 42 and/or 49 days post-
treatment). Two plain vaccutainer test tubes were used (Becton and sons- 
France) the tube containing no anticoagulant was left to clot, centrifuged at 
3000 rpm and serum was collected and kept at -20oC until analyzed for the 
concentration of sodium, potassium, chloride, calcium, phosphorus, 
magnesium, manganese, zinc, copper, iron, arsenic (as Cymelarsan), urea, 
creatinine, total protein, albumin, globulin, total cholesterol, glucose, 
triglycerides, phospholipids, and for the activity of glutamic oxaloacitic 
transaminase (GOT), and glutamic pyruvic transaminase (GPT), alkaline 
phosphatase (ALP), lactate dehydrogenase (LDH), creatine kinase (CK), 
pyruvate kinase (PK), succinate dehydroganese (SDH), amylase, lipase, 
determination of oxytetracycline and quinapyramine. 
The other tube  containing ethylene diamine tetra acetic acid (EDTA) was used for the 
determination of red blood cells (RBC), white blood cell (WBC) count, 
haemoglobin concentration (Hb), platelets counts, reticulocytes counts, 
packed cell volume (PCV) and differential white blood cell (WBC) count. 
2.11 Haematological methods 
The haematological methods for RBC (x106), WBC (x103), Hb (g/dl), differential WBC 
count, blood indices (MCV, MCH, MCHC) .and PCV% were done in 
Khartoum North Human Hospital by using an instrument called Cell-DYN®, 
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1700; manufactured by Diagnostics Division Abbott (Laboratories Abbott 
Park, IL60064 USA) Ireland and Sligo. 
2.11.1 Cell-DYN® Diff screen  
2.11.1.1Calibration  
The most efficient way to calibrate the open sample mode of the cell-
DYN 1700 system is to use calibrator and the auto-Cal method. When a 
control is used as a calibrator, a different lot or brand of control must be 
used for Daily Quality Control (DQC) the procedure as the following                          
Return each control at 2 – 8oC for 1min then  shake the DOQ and allow to 
rest and warm for 50 min. 
2.11.1.2 Procedure, principle and reagents 
The apparatus can suck 2ml of the blood and 2ml of screen reagent, computerized the 
data and the result were given in the screen. The screen reagents consist of 
diluents, lytic agent, detergent and enzymatic cleaner: 
2.11.1.2.1 Diluents:  
Cell-DYN® Diluents are formulated to meet following the requirements: WBC, RBC, 
PCV and Hb.  
-Rinse the sample probe and maintain the cell volume of RBC during the count. 
-Sizing portion of the measurement cycle.  
And it consists of: Sodium sulfate anhydrous < 1%, Sodium chloride < 0.5%, Anti-
microbial agent, <0.5%, Buffer, < 0.1% and Stabilizer < 0.1%. 
2.11.1.2.2Lytic agent  
It is formulated to meet the following requirements:  
-Rapidly lyses the RBC and minimize the result out cell stroma. 
-Alters the WBC membrane to allow the cytoplasm to slowly diffuse and allow the 
membrane to shrink around the nucleus and any granules that may present. 
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-Converts the Hb to a modified the hemoglobin cyanide complex that is measurable at 
540 nm.  
 It consists of:  Quaternary ammonium salt 50% (< 4.50%) and Potassium cyanide < 
0.08%. 
2.11.1.2.3Detergent  
Detergent is formulated to meet the following requirements:  
-Provide an optically clear solution that is used to obtain the zero 
preference during the Hb measurement cycle.  
-Provides proper meniscus formation in both metering tubes and 
maintain it during each run cycle and rinse both chambers, both metering 
tubes, and the HGB flow cell with minimal bubble formation.  
And it consists of:  Sodium sulfate anhydrous < 1.50%, Sodium 
chloride < 0.60%, Anti-microbial agent < 0.10% and Poly oxyethylene ether 
< 0.25%. 
2.11.1.2.4Enzymatic cleaner 
Enzymatic cleaner is formulated to effectively remove protein build 
up within the instrument.  
2.11.2 Staining and counting reticulocytes 
New methylene blue 0.5g, and potassium oxalate 1.6g were dissolved 
in distilled water 100.0 ml. 2 drops of blood with an equal quantity of stain 
mixed and left for 15 – 20 minutes, blood films were made and reticulocytes 
were counted under light microscope x40 (number of reticulocyte cells x 106 
µml/l) (Brecher, 1949). 
2.11.3 Thrombocytes count  
Dissolve sodium citrate 3.8g, formaldehyde (40%) 0.2 ml and brilliant 
crystal blue 0.1 g in distilled water 100.0 ml.1.0 ml from the diluting fluid 
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was taken by the RBC pipette; 0.5 ml of blood was added; mixed and 
shaken; expel a third of the fluid, fill both sides in haemocytometer. Place 
the haemocytometer in Petri dish containing filter paper keep it without 
touch. Count in erythrocytes counting area. The number of erythrocytes x 
1.0 = No. of erythrocytes/µl = thrombocyte cells x103µml/l. (Schalm et al. 
1981) 
2.12 Serobiochemical analysis 
Serobiochemical analysis was carried out using commercial kits (Randox Laboratories 
Ltd. U.K.) or (Plastic Laboratory Product Ltd. U.K) or (Linear chemicals, 
S.L.-Spain) or chemical– using absorption spectrophotometer (Unicam 
8625/U.V. Vis U.K.), atomic absorption (Cornning EEL 197Spectra- Evans 
Electroselenium Ltd., England) and (400 flame photometer corning – 
England).  
2.12.1Enzymes activity  
2.12.1.1 Determination of serum lactate dehydrogenase (LDH) (L-
Lactate: NAD oxidoreductase (1.1.1.27)).  
Lactate dehydrogenase was determined according to the method 
described by King (1965) using commercial kits (Linear chemicals, S.L.-
Spain). 
Principle 
Lactate dehydrogenase catalyzes the reduction of pyruvate by NADH. The rate of 
decreasing in concentration of NADH is proportional to the concentration of LDH 
present in the sample. 
 
NADH + H+ + Pyruvate    LDH   Lactate + NAD+ 
 
Reagents 
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Phosphate buffer, pH 7.4, 100 mmol/l, nicotinamide adenine 
dinuleotide and sodium pyruvate, 22.4 mmol/l  
Procedure 
Measure 2.4 ml phosphate buffer with spectrophotometer, then add 
0.1 ml serum and 0.1 reagent 2, mix well, allow to stand for 20 min at 25oC, 
then add reagent 3, monitor the rate of change extinction at 340 nm.     
  
Calculation  
Serum LDH (U/l) =    E340/min x 1000 x 2.7      
                                       0.1 x 6.3  
2.12.1.2Determination of serum creatine kinase (CK) (ATP: 
Creatine phosphotransferase(2.7.3.2 C)) 
It was measured according to Swanson and Wilkinson (1972) method 
using commercial kits (Linear Chemicals, S.L.-Spain). 
Principle 
Creatine kinase (CK) catalyzes the transfer of a phosphate group from phosphocreatine to 
ADP. This reaction is coupled to those catalyzed by hexokinase and glucose-6- phosphate 
dehydrogenase. The rate of NADPH formation is proportional to the concentration of CK 
present in the sample. 
Phosphocreatine +   CK   creatine + ATP 
ATP + Glucose    HK     glucose-6-phosphate + ADP 
-Glucose-6phosphate + NADP+      G6DH   6-phosphogluconate +NADPH + H+ 
 
Reagents  
Consist of Tris buffer, 50 mmol/l, pH 6.8, reagent mixture containing 
adenosine diphosphate, 1.25 mmol/l (60.5 mg) + creatine phosphate, 12.5 
mmol/l (408 mg) + glucose, 25 mmol/l (450 mg) + magnesium, 25 mmol/l 
(760 mg) + adenosine monophosphate 12.5 mmol/l (456 mg), make to 100 
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ml, IVADP+, 12 mmol/l. Dissolve a 2 mg of the monosodium salt in 10 ml 
tris buffer, pH 6.8 with 1 mol/l hydroxide stored frozen, cysteine, 74mmol/l. 
Prepare freshly each day. Dissolve 131 mg cysteine hydrochloride 
monohydrate in 10 ml deionside water, pH 6.8 with 1 mol/l sodium 
hydroxide and enzyme solution consisting of: glucose – 6 – phosphate 
dehydrogenese (9 units/ml) + 18 units/ml hexokinase in Tris buffer. 
Procedure 
Mix 2.4 ml reagent solution with  0.2 ml NADP+, 0.2 ml cysteine and 
0.1 ml enzyme solution place in 37oC for 10 min, then add 0.1 ml serum and 
mix and read in spectrophotometer (Unicam 8625/U.V. Vis U.K.) at 340 nm 
over a period of 10 – 15 min against blank. 
Calculation 
Serum creatinine kinase (U/l) = ∆E340/min x total volume in the 
cuvette (ml) x 103  
                                        603          volume of serum taken (ml) 
2.12.1.3 Determination of serum pyruvate kinase (PK) (ATP: 
pyruvate phosphotransferase (2.7.1.40C)) 
It was measured according to method described by (Gutmann and 
Berit.(1974). 
Principle 
Less trouble is experienced from colour in the blanks with this technique, due to its 
appearance in the earlier method to the hydrogen peroxide used. 
Pyruvate kinase (PK) catalyses the interconversion of phosphenolpyruvate (PEP) and 
pyruvate: 
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C3H3O3PO3 + ADP                C3H3O3-  
For the determination of PK activity the above reaction is coupled with the reduction of 
pyruvate by lactate dehydrogenase in the presence of NADH. PK is activated by 
potassium ions and inhibited by sodium.   
Reagents  
Consist of : Triethanolamine buffer: PH 7.5, 160 mmol /l containing 
120mmol/l KGI ,21 mml/l MgSO4 ,7 H2O ,40 mg EDTA. Dissolve 2.2 g 
triethanolamine ,0.7 g KGI ,0.4 g MgSO4 ,7 H2O ,40 mg EDTA (disodium 
salt), in about 50 ml water , adjust to pH 7.5 with 100 mmol/l sodium 
hydroxide and dilute to 75 ml, NADH-PEP : 6 mmol NADH/l and 32.5 
mmol PEP/l. Dissolve 2.2g 10mg NADH (disodium salt) and 45 mgPEP 
(trihexylamine  salt) and 10 mg sodium bicarbonate in 3 ml water, lactate 
dehydrogenase, 0.5 mg/ml. Dilute stock suspension with 2.2 mol/l 
ammonium sulphate solution, adenosine diphosphate ,100 mmol/l ,162 mg 
ADP(disodium salt) plus 30 mg sodium bicarbonate in 3ml water and 
Sodium chloride solution ,9 g/l  
Procedure 
Collect blood without stasis. Determine the red cell count. Serum 
should be free from haemolysis. For haemolysis wash the red cell from 0.20 
ml finger blood three times with 2 ml sodium chloride solution, centrifuging 
red after each wash for 10 min at approx. 3000 rpm. then suspend the 
centrifuged red cell in 2 ml redistilled water ,allow to stand for 15 min at +4 
oc ,centrifuge again and use the supernatant for the determine. Take 2.5ml 
buffer (and 2.0ml for haemolysate) and 0.1ml NADH-PEP. 0.5ml serum, 0.9 
redistilled water, 0.1ml NADH-PEP and 0.1ml supernatant., then add 50µl 
LD suspension, NADH-Pep, mix, incubate 5 min at 25 oC, pour into a 
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cuvette, read at 340nm against air (E1) or a dilute picric acid solution , 
prepare a diluent 1 or 2 drops of a 12g/l solution to 100ml with water, 
incubate at 25 oC and read again at 340 nm (E2) within 10min from the first 
reading, add 0.1ml ADP mix and read again (E3) and Incubate at 25oC and 
read again at 340nm within 10 min. (E4). 
Calculation 
 E340 due to PK activity =(E3 – E4) – (E1-E2) 
 PK activity (U/l) = E340 x 104.5. 
2.12.1.4 Determination of serum glutamic oxalocetic transaminase 
(GOT) (Asparate: 2-oxoglutrate aminotransferase or Asparate 
aminotransferase (AST)or glutamic oxaloacetic transaminase (2.6.1.1)) 
and glutamic pyruvic transaminase(L- Alanine : 2-oxoglutrate 
aminotransferase or Alanine aminotransferase (ALT)(2.6.1.2)) 
Their activities measured according to the method described by 
(Young et al., 1975) using commercial kits (Randox Laboratories Ltd. 
U.K.). 
Principle 
Alanine aminotransferase catalyzes the transfer of an amino group from alanine to 2-
oxoglutarate forming glutamate and pyruvate. The pyruvate produced is reduced to 
lactate dehydrogenase and NADH. The rate of decrease in concentration of NADH is 
proportional to the concentration of  ALT present in the sample. 
 
Alanine +2-oxoglutarate    ALAT         Glutamate + pyruvate 
NADH + H+ +Pyruvate   LDH lactate + NAD+ 
 
Reagent 
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Reagents (1) consist of:TRIS pH 7.3, 100mmol/l, and alanine, 
500mmol/l. 
Reagent (2) consists of: 2-oxoglutarate, 0.18 mmol/l, LDH, 1200U/L 
and NADH, 15mmol/l. 
In GPT 2-oxoglutarate, 0.18 mmol/l act as Starter and Reagent 3. 
Procedure 
Mix reagent (1) with (2) (working reagent), then add 100 µl sample 
and 1.0 ml from working reagent. And 100µl from reagent (3) in GPT 
measurement. Read in in spectrophotometer (Unicam 8625/U.V. Vis U.K.) 
at wavelength at 340 nm against blank. 
Calculation 
Serum AST U/L=             Reading x1750 
Serum ALT U/L =    Reading x 1905  
2.12.1.5 Alkaline phosphatase (ALP)((3.1.3.1)) 
It was measured according to the method described by (Young et  al.  
1975) it was done using commercial kits (Linear Chemical-). 
Principle 
Alkaline phosphatase catalyzes the hydrolysis of p-
nitrophenyphosphate, in the presence of magnesium ions, liberating 
inorganic phosphate and p-nitrophenol. The rate of p-nitrophenol to the 
concentration of ALP present in the sample. 
4-nitrophenilphosphate H2O         ALP   4-nitrophenol formation 
+Inorg. Phosphate      Reagents  
Reagent (1) consists of: DEA buffer pH 9.8, 1 mmol/l and 
reagent(2)consists of 4-nitrophenylphosphate, 10mmol/l. 
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Procedure 
Mix reagent (1) with (2)  (working reagent). Add 20µl sample and 
1.2ml from working reagent, read in spectrophotometer (Unicam 8625/U.V. 
Vis U.K.) at wavelength 405nm against blank at I min. then after 3 min.   
Calculation 
 Alkaline phosphatase (ALP)(U/L) =   Mean of reading x 3300  
2.12.1.6Determinationofserumα-amylase(α-1,4-glucan4  
glucanohydrolyase(3.2.1.1C)) 
Activity was measured according to the method described by (Young 
et al. 1975) using commercial kits (Linear Chemicals, S.L.-Spain). 
Principle 
α –amylase catalyzes the hydrolysis of blocked p-nitrophenylmatoheptaoside liberating 
oligomaltosides. The enzymes amyloglucosidase and α-glucosidase hydrolyse completely 
the oligomaltosides, liberating p-nitrophenol. The rate of p-nitrophenol formation is 
proportional to the concentration of α-amilase present in the sample. 
 
PNPG7bl.    αAmylase       PNP-oligomaltosides  
PNP-oligomaltosides     αglucosidase             Glucose 
             αamyloglucosidase 
Reagent 
Reagent(1) consists of: pipes pH 7.0 50 mmol/l and reagent 
(2)consists of : PNPG7bl. 1.6 mmol/l, amyloglucosidase 10 U/L and  
glucosidase 25 U/L. Dissolve a tablet of reagent 2 with one bottle of buffer 
reagent 1 and mix gently to dissolve contents. 
Procedure 
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Mix reagent (1) with (2) (working reagent): add to 100µl, 2.0ml from 
the working reagent at 25/305C or add to 50µl, 2.0 ml from the working 
reagent at 375C.  
Calculation 
 When measured under 25/305C the formula is: 
Serum α- amylase =   A/min.x2690 U/L 
When it measured under 25/305C the formula was: 
Serum α -amylase=               A/min.x5125 U/L 
2.12.1.6 Determination of serum lipase (glycerol ester hydrolyase 
(3.1.1.3)) 
Activity was measured according to method described by Tietz and 
Fiereck , (1972) 
Principle 
As the enzyme acts on substrates in emulsified form, the preparation 
of a stable emulsion is important. The most appropriate substrate is olive oil.  
Reagent 
It consists of: Purified olive oil 300 ml, remove the fatty acid by 
adding, whilst stirring, 60g; substrate emulsion. Mix 100 ml water plus 0.2g 
sodium benzoate plus 7g gum acacia till dissolved; add slowly 100ml  
purified olive oil mix for 10 min. keep at 4oC; Tris stock solution, 
800mmol/l. Dissolve 48.55g tris (hydroxyl methyl) aminomethane in water. 
Make to 500ml, Tris working buffer, 200mmol, pH 8at 27oC to 50ml; Tris 
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stock solution in a 200ml. Add 21.5ml, 1mol/l HCl and make up to the mark, 
sodium hydroxide solution, 50mmol/l; Aqueous ethanol, 950 ml ethanol/l 
and  thymolphthalein solution, 1g in 100ml reagent 7. 
Procedure 
Boil tube and keep it to cool then add 2.5 ml water, 10 ml emultion 
and 1 ml Tris buffer and bring to 37oC in a bath then add 1ml serum, cover 
the tubes and shake well, replace in the bath for 3 hours then add 3ml 
ethanol to both tubes to stop the reaction and bring the fatty acid into 
solution, then add 5 drops of indicators to each and titrate with sodium 
hydroxide, till definite blue colour then add the alkali quickly and shake 
well. 
Calculation 
Serum lipase (U/L) =   Titration of the test ml – titration of blank ml  
 2.12.1.7 Determination of serum succinate dehydrogenase (SDH) 
(succinate dehydrogenase –succinate: accepter oxireductase (1.3.99.1)) 
Activity was measured according to method described by McComb et 
al. (1976 or1975). 
Principle 
The reduced NAD+ and NADP+ has an absorption peak at 340nm and 
the oxidized form has little absorption at that wavelength. 
Calculation 
Serum SDH U/L = reading at 340nm x 1000   x total volume in the 
cuvette ml 
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          Volume of serum used ml   6.3 
2.12.2Other Biochemical change 
2.12.2.1 Determination of Serum creatinine 
Concentration was measured according to the method described by 
Balets and Bohmer (1972) using commercial kits (Randox Laboratories Ltd. 
U.K.). 
Principle 
Creatinine in the sample reacts with alkaline picrate forming a red complex. The rate at 
which the red complex develops is measured quickly to avoid interference from other 
serum constituents. 
Working reagents consists of: 
Picric acid: 35 mmol/l and sodium hydroxide 0.32 mmol/l 
Standard:  
2 mg/dl (177 mmol/l) creatinine  
add to 200l of the samples and standard 2 ml of the working reagent, 
read in spectrophotometer (Unicam 8625/U.V. Vis U.K) at wavelength 420-
510nm. Incubate at temperatures: 25oC/30oC/37oC for 30-60 sec.  against air 
and were measured as A standard and A samples 
Calculation 
 Serum creatinine concentration (mg/dl) =         A sample    x 2  
                                                                      A standard  
    
2.12.2.2 Determination of serum urea 
Concentration was measured according to the method described by 
Patton and Crowch (1977) using commercial kits (Randox Laboratories Ltd. 
U.K.). 
Principle 
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Urea in the sample is hydrolyzed enzymatically into ammonia and carbon dioxide. 
Ammonia reacts with salicylate and hypochlorite, in the presence of the nitroprusside, to 
form a green indophenol. The colour intensity is proportional to the concentration of urea 
present in the sample. 
 
Urea +H2O Urease   CO2 + 2NH3 
 
NH3+ Salicylate + Hydro chlorite Nitroprusside Indophenol 
      OH 
Reagent (1) 
Consists of 60 mmol/l phosphate buffer, 1.5 mmol/L EDAT, 60 
mmol/L sodium salicate and sodium nitroprusside 5.2 mmol/L. 
Enzyme reagent  
Reagent (2) consists of hypochloride solution consisting of: 18 
mmol/L sodium hypochloride and 450 mmol/L sodium.  Reagent (3) 
consists of 75000/urease. 
Standard 
Urea 50mg/dl 
 
 
Procedure 
Add 1ml of reagent 1 and 3 to 10µl of the sample and standard, 
incubate for 5min. then add 1ml of reagent 2. Read in spectrophotometer 
(Unicam 8625/U.V. Vis U.K.) at wavelength 580 nm – 600 nm and 
measurement against blank and were measured as A standard and A samples 
Calculation  
 Serum urea concentration (mg/dl) =      A sample       x 30or50 
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                        A standard  
2.12.2.3Determination of serum direct bilirubin 
Measured according to (Young et al. 1975) using commercial kits 
(Linear chemicals, S.L.-Spain). 
Principle 
Bilirubin in the sample reacts with diazotized sulfanilic acid in the presence of DMSO. 
The formed coloured azobilirubin is measured photometrically. 
 There are two Bilirubin fractions in serum, Bilirubin-glucuronide and free Bilirubin 
which bind with albumin. 
The term total or direct Bilirubin refers exclusively to the reaction characteristic in the 
presence or absence of an accelerator or solubilizer and are only approximate equivalents 
of the two Bilirubin fractions. 
Reagent 
Reagent (1) consists of:  Sulfanilic ac. 50mmol/l, DMSO 7mol/l and 
HCL 50 mmol/l. Reagent (2) consists of: Sodium nitrate 29 mmol/l. 
Procedure 
Add to 100µl of the samples 1.5ml of the reagent 1and 50µl from 
reagent 2. Mix and allow to rest at room temperature for 5 min. and measure 
the absorbance in  a spectrophotometer (Unicam 8625/U.V. Vis U.K.) at 
wavelength 555 nm against blank and  were measured as A blank and A 
samples. 
 
Calculation 
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Direct serum bilirubin (mg/dl) = Reading ( A sample- Absor. blank)   
x 7 
     (A standard- A standard blank)  
2.12.2.4 Determination of serum total bilirubin 
 Measured according to (Young et al.  1975) using commercial kits 
(Boehringer Mannheim GmbH Diagnostics, West Germany). 
Principle 
Bilirubin is coupled with diazothized sulphonilic acid in the presence of caffeine to give 
an azo dye. No caffeine is added when direct bilirubin is determined. The formed 
coloured azobilirubin is measured photometrically.  There are two bilirubin fractions in 
serum, bilirubin-glucuronide and free bilirubin which is bind with albumin. The term 
total or direct bilirubin refers exclusively to the reaction characteristic in the presence or 
absence of an accelerator or solubilizer and are only approximate equivalents of the two 
bilirubin fractions. 
Reagent 
Reagent (1) consists of:  Sulfanilic ac. 50mmol/l and HCL 50 mmol/l, 
Reagent (2) consists of: Sodium nitrate 29 mmol/l, Reagent (3) Caffeine 
9mmol/l and Reagent (4) consists of Sodium tartarate and hydroxide 
50mmol/l. 
Procedure 
Add to 100µl of the samples 1.5ml of the reagent (1) and 50µl from 
reagent (2) and (3). Mix and allow to rest at 20-25o for 10 min.  and add 
reagent (4) and allow to rest at 20-25o for 5-30 min. and measure the 
absorbance in  a spectrophotometer (Unicam 8625/U.V. Vis U.K.) at 
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wavelength 578 nm against blank and  were measured as A blank and A 
samples. 
Calculation 
Serum total bilirubin (mg/dl) = Reading x 10.8 
2.12.2.5Determination of serum total protein 
Concentration was measured according to the method described by 
King et al. (1956) with Biuret reagent using commercial kits (Randox 
Laboratories Ltd. U.K.). 
Principle 
Proteins in the sample give an intense violet – blue complex with copper salts (П) in an 
alkaline medium. The intensity of colour is proportional to the amount of total proteins 
present in the sample. 
Reagent 
Buiret reagent 
It consists of 100 mmol/L sodium hydroxide, 16 mmol/L sodium and 
potassium tartrate, 15 mmol/L potassium iodide and curpic sulphate    6 
mmol/L. 
Blank 
It consists of 100 mmol sodium hydroxide and sodium – potassium 
tratrate 16 mmol. 
Standard 
It consists of Protein 60 g/l 
Procedure  
Add 5ml of the working reagent, then add 100µml of the standard and 
samples, mix and incubate at 37oC for 20min. read in spectrophotometer 
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(Unicam 8625/U.V. Vis U.K.) at wavelength 540 nm against blank. and they 
were measured as A standard and A samples 
Calculation 
Serum total protein concentration (g/dl) =     A sample   x 60   
                                             A standard  
2.12.2.6 Determination of serum albumin 
It was measured according to Barthlomew and Delany (1966) using 
commercial kits (Randox Laboratories Ltd. U.K.). 
Principle 
Albumin in the sample produces, in the presence of Bromocresol green, a colour change 
of the indicator from yellow – green, to yellow – blue at a slightly acidic pH. 
Reagents 
BCG concentrate: 75 mmol/L, pH 4.2 succinate buffer and 0.15 
mmol/L Bromocresol green. 
Standard  
Serum albumin 45 g/l. 
Procedure  
Add to 20µl of the standard and samples, 4 ml from the working 
reagent then read in spectrophotometer (Unicam 8625/U.V. Vis U.K.) at 
wavelength 623 nm against blank and were measured as A standard and A 
samples 
Calculation 
 Serum albumin concentration (g/dl) =   A sample   x 45   
                         A standard  
2.12.2.7 Determination of serum globulin 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
It was done by deduction of the total protein values from albumin 
values. 
2.12.2.8 Determination of serum phospholipids 
Phospholipids were measured according to the method described by 
Connerty et al. (1961) using commercial kits (Linear chemicals, S.L.-Spain). 
Principle 
The technique used mostly for phospholipids has been to extract them into a suitable 
solvent, for example ethanol-ether, to digest an aliquot of the extract with sulphuric acid 
and hydrogen peroxide to oxidize the phosphorus to inorganic phosphate and determine 
this by one of the methods used to inorganic phosphate. 
Reagents 
Consist of Trichbracetic acid solution, 50 g/l, 50 ml water + 25 ml 
concentrated sulphuric acid + 25 ml perchloric acid, Sodium acetate 
solution, 500 g trihydrate, Ammonium molybdate solution 25 g/l and Metol, 
1 g/100ml/sodium hydrogen sulphite solution (30 g/l). 
 
Standard situation 
It consists 4.085 g anhydrous KH2PO4/1 and 2 ml concentrated 
sulphuric. 
Working standard  
0.12 mm01 dilute the stock standard to 250 with water.  
Blank 
It consists of 0.25 ml concentrated sulphuric acid, 1 ml sodium 
acetate, 1 ml molybdate, 1 ml metol and 8.75 ml water 
Procedure  
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Add serum sample 0.2 ml + 5 ml trichoracetic, then filtered, then add 
reagent 2, 1 ml, then heat gently until becomes coulorless, Allow to cool, 
add 1 ml water and boil, dd 1 ml sodium acetate and make it to 10 ml with 
water, add 1 ml ammonium molybdate, 1 ml metol, and mix well and after 
15 min read at 700 mm against blank in spectrophotometer (Unicam 
8625/U.V. Vis U.K.) at wavelength 555 nm against blank. and they were 
measured as A standard and A samples 
Calculation  
Serum phospholipids (mmol/l)       =           Reading of unknown       x 
3.0 
                                                       Reading of standard 
The reading was expressed in (mg/dl)                     
2.12.2.9Determination of serum triglycerides  
 Measured according to ( Bucolo and David (1973) using commercial 
kits (Linear chemicals, S.L.-Spain). 
Principle 
The triglycerides in the sample are hydrolyzed enzmatically to 
glycerol phosphate by Glycerol kinase. Glycerol phosphate is oxidized to 
dihydroxyacetone phosphate by Glycerol phosphate oxidase. The liberated 
hydrogen peroxide is detected by a chromogenic acceptor, chlorophenol-
ampyrone, in the presence of peroxidase. The red quinine formed is 
proportional to the amount of triglycerides present in the sample. 
Triglycerides + H2O lipase  Glycerol+fatty acids 
Glycerol + ATP GK  Glycerol-3-P + ADP 
Glycerol-3-P + O2 GPO   Dihydroxyacetone + H2O2 
H2O2 +P-chlorophenol + 4-AP POD    Quinone + H2O 
Reagents 
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Reagent (1) consists of: buffer pH7.5, 50mmol/l and p-chlorophenol, 
2mmol/l. 
Reagent(2) consists of: lipase, 150000U/L, GK, 500U/L, GPO 2500 
U/L, POD, 440 U/L, 4-AP, 0.1mmol/l and ATP 0.10.1mmol/l. 
Procedure 
Mix reagent (1) with reagent (2) (working reagent). Add to 20µl 
sample and  20µl standard; 2.0ml from working reagent. Read in 
spectrophotometer (Unicam 8625/U.V. Vis U.K.) at wavelength 505 nm 
against blank and they were measured as A standard and A samples 
Calculation  
Triglycerides (mg/dl) =   A sample  x 10  
                                    A Standard 
 
2.12.2.10 Serum Total cholesterol  
Concentration was measured according to the method described by 
(Trinder et.  al.1969) using commercial kits (Linear Chemicals, S.L.-Spain). 
Principle 
 
In the presence of cholesterol esterase, the cholesterol esters in the sample are hydrolyzed to cholesterol and free fatty acids. The 
cholesterol produced is oxidized by cholesterol oxides to cholestenone and hydrogen peroxide is detected by a chromogenic of 
peroxidase. The red quinine formed is proportional to the amount of cholesterol present in the sample. 
Cholesterol esters+H2O    CHE   Cholesterol   + Fatty acid 
 
Cholesterol +O2 +H2O  CHOD   cholestenone +H2O2 
 
H2O2 + phenol +4-AP     POD   Quinone +H2O 
 
Reagents 
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Reagent (1) consist of: pipes buffer pH6.9,90 mmol/l, phenol 26 
mmol/l. 
Reagents (2) consist of: CHE, 300 U/L, CHOD, 300 U/L POD, 1250 
U/L and 4-AP, 0.4 mmol/l. 
Procedure 
Mix reagent (1) with (2) (working reagent):  then add 20 µl sample, 
20 µl standard and 2.0 ml from working reagent. Read in spectrophotometer 
(Unicam 8625/U.V. Vis U.K.) at wavelength 505 nm against blank and they 
were measured as A standard and A samples. 
Calculation 
Serum cholesterol (mmol/L) =                  Reading of unknown     x  
26 
                    Reading of standard 
2.12.2.11 serum glucose 
It was measured according to (Trinder, 1969)) using commercial kits 
(Randox Laboratories Ltd. U.K.). 
Principle 
Glucose in the sample is oxidized to gluconic acid in the presence of Glucose oxidase. The liberated hydrogen peroxide is detected by 
a chromogenic oxygen accepter, phenol-ampyrone. The red quinone formed is proportional to the amount of glucose present in the 
sample. 
 
Gloucose +1/2 O2 +H2O GOD    Gluconic acid + H2O2 
2H2O +phenol + 4-AP   POD Red Quinone + 4H2O 
 Reagents 
 Reagent (1)consist of :TRIS Buffer pH 7.4, 92 mmol/L, buffer 
Solution Phenol0.3 mmol/L 
Reagents(2)consit of: Glucose Oxidase15000u/l.EnzymesPeroxidase 
1000 U/L, 4 Aminophenazone 2.6 mmol/L. 
Standard Glucose Sol.100 mg/dL 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 Procedure  
Add to 10µl of the standard and samples 1.0ml from the reagents. 
Mix, incubate 10 min at 37oC or 30 min at room temperature. The colour is 
stable 30 min at room temperature.Read in spectrophotometer (Unicam 
8625/U.V. Vis U.K.) at wavelength 505 (490 – 550) nm against blank.at 
temperature 25/30/37oC and they were measured as A standard and A 
samples. 
Calculation 
Serum glucose (mg/dL) =        A sample   x 100  
                                   A standard 
2.12.3Minerals and trace elements change 
2.12.3.1 Serum Sodium and Potassium  
Concentration were measured according to the method described by 
Varley (1975) using flame photometer (400 flame photometer Corning – 
England). 
Stock standard     
Dissolve 58.45 g NaCl in litre of distilled water. 
Working standard 
High standard for: 8.0 of the stock, made up to 1 litre with distilled 
water. 
Low standard: 7.0 ml of the stock, made up to 1 litre with the 
distilled water. 
Dissolve 7.4g potassium chloride in 1 litre of distilled water. 
High standard: 7ml of the stock made up 1 litre with the distilled 
water. 
Low standard: 5ml of the stock, made up to 1 litre with the distilled 
water. 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Mix the two high standards together and the two low standards 
together. 
Procedure 
It is based on passing under controlled conditions, a dilute serum 
(1:100) as a very fine spray in the air supply to a burner where the solution 
evaporates and the salt dissociates to give neutral atoms. Light of 
characteristic wavelengths was emitted and passed through a specific filter 
for sodium (or potassium) on to a selenium cell and the amount of current 
produced was read on a galvanometer. The air pressure was adjusted to 10 
Lb/square inch and compressed air through the flam, passing compressed air 
through an atomizer into which the diluted serum was drawn by suction and 
then entered the burner with its air supply formed the spray. The gas and the 
air pressured were carefully regulated in order to maintain a constant and 
steady flame. Changes in the galvanometer reading were recorded in mmol/l 
and were measured as A standard and A samples. 
Calculation 
Sodium concentration (mmol/l) =      A sample    x 140 
       A standard  
Potassium concentration (mmol/l) =      A sample    x 5 
           A standard  
2.12.3.2 Determination of chloride  
Concentration was measured by the method described by Schales and 
Schales (1941) using commercial kits (Linear chemicals, S.L.-Spain). 
Principle 
Chloride ions in the sample react with mercuric nitrate forming a coloured complex 
proportional to the amount of chloride ions present in the sample. 
Reagent  
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Consists of 8.5 mmol/l Mercuric nitrate solution, dissolve 2.9to 3g 
(Hg(NO3))2 H2O in 100ml water, made up to litre with distilled water, 
diphenylcarbazone indicator, dissolve 100mg in 100 ml ethanol, store at 4oC 
in dark place and standard chloride solution 100 mmol/l. 
Procedure Add 0.2ml serum sample + 1.8 ml water, and then add 60 
µl of the indicator. The mixture was titrating with mercuric nitrate solution, 
which calibrated to 0.01 ml/l. Repeat the titration on 2 ml of the standard 
chloride solution. And they were measured as A standard and A samples. 
Calculation  
Serum chloride (mmol/l) =  
  ml titrant needed for A sample           x 100  
            ml titrant needed for A standard               
2.12.3.3Serum Magnesium  
Measured according to the method described by Gindler et al.(1971) 
using commercial kits (Linear Chemicals, S.L.-Spain). 
Principle 
Magnesium in the sample forms a coloured complex when it reacts with a calmagite 
solution in the presence of EGTA at alkaline pH. The intensity of coloured formed is 
proportional to the amount of magnesium present in the sample. 
Reagents  
Reagent (1) consists of aminomethylpropanol1mmol/l and 
EGTA0.21mmol. 
Reagent (2) consists of calmagite0.3mmol/l 
Procedure 
Mix reagent (1) with (2)(working reagent). Add to 10µl of the sample 
and of the standard, 1.0ml incubate for 5min. at 28oC and read the result as 
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A sample and A standard in spectrophotometer (Unicam 8625/U.V. Vis 
U.K.) at wavelength 520nm. 
Calculation 
Serum magnesium (mg/dl) =       A sample        x0.73 
                                                            A standard 
2.12.3.4 Serum Calcium 
 It was measured according to Stern et al. (1957) using commercial 
kits (Linear Chemicals, S.L.-Spain). 
Principle 
Calcium in the csample reacts with o-cresolphtaleine at alkaline pH. 
The coloured complex formed is propotional to the amount of calcium 
present in the sample.  
Reagents: 
Reagent (1) consists of: Ethanolamine500mmol/l. 
Reagent (2) consists of: o-cresolphtalein0.62mmol/l and 8-
hidroxyquiinoline 69mmol/l. 
Procedure 
Add 1ml from reagent (1) and (2) to 20µl mix, incubate for 5min. at 
room temperature. Read the result as A sample and A standard in in 
spectrophotometer (Unicam 8625/U.V. Vis U.K.) at wavelength 570nm. 
Calculation 
Serum calcium (mg/dl)=   A sample          x0.25 
             A standard  
2.12.3.5 Serum Inorganic Phosphorus 
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It was measured according to (Young, 1975) using commercial kits 
(Linear Chemicals, S.L.-Spain). 
Principle 
Inorganic phosphate reacts with sodium molybdate forming a phosphomolybdate 
complex. Its subsequent reduction in alkaline medium originates a blue molybdenum 
complex. The density of colour formed is proportional to the amount of phosphorus 
present in the sample. 
Reagent 
Reagent (1) consists of molybdate-borate 1.21 mmol/l. 
Reagent (2) consists of 1,2 diphenylendiamine  
Procedure 
Mix reagent (1) with (2) (working reagent).  
Add 3.0 ml of the mixture of the reagent 1and 2to 100 µl standard solution and also to 100µl to the 
test; read each at the wave length 710 nm in spectrophotometer (Unicam 8625/U.V. Vis U.K.). 
Measurement was done against blank and they were measured as A standard and A samples. 
Calculation  
Serum inorganic phosphorus mg/dl =          A sample    x 2.59 
            A standard 
2.12.3.6 Serum Zinc  
It was measured according to the method described by to Dawson and 
Walker (1969). 
Principle 
About a third of the plasma zinc is bound loosely to albumin with the rest more firmly 
bound to globulin. Zinc is a component of a number of enzymes, particularly carbonic 
anhydrase, carboxypeptidase A, dehydrogenase acting on alcohol, glutamate, 
glyceraldehydes-3-phosphate and lactate. Zinc activates many enzymes including 
dipeptidases and aminopeptidase. 
Stock solution (100 mg/L): Dissolve 0.1g pure zinc in 10 ml of 5 hydrochloride acids, 
made up to 1 liter with water. 
Stock solution (10 mg/L): 10 ml of stock (1) was pipetted into 100 ml 
volumetric flask, made up to 100 ml with water. 
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Stock solution (100 mg/L):10 ml of 2 was made up to 100 ml with 
water. 
 Sodium stock solution (140 m/L): 8.2 g of dry NaCl (zinc free) was 
dissolved in 1 liter water. 
Calibration 
0, 10, 20 ml of zinc stock solution 3 were each pipetted into 100 ml 
flask each flask was made up to 20ml with water. 
Corresponding to 0, 100, 200 ml in the sample solutions, 200 ml of 
serum was made up to a 20 ml with water and they were measured as A 
standard and A samples 
Calculation  
Zinc in serum = reading x 10   x   100     mg/100 ml 
               0.2      1000       
The result was expressed in (µmol//) 
2.12.3.7 Copper 
Copper was measured according to Ventura and King (1951) method. 
Principle 
After releasing the copper from protein by hydrochloric acid, the proteins a\re 
precipitated by trichloroacitic acid, and the copper extracted into amyl alcohol and ether 
as a golden yellow coloured complex with sodium diethyldithiocarbamate for 
colorimetric determination. Sodium pyrophosphate is added to prevent interference from 
iron. 
 
Reagents and procedure 
To each 3ml add 1ml 100mmol hydrochloric acid, worm in boiling 
water until begun to cloud cool, then add 1.5ml hydrochloric acid 6mol/l, 
stand for 10 minutes, then add 3ml trichloracetic acid, 200g/1, mix, stand for 
minutes, centrifuge the mixture, remove the supernatant fluid; wash the 
precipitate with 3ml tricloracetic acid, 50g/l, centrifuge again, remove the 
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supernatant, then add 1ml sodium pyrophosphate + 2ml ammonia; then add 
5ml amyl alcohol-ether, remove the organic layer and dry shaking with a 
little powdered anhydrous sodium sulphate and then read in spetrophotometr 
(Unicam 8625/U.V. Vis U.K.) at wavelength 440nm. and they were 
measured as A standard and A samples. 
Stock standard solution 
Dissolve 500mg copper sulphate in water, then add 0.1 ml 
concentrated sulphuric acid and make up to 1 litre (2mmol/l). 
Standard work solution 
Dilute the above 1 to 100 to obtain a solution containing 20 nmol/l. 
Treat 5ml standard, (100 nmol of copper) in the same way as the serum. 
Calculation 
Serum copper (mmol/l) = A sample x    33. 3 
                          A standard 
The result was expressed in (µmol/l) 
2.12.3.8 Serum Manganese 
Principle 
The serum was dissolved with distilled water as 2ml to 8ml according 
to (Jeffery et al., 1989). Read the sample in atomic absorption (Cornning 
EEL 197Spectra- Evans Electroselenium Ltd., England) at wavelength 
279.5nm or 1-4 air acetylene/l (fuel lea). 
Calculation:  read the result from the standard curve as mmol/l. 
 
2.12.3.9 Serum Iron 
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Iron was measured according to the method of (Caraway, 1959 and 
1963) using commercial kits (Linear chemicals, S.L.-Spain). 
Principle 
Iron in the sample is dissociated from transferring-iron complex in weakly acid medium 
and the liberated iron is reduced into ferrous ions by means of ascorbic acid. The reduced 
form reacts with Tripyridil – Triazine (TPTZ) forming a blue complex. The coloured 
intensity is proportional to the iron concentration present in the sample.  
Reagent  
Reagent (1) consists of citrate pH 2.2 50mmol/l; reagent (2) consist of 
ascorbic acid 113.5mmol/l, while reagent (3) consists of Tripyridil – 
Triazine (TPTZ) 9.6mmol/l 
Procedure  
Mix reagent(1) and (2) (working reagent), then add 2.0 ml from the 
mixture of 1 and 2 and one drop from reagent 3 to 500µl, sample and 500µl 
standard, keep at20-50 oC for 5 min., read in spectrophotometer (Unicam 
8625/U.V. Vis U.K) at wavelength 595 nm. and they were measured as A 
standard and A samples 
Calculation 
   Serum iron (µg/dl) =  A sample    x 40 
                                       A standard 
2.13 Determination of serum hormones 
2.13.1 Determination of serum total T4  serum total T3 
It was done using Amersham, international, Amersham, Bucks, UK,  in 
gamma counter (Nuclear Enterprises, NE, 1612, Turbo) at RIA lab. Of 
Sudan Atomic Energy Commission (SAEC)-Khartoum. The results were 
analyzed using the WHO Immunoassay Programme (A5.2). 
Principle 
Antigen (Ag) and tracer (Agt) compete with a limited amount of 
antibody (Ab) to form Ab-Agt complexes. When this reaction reached an 
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eguilibrium, the free fraction of both antigen and tracer are removed using 
appropriate separating agent, then the Ab-Agt comlex is counted for 
radioactivity using appropriate gamma counter. 
Ag+ Ab +Agt                         (Ab - Ag) +(Ab-Agt) + Ag+Agt    = 
separation (to give) 
1- Counted in gamma counter               deposit (Ab-Agt) + (Ab- Ag) 
2- Decanted                      supernatant Agt + Ag 
2.13.1 .1Determination of serum total T4  
 Reagents  
It consists of : Assay phosphate buffer (0.05 M, pH 7.4): 7,13g 
Na2HPO4.2H2O and 1.53 g NaH2PO4.2H2O were dissolved in one litre of 
distilled water and stored at 4C with the addition of 0.1% NaN3; wash 
buffer: 0.1% triton X-100 in 0.05 M phosphate buffer; I125-T4: the high 
radioactive hormone was diluted by addition of assay buffer to give a 
solution of 20,000 counts/minutes (c.p.m.); quality control sera (Q.C): 
provided by SAEC and labeled (A) high, (B) normal and (C) low; standards: 
reconstitution of T4 standards gives concentrations of 300, 150, 85, 37.5, 
18.75 and 0.0 nmol/L; donkey Anti-Sheep Serum (DASS); sheep anti-T4 
serum and T4/ANS assay buffer 4 g of 8-anilino-I-naphthalene sulfonic acid 
(ANS) dissolved in 100ml of assay phosphate buffer. 
Procedure 
The assay is performed by using tubes containing: samples standards, 
quality control (Q.C) and non-specific binding (N.S.B); the total control 
count tube contains only 100 ul of the tracer; 50 µl of the sample, standard 
and Q,C, were pipetted, then to all tubes 100 µl of ANS (0.4%), 100 µl of 
DASS and 100 µ l of I125-T4 were added, 100 µ l of sheep anti-T4 antiserum 
were added to the tubes containing samples, standards and Q.C, all tubes 
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were vortexed and incubated for one hour at 37oC (water bath), one ml of 
wash buffer was added to all tubes, all tubes were centrifugated at 3000 rpm 
for 5 minutes at room temperature (20-26oC).  
Calculation  
The supernatant was decanted and the deposit was counted for 60 
seconds in a gamma counter, all tubes were prepared in duplicates and they 
were mixed after each addition. 
2.13.1.2 Determination of serum total T3 
Reagents It consists of Assay phosphate buffer (0.05 M, pH 7.4): 
7,13g Na2HPO4.2H2O and 1.53 g NaH2PO4.2H2O dissolved in one litre of 
distilled water and stored at 4 oC with the addition of 0.1% NaN3, wash 
buffer: 0.1% triton X-100 in 0.05 M phosphate buffer; I125-T3: the high 
radioactive hormone was diluted by addition of assay buffer to give a 
solution of 12,000 counts/minutes (c.p.m.); quality control sera (Q.C): 
provided by SAEC and labeled (A) high, (B) normal and (C) low; standards: 
reconstitution of T3 standards gives concentrations of 0.00, 0.6, 1.25, 1.25, 5 
and 10 noml/L; donkey Anti-Sheep Serum (DASS); sheep anti-T3 serum and 
T3/ANS assay buffer 2 g of 8-anilino-I-naphthalene sulfonic acid (ANS) 
dissolved in 100ml of assay phosphate buffer. 
ProcedureThe assay is performed by using tubes containing: samples 
standards, quality control (Q.C) and non-specific binding (N.S.B), The total 
control count tube contains only 100 µ l of the tracer to 50 µl of the sample, 
standard and QC, were pipetted then to all tubes 100 µ l of ANS (0.4%), 100 
µ l of DASS and 100 µl of I125-T3 were added and 100 µ l of sheep anti-T3 
antiserum were added to the tubes containing 50 µl samples, standards and 
Q.C. All tubes were well vortexed and incubated for one hour at 37oC (water 
bath) then add 1 ml of wash buffer was added to all tubes except that of the 
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total count then all tubes were centrifuged at 3000 rpm for 5 minutes at room 
temperature (20-26oC).  
Calculation 
 The supernatant was decanted and the deposit was counted for 60 
seconds in a gamma counter to all tubes were prepared in duplicates and 
they were mixed after each addition. 
2.13.1.3 Progesterone radio immuno assay (PRI)        
The kits (Agriculture Laboratory, Austria) were used and assembled 
by the Animal Production Unit, International Atomic Energy Agency 
(IAEA). The procedure was done according to FAO/IAEA assay protocol 
version 3-1 (1996). 
 
Principle 
The method depends on the competition between progesterone in 
serum samples and I-labeled for a limited number of binding sites on a 
progesterone specific antibody immobilized (coated) on the internal walls of 
the test tubes (solids phase). The proportion of the I-labeled progesterone 
bond to the antibody is inversely related to the concentration of the 
progesterone present in the serum. After completion of the reaction and 
separation of hormone, it is possible to calculate blood progesterone 
concentration from a standard curve, using serum standard.   
Reagents and technique 
Progesterone antibody coated tubes, buffered I-labelled progesterone 
(iodine tracer), and store at 2-8oC in glass bottles of 110 ml covered with a 
rubber stopper, progesterone standard (sodium azide and gentamicin as 
preservatives). 
Procedure 
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At room temperature, labeled anti body-coated tubes for standards 
(STD), internal quality control (QC), add 100µl of STD, QC and samples, 
then add 1ml of I-progesterone was pipetted into each tubes within five min., 
cover the tubes with parafilm and incubated for 4 h. at room temperature, 
hold the tubes upside-down to remove the residual droplets, read at gamma 
counter. 
Calculation 
The maximum binding percentage in the assay (B max) was 
calculated by dividing the average counts per minute(cpm) of the two zero 
standard tubes (B0) by the average (cpm) of the total count tubes(TC) and 
then multiplied by 100 as in the following equation: 
B max=  average cpm of zero STD x100 
             Average cpm of TC 
The percentage binding values for all, standards, samples and QC 
tubes were calculated by dividind each cpm of these tubes with that of zero 
STD tubes and then multiplied by 100 as in the following equation: 
B = Average cpm of STD( samples/ QC) x 100 
B0  Average cpm of B0 
Where theB/B0 was the percentage of the STD, samples or QC bound 
by the antibody in comprison with B max.  
Using the logit-log grah paper provided with the kits, the average 
percentage bound(B/B0) was plotted on the vertical Y axis and the 
progesterone standard concentraion on the horizental X axis in nmol/l.  
2.14 Total arsenic (as residues of Cymelarsan) in animal tissues, 
urine and bile 
Arsenical compounds were detected by measurement of total arsenic. 
CymelarsanR in milk and meat was measured by measurement of the total 
arsenic in infected camels in Kenya using recommended route (Sones, 1991) 
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and in camel’s serum in Morocco(Toutain,1989)using intravenous route. 
Groups of arsenical compounds (phynyle arsenoxides, arsphenamines, 
arsonic acids, acid-substituted phenylearsenoxides and inorganic arsenicals) 
in plasma were elucidated by detection of total arsenic in urine, stool, blood 
and tissues(Ralph et al,1944). The RM340, immiticide in infected dogs with 
(Dirofilaria immitis) with doses 2.5 mg/kg twice at 24h. intervals  (Toutain, 
1990) or 2.2 mg/kg twice at 3h. intervals (Toutain, 1990) or using 
intravenous rout in dogs (Sundlof et al,1986 and Guisppin, 1986).  
CymelarsanR is an arsenical, patented in (1985) and discovered by 
Friedheim. It is introduced to the market by Rhône, Mérièux – (France). It is 
a combination of Melarsenoxide and cyseamine. The residues of Cymelarsan 
were measured by  the total arsenic according to (AOAC, 1995) method. 
Tissues were ashed, but bile, serum and urine were used as such. 
2.14.1Total arsenic in tissue 
Dry ashing 
Blend tissue specimens in high-speed blender then pass fibrous tissue 
through meat grinder, weigh 10g tissue; add 3g MgO + 20 ml cellulose 
powder only 10 ml cellulose powder to muscle sample, mix well, then cool, 
add 3 g Mg (NO3) 2. 6H2O, place in 55o.* Reach, operating temperature, ash 
for 2h, cool, moisture ash with 10 ml H2O, make to 250 ml and Add 90 ml 
6N HCl (Erlenmeyer) dilute to 175 ml with H2O. 
 
 Reagents 
These consist of Silver diethyl dithiocarbamate and Chill 200 ml 
AgNO3, 0.1 M in 10oC (or lower); 200 ml sodium diethyl dithiocarbamate 
solution in 10; Add 1 to 2, filter; Dissolve salt in pyridine, chill, add cold 
water slowly, filter, wash with H2O; Dry pale yellow crystals under reduced 
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pressure (185 – 187o); Recrytallize; Store in refrigerator; Silver diethyl 
dithiocarbamate solution and Dissolved 0.5 g  in colorless pyridine 100 ml. 
Procedure 
Add 2 ml KI solution 15%, swirl then add 1 ml SnCl2 solution, swirl, 
cool for 45 min in 4oC, prepared blank containing 90 ml 6N HCl and 85 ml 
H2O, treat; Trapping solution it consists of: 3 ml silver diethyl 
dithiocarbamate, place in ice bath and add 10g Zn to cooled Erlenmeyer. 
Determine reagents and samples in spectrophotometer (Unicam 
8625/U.V. Vis U.K.) at wavelength 450 nm against blank. 
Arsenic standard solutions (stock) 
Dissolve 0.66 AS2O3 in 25 µl 2N NaoH, dilute to 1 litre with H2o; 
working solutions (0 – 2 ppm) before use and dilute with H2o 
Preparation of standard curve 
Add 2 ml working standard solution to 10 g tissue to provide curve 
desired range (0 – 2 PPAS) then carry samples through ashing and 
distillation and determine best fitting straight line from ≥ 4 sets of 
determination for each tissue by method of least squares. 
Calculation 
Determine As content from standard curve. 
2.14.2Total arsenic in urine, serum and bile  
To 5ml of the sample; add 3g MgO + 20 ml cellulose powder mix 
well then cool, add 3 g Mg (NO3) 2. 6H2O, place in 555o. Reach, operating 
temperature, ash 2h, cool, moisture ash with 10 ml H2O, make to 250 ml and 
Add 90 ml 6N HCl (Erlenmeyer) dilute to 175 ml with H2O. 
 Reagents 
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Consist of Silver diethyl dithiocarbamate and Chill 200 ml AgNO3, 
0.1 M in 10oC (or lower); 200 ml sodium diethyl dithiocarbamate solution in 
10; Add 1 to 2, filter; Dissolve salt in pyridine, chill add cold H2O slowly, 
filter, wash with H2O; Dry pale yellow crystals under reduced pressure (185 
– 187o); Recrytallize; Store in refrigerator; Silver diethyl dithiocarbamate 
solution and Dissolved 0.5 g from a in colorless pyridine 100 ml. 
Procedure 
Add 2 ml KI solution 15%, swirl then add 1 ml SnCl2 solution, swirl, 
cool for 45 min in 4oC, prepared blank containing 90 ml 6N HCl and 85 ml 
H2O, treat; Trapping solution it consist of : 3 ml silver diethyl 
dithiocarbamate, place in ice bath and add 10g Zn to cooled Erlenmeyer. 
Determine reagents and samples in spectrophotometer (Unicam 
8625/U.V. Vis U.K.) at wavelength 450 nm against blank. 
Arsenic standard solutions (stock) 
Dissolve 0.66 AS2O3 in 25 µl 2N NaoH, dilute to 1 litre with H2o; 
working solutions (0 – 2 ppm) before use and dilute with H2o 
Preparation of standard curve 
Add 2 ml working standard solution to 10 g tissue to provide curve 
desired range (0 – 2 PPAS) then carry samples through ashing and 
distillation and determine best fitting straight line from ≥ 4 sets of 
determination for each tissue by method of least squares. 
Calculation 
Determine As content from standard curve. 
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2.15 The residues of oxytetracycline (OTC) in serum, urine, and 
tissue 
OTC was measured by two methods: Microbiology and with high 
pressure liquid chromatography (HPLC) assay as follows: 
 
2.15.1 The residues of oxytetracycline in serum, urine, bile and 
tissue 
microbiologically 
OTC was measured according to the method described by (Koenen-
Diericket.al.1995). 
Procedure of Culture medium 
Nutrient agar (Merck7883) was prepared with dextrose 0.4% w/v; 
then sterilized by autoclaving at 121oC for 20 min; pH 7 ± 0.05 1N NaOH 
and 1N HCl cool at 50oC; spore suspension (Merck10649) containing 104 
Bacillus subtilis BGA spores; 40 ml of the culture medium was pored into 9 
cm Petri dishes; keep at 4oC upside down in plastic bags; used between 1 – 7 
days.  
Control samples  
Four paper disks of 12.7mm diameter containing 1µg oxytetracycline. 
Preparation of standard curve 
Paper disks containing 0.5, 1.0, 2.0, and 4.0 µg of pure 
oxytetracycline (Glaxo Lab. Cairo, Egypt) was spotted on the agar medium 
in duplicate. The zones of inhibition were measured after incubation at 30oC. 
Then the standard curve was made. 
Samples of tissues  
6 – 8 mm diameter and 2mm thick of tissues was taken by cork and 
pored in the solidified agar medium then it was incubate overnight at 30oC. 
Samples of bile, urine and serum 
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Paper disks of 12.7mm diameter saturated with urine, bile and serum 
then pored in solidified agar medium.  
Calculation 
 Measure the inhibition zone and read from the standard curve then it 
was incubating overnight at 30oC. 
2.15.2 The residues of oxytetracycline (OTC) in serum, urine, bile 
and tissue using (HPLC) 
Material agents:  
Chromatograph:  LDC Model 4000. 
Wavelength:  SM 4000 and LDC IC 4000 integrator. 
Column: Hypersil 10 MOS (octylsilyl silica gel). Length 250 mm. 
Mobile phase: sodium dihydrogen orthophosphate 0.1 75v. 
  Acetonitrile 25v. 
  Add 7.8 g/l tetrabutylammonium bromide and adjust pH 
to with 2N sodium hydroxide solution. 
Isocratic program 
Flow: 1.5 ml/mn 
Injected volume 
20l 
Sensitivity of the detector 
0.2 AUFS. 
Preparation of solution   
Reference solution: 
Dissolve a 40 mg (4000IU) sample Ss (g) accurately weighted of 
oxytetracycline in 100 ml mobile phase. Dilute 5 times with same solvent. 
Test solution 
Dilute a 1.0 ml sample S of Remacycline L.A. in 100 ml of mobile 
phase. Dilute 25 times with same solvent. 
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Calculation 
The retention time of oxytetracycline contained in the test solution 
should be concordant with the retention time of the standard OTC. 
Determine the peak areas: 
A: peak area of OTC contained in the test solution. 
B : peak area of OTC contained in reference solution. 
The OTC content (g/ml) of the sample being examined is: 
  A*Ss   *500 
  B*S 
2.16 Detection of quinapyramine 
It was measured according to (Agropharm limited Buckingham 
House-England) 
Identity 
The infrared spectrum between 2.5 and 15u of a 0.1% dispersion of 
the sample in potassium bromide should not be significantly different from 
that of an authentic specimen of quinapyramine sulphate. Mix 0.1g sample 
in 10ml water, add 2 drop concentrated HCl, boil for 5min., cool and filter. 
Add 2 drops 10%w/v barium chloride solution to the filtrate and mix;  a 
white precipitate should be produced. 
Reagent 
Sodium hydroxide thiosulphate reagents: 
Mix 200 ml 50% w/v with 50 ml 16% w/v sodium thiosulphate and 
cool. 
Sample 
 0.25g 
Procedure 
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Weigh about 0.25g sample, add 6g anhydrous sodium sulphate, 0.6g 
yellow mercuric oxide, 13ml concentrated sulphuric acid and a few 
carborundum granules. Then heat, continue the digestion for 2 h. allow cool, 
adding continually 175 ml water, swirling to dissolve any solid and cool. 
Add 65 ml of the sodium hydroxide thiosulphate reagent carefully 
without mixing connect to an ammonia distillation apparatus, mix and distill 
into 50.0 ml 0.05M. sulphuric acid containing 3 drops screened methyl red 
indicator solution until bumping commences, wash down the  condenser and 
delivery tube with a little water, collect the washing in the flask containing 
the sulphuric acid and titrate the excess acid with 0.1 M sodium hydroxide. 
Blank 
12 ml concentrated sulphuric acid and distilling into mixture of 10.0 
ml of the 0.05M. sulphuric acid and 40 ml water. 
Microbial Contamination 
Carry out the determination in duplicate. 
Aseptically weigh 1g samples into 100ml of quarter strength Ringers 
solution in a jar, and shake vigorously to dissolve then filter through a 
0.45um porosity hydrophobic edged membrane. Wash the filter with 200ml 
sterile distilled water, place face up on a Trypton Soya Agar plate, incubate 
at 23oC for 7 days then count the number of colonies. 
Hi performance liquid chromatography (HPLC) examination 
Examine under the following condition: column 25cmx4.6mm i.d. 
Parlisil 5, mobile phase0.5%w/v ammonium acetate and 0.25%viv glacial 
acetic acid in methanol/water (9:1by volume), flow rate 2.0ml/min., sample 
solution a 0.1%w/v solution in methanol/water(1:1 by volume), reference 
solution a 0.1%w/v solution of an authentic specimen of  quinapyramine 
sulphate in methanol water (1:1 by volume)., detector  U.V. at 254nm, 
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injection volume 10ul, attenuation 0.5a.u. f.s  for quinapyramine and 0.05 
a.u.f.s for impurities.  
Calculation 
Quinapyramine sulphate % = 
    40 f1 + (B – A) f2) x 88.77 
                   W (100-L) 
Where: 
 A: ml 0.1M. sodium hydroxide used in sample titration 
 B: ml 0.1M sodium hydroxide used in  blank  titration 
 f1: factor of 0.05M. Sulphuric acid. 
 f2: factor of 0.05M. Sodium  hydroxide. 
 W: weight of sample used. 
L: loss on drying (1.5%) 
2.17 The effect of oxytetracycline on T. evansi in phosphate glucose buffer solution 
(PGS): 
The stock: 
0.59g of PGS 
9.5ml (0.1%) NaOH 
Complete to 100 ml with distilled water. 
The buffer 
 29.4g sodium citrate 
Complete to 100ml with distilled water. 
Citric acid 
21g citric acid. 
Complete to 100 ml with distilled water. 
Working solution: 
6 ml of the stock, 32 ml of the buffer and 17.3 ml of citric acid and complete to 1 liter 
with distilled water. 
The trypanosoma evansi added to the working solution and preserved in liquid nitrogen. 
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Oxytetracycline (100%) added to the work solution when there is a live trypanosomes in 
different concentration (0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.5 µg/ml) the live 
trypanosomes examined every hour for 72 hrs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Three 
Results 
Experiments with Nubian goats  
3.1Experiment 1: Toxicity and efficacy of CymelarsanR in goats infected with T. 
evansi at single and multiple doses  
The study included two control groups group (1)(uninfected untreated) and group 
2(infected untreated). 
3.1.1Parasitaemia 
3.1.1.1 Parasitaemia in peripheral blood 
a/ post-infection: 
Table (1) summarizes the parasitaemia in the peripheral blood of the goats infected 
with T. evansi and treated with single and multiple dosages of Cymelarsan T. evansi is 
detected in the peripheral blood of goats in group (2) which is mild on days4-5 (+), 
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moderate on day6 (++) and severe on days7-10 (++++) until the animals are died on 
days9-11. Goats in groups (3-10) also showed mild parasitaemia on day 4 and the 
severity gradually increased till day11 (+++++). 
b/ post treatment: 
Parasitaemia disappeared completely post treatment of goats of groups (5, 6, 9 and 
10) until they died or slaughtered but it appeared 3-4 days post treatment in goats of 
groups (7 and8) then disappeared completely until they died or were slaughtered. The 
parasitaemia in goats of group (3) was mild but animals died on day 13-15post 
treatment. 
3.1.1.2 Parasitaemia in liver impression smears  
Parasites detected by the liver impression smears in goats infected with T. evansi and 
treated with single and multiple dosages of Cymelarsan are summarized in table (2). 
No parasites were detected in goats of group (1) while; goats of group (2) showed 
moderate parasitaemia (++) throughout the period of 9-11 days post infection. Goats 
in groups (4-10) subjected to the slaughter program weekly for 5 weeks after the 
cessation of the drug treatment have not shown the parasites in their livers. It is 
noticed that livers of goats in group (3) showed mild parasites (+) at weeks 1, 2, 4 and 
5 but negative in week 3.  
3.1.2Clinical signs and investigation  
Table (3) and figures (1a and b) illustrate changes in the body weight, body  
temperature, pulse rate, respiratory rate, blood pressure and fate of the animals in 
Nubian goats infected with T. evansi and treated with single and multiple doses of 
Cymelarsan. 
No clinical signs were observed in goats of group (1). Goats in group (2) showed 4-7 
days post infection hypothermia, watery lacrimation, frothy salivation,  mucopurlent 
conjunctivitis, mucopurlent nasal discharge, decrease in appetite, severe diffuse 
alopecia (plate1), diarrhoea, depression, apathy, muscle tremors, slight increase in the 
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respiratory rate, decrease in the pulse rate , convulsion and shivering. In the second 
week, the lymph nodes and testes were hot and swollen, and animal became off food, 
cachexia, recumbent with lateral kink of the neck for 1-2days then the animals died.  
 
Post treatment (pt), in the first week, all goats showed swelling at the site of injection, 
which disappeared after 1-2 days in goats of groups (3, 4, and 5) and never 
disappeared in other groups. Goats in group (3) showed mild clinical signs as that of 
group (2) and there was keratitis while goats of group (4) showed nasal discharge and 
mild diarrhoea. Goats of group (5) showed no apparent clinical signs except the 
diarrhoea, which stopped on day 3 pt. In contrast, goats in groups (6-10) showed 
watery lacrimation with mucopurlent conjunctivitis, accompanied with blindness in 
goats of groups (6and 7) and in 75% of goats in groups (8-10), mucopurlent nasal 
discharge, frothy salivation, fever, depression, apathy, pressing the head against 
objects (plate2), watery diarrhoea for 3-4 days then changed to bloody diarrhoea, 
bloody urine, muscle tremors, decrease in appetite, slight increase in the respiratory 
rate, decrease in the pulse rate . In the second week, groups (8-10) showed hot and 
swollen lymph nodes and testis, severe diffuse alopica which is slight in the other 
treated groups, with no shivering or convulsion, weakness (tonic paralysis) in the 
forelimb (plate 3and 4), in sternal recumbent, off food, emaciation and anuria. These 
sings continued until the death. 
Goats in groups (6-10) showed skin lesions (plate 5)in the second week as red 3mm 
raised concave nodules which increased in size to 5mm then changed to a brown scab 
these scabs when removed by hand left white to yellowish ulcers, when excised a 
greasy white yellowish hard material was seen and remained until death. An increase 
in the body weight was observed in goats of groups (4-5) and it was decreased in 
groups (6-10). 
 3.1.3Gross findings pathology  
Table (4) summarizes the factually of the gross findings in goats infected with T. 
evansi and treated with single or multiple dosages of Cymelarsan. No gross findings 
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were observed in goats of group (1). The gross pathological findings in groups (2, 3 
and 6) were moderate to severe lesions, while goats in groups (4and 5) showed mild 
or no lesions. Lesions were congestion, oedema and haemorrhage in the different 
organs including lung (plate 6), froth on the trachea, and flabbiness and dilation of the 
heart (plate 7), while fatty change and or necrosis is investigated mainly in livers and 
kidneys. Haemorrhage under the liver capsule (atelectasis) were also observed (plate 
8)in addition nephritis, gastritis, enteritis, peritonitis and hydroperitoneum, 
spleenomegaly (plate 9), myositis and peripheral nerve necrosis (plate10) at the site of 
injection,  lymphadenitis, orchitis (plate 11) and hypoatrophy of the left testis (plate 
12) and the thyroid gland are also investigated. It was noticed that these lesions had 
disappeared by the fourth week post treatment in goats of groups (4and 5). The goats, 
which were, received multiple dosages of the drug showed mostly same lesions but 
increased in severity.  
3.1.4Histopathological findings  
Cerebellum: goats in groups (2-3and6- 10) showed diffuse vacculation around the 
neurons which were elongated in shape and with dark stain, some of them still 
maintained star-shapes with eccentric nuclei (plate 13), glial cell proliferation and 
widening of perivascular spaces(plate 14), congestion and haemorrhages (plate 
15).Goats in groups (4and 5) showed no significant lesions in cerebellum. 
Cerebrum: slight congestion and haemorrhages were observed in goats of group (6) 
while, goats in groups (2-3and 6-10) in addition showed vacculations mainly around 
neurons (plate 16) and  widened in prevascular’ spaces.  
Group (3) showed in the first two weeks slight widened perivascular spaces in the 
brain.  No significant changes were observed in goats of groups (4-5). 
Spinal cord: showed proliferation of ependymal canal with glial cell around the 
central canal in goats of groups (2, 6 and7),and vacculations in white matter were 
seen in goats in groups (2 and 3-10) while; goats in groups (6-8) showed widening 
prevascular spaces. In goats of group (9) the spinal cord showed vacculations, 
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irregular axons sheaths, and neurons degeneration, (rounded cells, and central 
chromatolysis) (plate17). No significant lesions were observed in the goats of groups 
(4and 5). 
Peripheral nerves: were normal in goats of groups (2-5), but showed diffuse 
vacculations in goats of groups (6-10) and loss of nerve structure in goats of groups 
(8-10). 
Tongue: Sections of goats in groups (2-7and 9-10) were normal.  Some goats of 
group (8) showed melanosis. 
Thyroid glands: goats in groups (2-10) showed congestion while in goats of groups 
(2, 6, 7,9and 10) the glands were atrophied with a loss of thyroid tissues. Some 
sections of goats in group (5) showed empty follicle.  
Lung: the lungs of goats in groups (2, 3, 6-10) were emphysematous, oedematous, 
and congested.  Exudates and RBC were seen in bronchioles of goats in groups (6- 
10). Alveoli were haemorrhagic and collapsed and focal pneumonitis was observed in 
groups (2, 3, 6, and 7). Goats in group (10) showed mononuclear cell infiltration 
(lymphocyte, and macrophage) thickened alveolar septa, fibrinous exudation in 
alveoli and foci of interstitial pneumonia (plate 18).  
Heart:  congestion, moderate haemorrhages and lymphocyte infiltration in the cardiac 
muscle were noticed in goats of groups (2, 6-10). Focal or diffuse vacculations in the 
cardiac muscles were seen in goats of groups (6-10). Goats in groups(4,5,8 and 10)  
showed myodegeneration, with neutrophils infiltration, oedema and slight 
haemorrhage (plate 19). 
Liver: goats in groups (2 and 6-10) showed congestion; sinusoidal dilatation, slight 
cetrilobular necrosis and some times scattered foci of lymphocytes and macrophages 
(plate20). Widened portal tracts were seen in goats of groups (2,6and 9). 
Haemosiderin, deposits were also observed in the liver of goats in groups (8and 9) 
while hepatic fibrosis was detected in goats of group (10). 
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Spleen: congestion and haemosedrosis were noticed in spleens in goats of groups (2-5 
and10), while goat in groups (6-10) showed haemosiderosis thickened trabiculae, and 
follicle around the white pulp. Groups (9-10) showed congestion and haemorrhages of 
the red pulp with haemosiderosis and depletion lymphoid tissue.  
Kidney: Goats of groups (2and3) showed dilatation of tubules, increase in glomerular 
cellularity, congestion and haemorrhage. Groups (4 and 5) showed slight congestion, 
and those of group (6) showed hypercellurity of glomerular tuft (extracted glomeruli), 
however,  group (7) showed widened tubules and haemorrhage, group (8) showed 
pale tubule, absence of nuclei, hypercellularity of glomerular tufts, and goats in group 
(9)  showed small lobulated glomerulai, thickened wall of glomerular and epithelial, 
diffuse interstitial tissue, glomerular, swollen vascular endothelium,., emptiness of 
glomerular capillaries and dilated tubules. Goats in group (10) showed dilated tubules 
and interstitial haemorrhage. 
Small intestine: Congestion and loss of villus epithelium were seen in goats of 
groups (6-10). Goats in groups (2,6 and10) showed submucosal oedema. Also the 
blood vessel's walls were thickened, was observed in goats of group (10) while, 
groups (4,5 and7) showed no significant changes.  
Colons:  section of groups (2 and 3) showed congestion and haemorrhage, also slight 
congestion was observed in group (6) and no lesions were observed in goats of groups 
(4,5and 7-10).  
Tendon: no obvious lesions were observed in goats of groups (2 -10). 
Sites of injection Goats of group (6) showed oedema and diffuse vacculations of 
peripheral nerves. 
Leg muscle: Section from groups (2-5) was normal while the leg muscle in goats of 
groups (6-10) showed oedema and cellular infiltration (plate 21). 
 Lymph nodes: section from groups (4-5) showed no significant changes, while that 
of groups(2-3)were congested and hyperplastic the medullar part attached with big 
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contained abundant interstitial tissues, and dilated blood vessels specially in goats of 
groups (6,8and 9) while lymph nodes of groups (7 and 10) were   haemorrhagic.  
Testis: there were congestion and haemorrhages in the testis of groups (2-5 and8). 
Goats of group (7) showed tubular atrophy. Some somniferous tubules in group (6) 
were necrotic and appeared as solid dark mass separated by a wide interstitial tissue 
(plate 22). However other tubules showed evidence of functional activity with few 
spermatogonia. Sections from group (9) showed congestion and evidence of slight 
activity while those of group (10) showed loss of some tubules and absence of activity 
(plate 23).  
3.1.5Hematological changes: 
Tables (5and 6) and figure (2a and b) summarize the haematological changes in goats 
infected with T. evansi and given Cymelarsan at single or multiple dosages. The 
haemoglobin concentration (Hb), packed cell volume (PCV) and red blood cell count 
(RBC) decreased significantly in goats of groups (2, 3, 6 -10) but were within 
reference interval in groups (4 and5) compared to the control group (1). Slight and 
statistically insignificant increase was observed in white blood cell counts (WBC) in 
all groups. Moderate increase was observed in the reticulocytes count of group (2), 
which slightly increased in goats of groups (3and 7 -10). Significant increases were 
observed in platelets count, neutrophiles and eosinophiles of goats in groups (2,6-10), 
but they were within reference interval in groups (3,4 and5) compared to control 
group (1). Basophiles were absent in control group (1) but showed an increase in 
other experimental groups; however monocyte counts fluctuated in the test animals. 
Lymphocytes count decreased significantly in all experimental animals compared to 
control group (1) and goats of groups (4and 5). Significant increase was observed in 
the MCV of all groups tested except goats in groups (1, 2,4and5) while the MCH 
decreased moderately in group (6) and sharply in group (3). No significant changes 
observed in the MCHC of all experimental animals. 
3.1.6 Serobiochemical changes 
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Tables (7-9) summarize the serobiochemical changes in goats infected with T. evansi 
and treated with single or multiple doses of Cymelarsan. The serum sodium 
concentration increased slightly but not significantly in all groups except goats that 
group (6) where there was a significant decrease. Serum potassium concentration 
showed moderate increases in groups (2,5,7-10) but slight decreases in group (6). The 
serum chloride concentration increased in groups (2,3,6,7,9and10) but not in groups 
(1,4,5 and8). Sharp decrease was depicted in the serum concentration of calcium and 
phosphorus in goats of groups (3and6), however increase was observed in the serum 
magnesium concentration in the same groups.  
No significant changes were observed in serum zinc and copper concentration among 
the experimental groups. Also no significant changes were detected in serum 
manganese except goats in groups (2 and 9) where it was increased in group (10) and 
decreased in the others Figure (3a and b). Slight decrease in serum iron concentration 
was observed in goats of groups (3,5 and6). 
Significant increase was noticed in serum concentration of bilirubin and direct 
bilirubin of goats in groups (2,6-10). Another significant increase was also observed 
in serum cholesterol concentration except in groups (1,4 and6), however, the 
triglyceride and phospholipid serum concentration increased in all the experimental 
animals except goats of groups (4and5) compared to the control group (1). The 
changes in serum glucose concentration increased in groups (2, 3, 7,9and10). 
An increase in total protein was noticed in goats of groups (2,3 and 6), however, the 
globulin concentration decreased in groups (7-10) and increased in groups (2and3). 
Generally there were decreases in the concentrations of urea and creatinine in most 
experimental groups compared to control group (1). 
No significant changes in the activities of serum LDH, CK, PK, and GPT were 
observed in any of the experimental groups. But, an increase was noticed in the 
activity of SDH and GOT and decreases in ALP and the amylase in most of the 
experimental animals compared to group (1). It was noticed that serum lipase activity 
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decreased in groups (2-6) and increased in groups (7-10) compared to goats of control 
group (1).  
3.1.7The concentration of the Cymelarsan in different organs, serum, bile and 
urine 
Goats in groups 6-10 showed increased amounts of arsenic in the tissues of liver, 
kidneys, heart, lung, spleen, cerebellum, cerebrum, fats, site of injection, leg muscle, 
uterus, ovary, testis, bile and serum figure (4a and b) and tables (10). The increase 
depends upon frequency of administration and dose dependent. While goats of groups 
(3-5) recorded values by the end of the slaughter program equal to that of goats in 
group (1). Values of arsenical concentration in urine increased slightly if compared to 
that of tissues.  
3.2Experiment 2: Toxicity and efficacy of oxytetracycline (OTC) in goats 
infected with T. evansi and treated with single and multiple dosages of 
oxytetracycline. 
3.2.1The parasitaemia 
3.2.1.1parasitaemia in peripheral blood                                                                                           
Table (1) summarizes the parasitaemia in the peripheral blood of the goats infected 
with T. evansi and treated with single and multiple dosages of OTC.  
a/ Post infection 
T. evansi was detected in the peripheral blood of goats in group (2) where it was mild 
on day4 (+), moderate on day6 (++) and severe on day7 (++++) until the animals 
were died on day11.  
b/ Post treatment  
Goats in group (3) showed moderate parasitaemia (++) between days1-3, mild (+) on 
days4-8, moderate (++) between days9-11 and animals died on days 10-11.Goats in 
group (4) showed moderate (++) between days1-3, mild (+) on days4-17, moderate 
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(++) between days18-24, and mild (+) on days 25-49. Goats of group (5) showed 
moderate parasitaemia (++) on days 1-3, parasite -free between days 4-21, then  mild 
parasitaemia (+) until day 49. Goats in group (6) showed moderate parasitaemia (++) 
in the first four days, mild (+) between days5-10 and moderate (++) for the three 
subsequent days followed by mild parasitaemia (+) till day14 -49. Goats in group (7) 
showed moderate parasitaemia (++) on day1-5, mild (+) on days6-8, moderate (++) 
on days9-12), then mild (+) on days13-19, parasite -free between days20-25 and mild 
parasitaemia till day 26-49. Goats in group (8) showed moderate parasitaemia (++) 
between day1-2, mild (+) on days3-9, then moderate parasitaemia (++), parasite -free 
between day10-13, mild between days 14-17 and animals are died between days16-
18. 
 3.2.1.2Detection of the parasites in liver impression smears 
Table (2) summarizes the detection of the parasites by liver impression smears. In 
dead goats in group (2) liver impression smears showed it is moderate parasitaemia. 
Group (3) also showed moderate parasitaemia (++) when dead animals were 
subjected to liver impression smears, while that of group (4) were mild during the five 
weekly slaughter program. Goats in groups (5 and6) showed moderate parasitaemia 
(++) in the first slaughters, mild parasitaemia in slaughter 2and 3 then parasites free 
on slaughters 4and 5 and goats in groups (7 and 8) were parasite -free during the five 
weekly slaughters program.  
3.2.2Clinical signs and clinical investigation 
No clinical signs were observed in goats of group (1). Goats in group (2) showed 4-7 
days post infection hypothermia, watery lacrimation, frothy salivation,  mucopurlent 
conjunctivitis, mucopurlent nasal discharge, decrease in appetite, severe diffuse 
alopecia (plate1), diarrhoea, depression, apathy, muscle tremors, slight increase in the 
respiratory rate, decrease in the pulse rate , convulsion and shivering. In the second 
week the lymph nodes and testes were hot and swollen and animals become off food, 
cachexia, recumbent with lateral curvature of the neck for 1-2days prior to death.  
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Goats in group (3) showed the same clinical signs as group (2). But these signs are 
disappeared in groups (4and 5) and goats didn't regain their appetite. Animals in 
groups (6- 8) showed weakness of the fore and hind limbs(plate  24), colic (plate 25), 
lacrimations, shivering, decrease of appetite, emaciation and over reflection in hind 
limb (plate 26and 27) which appeared 14-21 days post treatment and death occurred 
in goats of group (8) on days 16-18 post treatment 
Goats of group (2) showed hypothermia although it was not significant while, the 
respiratory rate increased in goats of groups (2-7); it decreased sharply in goats of 
group (8). Generally there were decreases in the body weights compared to goats of 
group (1). The blood pressure was generally decreased in all experimental groups 
compared to group (1). However the pulse rate was also decreased sharply in goats of 
group (7). Figure (5a and b).  
Death occurred in goats of groups (2, 3and 8) while the other groups were slaughtered 
at the rate of two animals/week on days 21, 28, 35, 42 and 49. Table (3). 
3.2.3 post-treatment findings  
Table (4) summarizes the post mortem findings in goats infected with T. evansi and 
treated with single and multiple dosages of oxytetracycline. No gross findings were 
observed in goats of group (1). The gross pathological finding in groups (2, 3, and 8) 
were severe or moderate lesions, while goats in groups (4and 5) had mild or no 
lesions. Lesions under investigation were congestion, oedema and haemorrhage, 
hyperaemia, froth on the trachea, and dilatation and flabbiness of the heart (plate 28). 
Fatty change or necrosis was seen mainly in livers (plate 29) and kidneys in addition 
nephritis, gastroenteritis, peritonitis, enteritis (plate35)hydropretoneum, 
spleenomegaly, myocitis at the site of injection (plate 30), inflamed and swollen 
nerve(plate 31) lymphadenitis, orchitis and the thyroid glands were observed in the 
different groups. It was noticed that these lesions disappeared in the fourth week post 
treatment in goats of groups (5and 6). Goats in group (6) showed greenish bile with 
white granules (plates 32 and33).  Goats in group (7) showed urine retention (plate 
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34). Goats in groups (5-8) showed atrophy of the right cerebellum (plates 36 and 37) 
and stiff muscle.                                                                                                               
3.2.4Histopathological findings                                                                             
Cerebellum: Goats in group (2) showed diffuse vacculations mainly around neurons, 
which appeared elongated with dark staining, and glial cell proliferation. Goats in 
groups (5 and 7-8) showed vacculations in white matter, atrophy, Goats of groups (3, 
4and 6) showed neuron degeneration with appearance of glial cells around some 
neurons (plates 38 and 39) and widened prevascular spaces(plate 42).  
Cerebrum: Showed capillary proliferation and congestion, vacculations in white 
matter, neuronal degeneration and proliferation of glial cells in goats of groups (5, 
6and 8). Four animals of groups (4 and 6-8) (plate 40, and41) showed satellitosis. 
Proliferations of ependymal cells with glial cells around the central canal and 
vacculations in white matter were recorded of goats in group (2). 
Spinal cord:  In all experimental infected and infected treated goats showed 
vacculations in white matter and slight glial cells proliferation around central canal 
(plate 43).                       
Peripheral nerve:  showed congestion in goats of groups (5, 7 and8) while those of 
the rest groups showed no significant changes.  
Thyroid glands: Sections of goats in groups (2, 3 and 6-8) were showed congestion 
and follicular atrophy. Interstitial infiltration by mononuclear cells was seen in goats 
of groups (3-8).  
Lung: the lungs of goats in group (2) showed congestion, emphysema, collapse, and 
pneumonia. Goats of groups (3, 6 and8) showed dilatation of alveoli and increase in 
the interlobular septa was observed in goats of groups (4-7).                                     
Heart:  goats in group (2) showed congestion and haemorrhage.                                     
 Liver: goats in group (2) showed congestion, sinusoidal dilatation was observed. 
Slight cetrilobular necrosis and sometime scattered foci of lymphocytes and 
macrophage, hyperplasia of portal tract, congestion and haemocedrein were seen in 
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goats of groups (3, 5 and 7) (plate 44 and 45). Haemorrhages also seen in goats of 
groups (4, and 6-8) (plate 46 and 47).                                                                                                  
 Kidney: Goats of group (2) showed dilatation of medulla and dilation of tubules, 
increase glomerular cellularity, haemorrhage and congestion. Oedema was seen in 
goats of groups (3and 6- 8) and congestion were seen in goats of groups (3, 7 and 8) 
(plate 48).      
Small intestine:  showed congestion, loss of villi submucosal oedema in goats of 
group (2). Goats of groups (4, 6 and8) showed losses of villius epithelium and 
intestinal glands were few and separated from each other (plate 49). Oedema of the 
submucosa and hypercellularity of lamina propria were observed in goats of groups 
(3and8).                                                                                         
Colon:  Congestion and haemorrhage were seen in goats of group (2).                
Site of injection: Purulent inflammatory changes were seen only in goats of groups 
(3,5and8).                                                                                                      
 Testis:  the testis of goats in group (2) showed congestion and haemorrhage. 
Tongue, spleen, leg muscles and lymph nodes: No significant changes were 
observed. 
3.2.5 Haematological changes 
Tables (5and 6) summarize the haematological change in goats infected with T. 
evansi and treated with single and multiple dosages of oxytetracycline. Decreases 
were seen in the Hb concentration, PCV and RBC in tested animals compared to 
group (1) while, an increase in the reticulocyte, platelets and WBC counts were 
absence. Figures (6a and b). The differential count of WBC demonstrated an increase 
in the basophiles and neutrophiles while the lymphocytes decreased and the 
eosenophiles and monocytes are fluctuated as compared to group (1). 
No significant changes were seen in MCV, MCH and MCHC in goats of groups (2-8), 
but generally an increase was seen in the MCV and MCH, while the MCHC follows a 
decreasing trend, compared to the control group (1). Figures (7a and b). 
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 3.2.6 Serobiochemical changes 
The serobiochemical changes are summarized in table (7-9) in goats infected with T. 
evansi and treated with single and multiple dosages of oxytetracycline. There were no 
significant changes in the serum concentration of sodium, potassium chloride, zinc, 
copper and iron. Decrease in serum calcium and phosphorus concentrations and also 
an increase in serum magnesium and manganese concentrations were observed. 
Changes were observed mostly in goats of groups (7and 8). 
Generally no prominent changes were observed in serum concentration of urea, 
creatinine, cholesterol, phospholipids and triglyceride in the experimental animals 
compared to group (1). Figure (8a and b). Slight increases were observed in serum 
concentration of bilirubin, direct bilirubin, total protein, albumin and globulin were 
observed in experimental goats compared to group (1). 
No apparent changes were detected in serum activity of LDH, CK, PK, GOT, GPT, 
ALP, SDH, amylase and lipase in the experimental goats compared to control group 
(1).  
3.2.7The concentration of the oxytetracycline in different organs 
The concentration of oxytetracycline in serum, organs (liver, kidney, heart, lung, 
spleen, cerebellum, cerebrum, fat, site of injection, leg muscle, uterus, ovary and 
testis), bile and urine are summarized in tables (10-12). 
The concentration of oxytetracycline increased significantly in the serum in goats of 
groups (3-8). The concentration of OTC was not recorded in serum after week four 
(second slaughter) in goats of groups (3, 4 and5) and avis versa in goats of groups (6-
8). Residues were also detected in the heart, kidney, liver, testis, lungs, spleen, leg 
muscle, fat, site of injection, cerebellum, cerebrum, uterus, ovary, bile and in urine 
goats of groups (3-8) during the (1-5) slaughters. Generally any changes in 
concentration recorded in the treated groups were compared to those of groups (1 and 
2).  
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3.2.8 The effect of oxytetracycline on T. evansi in phosphate glucose buffer 
solution (PGS): 
Table (13) summarizes the effect of oxytetracycline on T. evansi in phosphate glucose 
buffer solution (PGS). The effect of oxytetracycline (100%) in different 
concentrations(0.1-1and 1.5 - 15.5 µg/ml) on T. evansi was examined every hour for 
72 hr. The working solution after examination inoculated in rats. No trypanosomes 
were detected in the solution or rats when 4.4-15.0 µg/ml were added while, in the 
concentrations of 0.1-0.9 µg/ml the trypanosomes were still alive and 50% of the 
trypanosomes died when the concentration of 1-3 µg/ml examined. 
 
 
 
 
3.3Experiment 3: Efficacy and clinicopathological effect of Cymelarsan and      
oxytetracycline combination in goats infected with T. evansi                                       
3.3.1The parasitaemia 
3.3.1.1The parasitaemia in the peripheral blood 
Table (1) summarizes the parasitaemia in the peripheral blood of Nubian goats 
infected with T. evansi and treated with single or multiple doses of Cymelarsan and 
oxytetracycline combination. 
 a/ post infection 
 Goats in groups (2-6) showed mild parasitaemia on days 4-5 (+), moderate on day6 
(++) and severe on day7-14 (++++). Animals of group (2) died on day11.  
b/ post treatment  
Goats in group (3) showed moderate parasitaemia (++) on days 1-3, mild (+) on day 
4-6, then moderate (++) on days 7-14. The group died on days 13-15. 
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Goats of group (4) were clear of the parasites on days 1-6, then mild parasitaemia (+) 
on day7, they  showed severe parasitaemia (++++) on day 8, mild parasitaemia (+) on 
day 9, all the goats were negative on day 10-20 and they  showed mild parasitaemia  
(+) on days 21-35 then the animals were free of the parasite until day 49.  
Goats of group (5)  showed mild parasitaemia (+) on days 1-8, moderate (++) on days 
9-11 then they were free from the parasites until day 49 however, goats in group (6) 
were mild (+) on days 1-3, then they were negative until death on days 25-28.  
3.3.1.1.2Detection of the parasites in liver impression smears  
Table (2) summarizes the parasites in the liver impression smears of Nubian goats 
infected with T. evansi and treated with single or multiple doses of Cymelarsan and 
oxytetracycline combination within the withdrawal period. T. evansi was detected 
goats’ livers of groups (2) where they showed moderate parasitaemia (++) until they 
death on day 11. 
Goats of group (3) which died 13-15 days post treatment showed no parasites in week 
1 and 2 then they were mild and moderate. However, goats in group (4) are free of the 
parasites in the first and second slaughter, moderate in the third week and mild in the 
fourth and fifth slaughter while goats in groups (5and 6) were free of the parasites 
during the withdrawal period but goats of group (6) died after the second slaughter.                           
3.3.2Clinical signs and Clinical investigation 
Table (3) summarizes the clinical changes in goats infected with T. evansi and given 
Cymelarsan and oxytetracycline combination.  
No clinical signs were observed in goats of group (1). Goats in group (2) showed 4-7 
days post infection hypothermia, watery lacrimation, frothy salivation,  mucopurlent 
conjunctivitis, mucopurlent nasal discharge, decrease in appetite, severe diffuse 
alopecia (plate1), diarrhoea, depression, apathy, muscle tremors, slight increase in the 
respiratory rate, decrease in the pulse rate, , convulsion and shivering. In the second 
week the lymph nodes and testis were hot and swollen, were become off food, 
cachexia, recumbent with lateral curvature of the neck for 1-2days prior to death.  
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Post treatment all goats showed swelling at the injection site which disappeared after 
one day. Goats of groups (3 and 5) showed the same clinical signs of group (2), but 
mild and consistent throughout the experimental period while group (4)behaved 
similarly to group (3and 5)but signs were disappeared after 14 day post treatment and 
started to improve however,  goats of groups (6) showed hyperthermia, decrease in 
pulse rate, body weight and blood pressure was severe bloody diarrhoea without colic, 
bloody urine, and mild skin lesions weakness followed by paralysis of hind limbs 
without fetlock over reflection and died 25-28 day post treatment. In addition no 
swollen lymph nodes and testis, no alopecia, no pressing head against objects and no 
blindness were observed in all experimental groups. 
3.3.3Gross findings post-treatment 
Table (4) summarizes the gross findings in Nubian goats infected with T. evansi and 
treated with single or multiple doses of Cymelarsan and oxytetracycline-LA in 
combination. Atrophy of the brain (plate 50), inflammation of the peripheral nerves 
and myositis (plate 51) were observed in goats of groups (5and6). The flabbiness, 
dilatation of the right ventricle, and degeneration of the heart in groups (2-5), (plate 
52) with hydropericardium in groups (2, 3and 6) (plate 53) were observed. Slight to 
moderate fatty change, congestion and haemorrhage in the liver with distended gall 
bladder (plate 54) were also observed in groups (2, 3and 6-10) and no granules 
observed in gall bladder. There were various degrees of congestion in different organs 
specially that of the lungs, heart, kidneys (plate 55), liver, and intestine in most of the 
experimental animals, but mild in groups (5and 6). However pneumonia and atrophy 
of the testes (plate  56) were observed in most goats tested. Slight to moderate 
haemorrhages were observed in most groups tested. No gross findings were observed 
in goats of group (1). 
3.3.4Histopathological findings  
Cerebellum: Goats in groups (2-3) showed diffuse vacculations mainly around the 
neurons which were elongated in shape and with dark staining and some of them still 
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with star shape with nuclei in one side (plate 57)  glial cell proliferation, and neuronal 
degeneration. Haemorrhages and congestion were seen in goats of group (4).                                             
Cerebrum: Vacculations with widened prevascular and perineuronal spaces, and glial 
cells proliferation were noticed in goats of groups (2, 3,5and6).                      
Spinal cord: The spinal Showed recorded proliferations of ependyma with glial cell 
proliferation around the central canal in goats of groups (5and 6) and vacculations in 
white matter of goats in groups (2). 
 Peripheral nerves: showed slight congestion in goats of groups (4and 5) and no 
significant changes were seen in other groups. 
Tongues: No significant changes were seen in all experimental goats. 
 Thyroid glands: Goats in groups (2-4) showed congestion while those of groups (2) 
exhibited follicular atrophy. In group (6) some follicles were obviously dilated. No 
significant changes were seen in group (5).  
Lungs: The lungs showed congestion (group 2), emphysema in groups (2, 3 and6) 
and areas of collapse and pneumonia in groups (2, 4 and5).  
Heart:  All experimental goats showed congestion and haemorrhages. 
Liver: Congestion, sinusoidal dilatation in groups (2-4) (plate 58), slight cetrilobular 
necrosis and scattered foci of lymphocytes and macrophages (plate 59) were 
observed. Portal tracts are widened in goats of groups (2).  
Spleen: Congestion and haemosiderosis were noticed in goats of groups (2and3) and 
no obvious lesions were seen in the rest groups. 
Kidneys: Goats of groups (2 and 3) had haemorrhagic and congestionwhile, goats in 
groups (2 and 4-6) showed dilatation of renal proximal tubules and increase in 
glomerular cellularity.  
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Small intestines: showed congestion, loss of villus epithelium in groups (2 and3), 
while goats in groups (2, 5 and6) showed submucosal oedema and no significant 
changes were observed in goats of group (4). 
Colon:  congestion and haemorrhages were observed in goats of groups (2, 5 and 6),  
Leg muscles, lymph nodes and tendon: no abnormalities are detected in all 
experimental goats. 
Sites of injection:  showed congestion in goats of groups (5and 6). 
Testis: Congestion and haemorrhage were seen in animals of groups (2, 5and 6), 
histological evidence of active spermatogenesis was seen in sections of group (3) 
while few spermatogonia were seen in tubules of section from groups (2, 4 and 6) 
(plate 60). 
3.3.5Haematological Changes 
Tables (5and 6) summarize the haematological changes in Nubian goats infected with 
T. evansi and treated with single or multiple doses of Cymelarsan and oxytetracycline 
combination. Generally it was depicted that the Hb concentration, PCV, RBC and 
lymphocytes values declined although some of them were not statistically significant, 
also the reticulocytes, WBC, platelet, basophiles and neutrophiles counts increased 
significantly compared to group (1).  
Table (6) and figure (9) depicted the MCV, MCH and MCHC of Nubian goats 
infected with T. evansi and treated with single or multiple doses of Cymelarsan and 
oxytetracycline combination. The tables showed insignificant statistical difference in 
these parameters, but increase in MCV was noticed in groups (3and 4) while, 
increases in MCH and MCHC were noticed in groups (4and 5).  
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3.3.6Serobiochemical Changes 
Tables (7-9) summarize the changes in serobiochemistry of Nubian goats infected 
with T. evansi and treated with single or multiple doses of Cymelarsan and 
oxytetracycline combination. No significant changes were observed in the serum 
concentration of sodium, potassium, phosphorus, magnesium, zinc, copper and iron in 
all infected and treated groups compared to group (1).  There was a slight increase in 
the serum manganese in most of the groups while that of the calcium concentration 
showed slight decrease compared to group (1). 
It is noticed that although some parameters in the different group showed statistical 
significance, but still values remained within the normal ranges. figure (10). 
Also it was clear that most changes in serum activities of the serum LDH, CK, PK, 
GOT, GPT, SDH, amylase and lipase were normal and some slight significant 
variations were seen. 
3.3.7The concentration of Arsenic (Cymelarsan) and oxytetracycline 
Tables (10) summarizes the concentration of Cymelarsan in serum (figure (11)), 
organs; bile and urine in the goats increased with T. evansi and treated with single and 
multiple dosages of Cymelarsan and oxytetracycline combination. The arsenic 
concentration were found at the range above 100 µg/g in the liver, kidney, fat, site of 
injection and leg muscle of goats in group (6) while, the same group had a range of 
70-99 µg/g in heart, lung, cerebellum, testis, and urine, the rest of the organs were 
less than 60 µg/g. also organs in goats of group (5) showed 70-99 µg/g in liver and 
fat, while that less than 60 µg/g was noticed in the rest of the organs. However, 
records of arsenic in most different organs of the goats in groups (3and 4) were ≤0.07.  
The concentration of oxytetracycline in serum, organs, bile and urine increased 
significantly in the goats of groups (6-3) respectively in organs, bile and urine. It 
increased in site of injection, fat, kidney, liver, spleen, ovary, leg muscle, cerebellum, 
cerebrum, bile, uterus, urine, testis, heart, lung respectively. Oxytetracycline 
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concentration was not detected in liver, kidney, heart, and cerebellum. Cerebrum, 
ovary, testis and urine in goats of group (4) in the third slaughter, in the spleen,, 
cerebellum, cerebrum, leg muscle, uterus, ovary, testis in goats of group (5) whereas 
it was detected in the rest organs in the same groups and it was also detected in 
organs, bile and urine till days 15 and 28 in goats of groups (3and 6) respectively. The 
oxytetracycline concentration increased in goats’ serum in groups (7and 8) to 20±0.01 
and to 10.3±0.05 respectively, it was 5±1.10 on day 14 in goats of group (3) and 
1.5±0.02on day21 in goats of group (4). Generally any changes in concentration 
recorded in the treated groups compared to that of group (1 and 2). This was 
summarized in tables (11 and12).  
It was noticed that when Cymelarsan administered at single I/M 0.250 mg/kg 
combined with OTC at 10mg/kg or at 0.125mg/kg with 50mg/kg OTC the residual 
patern in the different organs and serum, urine and bile is not different from that 
recorded when those drugs are given alone and single dosages but, a surprising 
observation was noticed when Cymelarsan had been given at 0.250 mg/kg with 
combination of OTC given twice/week for two weeks or daily for 8days where the 
concentration of Cymelarsan is decreased and that of OTC increased when compared 
to results which were obtained when these drugs where administered alone at the 
same frequencies.   
3.4Experiment (4): Clinicopathological effect and Efficacy of Cymelarsan in 
Nubian goats infected with T. evansi and supplemented with zinc and copper.  
3.4.1The parasitaemia 
3.4.1.1The parasitaemia in the peripheral blood 
Table (1) summarizes the parasitaemia in the peripheral blood in the Nubian goats 
infected with T. evansi and treated with single and multiple dosages of Cymelarsan 
and supplemented with zinc and copper.  
a/ post infection  
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Goats in groups (2-6) showed mild parasitaemia (+) on days4-5, moderate (++) on 
day6 and severe (++++) on days7-10. Animals of group (2)   died on day11.   
b/ post treatment 
Goats of group (3) showed mild parasitaemia (+) until animals died on day 13-15. 
Goats of group (4) showed moderate parasitaemia (++) until day 9, and they were 
negative till the end of experiment. Goats of group (5) showed mild parasitaemia (+) 
during the first three days post treatment and they were negative until the animals 
died on day15 post treatment. But it appeared 3-4 days post treatment in goats of 
group (6) then disappeared completely until they died 15-18 day post treatment. 
3.4.1.2Detection of the parasites in liver impression smears  
Table (2) summarizes the parasites in the liver impression smears in the Nubian goats 
infected with T. evansi and treated with single and multiple dosages of Cymelarsan 
and supplemented with zinc and copper.  
The goats of group (2) died 11 days post infection and the parasite was detected in the 
liver in the range of 4-6 parasites/field. Goats in group (3) showed mild parasitaemia 
(+) at weeks 1, 2, 4 and 5 but were negative in week 3. While goats of groups (4-6) 
showed no parasites in the liver during the withdrawal period which started at 14 days 
post dosing and continued for other 5 weeks.  
3.4.2 Clinical signs and clinical investigation 
No clinical signs were observed in goats of group (1). Goats in group (2) showed 4-7 
days post infection hypothermia, watery lacrimation, frothy salivation,  mucopurlent 
conjunctivitis, mucopurlent nasal discharge, decrease in appetite, severe diffuse 
alopecia (plate 1), diarrhoea, depression, apathy, muscle tremors, slight increase in the 
respiratory rate, decrease in the pulse rate, convulsion and shivering. In the second 
week, the lymph nodes and testis were hot and swollen, animal become off food, 
cachexia, recumbent with lateral curvature of the neck for 1-2days before death. 
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At post treatment in the first week goats of groups (3-6) showed swelling at the site of 
injection, which disappeared after 1-2 days, goats of group the group showed mild 
clinical signs as those of group (2). Goats of group (4) showed no clinical signs post 
treatment. Goats in group (5) showed watery lacrimation with mucopurlent 
conjunctivitis accompanied with blindness (75% of the goats), mucopurlent nasal 
discharge, frothy salivation, fever, depression, apathy, pressing the head against 
objects, watery diarrhoea for 3-4 days then changed to bloody diarrhoea, bloody 
urine, muscle tremors, decrease in appetite, slight increase in the respiratory rate, 
decrease in the pulse rate . In the second week this group showed hot and swollen 
lymph nodes and testis, severe diffuse alopica which was slight in the other treated 
groups, no shivering and no convulsion, weakness in the forelimb, recumbent in 
sternal position, animals become off food, emaciation, a decreased in the body weight 
also was observed and anuria, these sings persisted until the death. Also the group 
showed skin lesions in the second week as red 3mm raised concave nodules which 
increased in size to 5mm then changed to a brown scab these scabs when removed by 
hand leave white to yellowish ulcer, when excised a greasy white yellowish hard 
material was seen and remain until death. While, goats of group (6) showed nasal 
discharge, pyrexia, bloody urine, bloody diarrhea, skin lesion and paralysis in hind 
limb. 
Table (3) summarizes the clinical changes in the goats infected with T. evansi and 
treated with single and multiple dosages of Cymelarsan and supplemented with zinc 
and copper. The table showed normal values for goats of group (1). Goats of group 
(2) showed decreases in the body weight and, respiratory rate, blood pressure and in 
body temperature. A decreased in the body weight, body temperature, blood pressure 
was observed in goats of group (3) and the respiratory rate is within the reference 
interval.  Results obtained from goats of group (4) as nearer those recorded in group 
(1).  While a decrease in respiratory rate and pulse rate, normal body weight and 
blood pressure and hyperthermia, observed in goats of group (5), however, those of 
group (6) recorded hyperthermia, decrease in pulse rate, body weight and an increase 
in respiratory rate and blood pressure. 
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3.4.3Gross findings post-treatment 
Table (4) summarizes the gross finding in the goats infected with T. evansi and 
treated with single and multiple dosages of Cymelarsan and supplemented with zinc 
and copper.  
 No gross findings were observed in goats of group (1). The gross pathological 
findings in groups (3 and 5) are moderate to severe lesions. Lesions under 
investigation were congestion, oedema and haemorrhage in the different organs and in 
the lung (plate 61)and heart (plate 63 ), pneumonia (plate 62), froth on the trachea, 
and flabbiness and dilation of the heart (plate 64), while fatty change and or necrosis 
is investigated mainly in livers (with whit bile)(plate 65) and kidneys(plate 67) in 
addition, gastroenteritis, peritonitis and hydroperitoneum, spleenomegally (plate 66), 
myositis and peripheral nerve (femoral), necrosis (plate 69 and 70) at the site of 
injection, swollen lymph node and testis and urinary retention(plate 68). The thyroid 
gland showed no apparent lesions. Generally the lesions observed in the dosed goats 
of groups (4) were mild or disappeared compared to group (2). Far away, lesions of 
goats in group (6) are more prominent in the intestine, site of injection as well as the 
congestion in the liver and kidneys and showed similarities as those of group (3).  
3.4.4The histopathological findings  
Cerebellum: goats in groups (2, 3and5) showed diffuse vacculations mainly around 
the neurons which were elongated in shape and with dark stained. Some of them still 
maintained their star shape with nuclei. Glial cell proliferation, haemorrhage and 
congestion (plate 71) and widened in prevascular spaces.                                                                      
Cerebellum and cerebrum: many neurons appeared small and oval in shape 
showing pyknotic nuclei. Vacculations and widened prevascular spaces were also 
seen in groups (2, 3, 5and 6).                                                                       
Spinal cord: recorded proliferations of ependymal cells with glial cells proliferation 
around the central canal in goats of group (2)and vacculations in white matter in goats 
of groups (2, 3 and5) (plate 72), widened prevascular spaces were also seen in group 
(5).                                             
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Peripheral nerve:  showed in goats of group (6) slight congestion in goats of groups 
(2, 3and 4). While, diffuse vacculation observed in goats in group (5) with loss of 
nerve structure in goats in group (6).   
Tongue: in goats of groups (2-4) were normal. Some goats in group (5) showed 
melanosis.                                                   
Thyroid glands: goats in groups (2-5) showed congestion and the glands were 
atrophied with loss of thyroid tissues and goats in groups (4and 6) has same follicles 
and dilatation were occurred.                
Lungs: the lungs of goats in group (2) were congested; groups (2, 3 and 5) were 
emphysematous, edematous and congested. In groups (2, 3 and4) areas of collapse, 
emphysema, pneumonic foci and haemorrhage in alveoli and bronchi were seen (plate 
73). 
Heart:  all goats showed congestion and haemorrhages. However, lymphocytic 
infiltration in the cardiac muscle was noticed in goats of groups (2 and 5).  But in 
goats of groups (4and 6) the muscle fibers appeared thin with elongated nuclei. Focal 
or diffuse vacculations in the cardiac muscles were seen in goats of groups (5). Goats 
in group (5) showed myodegenration, with neutrophils infiltration, oedema and slight 
haemorrhage. 
Liver: goats in groups (2and 5) showed congestion, sinusoidal dilatation, slight 
cetrilobular necrosis and scattered foci of lymphocytes and macrophage (plate 75). 
Widened of portal tract was seen in goats of groups (2and 6). Haemosedrein, deposits 
are also observed in the liver of goats in groups (5). 
Spleen: goats of groups (2, 3 and 4) showed congestion and haemosiderosis.  Goat in 
group (5) showed haemosiderosis thickened trabicula, around the white pulp. In group 
(5) showed congestion and haemorrhages of the red pulp with haemocedrosis and 
depletion lymphoid tissue.  
Kidneys: groups (2-6) showed varying degrees dilatation of renal tubules, increase in 
glomerular cellularity, haemorrhage and congestion.       
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Small intestine: showed congestion, loss of villus epithelium in goats of groups (2 -
6). Goats in groups (2and 4) were showed intestinal glands while, widened in lamina 
propria and submucosal oedema are seen in group (6).                                                                                
Colon:  showed congestion and haemorrhages in goats of groups (2and 3) and normal 
in goats of groups (4-6).      
Site of injection: Purulent inflammatory reaction and congestion was noticed in goats 
of group (6). 
Leg muscle:  showed congestion in goats of groups (5and 6) and normal in goats of 
groups (2-4).                                                                                                                    
Lymph nodes: Sections showed congestion and haemorrhage in goats of group (6) 
and were normal in goats of group (4). While that of groups (2-3)were congested and 
hyperplastic the medullar part contained abundant interstitial tissues, and dilated 
blood vessels specially in goats of group (5). 
Tendon: in all goats no lesions were observed.  
Testis: Section in goats of groups (2-3and 5-6) showed congestion, abundant 
interstitial tissues, eosinophilic material in some semineferous tubules and some 
tubules showed loss of germinal cells with loss of activity haemorrhage. 
Semineferous tubules animals in group (4) showed many vacules and little activity 
(plate 74).  
3.4.5Haematological changes 
Table (5 and6) summarizes the haematological changes in the goats infected with T. 
evansi and treated with single and multiple dosages of Cymelarsan and supplemented 
with zinc and copper. The Hb, RBC, PCV and lymphocytes values  decreased 
significantly in goats of groups (2-6) while, the count of WBC, reticulocyte, platelet, 
basophiles, eosenophiles, monocytes and neutrophiles  increased significantly in goats 
of groups (2-6).  However, no statistical significance was observed in MCV, MCH 
and MCH post infection and post treatment, but the MCH decreased sharply in goats 
of group (3). Figure (12). 
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3.4.6The Serobiochemical changes 
Tables (7-9) summarizes the serobiochemical changes in Nubian goats infected with 
T. evansi and treated with single and multiple dosages of Cymelarsan and 
supplemented with zinc and copper.  No significant changes were seen in serum 
concentration of sodium, calcium, phosphorus, zinc, copper and in serum activity of 
LDH, CK, GOT, GPT and SDH with groups in under experiment. However, an 
increase in potassium, total bilirubin, direct bilirubin and decreased in globulin, lipase 
in group (5). An increase in chloride, glucose, protein and lipase and sharp decrease 
was seen in calcium, phosphorus, iron in group (3). No significant changes were 
observed the in serum activity of PK, and ALP in groups (1, 4 and6) compared to that 
of group (1). Generally it was observed that changes in goats of group (6) is more 
towards that of group(2) while, that of group(4) is near to that of group(1) specially in 
the serum concentration of potassium, chloride, magnesium, manganese, iron, total 
bilirubin, direct bilirubin, total protein, albumin, globulin, cholesterol, glucose, 
phospholipids and triglycerides and serum activity of amylase and lipase. figure (13).   
 
3.4. 7The concentration of Cymelarsan in serum, urine, bile and organs         
Table (10) is summarize the concentration of Cymelarsan in serum(figure (14)), urine, 
bile and organs in Nubian goats infected with T. evansi and treated with single and 
multiple dosages of Cymelarsan and supplemented with zinc and copper. It is noticed 
that the serum arsenic amount of the serum, bile, urine and in the different organs of 
groups (land2) <0.07. Goats of groups (5and 6) which died15 day post treatment and 
expressed to 7 days only withdrawal period recorded values<0.07 in the cerebellum, 
cerebrum, fat, leg muscle and testis and still high values recorded in the urine, site of 
injection, heart, kidney and liver in addition spleen, uterus, ovary is least (1-15). 
Samples in goats of groups (3and 4) which taken the withdrawal period recorded 
<0.07 is kidney, heart, lung, spleen, cerebellum, site of injection, leg muscle, uterus, 
ovary, testis, bile and urine.  While, the liver and fat were recorded <0.07 in the 2nd, 
3rd, 4th and 5th week of the withdrawal period. The serum recorded a mean value 
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0.41µg/ml post treatment. Generally any changes in concentration recorded within the 
treated groups compared to that of groups (1 and 2).  
3.5Experiment 5: Toxicity and efficacy of quinapyramine in goats infected with 
T. evansi 
3.5.1The parasitaemia 
3.5.1.1The parasitaemia in the peripheral blood 
Table (1) summarizes the parasitaemia in the peripheral blood of Nubian goats 
infected with T. evansi and treated with single or multiple doses of quinapyramine. 
 a/ post infection 
Goats in groups (2-8) showed mild parasitaemia (+) on day4-5 (+), moderate (++) on 
day6and severe (++++) on day7-14, but animals of group (2) died on day11.  
a/ post treatment 
Goats of group (3) showed mild parasitaemia (+) on day 1-6, parasite -free on day 7-
20, mild (+) on day 21-56,while goats of groups (4,5,6,7 and8) showed mild (+) on 
day 1-3, 1-8, 1-4, 1-6, 1-6 respectively, then they were free of the parasite thereafter. 
 
 
3.5.1.2Detection of the parasites in liver impression smears 
Table (2) summarizes the parasite detected by liver impression smears of Nubian 
goats infected with T. evansi and treated with single or multiple dosages of 
quinapyramine. Goats in group (2) showed moderate parasite (++) until death on day 
11post infection. 
Animal infected and treated with 0.1mg/km I/M (group 3) the first, third, fourth and 
fifth slaughter showed mild parasite (+) while the second slaughter was free from the 
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parasite. On the other hand, animals in groups (4, 5, 6, 7 and 8) were negative 
throughout the 5 slaughters of withdrawal period. 
3.5.2Clinical signs and clinical investigation 
No clinical signs were observed in goats of group (1). Goats in group (2) showed 4-7 
days post infection hypothermia, watery lacrimation, frothy salivation,  mucopurlent 
conjunctivitis, mucopurlent nasal discharge, decrease in appetite, Severe diffuse 
alopecia (plate1), diarrhoea, depression, apathy, muscle tremors, slight increase in the 
respiratory rate, decrease in the pulse rate , convulsion and shivering. In the second 
week the lymph nodes and testis were hot and swollen, off food, cachexia, recumbent 
with lateral curvature of the neck for 1-2days then the animals died.  
post treatment these signs were seen in goats of groups (3-8) but they were mild and 
disappeared 10-15 days then continued milder in goats of group (8), whereas in group 
(3) they are mild until the slaughter of the animals. 
The body temperature, respiratory rate, pulse rate, body weight and blood pressure 
different recorded but not significant changes were seen, but that of group (6) 
recorded decrease and an increase in body temperature.  Table (3). 
3.5.3Gross findings   
Table (4) summarizes the gross pathologically findings in goats infected with T. 
evansi and treated with single and multiple dosage of quinapyramine. Varying 
degrees of congestion and haemorrhage were observed in the different organs 
examined such as heart, kidney (plate 77), and lungs fatty changes and/or necrosis 
were noticed in the liver and kidneys specially of those in groups (2, 6 and 8).  The 
lungs showed congestion, haemorrhages, emphysema and small area of hepatization 
specially that of groups (2, 6 and8) (plate 75). However, enteritis and hypoatrophy of 
the testis were mild but affected most of the animals in the different groups. The heart 
is flabby, soft and dilated specially the right side and the apex is round specially goats 
of group (2, 6 and 8) (plate 76). Generally lesions were more severe in group (2, 6 
and8). No changes were observed in group (1).  
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3.5.4Histopathological changes:  
Cerebellum and cerebrum: In cerebellum proliferation of glial cells in white matter 
was observed in groups (2, 3, 6, 5and 8) and irregular of axon cheats, old neuron and 
central chromatolysis (plate 78). Cerebrum showed meningeal congestion, 
haemorrhages (plate 79), diffuse vacculations, infiltration and glial cell proliferation 
with satellitosis (plate 80and 81) were seen in cerebral sections in groups (2, 3, 6, 
5and 8).  
Spinal cord: proliferation of ependymal cells with glial cells around the central canal 
and vacculations in white matter were recorded in goats in groups (2and 3);  
demyelenation, moderate dilatation of axons sheath and vacculations in white matter 
in groups (6- 8) (plate 82).        
Peripheral nerve: in goats of groups (2-8) were normal 
Tongue: in goats of groups (2-7) were normal.  
Thyroid glands: goats in groups (2, 3, 6 and 8) showed congestion and atrophy of 
thyroid follicles. 
Lungs: the lungs of goats in groups (2-5) were congested and showed areas of 
emphysema and collapse, with focal pneumonitis. Goats in groups (6-8) showed 
emphysema, haemorrhage in alveoli and bronchi (plate 83).  
Heart:  goats in group (2) showed congestion and haemorrhages while goats of 
groups (6-8) the cardiac muscles were elongated with closely arranged nuclei and 
vacculations however, goats in group (5) the cardiac muscles were elongated with 
pyknotic nuclei.  
Liver: goats in group (2and3) showed congestion and sinusoidal dilatation. Slight 
cetrilobular necrosis (plate 84) and sometimes scattered foci of lymphocytes and 
macrophage but, haemorrhages and haemocedrosis (plate 85) were observed in goats 
of group (4-8) and portal areas were thickened with cellular infiltration (plate 86). 
Kidney: goats in groups (2and 3) showed dilatation of renal tubules, increase in 
glomerular cellularity, haemorrhage and congestion, but the lesions were slight in 
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goats of group (3). Goats in groups (5-8) showed hypercellularity of the glomerular 
tuft; congestion and swelling of tubules cells.                                                                               
Small intestine: Congestion, loss of villus epithelium with submucosal oedema were 
seen in goats of groups (2, 3, 5, 6 and7). Haemorrhages, few intestinal glands and 
infiltration of lamina propria villi macrophage, lymphocytes and submucosal oedema 
were seen in goats of groups (3, 5 and 7) (plate87).  
Colon:  showed congestion and haemorrhage in goats of groups (2, 3 and6-8),  
Leg muscle and lymph nodes: in goats of groups (2-8) were normal.                             
Testis: Section from goats of groups (2, 3, and 5-8) showed congestion and 
haemorrhage while that of group (4) appeared normal. 
3.5.5Haematological changes 
Tables (5 and6) summarize the haematological changes in Nubian goats infected with 
T. evansi and treated with single or multiple dosages of Quinapyramine. Significant 
lowering was seen in goats of groups (2,3,5and 6) in the Hb, PCV, and RBC counts 
while there were no changes in lymphocyte and monocyte counts in all experimental 
animals except that of group (2). No significant changes were observed in the total 
WBC count and the eosenophile, slight increases were seen in the platelet count in 
groups (2and 6) and also increases were observed in the basophiles of goats of groups 
(2,5and 6). Generally there was an increase in the reticulocyte and neutrophiles count. 
In goats, which received multiple dosages of the drugs, no significant changes were 
observed in the lymphocyte and neutrophiles count in groups (7and 8). Also it is 
noticed that goats of group (8) followed the same trend of those in group (1). No 
significant changes were observed in the MCV, MCH and MCHC values in all 
experimental groups. These findings were compared to that of goats in group (1). 
Figure(15a and b). 
 
3.5.6 Serobiochemical changes: 
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Tables (7-9) summarize the serobiochemical changes in Nubian goats infected with T. 
evansi and treated with single and multiple dosages of quinapyramine. No significant 
changes were seen in serum iron and copper in all groups while significant decreases 
in serum zinc were observed only in group (8). Generally increases in serum 
manganese concentrations were observed in most of the treated groups compared to 
that of group (1). Increases in the phosphorus concentration were also detected in 
goats of groups (2,6and 8) while serum calcium values decreased significantly in 
goats of groups (2,3 and8). Generally the chloride serum concentration increased in 
all treated groups comparable to that of group (1), while the serum concentration of 
potassium and sodium increased in groups (2, 6 and8). 
Changes in the serum concentration of bilirubin, direct bilirubin, urea, creatinine were 
within the normal known levels, but significant increase in serum total protein, 
albumin and globulin in all goats except in goats of groups (4and 7). 
Significant decreases were observed in most treated groups in the concentration of the 
serum thyroxin hormone (T4) and serum progesterone (figure (16,17a and b))and in 
the activities of serum lipase, while slightly significant increase of SDH was observed 
in goats of groups (2and 8). No significant changes were detected in the serum 
activities of LDH, GOT, GPT and ALP as they were within the normal levels.  
  3.5.7 The concentration of the quinapyramine in different organs in the goats 
Table (10and11) summarizes the concentration of quinapyramine in Nubian goats 
infected with T. evansi and treated with single and multiple dosages of 
quinapyramine. The quinapyramine concentration increased in goats of groups (3-7) 
but decreased in the slaughtered animals, being nil in the last slaughtered animals and 
nil in the cerebrum and in the lung. Generally any changes in concentration of 
quinapyramine recorded within the treated groups comparable to that of group (1 and 
2).  
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3.6Experiment 6: Toxicity and efficacy of homidium bromide in goats infected 
with T. vivax 
3.6.1The parasitaemia 
3.6.1.1The parasitaemia in the peripheral blood 
Table (1) summarizes the parasitaemia in the peripheral blood of Nubian goats 
infected with T. vivax and treated with single or multiple doses of ethidium bromide. 
a/ post- infection  
Goats in groups (2-7) showed mild parasitaemia (+) on day4-5, severe (+++) on   
day6, very severe (++++) on day7-10, moderate on day11-12, severe on day 13-17 
goats of group (2) died on day17.  
b/post treatment  
The peripheral blood post treatment shows in the goats of group (3) showed mild 
parasitaemia (+) on day 1then it disappeared on 2-7 days then appeared slightly on 
day 8-20 then disappeared on day 21-34 and appeared mildly on day 35, 3 goats died 
between day 16-20, where two were survived on day 28 and 35. , but that of goats in 
group (4) appeared mild on day 1-7 then became free on the following days. 
However, goats of group (5) showed slight parasitaemia on days 1-4 then disappeared 
for 3 days where the animals died. Goats in group (6) showed mild parasitaemia (+) 
until day 19, and then disappeared until the end of the experiment except mild 
parasitaemia (+) appearing on day 23-25. Goats of group (7) showed mild 
parasitaemia (+) on day 1-4 then the animals were free from parasites on day 6-16 and 
they were died on day 16-20. 
 3.6.1.2Detection of the parasites in liver impression smears 
Table (2) summarizes the parasitaemia in the liver impression smears of Nubian goats 
infected with T. vivax and treated with single or multiple doses of ethidium bromide.  
Goats in group (2) showed moderate parasitaemia (++). 
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Goats in group (3) showed mild parasites (+) during the first, second, fourth and fifth 
slaughter whereas, in the third slaughter they were parasite -free also, goats in groups 
(4-7) were parasite -free throughout the slaughter time.  
 
3.6.2Clinical signs and clinical investigation 
Goats in groups (2) started clinical signs at 7-10 days post infection, which included 
hypothermia, watery lacrimation with mucopurlent conjunctivitis, mucopurlent nasal 
discharge and frothy salivation. Lately week post infection decrease in appetite, 
depression, watery yellowish diarrhoea, muscle tremors, with lateral curvature of the 
head. 
Post treatment goats of groups (3and 5) showed the same clinical signs as that of 
group (2) but mild, death occurred between days 16-20 while the other two survived 
goats are slaughtered day 28 and day 35 while goats of group (5) were died 3-8 day. 
Goats of groups (4 and6) showed the same signs but mild and disappeared after 7 
days where the animals regain appetite and weight, alopica improved and orchitis 
subsides. While that of group (7) were severe, there is colic and bloody diarrhoea and 
death occurred 16-20 days post treatment.  
Tables (3) summarize the clinical investigation. The body temperature decreased 
significantly in goats of group (2), after treatment group (3) showed decrease in body 
temperature which increased in goats of group (5) but was normal in goats of groups 
(4,6and 7).  
Significant increase was seen in respiratory rate in goats in all groups whereas 
significant decrease was seen in blood pressure in goats in all groups except goats in 
groups (4and 6).  
Goats in groups (4 and6) were slaughtered after day 28 post treatment and two 
animals weekly, goats in group (2)   died on day 9-11, goats in groups (3 and7)   died 
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between days 16-20, goats in groups (4and 6) post dosing and goats in group (5)   
died between days 3-8 post dosing.  
3.6.3Gross findings  
Table (4) summarizes the gross findings in goats infected with T. vivax and treated 
with single and multiple dosages of ethidium bromide. It is noticed that most of the 
lesions in the different organs were in groups (2, 3, 5 and7). These lesions consist of 
varying degrees of congestion, haemorrhages, flabbiness of the heart observed in all 
groups (plate 88), froth in trachea, emphysema of the lungs (plate 89), fatty changes 
in the liver and kidneys (plate 90), hepatic atelectasis (plate 91)and enteritis. No 
apparent lesions are seen in goats of groups (4 and6) compared to that of group (1). 
Other post mortem changes in the other groups were mild and goats of groups (3and 
5) showed dark with distended gall bladder greenish bile and urinary retention. Goats 
of group (7) showed swollen of the femoral nerve (plate 92). 
3.6.4Histopathological findings  
Cerebellum:  Sections from groups (2, 3 and 5) showed very diffuse vacculations 
mainly around the neurons where some of them were elongated in shape and with 
dark stained nuclei but, others were still maintained star shape with nuclei on one side 
and glial cell proliferation and neuronal degeneration (plate 93) however, goats of 
groups (4, 6 and 7) showed slight changes. 
Cerebrum: goats in groups (2-5) showed vacculations (plate 94) and glial cells 
proliferation, congestion and degeneration changes (plate 95) while, that of groups (6-
7) showed slight changes.                      
Spinal cord: Sections of groups (2, 3 and5) showed proliferations of ependymal cells 
and glial cells around the central canal and vacculations of the white matter while, 
that of groups (4, 6and 7) showed slight changes.                      
Peripheral nerve: slight vacuolated cytoplasm, slight segmental demyelination, 
aggregates of macrophages and slight oedema were observed in sections from groups 
(5-7) (plate 96).  
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Thyroid glands: Section from groups (2, 3and5) showed congestion and follicular 
atrophy.  
Lungs: Sections of lungs in groups (2, 3, 5 and7) showed congestion, emphysema, 
areas of collapse, small foci of pneumonitis. Goats of groups (4and 6) look normal. 
Heart:  goats in groups (2, 3, 5 and 7) showed congestion and haemorrhage. Muscle 
nuclei tended to be elongated in goats of groups (3, 4, 5 and7) however while, that of 
groups (6) showed no changes.                      
Liver: goats in groups (2, 3 and5) showed congestion, sinusoidal dilatation. Slight 
centrilobular necrosis, haemorrhages (plate 97)  and sometimes scattered foci of 
lymphocytes and macrophages, widened of portal tracts in addition to haemosedrosis 
in goats of groups (5-7) while, that of groups (4 and6) showed slight changes.                      
Kidney: goats in groups (2, 3, 5 and7) showed dilatation of renal tubules (plate 98), 
increase in glomerular cellularity haemocedrosis (plate 99), haemorrhage and 
congestion.  
Small intestine: showed congestion, loss of villus epithelium and submucosal 
oedema in goats of groups (2, 3 and5) (plate 100) while, in groups (4 and6) were 
normal.                      
Colons:  congestion and haemorrhages in goats of groups (2,3, 5 and7) while, in 
groups (4 and6) were slight.                      
Peripheral nerve and lymph nodes: in goats of groups (2-7) sections were normal.                                
Leg muscle: infiltration, myositis, dark staining fibers in groups (6-7) (plate 101) 
while, in groups (2-5) were normal.                      
Testis: goats of groups (2-5and 7) showed congestion and haemorrhage while, in 
group (6) were normal.                      
3.6.5Haematological changes 
Tables (5 and6) summarize the haematological changes. Most of the experimental 
groups showed decreases in the Hb concentration, PCV, RBC and lymphocyte count, 
increase in the reticulocytes, WBC, platelets, eosenophiles and neutrophiles count. 
However changes were observed in the basophiles count, the monocytes were 
increased in most of the groups tested except goats of groups (6and 7). These values 
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were compared to those of the control group (1). It is clear that no significant changes 
were seen in MCV, MCH, MCHC values in test animals compared to goats of group 
(1) in addition the values recorded were with the normal levels. Table (6) and figure 
(18 a and b). 
3.6.6 Serobiochemical changes 
Tables (7-9) summarize the Serobiochemical changes in Nubian goats infected with 
T. vivax and   treated with single and multiple dosages of ethidium bromide. No 
significant changes were observed in serum concentration of iron, copper and zinc. It 
is noticed that although some groups showed significant changes in serum 
concentration of sodium, potassium, calcium and phosphorus other were within the 
normal levels. Slight significant increase in serum concentration of cholesterol and 
magnesium in group (7) was seen while the serum concentration of the manganese 
increased in groups (2, 3,5and 7). These values were comparable to that of goats in 
group (1).  
It is clear that most values of serum concentration of bilirubin, direct bilirubin, urea, 
creatinine, total protein, albumin, globulin, cholesterol and glucose were within 
normal level although some showed significant change.  
Table (9 a and b) summarizes the serum activities, showing that most of the values of 
enzymes investigated were within normal levels; also it is clear that values of group 
(2) in most of the enzymes under examination changed significantly but some of them 
were within the normal levels. Slight changes were observed in serum concentration 
of thyroxin and progesterone where most values were within the normal levels. 
Biochemical changes under investigation were comparable with goats of group (1). 
Figure (19,20a and b). 
3.7Experiment 7: Efficacy and clinicopathological effect of quinapyramine and 
homidium bromide combination in goats infected with T. evansi or T. vivax 
3.7.1The parasitaemia 
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3.7.1.1The parasitaemia in peripheral blood 
Table (1) summarizes the parasitaemia in the peripheral blood of Nubian goats 
infected with T. evansi or T. vivax and treated with single dosages of quinapyramine 
and homidium bromide combination. 
a/post infection  
Goats in groups (2*, 3and 4), which infected with T. evansi showed mild parasitaemia 
on day4-5 (+), moderate on day6 (++) and severe on day7-14 (++++), but animals of 
group (2*) died on day11. Goats in groups (2**, 5and 6) which infected with T. vivax 
showed mild parasitaemia (+) on day4-5, severe (+++) on   day6, very severe (++++) 
on day7-10, moderate on day11-12, severe on day 13-17 goats of group (2**) died on 
day17.  
 
b/ post treatment  
Goats in group (3) showed mild parasitaemia (+) on day 1-6, thy were negative on 
day 7-25, mild (+) on day 26-56, wile goats of group (4) wee showed mild (+) on 
day1-5, parasite -free on day6-35, mild (+) on day 36-49, parasite -free on day56, 
goats in group (5) showed mild parasitaemia (+) on day 1-10, parasite -free on day 
11-13, mild (+) on day 14-20, moderate (++) on day 21-22, mild (+) on day23-25, 
parasite -free on day 26-56, also goats in group (6) showed mild parasitaemia (+) on 
day 1-4, parasite -free on day 5-17, mild (+) on day 18-23 an they were parasite -free 
on day 24-56. 
3.7.1.2The parasitaemia in liver impression smears 
Table (2) summarizes the parasite in the liver impression smears of Nubian goats 
infected with T. evansi or T. vivax and treated with single dosing of quinapyramine 
and homidium bromide combination. T. evansi is detected in goats’ livers of groups 
(2*, 2**and 3) they showed moderate parasitaemia (++) whereas the other groups 
were parasite -free. 
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3.7.2 Clinical signs and clinical investigation 
No clinical signs were observed in goats of group (1). Goats in group (2*) which were 
infected with T. evansi showed 4-7 days post infection hypothermia, watery 
lacrimation, frothy salivation,  mucopurlent conjunctivitis, mucopurlent nasal 
discharge, decrease in appetite, Severe diffuse alopecia (plate1), diarrhoea, 
depression, apathy, muscle tremors, slight increase in the respiratory rate, decrease in 
the pulse rate , convulsion and shivering. In the second week the lymph nodes and 
testis were hot and swollen, off food, cachexia, recumbent with lateral curvature of 
the neck for 1-2days then the animals died. And goats in group (2**) which were 
infected with T. vivax started clinical signs at 7-10 days post infection, which 
included hypothermia, watery lacrimation with mucopurlent conjunctivitis, 
mucopurlent nasal discharge and frothy salivation. Lately week post infection 
decrease in appetite, depression, watery yellowish diarrhoea, muscle tremors, with 
lateral curvature of the head. 
In goats of group (3-6) 4 days post treatment signs started to decrease in severity and 
started to regain the appetite, the diarrhoea stopped 10 days later. These animals 
became healthy and looked normal within the third week post dosing. Tables (3) 
summarize the clinical changes in Nubian goats infected with T. evansi or T. vivax 
and treated with single dosing of quinapyramine and homidium bromide combination. 
The body temperature, respiratory rate, pulse rate, blood pressure and body weight 
were within the normal range in all the groups although there were significant 
changes in some parameters under investigation compared to goats of group (1). 
However goats of groups (2*and 2**) showed decrease in body temperature, 
respiratory rate, pulse rate, body weight and blood pressure changes comparable to 
control or treated groups.  
3.7.3Gross findings   
Table (4) summarizes the gross findings in Nubian goats infected with T. evansi or T. 
vivax and treated with single dosage of quinapyramine and homidium bromide 
combination. No gross findings were observed in goats of group (1). The gross 
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pathological findings in the different organs, which had been examined, which had 
been developed by trypanosomosis either, flabbiness of the heart in goats of groups 
(2*, 2**, 3, and 6) (plate 102), hepatic atelectasis especially in groups (2and3) (plate 
103), fatty changes in liver and kidneys (plate 104) absent or mild lesions. Goats in 
groups (3-4) showed distended urinary and gall bladder (plate 105and 106).                                               
3.7.4Histopathological changes 
Cerebellum and cerebrum: showed vacculations, glial cells proliferation mainly in 
white matter with oval and pyknotic nuclei, widened in prevascular spaces (plate 108) 
in goats of groups (2*, 2**) which infected with T. evansi and T. vivax respectively, 
and also these lesions were observed in goats of groups (3 and4), irregular of axons 
cheats, degeneration were noticed in groups (5-6) (plate 107).                                                                     
Spinal cords: Sections from groups (2*, 2** -6) showed vacculations in white matter, 
proliferations of ependymal cells and glial cells around the central canal. Sections 
from groups (4-5) showed some widened of prevascular spaces.                         
Peripheral nerve: were normal.              
Thyroid glands: goats of groups (2*, 2**, 3 and5) showed congestion and atrophy of 
some follicles.  
Lung: Section of lungs of groups (2*, 2** and 4) showed congestion, emphysema, 
areas of collapse and pneumonitis. Goats in groups (5-6) showed alveolar and 
bronchial haemorrhages and emphysema while goats of groups (3and5) showed 
collapse and thickened interlobular septa (plate 109).                                                                
 Heart:  Sections from groups (2*, 2**, 3 and5) showed congestion and 
haemorrhages while, the cardiac muscles were thin and had elongated nuclei goats of 
groups (4-5) while, in groups (6) were normal.                      
Liver: In goats of groups (2*, 2** -5) congestion and sinusoidal dilatation were 
observed together (plate 110) with slight centrilobular necrosis and sometime 
scattered foci of lymphocytes and macrophages (plate111) in addition to 
haemocedrein deposits. Goats in groups (3 and5) showed areas of haemorrhage, 
widened portal tracts due to mononuclear cells infiltration and widened central and 
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portal veins. Goats in groups (5-6) showed multifocal areas of degeneration, dilation 
of hepatic veins and sinusoidal congestion. 
Spleen: goats in groups (4-6) showed thickened capsule and the white pulp were 
depleted while, in groups (2*, and2**-3) were normal.                      
Kidney: goats of groups (2*, 2**, 4, 5and 6) showed dilatation of renal tubules, 
increase in glomerular cellularity (plate 112), haemorrhages and congestion while, in 
groups (3) were normal.                      
Small intestine: showed congestion, loss of villus epithelium with submucosal 
oedema in goats of groups (2*, 2**, 3 and6) while, in groups (4 and5) were normal.                      
Colon:  showed congestion and haemorrhages in goats of groups (2*, 2** and 5) 
while, in groups (4 and6) were normal.                      
Site of injection:  showed congestion, in goats of group (5) while, in groups (2*,2**-
4and6)were normal.          
Peripheral nerve, leg muscle and lymph nodes: were normal.              
Testis: Sections from goats of groups (2*, 2** -5) showed congestion and 
haemorrhage, while goats of groups (5-6) showed little evidence of activity with 
vacculations in somniferous tubules (plate113).                                                                       
3.7.5Haematological Changes 
The haematological changes are summarizes in tables (5-6) in Nubian goats infected 
with T. evansi or T. vivax and treated with single dosage of quinapyramine and 
homidium bromide combination. No significant changes were observed in the 
haemoglobin concentration, PCV, RBC counts, WBC counts, reticulocytes, platelet 
counts, eosenophiles counts, basophiles counts, neutrophiles counts, monocytes 
counts and lymphocyte counts compared to that of group (1). Significant changes 
observed in goats of groups (2*, 2**, 3, 4 and5). No significant changes observed in 
the MCV, MCH and MCHC in all animals. Generally any changes observed within 
the treated groups compared to that of group (1) still within the normal levels. Figure 
(21). 
 3.7.6 The Serobiochemical changes 
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The Serobiochemical changes summarize in tables (7-9) and figures (22-25) in 
Nubian goats infected with T. evansi or T. vivax and treated with single dosage of 
quinapyramine and homidium bromide combination. No significant changes were 
observed in the serum concentration of sodium, calcium, phosphorus, copper, zinc, 
iron bilirubin and glucose within the experimental groups. Significant changes were 
recorded in the serum chloride, magnesium, manganese, direct bilirubin, cholesterol, 
glucose, total protein, albumin globulin urea and creatinine. Significant increase was 
recorded in serum potassium only in goats of groups (2* and 2**). 
No significant changes were observed in serum activity of LDH, GOT, GPT, SDH, 
amylase in any of the experimental groups, while significant increase was observed in 
the concentration of the serum thyroxin and progesterone of goats in groups (2*, 2** 
and 3). The serum lipase decreased significantly only in goats of group (1) while the 
serum ALP decreased slightly in goats of groups (2*, 2** and 3) comparable to that 
of group (1). 
 
3.7.7The concentration of the quinapyramine in different organs in the goats 
Table (10and 11) summarizes the concentration of quinapyramine in Nubian goats 
infected with T. evansi or T. vivax and treated with single and multiple dosage of 
quinapyramine and homidium bromide combination. The quinapyramine 
concentration increased in goats of groups (3-6) but decreased in the following 
slaughtered animals except in goats of group (6). It was nil in the cerebrum and in the 
lung in the last slaughtered animals. The quinapyramine concentration increased in 
the serum of goats in groups (3and6). Generally any changes in concentration 
recorded within the treated groups comparable to that of groups (1 and 2* or 2**). 
Experiments of camels 
3.8Experiment 1: Toxicity and efficacy of Cymelarsan in camels (Camelus 
dromedarius) naturally infected with T. evansi and treated with single and 
multiple dosages of Cymelarsan 
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3.8.1The parasitaemia  
3.8.1.1The parasitaemia in the peripheral blood 
The parasitaemia in the naturally infected camels with T. evansi and treated with 
single and multiple dosages of Cymelarsan is summarizes in table (1).  
post infection 
No parasites were detected in camels of group (1). Camels in groups (2) showed mild 
(+) parasitaemia on day1-7, moderate (++) on day8-11, and severe (+++) on day12-
18, and very severe (++++) on day 19-22 until death on day 22.  
b/Post treatment  
Dosing was start on day 22 post infection. Camels of groups (3and 4) showed mild 
parasitaemia (+) 2-3days post treatment and then they were negative there after. 
However, camels in group (5) showed moderate parasitaemia (++) in the first 8 days 
post treatment, mild (+) on days 9-17, then negative parasitaemia on day 18-23, mild 
(+) on day 24-26 and then parasite -free thereafter till day 42. 
3.8.1.2Detection of the parasites in liver impression smears 
Table (2) summaries the liver impression smears in camels naturally infected with T. 
evansi and treated with single and multiple dosage of Cymelarsan. Camels of group 
(2) showed severe parasites (+++) post infection while camels in groups (3-5) was 
clear from the parasites since day 14post treatment. 
3.8.2 Clinical signs  
Camels of group (2) showed at the first week, which include lacrimation, nasal 
discharge which become purulent after the first week, shivering, hypothermia 
(33±0.02), decrease in the respiratory (7±0.01) and pulse rate (22±0.03). At the 
second week decrease of appetite, but, at week three these signs were severe and there 
were keratitis, diarrhoea, muscle tremor specially of the hind and forelimbs. Three 
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camels were crying, kicking, and hyperesthesia, anxiety episodes of upward - 
backwards form, movement of the neck, loss of weight (plate114) and loss of 
appetite. These same signs were observed in camels of groups (3 and4) during the 
treatment period but they were mild and disappeared 12-14day post treatment while 
that of group (5) were also milder and which disappeared 21day post treatment. All 
camels showed swollen at the site of injection disappeared after 1-2 days. These 
animals in groups (3-5) regain the appetite and the weight gradually thereafter. 
3.8.3Gross findings  
The gross findings in the naturally infected camels with T. evansi and treated with 
single and multiple dosages of Cymelarsan are summarized in Table (3). Infected 
camels in group (2) showed enlargement of thyroid gland, spleen, kidney, lymph 
nodes, flabby heart with observable hydropericardium, gelatinization of fat and 
muscles, congestion in brain, nasal cavity, lung(plate 115), liver(plate 118), 
kidney(plate 120), and intestine(plate121). Haemorrhages were observed in the heart 
(plate 117), pleura, lung (plate 115), liver (plate 118), kidneys (plate 120), intestines 
(plate121) and emphysema, necrotic foci and pneumonia (plate116), hypoatrophied 
and inflamed testes and spleenomegaly (plate 119). Camels under treatment in groups 
(3-5) either showed slight or absence of lesions mainly in lungs; heart and spleen 
(plate 122-125).  
3.8.4The histopathological findings 
Cerebellum and spinal cords: showed vacculations, glial cell proliferation and 
neuronal degeneration in camels of group (2) while, the rest groups were normal.                      
Cerebrum: showed congestion, haemorrhage, and slight vacculations in camels of 
groups (2and3) while, the rest groups were normal.                                                                                      
Lung: Alveolar haemorrhages were observed in goats of groups (2and3), areas of 
collapse and haemorrhage in bronchi and alveoli were also observed in camels of 
groups (2and4) while, in group (5) were normal.                      
Heart:  showed congestion and vacculations in camels of groups (2) while, the rest 
groups were normal.              
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Liver:  showed congestion and haemorrhage in camels of groups (2and3), while 
proliferation of Coffle’s cells, sinusoidal congestion was noticed in camels of groups 
(2, 4 and5).                      
Kidney:  camels of groups (2and5) showed congestion, haemorrhage, dilatation of 
tubules and nephritis while, in groups (3and 4) were normal.  
Small intestine: No obvious lesions are detected. 
3.8.5 Haematological changes 
Table (3and 4) summarize the haematological changes in camels naturally infected 
with T. evansi and treated with single and multiple dosages of Cymelarsan. 
Significant decreases were seen in the PCV, Hb concentration, and RBC count and an 
increase in the WBC count in camels of group (2) while no significant changes were 
observed in camels of groups (3, 4 and 5) as compared to group (1). 
There are no significant changes in the MCV, MCH and MCHC in groups (3-5) but 
the MCV in camels of group (2) is increased and the MCH and MCHC are decreased. 
Figure (26). 
3.8.6 Serobiochemical changes  
Table (5and 6) summarize the serobiochemical changes in camels infected naturally 
with T. evansi and treated with single dosages of Cymelarsan. Significant decrease in 
serum concentrate of calcium and phosphorus and urea, is seen in camels of groups 
(2-4) they were within the reference interval in camels of group (5). The serum 
creatinine decreased significantly in camels of groups (2-3) and it was within 
reference interval in groups (4-5). 
The serum total protein, albumin increased significantly in camels of groups (2-5) 
(the serum total protein was reference interval in camels of group 4) however, the 
serum globulins was within reference interval post – infection, it decreased 
significantly in camels of groups (3, 4 and5). The serum cholesterol, triglyceride 
concentration and GOT activity decreased in groups (2-5). The serum glucose 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
increased post – infection slightly and decreased significantly in camels of groups 
(2,3 and5). Figure (27). 
The serum GPT is within reference interval in camels of groups (3-5); it was 
significantly increased in camels of group (2) however, the serum ALP activity 
decreased significantly in camels of groups (2and 4), it was raised in camels of group 
(3) and it within reference interval in group (5). 
The serum progesterone was within reference interval in camels of group (5), it was 
significantly increased in camels of groups (2-4) while, the serum T3 decreased 
significantly post – infection, increased slightly in camels of groups (3, 4 and5). 
However, the serum T4was within reference interval in camels of groups (4 and5) and 
it decreased significantly in camels of groups (2 and3). figure (28-30). 
3.8.7The concentration of Cymelarsan 
 Table (7) summarizes the concentration of arsenic in organs, serum, and urine in 
camels naturally infected with T. evansi and treated with single and multiple dosage 
of Cymelarsan.  All groups of treated animals tend to record ≥0.07µg/ml arsenic in 
serum, urine or in the organs which include leg muscle, urine, liver, lung, spleen, 
cerebellum, cerebrum, fat, uterus, ovary, testis and the ≥0.07 were recorded 14-28day 
since cessation of the drug except the kidneys, heart, site of injection record high 
values of 5µg/ml and which decreased gradually till ≥0.07 by 28-42 day after the 
cessation of the drug treatment. 
 
3.9Experiment2: Toxicity and efficacy of oxytetracycline (OTC) in camels 
infected with T. evansi and treated with single and multiple dosages of 
oxytetracycline 
3.9.1The parasitaemia 
3.9.1.1The parasitaemia in the peripheral blood 
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The parasitaemia in the peripheral blood of naturally infected camels with T. evansi 
and treated with single and multiple dosages of oxytetracycline were summarizes in 
Table (1). No parasites were detected in camels of group (1). Camels in groups (2-7) 
showed mild parasitaemia on day1-7 (+), which increased gradually until became 
very severe (++++) on day14, then severe on day 15-18 and very severe (++++) on 
day 19-22 where the animals of group (2) died on day 22.  
Post treatment camels in group (3) showed moderate parasitaemia (++) on day 1-3, 
mild (+) on day 4-16, then moderate (++) on day17-19 until they   died on day18-20, 
camels of group (4, 5, 6and 7) showed moderate parasitaemia (++) until days 2,3,8 
and10 respectively then mild (+) until days 12,8,11and 13 respectively. These groups 
were free of the parasite then for 14, 27,15and 25 days, the mild parasitaemia (+) 
occurred again in camels of groups (4,5,6and 7) after the free- parasite period.  
3.9.1. 2 Detection of the parasites in liver impression smears 
Table (2) summaries the parasites in liver impression smear of camels naturally 
infected with T. evansi and treated with single and multiple dosages of 
oxytetracycline. Camels in group (2) showed severe parasites (+++) while camels in 
group (3) were negative in the second slaughter 28 days after the prohibition of the 
drug dosages, moderate (++) in the fifth slaughter and mild (+) in the first, third and 
fourth slaughter. While camels in group (4) showed moderate parasites (++) in the 
second, third and fifth slaughter but they were negative in the first slaughter and mild 
in the fourth slaughter. However, camels in groups (5,6and 7) were parasite -free 
thought out the withdrawal period. 
3.9.2 Clinical signs  
Camels of group (2) showed at the first week, which include lacrimation, nasal 
discharge which become purulent after the first week, shivering, hypothermia 
(33±0.02), decrease in the respiratory (7±0.01) and pulse rate (22±0.03). At the 
second week decrease of appetite, but, at week three these signs were severe and there 
were keratitis, diarrhoea, muscle tremor specially of the hind and forelimbs. Three 
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camels were crying, kicking, hyperesthesia, anxiety episodes of upward - backwards 
form, movement of the neck, loss of weight (plate 114) and loss of appetite.  Camels 
of group (3) showed clinical signs as group (2) but mild and persist until they are died  
20day  post treatment and no signs were in camels of groups (4and5), while camels of 
groups (6and7)  showed the same signs as in group (2) but mild in addition to bloody 
diarrhoea, bloody urine, also the hoof was over reflected one week after cessation of 
the drug and continued for another two weeks then improved and the  condition 
reversed to the normal until they are slaughtered. Alopecia did not recovered 
completely in all of the experimental tested groups but there is improved until they 
were died or slaughtered; all animals except group (3) improved the appetite and body 
weight gain. 
3.9.3Gross findings  
Most of the finding which seen in camels in group (2) either became mild or absent, 
but the right cerebellum in camels under treatment were hypoatrophied. Tissue at the 
site of injection are stained yellow in groups (6and 7) small aggregates yellowish 
colour of the drug which can easily crushed by hand, serous fluids, congestion and 
haemorrhages mainly in the heart with congested blood vessels (plate 126), lung 
(plate 127) and the peripheral nerves (femoral nerves) were swollen, edematous, 
congested and haemorrhagic. No lesions observed in camels of group (1). Generally 
fever subside 10 days post treatment but it is continued in group (3). The site of 
injection in groups (6and 7) showed no swelling also no lameness in the two groups. 
Tables (3) 
3.9.4The histopathological findings   
Cerebellum and spinal cords: showed vacculations, glial cell proliferation, neuronal 
in camels of groups (2, 5-7) while, in groups (3and 6) were normal.                                                            
Cerebrum:  showed haemorrhages, congestion, slight vacculations in camels of 
groups (2, and5-7) while, in groups (3and 6) were normal.                             
Lungs:  showed alveolar haemorrhage, in camels of groups (2, 3and6-7).areas of 
collapse, haemorrhage in bronchi and alveoli of camels in groups (2, 6-7) while, in 
groups (4and 5) were normal.                                                                       .             
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Heart: showed congestion, diffuse vacculations were detected in camels of groups 
(2,3,5and7)while, in groups(4and6)were normal. 
 Liver: showed congestion, haemorrhage in camels of groups (2and3), proliferation of 
Coffle’s cells, and sinusoidal congestion in camels of groups (2and3) while, in groups 
(4-7) were normal.                                                                       .                             
Kidney:  showed congestion, haemorrhage, dilatation of renal tubules in camels of 
groups (2and7) nephritis with, unshaped renal tubular cells and due to indefinite 
proliferation , some of the cells had pyknotic nuclei, in camels of groups (2and5-7) 
while, in groups (3and 6) were normal.                                                                                                         
Small intestine:  showed attachment of villi with creps due to regeneration in camels 
of groups (2,6and7) while, in groups (3,4and 5) were normal.                                                                     
3.9.5 Haematological changes 
Table (4) summaries the haematological changes in camels naturally infected with T. 
evansi and treated with single and multiple dosages of oxytetracycline. There is no 
significant changes in the PCV and the WBC of camels under experiment, but the Hb 
concentration was generally decreased in camels of group (2) and moderately in 
groups (3and 5) while it is insignificant in groups (4,6 and7) compared to control 
group (1). The RBC count decreased in camels of groups (2,6 and7) and were of 
insignificant changes in camels of groups (3,4and5) compared to control group (1). 
No significant changes are detected in the values of the MCV and MCH of camels in 
all groups, but the MCHC is significantly decreased in camels of group (2). Figure 
(31). 
3.9.6 Serobiochemical and hormonal changes  
Table (5-6) summarizes the Serobiochemical and hormonal changes in camels 
naturally infected with T. evansi and treated with single and multiple dosages of 
oxytetracycline. No significant changes in the serum concentration of calcium and 
phosphorus in different the groups except a decrease is noticed in groups (2and 6). 
Changes in serum urea, creatinine, cholesterol, glucose and triglycerides were with 
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the normal level although same groups showed vice versa. Figure (32). Also there are 
no significant changes were recorded for serum activity GOT, GPT and for the 
concentration of progesterone, T3 and T4, values showed significant changes still 
within the normal level except there is an increase in the T3 and decrease in the T4of 
camels in group (4). Also it is noticed that progesterone is high in camels of group 
(2), these results were compared statistically with the control camels of group (1). 
Figure (33-35). 
3.9.7The concentration of Oxytetracycline 
Table (7 and8) summarizes the Serobiochemical and hormonal changes in camels 
naturally infected with T. evansi and treated with single and multiple dosages of 
oxytetracycline.  The drug concentration reach the peak in the serum 3hours post 
dosing then decrease gradually until 3 days post dosing and then nil in groups (3and 
4). 
The drug concentration increased as the drug administration continued and then 
decreases as the withdrawal period progressed and recorded nil on day 21 post dosing 
(group7). However, serum concentration of the drug in group of camels that received 
the drug intermittently recorded fluctuated values up and down where the increase 
follow the administration all days and vise versa and never recorded zero values until 
the end of the experiment. Generally any changes in concentration recorded within 
the treated groups compared to that of groups (1 and 2).  
3.10Experiment 3: Efficacy and clinicopathological effect of Cymelarsan and 
oxytetracycline combination in camels infected with T. evansi 
3.10.1The parasitaemia 
3.10.1.1The parasitaemia 
 The parasitaemia in the naturally infected camels with T. evansi and treated with 
single dosages of Cymelarsan and oxytetracycline combination is summarized in 
Table (1). No parasites were detected in camels of group (1).  
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 
 
a/ Post infection  
Camels in groups (2-5) showed mild parasitaemia (+) on day1-7, moderate (++) on 
day8-11, and severe on day12-13 (+++), very severe (++++) on day14, severe on day 
(+++) 15-18, very severe (++++) on day 19-22 and the animals of group (2) died on 
day 22.  
b/ Post treatment 
The peripheral blood was free of the parasite 23, 18 and 11 days post treatment in 
groups (3), (4) and (5) respectively. 
3.10.1.2Detection of the parasites in the liver impression smears 
Table (2) summarizes the parasite in liver impression smears in camels naturally 
infected with T. evansi and treated with single dosages of Cymelarsan and 
Oxytetracycline combination. Camels of group (2) showed severe parasites (+++) 
whereas the parasite was not detected in the liver tissue of camels in other groups (3,4 
and5) in the five weeks slaughter program.  
3.10.2 Clinical signs  
Camels of group (2) showed at the first week, lacrimation, and nasal discharge which 
become purulent later, shivering, hypothermia (33±0.02oC), decrease in the 
respiratory (7±0.01/min) and pulse rate (22±0.03/min) and alopecia. At the second 
week decrease of appetite, but, at week three these signs were severe and there were 
keratitis, diarrhoea, muscle tremor specially of the hind and forelimbs. Three camels 
were crying, kicking, hyperesthesia, anxiety, episodes of upward - backwards, 
movement of the neck, in addition no over reflection of the hind limbs, no bloody 
diarrhoea or bloody urine, no alopecia, loss of weight (plate 114). The same signs 
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were observed in camels of groups (3-5) but they were mild and disappeared two 
weeks before the end of the experiment. The site of injection is swollen for 1-2 days. 
3.10.3Gross findings  
The gross findings in the naturally infected camels with T. evansi and treated with 
single and multiple dosages of Cymelarsan and OTC-LA combination is summarized 
in table (3). Most of the lesions observed in tissues and organs of camels in group (3,4 
and 5) either disappeared or they were mild(plate128 and129). 
 3.10.4The histopathological findings  
Cerebellum, cerebrum and spinal cords: the cerebellum and spinal cords showed 
vacculations, glial cell proliferation, neuronal degeneration in camels of groups (2,4-
5) while, in groups (3) were normal while, the cerebrum showed haemorrhage, 
congestion, and slight vacculations in camels of groups (2-5) while, in groups (3and 
4) were normal.                                                                        
Lungs:  showed alveolar haemorrhage, in camels of groups (2and3). Areas of 
collapse haemorrhage in bronchi and alveoli of camels in groups (2-4) while, in group 
(5) were normal.                 
Heart:  showed congestion, haemorrhage and diffuse vacculations in camels of 
groups (2and3) while, in group (4) were normal.                                                                                        
Liver:  showed proliferation of Coffle’s cells, congestion of the sinusoids of         
camels in groups (2,3and5). In addition to congestion and haemorrhage while, in 
group (4) were normal.                                                 
Kidney:  showed congestion, haemorrhage, dilatation of renal tubules, nephritis with 
unshaped cells of renal tubules some of the cells were pyknotic in camels of groups 
(2-3) while, in groups (4and 5) were normal.                                                                        
Small intestine:  the intestinal of villi were attached with creps due to regeneration in 
camels of groups (2,3and5) while, in group (4) were normal.                                                                       
3.10.5Haematological changes 
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Table (4 and5) summarizes the haematological changes in camels naturally infected 
with T. evansi and treated with single dosages of Cymelarsan and oxytetracycline 
combination. There were no changes in Hb concentration, PCV, RBC and WBC 
count in camels of groups (3-5). No significant changes were observed in the MCH, 
MCHC and MCV on experimental camels. Also decreases in the MCV and an 
increase in MCHC were observed in camels of group (2) compared to control group 
(1). figure (36). 
3.10.6The Serobiochemical changes and hormonal changes 
Table (6 and7) summarizes the serobiochemical changes in camels naturally infected 
with T. evansi and treated with single dosages of Cymelarsan and oxytetracycline 
combination. The serum activity GOT, GPT and ALP and serum concentration of 
urea, creatinine, total protein and cholesterol within the reference interval in the 
different groups tested However, No significant changes were seen in serum 
concentration of globulins, triglycerides and glucose in groups (3-5). Compared to 
control group (1) Figure (37). However, a decrease in the globulin value was detected 
only in group (5). But significant increase in the progesterone was observed in group 
(2), while decrease in the level of T3, T4 and phosphorus was also detected in the 
same group. Figure (38-40). 
3.10.7The concentration of the Cymelarsan and Oxytetracycline 
Table (8) summarizes the concentration of the Cymelarsan in camels naturally 
infected with T. evansi and treated with single dosages of Cymelarsan and 
oxytetracycline. Table (9-10) summarizes the concentration of the Oxytetracycline in 
camels naturally infected with T. evansi and treated with single dosages of 
Cymelarsan and oxytetracycline combination. It was noticed that in camels of groups 
(3-5) the concentration of Cymelarsan return to the control value group (1) when 
camels were slaughtered on day 21 post treatment, for the tissues organs, fluids 
investigated. High concentration of oxytetracycline were detected in group (5) which 
received five times the recommended dose compared to groups (3and 4), in addition 
site of injection, kidneys, liver, cerebrum, fat, leg muscle, cerebellum and lungs 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
recorded high concentration. Also it is noticed that some organs do not release the 
drug rapidly such as the kidneys, heart, fat, site of injection and leg muscle. The least 
organs where the drug is concentrated after 21 days post treatment were urine, testis, 
ovary, spleen and the uterus. Table (9) summarizes the concentration of the 
Oxytetracycline in serum of camels naturally infected with T. evansi and treated with 
single dosages of Cymelarsan and oxytetracycline combination. Also when the 
residues amount of Cymelarsan studied in the different camels' tissues and urine it is 
noticed that when the concentration of OTC increased the residual amount of 
Cymelarsan decreased. No oxytetracycline residues were detected in the serum of 
camels in the different groups 10 days post treatment. Generally any changes in 
concentration recorded within the treated groups compared to that of group (1 and 2). 
Table (1) The parasitaemia  in the prepheral blood of Nubian goats infected  with T. evansi and 
given single and multiple dosages of Cymelarsan. 
a/post infection 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group (1) 
 - 
 
Group (2) 
 
 -ve  + + ++ ++++ ++++ ++++ +++++  
Died 
Group (3) 
0.125 
mg/kg 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (4)  
0.25mg/kg 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
Group 
(5)0.625 
mg/kg 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (6)  
1.25mg/kg 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (7)  
0.125mg/kg 
twice/week for 
2weeks 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (8) 
0.125mg/kg 
daily for 8days 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (9) 
0.25mg/kg 
twice/week 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (10)  
0.25mg/kg 
daily for 8days 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
  + = 1-4 parasite/field  (milde), ++ = 5-8 parasite/field (moderate), +++ = 9-14 parasite/field (severe),  more than++++ 
=15-20 parasite/field(very severe) and –ve = no parasite detected. 
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Table (1) The parasitaemia  in the peripheral blood of Nubian goats infected  with T. evansi and 
given single and  multiple dosages of Cymelarsan. 
 post treatment 
ment 
withdrawal period 
s 
s 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
(1) - 
(2) * 
(3) 
5 
g 
+ + + + - ++ Died 
(4)  
/kg 
+ 
 
 
 
+ 
 
+ + - 
0.625 
g - 
(6)  
/kg - Died 
(7)  
g/kg 
ek for 
ks 
+ 
+ 
+ 
+ 
+ 
+ - Di
(8) 
g/kg 
8days 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- Di
(9) 
/kg 
ek for 
ks 
- 
(10)  
g daily 
ays 
- 
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- = no parasites were detected    + = 1-4 parasites/field  (mild),  ++= 5-8 parasites/field (moderate), +++ = 9-14 
parasites/field (severe),  more than++++ =15-20 parasites/field (very  severe), and * =  animals in group (2) died on day 
11 post infection.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the prepheral blood of Nubian goats infected with T. evansi an 
given single and multiple dosages of oxytetracycline. 
a/post infection 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group (1) 
 - 
Group (2) 
 
- - - + + ++ ++++ ++++ ++++ +++++  
Died 
Group (3) 
20mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (4) 
50mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (5) 
100mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (6) 
20mg/kg  
weekly for 
3weeks 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (7)  
20 mg/kg 
twice/week 
for 2weeks 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
Group (8) 
20mg/kg daily 
for 8days 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
- = no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
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Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi an 
given single and multiple dosages of oxytetracycline. 
post treatment 
 
post treatment 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
Group (1) - 
Group (2) 
* 
Group (3) 
20mg/kg 
+
+ 
+
+ 
+
+ 
+ + + + + +
+ 
+
+ Died 
Group (4) 
50mg/kg 
+
+ 
+
+ 
+
+ 
+ + + + + + + + + + + + + + +
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+ + + 
Group (5) 
100mg/k
g 
+
+ 
+
+ 
+
+ - + + + + + + 
Group (6) 
20mg/kg  
weekly for 
3weeks 
+
+ 
+
+ 
+
+ 
+
+ 
+ + + + + + +
+ 
+
+ 
+
+ 
+ + + + + + + + + + + + + + 
Group (7)  
20 mg/kg 
twice/week 
for 2weeks 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+ + + +
+ 
+
+ 
+
+ 
+
+ 
+ + + + + + + - + + 
Group (8) 
 20mg/kg 
daily for 
8days 
+
+ 
+
+ 
+ + + + + + + - + + + + Died 
+ = 1-4 parasites/field  (mild),  - = no parasite detected and * =  animals in group (2 died on day 11 post infection.                                         
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Table (1) The parasitaemia in the pripheral of blood Nubian goats infected with T. evansi and 
given single and multiple dosages of Cymelarsan and suplemented with zinc and copper. 
a/post infection 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group (1) 
 - 
Group (2) 
 
- - - + + ++ ++++ ++++ ++++ +++++  
Died 
Group (3) 
0.125mg/kg+Zn+Cu 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (4) 
0.125mg/kg+Zn+Cu 
daily for 8days 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
- = no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
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Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi and 
given single and multiple dosages of Cymelarsan and suplemented with zinc and copper. 
 
post treatment 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 1
Group (1) 
 - 
 
Group (2) 
 * 
Group (3) 
0.125 mg/kg 
+ + + + + -ve 
Group (4) 
0.125mg/kg+Zn+Cu 
++ ++ ++ ++ ++ ++ ++ ++ -v
Group (5)  
0.125mg/kg daily for 
8days 
+ + + + 
Group (6) 
0.125mg/kg+Zn+Cu 
daily for 8days 
+ + + - 
- = no parasite detected,    + = 1-4 parasites/field  (mild), ++ = 5-8 parasites/field (moderate) * =  animals in group (2)  
died on day 11 post infection.   
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Table (1) The parasitaemia in the prepheral blood of Nubian goats infected with T. evansi an 
given single and multiple doses of Cymelarsan and oxytetracyclie. 
a/ post infection 
Post infection 
Parameter 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group (1) 
 -  
Group (2) 
 
- - - + + ++ ++++ ++++ ++++ +++++  
Died 
Group (3) 0.125 
mg/kg of 
MelCy+10mg/kg 
of OTC  
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (4) 0.125 
mg/kg of 
MelCy+50mg/kg 
of OTC 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (5) 0.125 
mg/kg of 
MelCy+20 
mg/kg of 
OTCtwice/ 
Week 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group (6) 0.125 
mg/kg of 
MelCy+20mg/kg 
of OTC daily for 
8days 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
- = no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very (severe) 
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Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi an 
given single and multiple doses of Cymelarsan and oxytetracyclie combination. 
post treatment 
Post  treat ment 
Parameter 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
Group (1) 
 - 
Group (2) 
 * 
Group (3)  
0.125 mg/kg of 
MelCy+10mg/kg 
of OTC  
+
+ 
+
+ 
+
+ 
+ + + +
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ 
+
+ Died
Group (4)  
0.125 mg/kg of 
MelCy+50mg/kg 
of OTC 
- + ++
+
+ 
+ - +
Group (5)  
0.125 mg/kg of 
MelCy+20 
mg/kg of 
OTCtwice/week 
for 2weeks 
+ ++ ++ ++ - 
Group (6) 0.125 
mg/kg of 
MelCy+20mg/kg of 
OTC daily for 
8days 
+ + + - 
- = no parasite was detected,    + = 1-4 parasites/field  (mild),+ = 5-8 parasitesfield (moderate), more than +++ = 9-14 
parasites/ield (severe) and more than++++ =15-20 parasitesfield(very severe) 
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Table (1) The parasitaemia in the prepheral blood of Nubian goats infected with T. evansi an 
given single  and multiple dosages of Quinapyramine. 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group(1)   
 
 
- 
 
Group(2) 
 
 
- - - + + ++ ++++ ++++ ++++ +++++  
Died 
Group(3) 
treated 
with5mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(4) 
treated 
with12.5 
mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(5) 
treated 
with25 
mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(6) 
treated 
with1mg/kg 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
Group(7)  
50 
mg/kgweekly 
for 3weeks 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
Group(8)  
5 mg/kg daily 
for 8days 
 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
-= no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
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Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi an 
given single  dosages of Quinapyramine. 
post treatment 
Days 
Group 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 35 42 4
Group(1)   
 
 
- 
Group(2) 
 
 
* 
Group(3) 
eated with5 
mg/kg 
+ - ve + 
Group(4) 
treated 
th12.5mg/kg 
+ - ve 
Group(5) 
eated with25 
mg/kg 
+ - ve 
Group(6) 
treated 
ith50mg/kg 
+ -ve died  on day 12-18 
Group(7)  
mg/kgweekly 
for 3weeks 
+ - 
Group(8)  
mg/kg daily 
for 8days 
 
+ -ve  died  on day 16-20 
- = no parasite was detected,    + = 1-4 parasites/field  (mild)  
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Table (1) The parasitaemia in the prepheral blood of Nubian goats infected with T. evansi an 
given single and multiple dosages of Homidium Bromide. 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 13-17 
Group(1)   
 
 
- 
 
Group(2) 
 
 
- - - + + ++ ++++ ++++ ++++ +++++  
Died 
Group(3) 
treated 
with1 
mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(4) 
treated 
with2.5 
mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(5) 
treated 
with5 
mg/kg 
- - - + + ++ ++++ ++++ ++++ +++++ +++++ 
Group(6) 
 1mg/kg 
weekly for 
3weeks 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
Group(7) 
1mg/kg daily 
for 8days 
 
- - - + + ++ ++++ ++++ ++++ ++++ ++++ 
-= no parasite was detected,    + = 1-4 parasite/field  (mild),++ = 5-8 parasite/field (moderate) more than +++ = 9-
14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe 
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Table (1) The parasitaemia in the peripheral blood o f Nubian goats infected with T. evansi an 
given single and multiple dosages of Homidium Bromide. 
Post treatment 
Post treatment 
Days 
Group 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Group(1)   
 
 
- 
Group(2) 
 
 
* 
Group(3) 
treated 
with1 
mg/kg 
+ - + -ve** 
Group(4) 
treated 
with2.5 
mg/kg 
+ - 
Group(5) 
treated 
with5 
mg/kg 
+ - Died 
Group(6) 
 1mg/kg 
weekly for 
3weeks 
+ - + 
Group(7) 
1mg/kg daily 
for 8days 
 
+ - Died 
- = no parasite was detected,    + = 1-4 parasites/field  (mild)*= died 13-17 day post infection. **= the three died 
animals were + and the rest as shown above.   
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Table (1) The parasitaemia in the pripheral blood of Nubian goats infected with T. evansi an 
given single dosages of  quinapyramine and Homidium Bromide. 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 
Group(1)   
 
 
- 
 
Group(2) 
 
 
 -ve  + + ++ ++++ ++++ ++++ +++++  
Died 
*Group(3)  
5 mg/kgof quina. 
+1mg/kg of eth. 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
*Group(4) 
12.5mg/kgof 
quina.+1 mg/kg 
of eth. 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
**Group(5)  
5 mg/kgof quina. 
+1mg/kg of eth. 
   + + ++ ++++ ++++ ++++ +++++ +++++ 
**Group(6) 
5mg/kgof 
quina.+2.5mg/kg 
of eth 
   + + ++ ++++ ++++ ++++ ++++ ++++ 
-= no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) *      = Infection 
was done by T. evansi. **   = Infection was done by T. vivax. quina.= quinapyramine.     hom.  = homidium bromide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi an 
given single dosages of  quinapyramine and Homidium Bromide combination. 
Post treatment 
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Post treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 35 42 
Group (1) 
 - 
Group (2) 
 * 
Group(3)  
g/kgof quina. 
mg/kg of eth. 
+ - + 
Group(4) 
.5mg/kgof 
na.+1 mg/kg 
of eth. 
+ - +
*Group(5)  
g/kgof quina. 
mg/kg of eth. 
+ - + ++ + - 
*Group(6) 
5mg/kgof 
a.+2.5mg/kg 
of eth 
+ - + - 
-= no parasite was detected,    + = 1-4 parasites/field  (mild),++ = 5-8 parasites/field (moderate),  *      = Infection was 
done by T. evansi. **   = Infection was done by T. vivax. quina.= quinapyramine.     hom.  = homidium bromide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the pripheral blood camels naturally infected with T. evansi and 
given single and multiple dosages of Cymelarsan. 
a/Post infection 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
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Group (1) 
 - 
Group (2) 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ 
Group(3) 
0.25mg/kg 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ 
Group (4) 
0.625mg/kg 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ 
Group (5)  
0.125 mg/kg 
weekly/3weeks 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ +++ +++ +++ +++ +++ 
-= no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood camels naturally infected with T. evansi and 
given single and multiple dosages of Cymelarsan. 
Post treatment 
Post treatment Days 
Groups 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group (1) 
 
 
- 
Group (2) * 
Group(3) 
0.25mg/kg 
 
+ - 
Group (4) 
 0.625mg/kg 
 
+ + - 
Group (5)  
0.125 mg/kg 
weekly for 
3weeks 
 
++ + - 
-= no parasite was detected,    + = 1-4 parasites/field  (mild), ++ = 5-8 parasites/field (moderate)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the pripheral blood of camels naturally infected with T. evansi and 
given single and multiple dosages of Oxytetracycline. 
Post infction 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Group (1) 
 - 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group (2) 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group (3) 
20 mg/kg 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group (4)  
50mg/kg 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group (5)  
100 mg/kg 
 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group (6) 
20mg/kg 
twice/week for 
2weeks 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group (7)  
20mg/kg daily for 
8days 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
-= no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood of camels naturally infected with T. evansi 
and given single and multiple dosages of Oxytetracycline. 
Post treatment 
Post treatment Days 
Groups 1 2 3 4 5 6 7 8 9 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Group (1) 
 - 
Group (2) 
 * 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group (3) 
20 mg/kg 
 
++ ++ ++ + ++ 
Group (4)  
50mg/kg 
 
++ ++ + - 
Group (5)  
100 mg/kg 
 
++ + - 
Group (6) 
20mg/kg 
twice/week for 
2weeks 
++ + ++ - 
Group (7)  
20mg/kg daily 
for 8days 
++ + - 
-= no parasite was detected,    + = 1-4 parasites/field  (mild),++ = 5-8 parasites/field (moderate)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the pripheral blood camels naturally infected with T. evansi and 
given single and multiple dosages of Cymelarsan and Oxytetracycline. 
Post infection 
Days 
Groups 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
 Group( 1) - 
 Group (2) + + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group(3) 
0.25mg/kgof 
MelCY+20mg/kg of 
OTC 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group(4)  
0.125mg/kgof 
MelCY+50mg/kg of 
OTC 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
Group(5)  
0.125mg/kgof 
MelCY+100mg/kg of 
OTC 
+ + + + + + + ++ ++ ++ ++ +++ +++ ++++ +++ +++ +++ +++ 
-= no parasite was detected,    + = 1-4 parasite/field  (milde) ++ = 5-8 parasite/field (moderate) more 
than +++ = 9-14 parasite/field (severe) and more than+++++ =15-20 parasite/field(very severe) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood camels naturally infected with T. evansi and 
given single and multiple dosages of Cymelarsan and Oxytetracycline combination. 
Post treatment 
 Post treatment 
Days 
Groups 
1 2 3 4 5 6 7 8 9 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
 Group( 1) 
 - 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 Group (2) 
 * 
Group(3) 
0.250 mg/kgof 
MelCY+20mg/kg 
of OTC 
++ - + 
Group(4)  
0.125mg/kgof 
MelCY+50mg/kg 
of OTC 
++ - + - 
Group(5)  
0.125mg/kgof 
MelCY+100mg/kg 
of OTC 
++ + - 
-= no parasite was detected,    + = 1-4 parasites/field  (mild),++ = 5-8 parasites/field (moderate)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. evansi an 
given single dosages of  quinapyramine and Homidium Bromide. 
Post treatment 
Post treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 35 42 
Group (1) 
 - 
Group (2) 
 * 
Group(3)  
ated with5 
mg/kg 
+ - +
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group(4)  
g/kgof quina. 
mg/kg of eth. 
+ - + 
Group(5) 
.5mg/kgof 
na.+1 mg/kg 
of eth. 
+ - +
-= no parasite was detected,    + = 1-4 parasites/field  (mild),*      = died on day 11.  quina.= quinapyramine.     hom.  = 
homidium bromide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (1) The parasitaemia in the peripheral blood of Nubian goats infected with T. vivax  an 
given single dosages of  quinapyramine and Homidium Bromide. 
Post treatment 
Post treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 35 42
p (1) - 
p (2) * 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
up(3) 
d with1 
/kg 
+ - + - +
up(4)  
of quina. 
g of eth. 
+ - + ++ + - 
up(5) 
kgof 
.5mg/kg 
eth 
+ - + - 
-= no parasite was detected,    + = 1-4 parasites/field  (milde) ++ = 5-8 parasites/field (moderate),*      = died 
on day 17.  quina.= quinapyramine.     hom.  = homidium bromide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and given  
single and multiple dosages of Cymelarsan . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1) 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
* Group (2)  
+ + + + -ve 
 
+ + + Group (3)** 
0.125mg/kg 
 
-ve Group (4) 0.250 mg/kg 
-ve Group (5) 0.625mg/kg 
(-ve) Died on day17   -ve Group (6) 1.25mg/kg 
(-ve) Died on day 28   -ve Group (7) 0.125 mg/kg 
twice/week for 2 
weeks 
(-ve) Died on day28   -ve Group (8) 0.125mg/kg daily 
(-ve) Died on day21   -ve Group (9) 0.250 mg/kg 
twice/week 
for 2 weeks 
(-ve) Died on day15   Group (10) 
0.250 mg/kg 
daily for 8 days 
-ve = no parasite detected , += 1-3 parasites/field,  ++ = 4-6 parasites/field, * = Died on day 11post infection and 
showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and given  
single and multiple dosages of oxytetracycline . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1) 
* Group (2) 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
(++) Died on day 10  Group (3) 
20mg/kg 
+ Group (4) 50mg/kg 
-ve ++ + ++ ++ Group (5) 
100mg/kg 
-ve ++ + ++ ++ Group (6) 20mg/kg 
weekly 
for3weeks 
-ve Group (7)  20 mg/kg 
twice/week 
(-ve)     Died on day18   -ve 
Group (8)  
20mg/kg daily 
-ve = no parasite detected , += 1-3 parasites/field,  ++ = 4-6 parasites/field, * = Died on day 11post infection and 
showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and  
given single and multiple dosages of Cymelarsan and supplemented with zinc and copper . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* 
Group (2) 
 
+ + + + -ve 
 
+ + + Group (3)** 
0.125mg/kg  
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
-ve Group (4) 0.250mg/kg+Zn+Cu 
(-ve)Died on day 15  Group(5) 
0.250 mg/kg 
daily for 8 days 
(-ve)Died on day15  -ve Group (6)  0.250mg/kg+Zn+Cudaily 
-ve = no parasite detected , += 1-3 parasites/field,  * = Died on day 11post infection and showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and  
given  single and multiple dosages of Cymelarsan and oxytetracycline . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
++ ++ + + + + -ve -ve -ve -ve Group (3)** 
0.125 mg/kg of 
MelCy+10mg/kg of 
OTC 
+ + + ++ ++ ++ ++ -ve -ve -ve Group (4) 
0.125 mg/kg of 
MelCy+50mg/kg of 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
OTC 
-ve Group (5) 0.125 mg/kg of 
MelCy+20 
mg/kg of OTC twice/ 
week for 2 weeks 
(-ve) Died on day28 
 
Group (6) 
0.125 mg/kg of 
MelCy+20mg/kg of 
OTC daily for 8days 
-ve = no parasite detected , += 1-3 parasites/field,  ++ = 4-6 parasites/field, * = Died on day 11post infection and 
showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and  
given single and multiple dosages of Quinapyramine . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
+ + + + + + -ve -ve + + Group(3) ** 
5 mg/kg 
-ve Group(4) 12.5 mg/kg 
–ve Group(5) 25 mg/kg 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
(–ve)Died on day12-18  Group(6) 
1 mg/kg 
-ve Group(7) 5mg/kg weekly for 
3weeks 
(–ve)Died on day16-20  Group(8) 5 mg/kg daily for 8 days 
-ve = no parasite detected , += 1-3 parasites/field,  ++ = 4-6 parasites/field, * = Died on day 11post infection and 
showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and  
given  single and multiple dosages of Homidium  Bromide . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
+ + + + -ve + + + + Group (3) ** 1 mg/kg 
 
Group (4)  
2.5 mg/kg 
Group (5)  
5 mg/kg 
 
 
-ve 
Group (6) 
 1mg/kg weekly 
for 3weeks 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group (7)  
1mg/kg daily 
 
-ve = no parasite detected , += 1-3 parasites/field,   * = Died on day 11post infection and showed ++parasites/field. 
**=  Died on days26-28  post infection. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 
35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in Nubian goats infected 
with T. evansi and  
given  single and multiple dosages of Quinapyramine and Homidium Bromide . 
 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
-ve *Group(3)  5 mg/kgof quina. 
+1mg/kg of eth. 
-ve *Group(4) 12.5mg/kg of 
quina.+1 mg/kg of 
eth. 
-ve **Group(5)  5 mg/kgof quina. 
+1mg/kg of eth. 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
-ve **Group(6) 5mg/kgof 
quina.+2.5mg/kg of 
eth 
*      = Infection was done by T. evansi. **   = Infection was done by T.vivax. quina.= quinapyramine.     hom.  = 
homidium bromid,  
* = Died on day 11post infection and showed ++parasites/field.   Week1 (w1)=14day post treatment (d.p.t), 
w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in camels naturally 
infected with T. evansi and 
given single and multiple dosages of Cymelarsan . 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
-ve Group (3) 
0.250 mg/kg 
 
-ve Group (4)  0.625mg/kg 
 
-ve Group (5)  0.125 mg/kg 
weekly/3weeks 
 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
* = Died on day 21post infection and showed +++parasites/field. 
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in camels naturally 
infected with T. evansi and  
given single and multiple dosages of oxytetracycline . 
 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
* Group (2) 
++ + + -ve + Group (3)** 
20 mg/kg 
 
+ 
+ 
+ ++ ++ -ve Group (4)  
50mg/kg 
 
Group (5)  
100 mg/kg 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Group (6) 
20mg/kg 
twice/week for 2 
weeks 
 
Group (7)  
20mg/kg daily for 
8 days 
-ve = no parasite detected,   + = 1-3 parasites/field, ++ = 4-6 parasites/field,  +++ =7-11,  * = Died on day 22 post 
infection and showed +++parasites/field, 
** = died on day 20. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2): Detection of the parasites by the liver impression smears in camels naturally 
infected with T. evansi and 
given  single dosages of Cymelarsan and oxytetracycline combination within the withdrawal 
period 
 
Slaughter  (week) 
W5 W4 W3 W2 W1 
Groups 
-ve Group (1)  
*  (2) Group 
Group (3) 
0.250 mg/kgof 
MelCY+20mg/kg of 
OTC 
Group (4) 
0.125mg/kgof 
MelCY+50mg/kg of 
OTC 
-ve 
 
Group(5) 
0.125mg/kgof 
MelCY+100mg/kg 
of OTC 
                          -ve = no parasite detected,   * = Died on day 21post infection and showed +++parasite/field.   
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (12) The effect of oxytetracycline on T. evansi in phosphate glucose 
buffer solution (PGS) 
OTC concentration 
(µg/ml) 
Trypanosomes in PSG Trypanosomes in rats 
0.1-0.9 
 
++ ++ 
1-3 
 
+ + 
4-15 
 
-ve - ve 
- ve= negative no parasite detected, + = 50% of the parasite added to PSG and ++ = all the parasites added 
to PSG 
 
 
 
 
 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Cymelarsan 
Groups 
Site Lesion (1)
 
(2)  (3) (4) (5)  (6)  (7) (8)   (9)  (10) 
Congestion - ++ ++ - - - + + - + Brain 
 Haemorrhage - + + - - + - - - - 
Nasal 
Cavity 
Congestion - + + + + - - ++ - - 
Congestion - - - - + ++ + + + + 
Haemorrhage - - - - - - - + + + 
 
Trachea 
 Froth - - - + + - + - + - 
Thyroid 
gland 
Enlargement - ++ + - - - - ++ - - 
Hepatization - ++ + - - ++ + + + +  
Lungs Congestion - +++ ++ + + + - + + + 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Haemorrhage - ++ + - - ++ + - + -  
Emphysema - + + + + - - ++ - - 
Congestion - - - - - ++ + + + + 
Haemoarrhage - + + - + ++ ++ ++ + ++ 
Flabiness - ++ ++ - - + ++ ++ ++ +++
 
Heart 
Hydropericardium - + + - - +++ ++ + ++ ++ 
Congestion - +++ +++ - - + - - + + 
Haemoarrhage - - - - - + +++ + - - 
Oedema - + ++ + + + ++ +++ +++ +++
 
Liver 
 
Fatty change and/ 
or Necrosis 
- + - - - ++ ++ - - - 
Haemorrhage - + - - - - ++ - - - 
Congestion - + - - - ++ ++ - - - 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ + + + + - - - - 
Congestion - ++ + - + ++ - - - - Spleen 
 Enlargment - +++ + - - ++ + ++ + + 
Congestion - +++  ++  - - + ++ - - - 
Haemorrhage - ++ ++ - - - - + + ++ 
 
Intestine 
 Enteritis -  + - - - - + - + + 
Peritonitis - - - - - - + + + ++ Peritoneum 
 Hydroperitonium - - - - - ++ + + + ++ 
Site of 
injection 
Damage - - - + + +++ ++ +++ +++ +++
Peripheral 
nerves 
Damage and 
congestion    
- - - - - +++ + + ++ ++ 
Lymph 
node 
Enlargement/lymph 
adenitis 
- + ++ - - ++ + + + ++ 
Testis Atrophy and/or 
orchitis 
- + + - - - - - - - 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
 
 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of oxytetracycline 
Groups 
    Site Lesion  (1) 
 
(2)  (3)  (4)  (5)   (6)   (7) (8)  
Congestion - ++ + + - - + + 
Haemorrhage - + + - - + - - 
Atrophy - - - - - ++ +++ +++ 
Brain 
 
Hyperaemia - - - - - ++ ++ ++ 
Nasal 
Cavity 
Congestion - + + + - - - - 
Congestion - - - - + + ++ ++ 
Haemorrhage - - - - - - - - 
 
Trachea 
 Froth - - - - + - + ++ 
Tyroid 
gland 
Enlargement - ++ ++ - - - + - 
Hepatization - ++ + - - - + ++  
Lungs Congestion - +++ - - - - - - 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Haemorrhage - ++ - - - - - -  
Emphysema - + + - - - + ++ 
Congestion - - + - - + + + 
Haemoarrhage - + + + + + + + 
Flabiness - ++ - - - + + ++ 
 
Heart 
Hydropericardium - + - - - ++ ++ ++ 
Congestion - +++ + - - + + + 
Haemoarrhage - - + + - + + + 
Oedema - + + - - + + + 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- + + - - + + + 
Haemorrhage - - + - - - + + 
Congestion - - + - - + ++ + 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ + + + + + + 
Congestion - ++ + + - + - - Spleen 
 Enlargment - +++ + - - + - + 
Congestion - +++  ++  + + + + + 
Haemorrhage - ++ ++ - - - - + 
 
Intestine 
 Enteritis - + - + + + + + 
Peritonitis - - + - - + + + Peritoneum 
 Hydroperitoneum - - + - - ++ + + 
Site of 
injection 
Myositis 
 
- - - - + + + + 
Damage  - - - - - + +++ +++ Peripheral 
nerves congestion - - + + + + + + 
Lymph 
node 
Enlargement/lymph 
adenitis 
- + - - - - - - 
Testis Atrophy and/or 
orchitis 
- + - - - - - - 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Cymelarsan and oxytetracycline combination. 
Groups  
     Organ Lesion (1) 
 
(2)  (3)  (4)  (5)   (6) 
Congestion - ++ - - ++ ++ 
Haemorrhage - + - - - - 
Brain 
 
Atrophy - - - - ++ ++ 
Nasal Cavity Congestion - + + - - - 
Congestion - - - - - - 
Haemorrhage - - - - - - 
 
Trachea 
 Froth - - - - - - 
Tyroid gland Enlargement - + + + - - 
Hepatization - ++ ++ + - + 
Congestion - +++ + + + + 
Haemorrhage - ++ - - - - 
 
Lungs 
 
Emphysema - + +  - + 
Congestion - + + + ++ + 
Haemoarrhage - + + + + + 
Flabbiness - ++ ++ - - - 
 
Heart 
Hydropericardium - + ++ - ++ - 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
Congestion - +++ + + ++ - 
Haemoarrhage - - - - - - 
Oedema - + - - - - 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- + + - - - 
Haemorrhage - + + - - - 
Congestion - + + - - - 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ ++ - - ++ 
Congestion - ++ - - - - Spleen 
 Enlargment - +++ - - - - 
Congestion - +++  + + - - 
Haemorrhage - ++ - - - - 
 
Intestine 
 Enteritis - + + - + + 
Peritonitis - - - - - - Peritoneum 
 Hydroperitoneum - - - - - - 
Site of injection Damage - - - - ++ -++ 
Peripheral 
nerves 
Damage and 
congestion 
- - - + + +++ 
Lymph node Enlargement/ adenitis - + - - - - 
Testis Atrophy and/or 
orchitis 
- + ++ + + ++ 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Cymelarsan suplemented with zinc and copper. 
Groups 
Site Lesion (1) 
 
(2)   (3)  (4)  (5)  (6)  
Congestion - ++ ++ + + + Brain 
 Haemorrhage - + + + - + 
Nasal Cavity Congestion - + + - - - 
Congestion - - - - + - 
Haemorrhage - - - - + - 
 
Trachea 
 Froth - - - - - - 
Tyroid gland Enlargement - ++ + - - + 
Hepatization - ++ + - + - 
Congestion - +++ ++ - + + 
Haemorrhage - ++ + - - - 
 
Lungs 
 
Emphysema - + + - - + 
Congestion - - - - + + 
Haemoarrhage - + + - + - 
Flabiness - ++ ++ - +++ - 
 
Heart 
Hydropericardium - + + - + - 
Congestion - +++ +++ + + ++ 
Haemorrhage - - - - - - 
Oedema - + ++ - +++ - 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- + - + - + 
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Haemorrhage - + - - - + 
Congestion - + - + - ++ 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ + + - + 
Congestion - ++ + - - + Spleen 
 Enlargment - +++ + - - - 
Congestion - +++  ++   - - + 
Haemorrhage - ++ ++ - ++ ++ 
 
Intestine 
 Enteritis +- + - - + ++ 
Peritonitis - - - - ++ - Peritoneum 
 Hydroperitoneum - - - - ++ - 
Site of 
injection 
Damage - - - - +++ ++ 
Peripheral 
nerves 
Damage and congestion   - - - - ++ - 
Lymph node Enlargement/lymph 
adenitis 
- + ++ - ++ - 
Testis Atrophy and/or orchitis - + + - - + 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
 
 
 
 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Quinapyramine. 
Groups  
Site Lesion (1) 
 
(2)  (3)  (4)  (5) (6) (7) (8) 
Congestion - ++ + - - + - +++ 
Haemorrhage - + - - - + + ++ 
Brain 
Nasal Cavity 
Congestion - - - + - + - ++ 
 
Trachea 
 
Congestion - + - - - + - ++ 
Haemorrhage - - - - - + - + 
Froth - - - - - + - +++ 
 
Tyroid gland 
Enlargement - - - - - + + ++ 
Lungs Hepatization - ++ + - - + - + 
Congestion - ++ + + + + + + 
Haemorrhage - +++ + + + + + + 
Emphysema - ++ - + + + + + 
 
 
Heart 
Congestion - + - + + + + + 
Haemoarrhage - + - - - + + + 
Flabiness - + - - - + + + 
Hydropericardium - ++ - - - + + + 
 
 
Liver 
 Congestion - + - - - + + + 
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Haemorrhage - +++ + - + - - + 
Oedema - - - - - - - - 
Fatty change and/ or 
Necrosis 
- + - + + - - - 
 
 
Kidneys 
 
Haemorrhage - + - + + + + + 
Congestion - + + + + + - + 
Fatty change and/or 
necrosis 
- + - - + - - + 
 
Spleen 
 
Congestion - ++ - - + + + + 
Enlargment - ++ + - - - + +  
Intestine Congestion - +++ - - - - + ++ 
Haemorrhage - +++  - - + + + + 
Enteritis - ++ - - + + + + 
 
Peritoneum 
 Peritonitis - + - - + + + + 
Hydroperitoneum - - + - - - - ++  
Site of 
injection 
Damage - - - - - + - ++ 
Peripheral 
nerves 
Damage and 
congestion 
- - - - - - _ ++ 
Lymph node Enlargement/lymph 
adenitis 
- - - - - - - - 
Testis Atrophy and/or 
orchitis 
- + - - - - - - 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Homidium Bromide. 
Groups 
Site Lesion (1) 
 
(2)  (3)  (4)  (5) (6) (7) 
Congestion - + + - - - - 
Haemorrhage - ++ + - - - ++ 
Brain 
 
Atrophy - + - - - - ++ 
Nasal Cavity Congestion - - - - - - +++ 
Congestion - + ++ - - - ++ 
Haemorrhage - + ++ - - - ++ 
 
Trachea 
 Froth - + ++ - - - ++ 
Tyroid gland Enlargement - ++ + - - - - 
Hepatization - ++ + - - + - 
Congestion - ++ + - - - - 
Haemorrhage - + ++ - + - ++ 
 
Lungs 
 
Emphysema - + + - + - ++ 
Congestion - + ++ + + - - 
Haemoarrhage - + ++ + + - ++ 
Flabiness - + ++ + + + - 
 
Heart 
Hydropericardium - + + - + - + 
Congestion - ++ + - + - ++ 
Haemoarrhage - ++ ++ - + - ++ 
 
Liver 
 Oedema - + + - - - + 
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Fatty change and/ or 
Necrosis 
- + + - + - ++ 
Haemorrhage - + + + - - ++ 
Congestion - ++ - - - - ++ 
 
Kidneys 
 Fatty change and/or 
necrosis 
- + - - - - - 
Congestion - ++ + - - - + Spleen 
 Enlargment - ++ - - - - + 
Congestion - +   ++ - - - + 
Haemorrhage - + + - - - + 
 
Intestine 
 Enteritis - + + - - - ++ 
Peritonitis - + + - - - ++ Peritoneum 
 Hydroperitoneum - + - - + - + 
Site of 
injection 
Damage - + - - - - + 
Peripheral 
nerves 
Damage and 
congestion 
- + - - - - - 
Lymph node Enlargement/lymph 
adenitis 
- + + - - + - 
Testis Atrophy and/or orchitis - + + + + - + 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
Table(4)  :Postmortem findings in Nubian goats infected with T. evansi and given single and 
multiple dosages of Quinapyramine and Homidium Bromide. 
groups 
Site Lesion (1) 
 
(2)* (2)** (3)  (4) (5) (6) (7) 
Congestion - ++ + ++ - + - - 
Haemorrhage - + ++ + - - - ++ 
Brain 
 
Atrophy - + + + - - - - 
Nasal Cavity Congestion - - - + - - - +++ 
Congestion - - + + - - - ++ 
Haemorrhage - - + + - - - ++ 
 
Trachea 
 Froth - ++ + + - - - ++ 
Tyroid gland Enlargement - ++ ++ + - - - - 
Hepatization - +++ ++ + + + - - 
Congestion - ++ ++ + - + - + 
Haemorrhage - + + + - + - ++ 
 
Lungs 
 
Emphysema - - + + - + - ++ 
Congestion - + + + - + - + 
Haemorrhage - ++ + + - + - ++ 
Flabiness - + + + + + - + 
 
Heart 
Hydropericardium - +++ + + - + - + 
Congestion - - ++ + - + - + 
Haemoarrhage - + ++ + - + - ++ 
Oedema - + + + - - - + 
 
Liver 
 
Fatty change and/ 
or Necrosis 
- + + + - + - ++ 
Haemorrhage - + + + - + - ++  
Kidneys Congestion - ++ ++ + - + - ++ 
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 Fatty change and/or 
necrosis 
- ++ + + - - - - 
Congestion - +++ ++ + - - - + Spleen 
 Enlargment - +++  ++ -  - - + 
Congestion - ++ +   + - - - +| 
Haemorrhage - + + - - - - ++ 
 
Intestine 
 Enteritis  - + - - + - ++ 
Peritonitis - - + + - - - + Peritoneum 
 Hydroperitoneum - - + - - + - + 
Site of 
injection 
Damage - - + - - - - + 
Peripheral 
nerves 
Damage and 
congestion 
- + + - - - - - 
Lymph node Enlargement/lymph 
adenitis 
- + + - - - - - 
Testis Atrophy and/or 
orchitis 
- + + + - + - - 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. *= infection done by T. evansi, 
**= infection done by T. vivax.  
Table(4)  :Postmortem findings in camels naturally infected with T. evansi and given single 
and multiple dosages of Cymelarsan. 
Groups 
Site Lesion (1) 
 
(2)  (3)  (4)  (5) 
Congestion - ++ + - - Brain 
 Haemorrhage - + + - - 
Nasal Cavity Congestion - + - - - 
Congestion - - - - - 
Haemorrhage - - - - - 
 
Trachea 
 Froth - - - - - 
Tyroid gland Enlargement - ++ - - - 
Hepatization - ++ + - - 
Congestion - +++ + + - 
Haemorrhage - ++ + + - 
 
Lungs 
 
Emphysema - + - - + 
Congestion - - - - + 
Haemoarrhage - + - - - 
Flabiness - ++ - - - 
 
Heart 
Hydropericardium - ++ - - - 
Congestion - +++ + + + 
Haemoarrhage - - + - + 
Oedema - - - - - 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- - - - - 
Haemorrhage - + + + - 
Congestion - + + + - 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ - + - 
Spleen Congestion - ++ - - - 
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Enlargment - +++ - - + 
Congestion - +++   - - - 
Haemorrhage - ++ - - - 
 
Intestine 
 Enteritis - + + - - 
Peritonitis - - - - - Peritoneum 
 Hydroperitoneum - - - - - 
Site of 
injection 
Damage - - - - - 
Peripheral 
nerves 
Damage and congestion   - - - - - 
Lymph node Enlargement/lymph 
adenitis 
- + - - - 
Testis Atrophy and/or orchitis - + + - - 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
 
Table(4)  :Postmortem findings camels  infected naturally with T. evansi and given single 
and multiple dosages of Oxytetracycline. 
Groups 
Site Lesion (1) 
 
(2)  (3)  (4)  (5) (6) (7) 
Congestion - ++ - - + + + 
Haemorrhage - + - - + + + 
Brain 
 
Atrophy - - - - + + - 
Nasal Cavity Congestion - + - - - - - 
Congestion - - - - - - - 
Haemorrhage - - - - - - - 
 
Trachea 
 Froth - - - - - - - 
Tyroid gland Enlargement - ++ + - + - - 
Hepatization - ++ + - - - - 
Congestion - +++ + - - - - 
Haemorrhage - ++ + - - + + 
 
Lungs 
 
Emphysema - + - - - - - 
Congestion - - + - - + - 
Haemorrhage - + - - - - - 
Flabiness - ++ + - - + - 
 
Heart 
Hydropericardium - ++ - - - - - 
Congestion - +++ + - - - - 
Haemorrhage - -    + - - - - 
Oedema - - - - - - - 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- - - - - - - 
Haemorrhage - + - - - - + 
Congestion - + - - - - + 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ - - + - + 
Congestion - ++ - - - - - Spleen 
 Enlargment - +++ + + - + - 
 Congestion - +++  - - - - - 
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Haemorrhage - ++ - - - - + Intestine 
 Enteritis - + - - - + + 
Peritonitis - - - - - - - Peritoneum 
 Hydroperitoneum - - - - - - - 
Site of 
injection 
Damage - - - - - + ++ 
Peripheral 
nerves 
Damage and 
congestion 
- - - - - + ++ 
Lymph node Enlargement/lymph 
adenitis 
- + + + + + - 
Testis Atrophy and/or orchitis - + + - - + + 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe. 
Table(4)  :Postmortem findings camels naturally  infected with T. evansi and given single 
and multiple dosages of Cymelarsan and Oxytetracycline combination. 
Groups 
Site Lesion (1) 
 
(2)  (3)  (4)  (5) 
Congestion - ++ + + - 
Haemorrhage - + - - - 
Brain 
 
Atrophy - - + - - 
Nasal Cavity Congestion - + - + + 
Congestion - - - + - 
Haemorrhage - - - + + 
 
Trachea 
 Froth - - + - - 
Tyroid gland Enlargement - ++ - - - 
Hepatization - ++ + - - 
Congestion - +++ + + - 
Haemorrhage - ++ + + + 
 
Lungs 
 
Emphysema - + + - - 
Congestion - - - - - 
Haemoarrhage - + ++ + - 
Flabiness - ++ + + + 
 
Heart 
Hydropericardium - ++ + - - 
Congestion - +++ - - + 
Haemoarrhage - - + - - 
Oedema - - + + + 
 
Liver 
 
Fatty change and/ or 
Necrosis 
- - + - - 
Haemorrhage - + - - - 
Congestion - + + - - 
 
Kidneys 
 Fatty change and/or 
necrosis 
- ++ - + + 
Congestion - ++ + - - Spleen 
 Enlargment - +++ + + + 
Congestion - +++  + - + 
Haemorrhage - ++ - ++ + 
 
Intestine 
 Enteritis - + - - - 
Peritonitis - - + + - Peritoneum 
 Hydroperitoneum - - + - - 
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Site of 
injection 
Damage - - + - - 
Peripheral 
nerves 
Damage and congestion   - - + + - 
Lymph node Enlargement/lymph 
adenitis 
- + + - - 
Testis Atrophy and/or orchitis - + + + + 
          -   =   no lesion , + = mild, ++ = moderate,  +++  =   severe.  
 
Table(7) The Sodium, Potassium, Chloride, Calcium, Phosphorus, Magnesium, Zinc, Copper, Manganese, and Iron  in Nubian 
goats infected with T. evansi and given  Cymelarsan (M±SE). 
ParameterGro
ups 
Sodium 
(mmol/l) 
Potassium 
(mmol/l) 
Chloride 
(mmol/l) 
Calcium 
(mg/dl) 
Phosphorus 
(mg/dl) 
Magnesium 
(mg/dl) 
Zinc 
(µmol/l) 
Copper 
(µmol/l) 
Ma
(
Group (1) 
 
145.0a 
±0.50 
3.8a 
±0.02 
125.4a 
±0.19 
9.5a 
±0.04 
4.9a 
±0.04 
2.3a 
±0.08 
12.aa 
±0.01 
10.7a 
±0.06 
Group (2) 
 
149.8a 
±0.296 
4.6b 
±0.03 
134.0b 
±0.39 
7.4b 
±0.06 
3.1b 
±0.06 
3.9b 
±0.04 
10.1a 
±0.02 
11.3a 
±0.05 
Group(3) 
0.125 
mg/kg 
146.06a 
±0.11 
3.5a 
±0.011 
135.7b 
±0.07 
2.9c 
±0.03 
2.0c 
±0.09 
4.4b 
±0.03 
10.2a 
±0.02 
 
12.5a 
±0.02 
Group (4) 
0.250 
mg/kg 
144.6a 
±0.11 
3.1a 
±0.01 
127.8a 
±0.08 
6.5b 
±0.03 
4.2a 
±0.03 
2.5a 
±0.03 
11.3a 
±0.12 
9.9a 
±0.02 
Group (5) 
0.625 
mg/kg 
144.0a 
±0.51 
4.3b 
±0.02 
128.2a 
±0.11 
 
6.9b 
±0.04 
4.4a 
±0.02 
2.5a 
±0.01 
13.9a 
±0.01 
11.5a 
±0.12 
Group (6) 1.25 
mg/kg 
103b 
±0.81 
1.8c 
±0.02 
139.9b 
±0.11 
2.9c 
±0.03 
1.5c 
±0.03 
4.5b 
±0.02 
12.0a 
±0.02 
9.7a 
±0.02 
Group (7) 
0.125 
mg/kg 
twice/week for 
2weeks 
149.7a 
±0.03 
5.9ac 
±0.02 
133.5b 
±0.08 
7.8a 
±0.23 
4.4a 
±0.02 
2.8a 
±0.01 
13.0a 
±0.20 
10.1a 
±0.02 
Group (8) 
0.125mg/kg 
daily for 8 
days 
152.9a 
±0.13 
5.6ac 
±0.03 
131.7a 
±0.14 
10.8a  
±0.02 
5.2b  
±0.05 
2.5a 
±0.03 
14.2a 
±0.05 
9.4a 
±0.03 
Group (9) 
0.250 
mg/kg 
twice/week for 
2weeks 
153.3a 
±0.24 
 
4.6a 
±0.04 
138.1b 
±0.07 
5.2b 
±0.03 
3.4a 
±0.02 
2.4a 
±0.01 
11.9a 
±0.02 
10.9a 
±0.01 
Group (10) 
0.250 
mg/kg daily 
for 8 days 
134.3a 
±0.04 
4.3b 
±0.07 
136.5b 
±0.159 
5.7b 
±0.08 
3.7a 
±0.07 
 
3.2b 
±0.02 
14.5a 
±0.10 
10.8a 
±0.02 
Same letters in one column showed  no  significant changes p≤0.05. 
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Table (8)  The Bilirubin, Direct bilirubin, Urea, Creatinine, Total protein, Albumin, 
Globulin,  Cholesterol, Glucose, Phospholipids and Triglyceride in Nubian goats infected 
with T. evansi and given  and given  Cymelarsan (M±SE). 
 
ParameterGro
ups 
Bilirubin 
(mg/dl) 
Direct 
bilirubin 
(mg/dl) 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
Total protein 
(g/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
Cholesterol 
(mg/dl) 
Group (1) 
 
0.56a 
±0.001 
0.29a 
±0.002 
18.7a 
±0.08 
2.1b 
±0.08 
8.5a 
±0.06 
3.3a 
±0.03 
5.2a 
±0.03 
125a 
±0.06 
Group (2) 0.85b 
±0.012 
0.49b 
±0.01 
13.0b 
±0.09 
1.6a 
±0.05 
12.0b 
±0.26 
5.9b 
±0.18 
7.1b 
±0.08 
 
 
141.5b 
±0.14 
 
 
Group(3) 
0.125 
mg/kg 
1.05b 
±0.01 
0.61c 
±0.005 
11.2b 
±0.05 
1.6 a 
±0.01 
12.8b 
±0.04 
4.5ab 
±0.01 
8.3b 
±0.03 
129.3a 
±0.07 
Group (4) 
0.250 
mg/kg 
0.60a 
±0.01 
0.295a 
±0.01 
18.0 a 
±0.000 
2.0b 
±0.01 
9.0a 
±0.07 
3.5a 
±0.07 
5.5a 
±0.00 
126.0a 
±0.01 
 
Group (5) 
0.625 
mg/kg 
0.58a 
±0.02 
0.33ab 
±0.01 
17.3 a 
±0.01 
1.9 a 
±0.04 
9.1a 
±0.04 
3.9a 
±0.01 
5.2a 
±0.03 
138.1b 
±0.01 
Group (6) 1.25 
mg/kg 
1.02b 
±1.20 
0.57c 
±0.01 
8.2c 
±0.01 
0.5 c 
±0.04 
14.9c 
±0.06 
8.4c 
±0.05 
6.5a 
±0.01 
128.4a 
±0.09 
Group (7) 
0.125 
mg/kg 
twice/week for 
2weeks 
0.99b 
±0.003 
0.50b 
±0.002 
15.0a 
±0.07 
2.3a 
±0.08 
10.8a 
±0.07 
6.9b 
±0.05 
3.9a 
±0.02 
141.3b 
±0.17 
Group (8) 
0.125mg/kg 
daily for 8 
days 
0.12c 
±0.013 
0.73b 
±0.004 
11.0b 
±0.04 
1.5b 
±0.04 
10.9a 
±0.13 
9.9b 
±0.04 
1.1c 
±0.08 
143.7b 
±0.14 
Group (9) 
0.250 
mg/kg 
twice/week for 
1.04b 
±0.005 
0.58b 
±0.005 
 
14.0a 
±0.08 
1.8b 
±0.09 
10.3a 
±0.06 
7.9b 
±0.01 
2.4a 
±0.005 
144.0b 
±0.19 
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2weeks 
Group (10) 
0.250 
mg/kg daily for 
8 days 
1.24b 
±0.02 
0.74b 
±0.005 
10.1b 
±0.17 
1.7b 
±0.09 
10.8a 
±0.16 
9.2b 
±0.05 
1.6c 
±0.11 
140.8b 
±0.11 
Same letters in one column showed  no  significant changes p≤0.05. 
 
 
 
 
 
 
 
 
Table (9)  The Lactate dehydrogenase (LDH) Creatinine Kinase (CK), Pyrovate Kinase (PK), (GOT),  (GPT), Alkaline  
phosphatase (ALP), Succinate Dehydrogenase(SDH), Amylase and  Lipase in Nubian goats infected with T. evansi and given  
Cymelarsan (M±SE). 
Parameter 
Groups 
LDH 
(U/L) 
CK 
(U/L) 
PK 
(U/L) 
GOT 
(U/L) 
GPT 
(U/L) 
ALP 
(U/L) 
SDH 
(U/L) 
Amylase 
(U/L) 
Lipase 
(U/L) 
Group (1) 
 
326.6a 
±0.38 
33.4a 
±0.13 
31.6a 
±0.08 
35.5a 
±0.14 
14.0a 
±0.09 
87.0a 
±0.37 
27.2a 
±0.14 
 
102.80a 
±0.11 
315.6a 
±0.621 
Group (2) 
 
37.0a 
±0.49 
35.0a 
±0.124 
40.4b 
±0.44 
40.3a 
±0.14 
15.5a 
±0.07 
76.3b 
±0.49 
33.1b 
±0.25 
95.39b 
±0.09 
242.4b 
±0.6 
Group(3) 
0.125 
mg/kg 
315.a 
±0.13 
40.8a 
±0.03 
39.4b 
±0.63 
42.6a 
±0.07 
17.3a 
±0.07 
63.0b 
±0.01 
36.1b 
±0.03 
81.4b 
±0.06 
266.3b 
±0.47 
roup (4) 0.25 
mg/kg 
321.3a 
±0.23 
40.7a 
±0.11 
36.6a 
±0.12 
40.6a 
±0.08 
15.9a 
±0.26 
63.0b 
±0.35 
32.2b 
±0.16 
48.8c 
±0.27 
279.0b 
±0.73 
Group (5) 
0.625 
mg/kg 
318.3a 
±0.13 
38.5a 
±0.02 
36.9a 
±0.09 
40.8a 
±0.04 
13.6a 
±0.05 
69.0b 
±0.36 
36.2b 
±0.09 
101.5a 
±0.03 
267.2b 
±0.37 
oup (6) 1.25 
/kg 
321.2a 
±0.252 
39.9a 
±0.05 
36.7a 
±0.11 
40.1a 
±0.11 
15.5a 
±0.02 
66.7b 
±0.23 
39.1b 
±0.18 
96.9b 
±0.07 
246.4b 
±0.27 
Group (7) 
0.125 
mg/kg 
ice/week for 
2weeks 
318.0a 
±0.11 
36.8a 
±0.02 
35.0a 
±0.09 
36.2a 
±0.03 
14.1a 
±0.03 
66.9b 
±0.35 
32.4a 
±0.07 
98.5b 
±0.08 
343.7c 
±0.46 
Group (8) 
0.125mg/kg 
ily for 8 days 
315.9a 
±0.11 
35.2a 
±0.19 
37.7a 
±0.09 
43.6a 
±0.14 
14.4a 
±0.03 
60.7b 
±0.27 
32.5a 
±0.52 
98.0b 
±0.03 
349.9c 
±0.47 
roup (9) 0.25 
mg/kg 
ice/week for 
2weeks 
369.4b 
±0.00 
39.3a 
±0.06 
36.8a 
±0.12 
35.4a 
±0.23 
 
14.3a 
±0.35 
59.5c 
±0.21 
35.1a 
±0.52 
97.2b 
±0.09 
330.4b 
±0.51 
 
oup (10) 
50 
/kg daily for 
ays 
315.9a 
±0.19 
34.2b 
±0.08 
36.0a 
±0.11 
36.3a 
±0.26 
17.1a 
±0.11 
63.0b 
±0.36 
38.2a 
±0.18 
104.3a 
±0.23 
491.6d 
±0.87 
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Same letters in one column showed  no  significant changes p≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table ( 5)  The Hemoglobin concentration, Packed Cell volume,  the count of Red blood Cell, Reticulocyte, White Blood 
Cell,Platelet,Eosinophils, Basophiles, Monocytes, lymphocyte and Neutrophils in Nubian goats infected with T. evansi and 
given  Cymelarsan (M±SE). 
ParameterGr
oups 
Hb 
(g/dl) 
PCV 
(%) RBC 
(x106/m3) 
Reticulocytes 
(106/m3) 
WBC 
(x103/m3) 
Platelet 
(x103/m3) 
Eosinophils 
(%) 
Basophils 
(%) 
Group (1) 
 
9.0a 
±0.24 
32.3a 
±0.02 
14.5a 
±0.21 
5.7a 
±0.02 
11.7a 
±0.32 
410.7a 
±0.73 
2.0a 
±0.00 
0.00a 
±0.00 
Group (2) 
 
5.7b 
±0.02 
24.8b 
±0.21 
10.7b 
±0.31 
7.8b 
±0.02 
13.8a 
±0.31 
489.5b 
±0.71 
3.6b 
±0.002 
2.8b 
±0.001 
Group(3) 
0.125 
mg/kg 
3.4c 
±0.01 
16.7c 
±0.22 
11.4b 
±0.21 
 
11.4c 
±0.13 
13.2a 
±0.18 
520.3c 
±0.74 
2.1a 
±0.05 
1.5a 
±0.05 
Group (4) 
0.250 
mg/kg 
9.2a 
±0.01 
33.1a 
±0.21 
13.4a 
±0.20 
6.1a 
±0.01 
12.5a 
±0.17 
415.1a 
±0.74 
2.5a 
±0.04 
1.0a 
±0.04 
Group (5) 
0.625 
mg/kg 
8.5a 
±0.01 
31.7a 
±0.21 
13.8a 
±0.19 
5.5a 
±0.1 
13.9a 
±0.18 
 
419.9a 
±0.82 
2.0a 
±0.04 
2.5b 
±0.02 
Group (6) 1.25 
mg/kg 
4.4bc 
±0.12 
15.4c 
±0.01 
9.5b 
±0.20 
5.7a 
±0.02 
15.3a 
±0.14 
530.1c 
±0.79 
7.5c 
±0.01 
1.0a 
±0.01 
Group (7) 
0.125 
mg/kg 
twice/week for 
2weeks 
6.1b 
±0.02 
15.0c 
±0.01 
10.0a 
±0.21 
13.7c 
±0.12 
15.5a 
±0.72 
490.7b 
±0.40 
3.5a 
±0.00 
1.5b 
±0.00 
Group (8) 
0.125mg/kg 
daily for 8 
days 
5.0b 
±0.01 
14.1c 
±0.09 
9.5a 
±0.22 
13.0c 
±0.31 
12.2a 
±0.52 
520.4b 
±0.50 
6.5b 
±0.02 
1.5b 
±0.00 
Group (9) 5.5b 13.1c 8.4ab 12.8c 13.4a 495.7b 5.5b 2.5b 
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0.250 
mg/kg 
twice/week for 
2weeks 
±0.10 ±0.02 ±0.31 ±0.41 ±0.74 ±0.20 ±0.00 ±0.00 
Group (10) 
0.250 
mg/kg daily 
for 8 days 
5.8b 
±0.10 
16.2c 
±0.00 
8.3ab 
±0.21 
15.1c 
±0.42 
13.8a 
±0.54 
532.9bc 
±0.22 
6.5b 
±0.01 
0.00a 
±0.00 
Same letters in one column showed  no  significant changes p≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table ( 3)  The  body weight and temperature, respiratory rate, blood pressure and  fate of the animals in Nubian goats infected with T. 
evansi and given  Cymelarsan (M±SE). 
Parameter 
Groups 
Body 
temperature 
( Oc) 
Respiratory 
rate( /min.) 
Pulse rate (/min) Body weight 
(Kg) 
Blood pressure 
(mmHg) 
Group (1) 
 
39.5a 
±0.01 
26.1a 
±0.00 
75.5a 
±0.02 
9.5a 
±0.05 
125/75a 
±1.12/1.5 
Group (2) 
 
34.3b 
±0.02 
38.5b 
±0.01 
60.5b 
±0.01 
7.8b 
±0.04 
90/44b 
±1.11/1.3 
Group(3) 
0.125 
mg/kg 
36.5b 
±0.03 
25.8 a 
±0.05 
68.0 ab 
±0.02 
7.0b 
±0.01 
87/42 b 
±0.9/1.4 
Group (4) 0.250 
mg/kg 
39.5a 
±0.01 
26.5 a 
±0.01 
80.3a 
±0.02 
11.2a 
±0.05 
117/58 a 
±0.8/1.2 
Group (5) 0.625 
mg/kg 
38.7a 
±0.01 
26.5 a 
±0.02 
81.3 a 
±0.03 
12.5a 
±0.04 
125/65 a 
±0.5/1.3 
Group (6) 1.25 
mg/kg 
38.4a 
±0.05 
32.0 b 
±0.25 
85.3 a 
±0.05 
6.2b 
±0.01 
75/40 b 
±0.4/0.1 
Group (7) 0.125 
mg/kg twice/week 
for 2weeks 
39.5a 
±0.03 
20.0 a 
±0.04 
75.5 a 
±0.01 
7.5a 
±0.05 
80/50bc 
±0.8/0.5 
Group (8) 41.3a 15.5 c 70.5 a 9.4a 70/40c 
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0.125mg/kg daily 
for 8 days 
±0.20 ±0.01 ±0.08 ±0.05 ±0.9/0.8 
Group (9) 0.250 
mg/kg twice/week 
for 2weeks 
40.0a 
±0.4 
15.5 c 
±0.03 
75.5 a 
±0.01 
7.7a 
±0.11 
65/40c 
±1.5/1 
Group (10) 0.250 
mg/kg daily for 8 
days 
41.2a 
±0.22 
15.0 c 
±0.01 
60.0 b 
±0.02 
6.2bc 
±0.16 
60/35c 
±1.2/1.2 
 
Same letters in one column showed  no  significant changes p≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (6)  The mean ± Standard Error(M±SE) of (MCV), (MCH), and (MCHC) in Nubian goats infected with T. evansi and given  
Cymelarsan.  
 
Paramet 
erGroups 
MCV 
(fl) 
MCH 
(pg) 
MCHC 
(%) 
Group (1) 
 
22.2a 
±0.03 
62.06 a 
±0.04 
27.8 a 
±0.01 
Group (2) 
 
23.17 a 
±0.00 
53.2 a 
±0.05 
22.9 a 
±0.03 
Group(3) 
0.125 
mg/kg 
14.6 b 
±0.05 
29.9 c 
±0.1 
20.35 a 
±0.01 
Group (4) 
0.250 
mg/kg 
24.7 a 
±0.02 
68.6 a 
±0.08 
27.8 a 
±0.02 
Group (5) 
0.625 
mg/kg 
22.9 a 
±0.01 
61.5 a 
±0.07 
26.8 a 
±0.04 
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Group (6) 1.25 
mg/kg 
16.2 b 
±0.01 
46.31 b 
±0.03 
28.5 a 
±0.05± 
Group (7) 
0.125 
mg/kg 
twice/week for 
2weeks 
40.6 b 
±0.07 
61.0 a 
±0.07 
40.6 a 
±0.05 
Group (8) 
0.125mg/kg 
daily for 8 days 
35.46 b 
±0.03 
52.6 a 
±0.04 
35.4 a 
±0.03 
Group (9) 0.25 
mg/kg 
twice/week for 
2weeks 
41.9 b 
±0.02 
65.7 a 
±0.03 
41.9 a 
±0.04 
Group (10) 
0.250 
mg/kg daily for 
8 days 
35.8 b 
±0.04 
69.8 a 
±0.02 
35.8 a 
±0.09 
The different letters in one column showed the significant changes p≤ 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (5) The calcium, phosphorus, urea, creatinine, total protein, albumin, 
globulin, cholesterol, glucose and triglycerides in camels naturally infected with T. 
evansi and given single and multiple dosages of Oxytetracycline (M±SE) 
r Calcium 
(mg/dl) 
Phosphorus 
 (mg/dl) 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
Total protein 
(g/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
Cholesterol 
(mg/dl) 
Glucose 
(mg/dl) 
Tr
) 9.4a 
±0.02 
6.5 a 
±0.01 
35.5a 
±0.02 
2.3a 
±0.00 
6.4a 
±0.02 
2.5a 
±0.02 
4.1a 
±0.01 
36.5a 
±0.05 
91.02a 
±0.02 
) 6.8b 
±0.02 
4.3b 
±0.02 
24.9b 
±0.02 
1.1b 
±0.01 
8.2b 
±0.02 
4.1b 
±0.04 
4.1a 
±0.04 
31.3b 
±0.08 
93.3a 
±0.02 
 
) 8.8a 
±0.01 
5.5ab 
±0.04 
25.4b 
±0.05 
2.02a 
±0.05 
8.9b 
±0.06 
3.5ab 
±0.05 
5.4a 
±0.05 
31.3b 
±0.02 
128.1b 
±0.07 
)  6.6b 
±0.04 
5.6ab 
±0.08 
32.1a 
±0.06 
1.07b 
±0.07 
10.4b 
±0.06 
3.71ab 
±0.03 
6.7b 
±0.04 
35.4a 
±0.08 
 
91.3a 
±0.03 
) 
g 
9.12a 
±0.05 
6.9a 
±0.02 
35.1a 
±0.06 
1.5b 
±0.04 
6.5a 
±0.02 
3.6ab 
±0.05 
2.9c 
±0.04 
33.9ab 
±0.03 
87.3a 
±0.06 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
g 
e
2 
6.0b 
±0.04 
5.6ab 
±0.01 
32.1a 
±0.02 
2.07a 
±0.04 
10.4b 
±0.02 
6.7b 
±0.03 
3.71ab 
±0.06 
35.4a 
±0.05 
 
105.3a 
±0.03 
g 
r 
8.12a 
±0.05 
4.9a 
±0.02 
35.1a 
±0.06 
1.0b 
±0.03 
7.9a 
±0.02 
5.0b 
±0.05 
2.9c 
±0.08 
23.9c 
±0.03 
97.3a 
±0.00 
Same letters in one column showed  no  significant changes p≤0.05.   
 
 
 
 
 
 
 
 
 
 
 
Table (6) The glutamic oxalocetic transaminase (GOT), glutamic 
pyruvic transminase (GPT), 
Alkaline  phosphatase (ALP),  T3, T4 and progesterone in camels  naturally infected 
with T. evansi and given single and multiple dosages of Oxytetracycline (M±SE) 
Parameter 
Dose 
GOT 
(U/l) 
GPT 
(U/l) 
ALP 
(U/l) 
Progesterone 
(nmol/l) 
T3 
(nmol/l) 
T4 
(nmol/l) 
 Group( 1) 47.7a 
±0.01 
6.4a 
±0.05 
31.0a 
±0.04 
1.3a 
±0.05 
75.4a 
±0.01 
 
 
1.3a 
±0.09 
 Group (2) 46.1a 
±0.03 
 
9.5b 
±0.04 
24.06b 
±0.06 
5.5b 
±0.02 
56.6b 
±0.03 
0.5b 
±0.07 
Group (3) 
20 mg/kg 
41.8b 
±0.03 
11.5b 
±0.08 
25.6b 
±0.01 
3.8c 
±0.05 
65.2c 
±0.02 
0.5b 
±0.03 
Group (4)  38.9b 8.5b 21.6b 2.1a 65.1c 0.7b 
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50mg/kg ±0.04 ±0.07 ±0.06 ±0.06  
±0.06 
±0.03 
Group (5) 
100 mg/kg 
37.3b 
±0.06 
9.6b 
±0.05 
27.7a 
±0.04 
2.5a 
±0.01 
118.6d 
±0.03 
1.03a 
±0.07 
Group (6) 
20mg/kg 
twice/wee
k for 2 
weeks 
42.4b 
±0.02 
15.2c 
±0.05 
20.5b 
±0.01 
4.8c 
±0.01 
56.2b 
±0.02 
0.3b 
±0.03 
Group (7)  
20mg/kg 
daily for 
8days 
48.6a 
±0.00 
8.5b 
±0.02 
21.6b 
±0.06 
2.1a 
±0.06 
65.1c 
 
±0.03 
0.5b 
±0.03 
                                                       Same letters in one column showed no significant changes p≤0.05.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4) The Haemoglobin (Hb), Packed Cell volume (PCV), Red blood Cell count (RBC), White 
Blood Cell count (WBC), MCV, MCH and MCHC in camels naturally infected with 
T. evansi and given single and multiple dosages of Oxytetracycline (M±SE) 
    Parameter 
Dose 
Hb 
(g/dl) 
PCV 
 (%) RBC 
(x106/m3
) 
WBC 
(x103/m3) 
MCV 
 (fl) 
MCH  
(pg) MCHC   
(%) 
 Group( 1) 10.3a 
±0.08 
25.5a 
±0.01 
8.3a 
±0.05 
11.4a 
±0.03 
30.7a 
±0.01 
12.4 a 
±0.03 a 
40.3 a 
±0.05 
 Group (2) 4.9b 
±0.03 
21.7a 
±0.07 
6.4b 
±0.04 
14.1a 
±0.07 
34.4 a 
±0.02 
7.7 a 
±0.01 
22.5 b 
±0.02 
Group (3) 
20 mg/kg 
7.3c 
±0.04 
20.6a 
±0.03 
6.3b 
±0.01 
10.2a 
±0.07 
32.6 a 
±0.03 
11.5 a 
±0.01 
35.4 a 
±0.01 
Group (4)  
50mg/kg 
10.1a 
±0.02 
23.7a 
±0.01 
7.5a 
±0.03 
12.3a 
±0.06 
31.6 a 
±0.05 
13.4 a 
±0.03 
42.6 a 
±0.02 
Group (5) 
100 mg/kg 
7.7c 
±0.08 
25.1a 
±0.06 
8.9a 
±0.06 
10.3a 
±0.08 
28.2 a 
±0.02 
8.6 a 
±0.01 
30.6 a 
±0.02 
Group (6) 8.5a 25.6a 6.6b 12.3a 35.0 a 15.5 a 33.4 a 
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20mg/kg 
twice/wee
k for 2 
weeks 
±0.02 ±0.05 ±0.05 ±0.00 ±0.02 ±0.01 ±0.05 
Group (7)  
20mg/kg 
daily for 
8days 
10.0a 
±0.01 
23.0a 
±0.02 
8.5a 
±0.02 
9.0b 
±0.01 
30.5 a 
±0.01 
15.0a 
±0.01 
45.8 a 
±0.04 
 
Same letters in one column showed no significant changes p≤0.05.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (5) The calcium, phosphorus, urea, creatinine, total protein, albumin, 
globulin, cholesterol, glucose and triglycerides in camels naturally infected with T. 
evansi and given single dosages of Cymelarsan (M±SE) 
 
ter Calcium 
(mg/dl) 
Phosphorus 
 (mg/dl) 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
Total protein 
(g/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
Cholesterol 
(mg/dl) 
Glucose 
(mg/dl) 
T
1) 9.4a 
±0.02 
6.5 a 
±0.01 
35.5a 
±0.02 
2.3a 
±0.00 
6.4a 
±0.02 
2.5a 
±0.02 
4.1a 
±0.01 
36.5a 
±0.05 
91.02a 
±0.02 
2) 6.8b 
±0.02 
4.3b 
±0.02 
24.9b 
±0.02 
1.1b 
±0.01 
8.2b 
±0.02 
4.1b 
±0.04 
4.1a 
±0.04 
31.3b 
±0.08 
93.3a 
±0.02 
 
3) 
/kg 
9.8a 
±0.02 
7.6 a 
±0.03 
32.2a 
±0.02 
1.6b 
±0.07 
5.7a 
±0.02 
3.02a 
±0.01 
2.6b 
±0.05 
40.5c 
±0.02 
85.2b 
±0.01 
(4) 
/kg 
10.8b 
±0.03 
7.02 a 
±0.01 
34.02a 
±0.02 
2.5a 
±0.03 
5.3a 
±0.04 
2.2a 
±0.03 
3.1a 
0.06± 
39.4a 
±0.00 
86.8b 
±0.00 
(5)  
g/kg 
weeks 
10.7b 
±0.03 
7.9 a 
±0.02 
36.8a 
±0.03 
2.3a 
±0.01 
4.3a 
±0.02 
3.06a 
±0.03 
1.2b 
0.01± 
39.4c 
±0.02 
87.4b 
±0.01 
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Same letters in one column showed  no  significant changes p≤0.05.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (6)The glutamic oxalocetic transaminase (GOT), glutamic 
pyruvic transminase (GPT), 
Alkaline  phosphatase (ALP),  T3, T4 and progesterone in camels naturally infected 
with T. evansi and given single dosages of Cymelarsan (M±SE) 
Parameter 
Dose 
GOT 
(U/l) 
GPT 
(U/l) 
ALP 
(U/l) 
Progesterone 
(nmol/l) 
T3 
(nmol/l) 
T4 
(nmol/l) 
Group (1) 47.7a 
±0.01 
6.4a 
±0.05 
31.0a 
±0.04 
1.3a 
±0.05 
75.4a 
±0.01 
 
 
1.3a 
±0.09 
Group (2) 46.1a 
±0.03 
 
9.5b 
±0.04 
24.06b 
±0.06 
5.5b 
±0.02 
56.6b 
±0.03 
0.5b 
±0.07 
Group(3) 
0.250mg/kg 
44.4a 
±0.02 
5.7a 
±0.02 
33.06a 
±0.07 
4.0b 
±0.03 
80.3a 
±0.07 
0.8b 
±0.06 
Group (4) 
0.625mg/kg 
35.12b 
±0.01 
5.18a 
±0.06 
28.4b 
±0.03 
2.0a 
±0.08 
81.3a 
±0.04 
 
1.4a 
±0.05 
Group (5)  
0.125 mg/kg 
33.7b 
±0.04 
6.2a 
±0.01 
31.3b 
±0.02 
1.5a 
±0.08 
77.9a 
±0.02 
1.4a 
±0.01 
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weekly/3weeks  
                                                                Same letters in one column showed  no  significant changes p≤0.05.    
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4) The Haemoglobin (Hb), Packed Cell volume (PCV), Red blood Cell (RBC), White Blood 
Cell (WBC),MCV, MCH and MCHC in camels naturally infected with T. evansi and 
given single dosages of Cymelarsan (M±SE) 
 
    Parameter 
Dose 
Hb 
(g/dl) 
PCV 
 (%) RBC 
(x106/m3
) 
WBC 
(x103/m3) 
MCV 
 (fl) 
MCH  
(pg) MCHC   
(%) 
Group (1) 10.3a 
±0.08 
25.5a 
±0.01 
8.3a 
±0.05 
11.4a 
±0.03 
30.7a 
±0.01 
12.4 a 
±0.03 a 
40.3 a 
±0.05 
Group (2) 4.9b 
±0.03 
21.7a 
±0.07 
3.5a 
±0.04 
14.1a 
±0.07 
34.4 a 
±0.02 
7.7 a 
±0.01 
22.5 b 
±0.02 
Group(3) 
0.250mg/kg 
9.9a 
±0.08 
27.4a 
±0.01 
8.03a 
±0.08 
11.5a 
±0.04 
21.03 a 
±0.01 
10.9 a 
±0.09 
51.1 a 
±0.01 
Group (4) 
0.625mg/kg 
10.7a 
±0.07 
27.9a 
±0.01 
8.7a 
±0.01 
12.1a 
±0.06 
25.3 a 
±0.05 
11.27 a 
±0.01 
44.5 a 
±0.09 
Group (5)  
0.125 mg/kg 
weekly/3weeks 
10.4a 
±0.04 
27.5a 
±0.03 
8.3a 
±0.01 
12.1a 
±0.01 
28.3 a 
±0.09 
11.5 a 
±0.04 
41.1 a 
±0.2 
                          Same letters in one column showed  no  significant changes p≤0.05.    
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Table (5) The calcium, phosphorus, urea, creatinine, total protein, albumin, 
globulin, cholesterol, glucose and triglycerides in camels (Camelus dromedarius) 
naturally infected with T. evansi and given single dosages of Cymelars and  
Oxytetracycline combination (M±SE) 
er Calcium 
(mg/dl) 
Phosphorus 
 (mg/dl) 
Urea 
(mg/dl) 
Creatinine 
(mg/dl) 
Total protein 
(g/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
Cholesterol 
(mg/dl) 
Glucose 
(mg/dl) 
Tr
1) 9.4a 
±0.02 
6.5 a 
±0.01 
35.5a 
±0.02 
2.3a 
±0.00 
6.4a 
±0.02 
2.5a 
±0.02 
4.1a 
±0.01 
36.5a 
±0.05 
91.02a 
±0.02 
65.
±51
2) 6.8b 
±0.02 
4.3b 
±0.02 
24.9b 
±0.02 
1.1b 
±0.01 
8.2b 
±0.02 
4.1b 
±0.04 
4.1a 
±0.04 
31.3b 
±0.08 
93.3a 
±0.02 
 
63.
±0.
) 
gof 
0m
TC 
7.9ab 
±0.03 
6.2a 
±0.06 
39.4b 
±0.04 
1.0b 
±0.05 
7.0b 
±0.03 
3.0c 
±0.04 
4.0a 
±0.06 
40.3b 
±0.03 
90.7a 
±0.01 
61.
±0.
) 
gof 
0m
TC 
6.6b 
±0.05 
6.5a 
±0.06 
33.9a 
±0.06 
0.7b 
±0.06 
6.2a 
±0.01 
2.0a 
±0.04 
4.0a 
±0.03 
40.3b 
±0.01 
87.0a 
±0.06 
 
63.
±0.
) 
gof 
00
f 
9.1a 
±0.03 
6.9a 
±0.05 
35.6a 
±0.01 
0.7b 
±0.03 
6.5a 
±0.02 
6.0d 
±0.08 
1.5b 
±0.02 
34.8a 
±0.03 
88.3a 
±0.01 
72.
±0.
Same letters in one column showed no significant changes p≤0.05.  MelCy = Cymelarsan    OTC   =  
Ocxytetracyline 
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Table (6) The glutamic oxaloacetic transaminase (GOT), glutamic 
pyruvic transaminase (GPT), alkaline  phosphatase (ALP),  T3, T4 and 
progesterone in camels (Camelus dromedarius) naturally infected with 
T. evansi and given single dosages of Cymelarsand  Oxytetracycline 
combination (M±SE) 
Parameter 
Dose 
GOT 
(U/l) 
GPT 
(U/l) 
ALP 
(U/l) 
Progesterone 
(nmol/l) 
T3 
(nmol/l) 
T4 
(nmol/l) 
 Group( 1) 47.7a 
±0.01 
6.4a 
±0.05 
31.0a 
±0.04 
1.3a 
±0.05 
75.4a 
±0.01 
 
 
1.3a 
±0.09 
 Group (2) 46.1a 
±0.03 
 
9.5b 
±0.04 
24.06b 
±0.06 
5.5b 
±0.02 
56.6b 
±0.03 
0.5b 
±0.07 
 
Group(3) 
0.250mg/kgof 
MelCY+20m
g/kg of OTC 
39.5b 
 
±0.04 8.8
b 
±0.02 
 
28.6a 
±0.07 
1.4a 
±0.02 
80.2c 
±0.06 
0.9b 
±0.04 
Group(4) 
0.125mg/kgof 
MelCY+50m
40.1b 
±0.03 9.5b 
±0.03 
29.8a 
±0.05 
1.3a 
±0.04 
80.2c 
±0.04 
1.5a 
±0.08 
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g/kg of OTC 
Group(5) 
0.125mg/kgof 
MelCY+100
mg/kg of 
OTC 
35.4b 
±0.04 
6.0a 
±0.05 
28.7a 
±0.03 
1.3a 
±0.02 
77.7a 
±0.03 
 
 
 
 
1.3a 
±0.05 
Same letters in one column showed  no  significant changes p≤0.05.    MelCy = 
Cymelarsan, OTC  = Oxytetracycline 
                                                                                                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4) The Haemoglobin (Hb), Packed Cell volume (PCV), Red blood Cell (RBC), White Blood 
Cell (WBC),MCV, MCH and MCHC in camels (Camelus dromedarius) naturally 
infected with T. evansi and given single dosages of Cymelars and  Oxytetracycline 
combination (M±SE) 
    Parameter 
Dose 
Hb 
(g/dl) 
PCV 
 (%) RBC 
(x106/m3
) 
WBC 
(x103/m3) 
MCV  
(fl) 
MCH 
(pg) MCHC   
(%) 
 Group( 1) 10.3a 
±0.08 
25.5a 
±0.01 
8.3a 
±0.05 
11.4a 
±0.03 
30.7a 
±0.01 
12.4 a 
±0.03 a 
40.3 a 
±0.05 
 Group (2) 4.9b 
±0.03 
18.3b 
±0.04 
6.3b 
±0.04 
14.1b 
±0.07 
29.0 a 
±0.02 
7.7 a 
±0.01 
26.7 b 
±0.02 
Group(3) 
0.250mg/kgof 
MelCY+20m
g/kg of OTC 
9.5a 
±0.03 
21.7a 
±0.07 
8.7a 
±0.06 
10.5a 
±0.04 
24.9a 
±0.08 
10.9 b 
±0.07 
43.7 a 
±0.07 
Group(4) 
0.125mg/kgof 
MelCY+50m
g/kg of OTC 
10.6a 
±0.08 
23.8a 
±0.05 
9.4a 
±0.08 
12.4a 
±0.06 
25.3 a 
±0.02 
11.1 a 
±0.07 
44.5 a 
±0.07 
Group(5) 
0.125mg/kgof 
MelCY+100
mg/kg of 
OTC 
8.05a 
±0.04 
22.5a 
±0.06 
6.9a 
±0.06 
11.9a 
±0.02 
32.6 a 
±0.04 
11.9 a 
±0.01 
35.8 b 
±0.08 
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                                 Same letters in one column showed  no  significant changes p≤0.05.     MelCy = 
Cymelarsan        OTC   =  Oxytetracycline 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (4) The Mean ±Standard Error of MCV, MCH and MCHC   in camels (Camelus 
dromedarius)  
naturally infected with T. evansi and given multiple doses of Cymelars and  
Oxytetracycline (M±SE) 
Parameter 
Dose 
MCV  
(fl) 
MCH 
(pg) MCHC   
(%) 
 Group( 1) 30.7a 
±0.01 
12.4 a 
±0.03 a 
40.3 a 
±0.05 
 Group (2) 34.4 a 
±0.02 
7.7 a 
±0.01 
22.5 b 
±0.02 
Group(3) 
0.250mg/kgof 
MelCY+20m
g/kg of OTC 
21.4 b 
±0.08 
10.9 b 
±0.07 
51.9 a 
±0.07 
Group(4) 
0.125mg/kgof 
MelCY+50m
g/kg of OTC 
34.7 a 
±0.02 
13.3 a 
±0.07 
38.4 a 
±0.07 
Group(5) 
0.125mg/kgof 
MelCY+100
mg/kg of 
OTC 
31.6 a 
±0.04 
11.9 a 
±0.01 
37.8 a 
±0.08 
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Same letters in one column showed  no  significant changes p≤0.05.   
                                                                             Mel Cy =   Cymelarsan        OTC   = Oxytetracycline 
                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      Table(11) The concentration of Oxytetracycline in organs, bile and urine(µg/g)  
in Nubian goats infected with T. evansi and given single and multiple dosages of Cymelarsan and 
oxytetracycline combination(M+SE). 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uterus Ovary Testis Bile 
 
 
)  
Mel
kg 
0.5±0.0
1/0.03±
0.02 
0.4±0.0
1/0.3± 
0.01 
0.5±0.5/ 
0.4±0.00 
0.3±0.00/
0.02±0.01 
0.4±0.0
1/0.0±0
2±0.02 
0.04±0.001/0
.01±0.000 
0.03±0.00
/0.01± 
0.000 
1±0.3/ 
0.05± 
0.2 
0.5±0.4/ 
0.05±0.5 
0.2±0.1/0.
01±0.00 
0.01±0.01 
0.001± 
0.001 
0.001±0.00/0
.001±0.00 
0.01±0.00
/ 
0.01±0.00 
0.2±0.0
1/0.05±
0.02 
)  
kg 
50
f 
3.5±0.0
1/1.5±0
.000 
 
 
5±0.1/1
.2±0.01 
2.5±0.00/
0.5±0.01 
0.5±0.1/0.
5± 
0.2 
0.5±0.0
1/0.3± 
0.02 
0.5±0.01/0.3
±0.02 
0.5±0.01/ 
0.3±0.000 
10±1.5/ 
7± 1.0 
5±0.5/5.5 
±0.3 
5±0.2/ 
5±0.1 
6±1.5 
/7±1.1 
1.0± 
0.00/ 
0.7± 
0.00 
5±0.1/ 
0.5± 
0.01 
15±0.0
1/7.0±
0.02 
)  
f 
0 
TC
ek 
ks 
5±0.1/1
0±0.2 
 
 
10.5±1.
0/15.0±
1.1 
5±0.1/3±0
.2 
5±0.1/5±0
.5 
0.5±0.0
1/0.3± 
0.02 
0.3±0.01/0.2
±0.01 
0.1±0.00/ 
0.5±0.00 
10±1.0/ 
7.5±0.5 
5.5±0.2/ 
5±0.4 
0.5±0.2/ 
0.5±0.4 
1±0.5/0.5
±0.01 
1.0±1.2/0.5±
0.00 
0.5±0.2/0.
1±0.01 
5±0.01/
2± 
0.02 
)  15±0.2/ 18±0.4/ 2.0±0.3/2. 1.0±0.1/1. 5.5±0.0 5.5±0.01/3.5 5.0±0.01/ 20.8±1. 20.5±0.9/ 5±0.2/ 2.5±1.1/ 6.0±0.01/5.0 2.0±0.02/ 5.0±0.0
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f 
0 
TC 
r 
20±0.1 
 
 
20.5±0.
5 
5±0.2 0± 
0.0.2 
1/5.5± 
0.02 
±0.01 5.2±0.3 1/20± 
1.2 
30.5±0.8 7.5±0.3 3.0±0.00 ±0.01 1.0±0.01 2/10.5±
0.01 
MelCy = CymelarsanR  OTC = Ox tetracycline (RemacyclinR),Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, 
w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                           Table(7) Mean±standard error (SE) of the concentration of Cymelarsan in different 
organs(µg/100g)  and serum , urine, bileµg/ml  
                                 in camels (Camelus dromedarius) infected with T. evansi and given single and multiple 
dosages of Cymelarsan (M+SE). 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uterus Ovary Testis Bi
≤0.07 
≤0.07 
5±0.001/
2.5±0.00
2/≤0.07 
10 ±0.5 
/3 ±0.01 
/≤0.07 
0.5 ±0.01 
/0.6±0.00 
/≤0.07 
≤0.07 0.1 ±0.02 
/≤0.07 
≤0.07 ≤0.07 0.5 ±0.05 
/≤0.07 
5 ±0.2 
/≤0.07 
≤0.07 2.2 ±0.01 
/≤0.07 
0.5 ±0.02 
/≤0.07 
0.2 ±0.01 
/≤0.07 
1.5 ±
/≤0
10±0.1/5
.5 
±0.001 
/≤0.07 
5.5 
±0.05 
/≤0.07 
2.5 ±0.06 
/≤0.07 
≤0.07 ≤0.07 0.1 ±0.02 
/≤0.07 
0.2 ±0.01 
/≤0.07 
0.5 ±0.03 
/0.5 0.04 
/≤0.07 
0.2 ±0.001 
/≤0.07 
0.1± 
0.02 
/≤0.07 
≤0.07 0.2 ±0.01 
/≤0.07 
0.12 
±0.03 
/≤0.07 
0.2 ±0
/≤0
5 ±0.1 
/2.5±0.1
0.02 
/≤0.07 
2.5 
±0.001 
/≤0.07 
3.5 ±0.01 
/≤0.07 
≤0.07 ≤0.07 ≤0.07 ≤0.07 0.2 
±0.001 
/0.1±0.00
3 /≤0.07 
0.5 ±0.01 
/≤0.07 
0.5 
±0.001 
/≤0.07 
0.2 ±0.05 
/≤0.07 
0.1 ±0.00 
/≤0.07 
≤0.07 2.5 ±
/≤0
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Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(10) The concentration of Cymelarsan (Arsenic) in Different organs( µg/g) and 
serum, bile and urine µg/ml Nubian goats infected with T. evansi and    given single 
or multiple dosages of Cymelarsan (M±SE). 
Serum Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uterus Ovary Testis Bi
≤0.07a ≤0.07 
≤0.07a ≤0.07 
0.10b 
±0.14 
0.2±0.22 
/≤0.07 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 0.1±0.0
2/ 
≤0.07 
0.2±0.0/≤
0.07 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07
0.12b 
±0.14 
 
3± 0.0/ 
3.5±0.0/
≤0.07 
5±0.2/ 
0.3±0.2/ 
≤0.07 
0.1± 
0.01 
≤0.07 ≤0.07 ≤0.07 ≤0.07 0.2 
±0.01/ 
≤0.07 
0.5±0.1/ 
≤0.07 
≤0.07 0.7±0.0/ 
≤0.07              
0.1±0.0/ 
≤0.07 
0.2±0.0/ 
≤0.07 
1.5±0
≤0.07
0.15b 
±0.19 
5±0.0/ 
3.5±0.0/
2±0.0/ 
≤0.07 
3±0.1/1±
0.2/0.5± 
0.0/ 
≤0.07 
≤0.07 ≤0.07 ≤0.07 0.1  ±0.0 
/≤0.07 
0.5±0.02/ 
≤0.07 
0.1±0.0/ 
0.1±0.0/ 
≤0.07 
0.5±0.2 
/0.2±0.0/ 
0.1±0.0 
/≤0.07 
≤0.07 0.5±0.0/0.5 
/±0.0/0.2 
±0.001/ 
≤0.07 
0.2±0.1/ 
0.1 
±0.02/ 
≤0.07 
1.5±0.01/ 
≤0.07 
1±0.1
≤0.07
2.7c 
±0.09 
30 ±1.1 
/25±1.0 
35±0.2/ 
30 ±0.4 
40± 
0.1/  
33 ±0.9 
20±1.01/
25±1.2 
20±0.2/
15± 
0.1 
10±0.4/ 
1±0.1 
15±0.1/ 
10± 0.3 
3±0.1/ 
2± 0.0  
5±0.01/ 
5.5 ±0.2  
25±0.2/ 
20 ±0.5 
10±1.0/ 
8± 0.7 
5±0.1/ 
5± 0.0 
15±0.2/ 
20 ±0.3 
10±0.
15 ±0
2.5c 
±0.02 
50±1.5/ 
60.5± 
1.3 
70±0.5/ 
85± 0.2 
30±1.5/ 
35 ±1.2 
15±0.9/ 
20±0.3 
40±0.3/
35± 0.5 
10±0.4/ 
15 ±0.1 
5± 0.4/ 
 5± 0.7 
50±0.4/ 
45 0.5  
80±0.2/ 
95 ±0.3 
40±0.3/ 
30± 0.4  
20±0.2/ 
25± 0.4 
10±1.0/ 
15± 1.2 
30±0.5/ 
25 ±0.4 
20±0.
40 ±0
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The different letter in one columes showed significant changes p<0.05, Week1 (w1)=14day post 
treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 Table(7) Mean±standard error (SE) of the concentration of Oxytetracycline  in Different 
organs(µg/g) and serum, bile, urine µg/ml  
                              in camels Camelus dromedarius) infected with T. evansi and given single and multiple 
dosages of oxytetracycline (M+SE). 
Organs 
 
Dose 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uterus 
Group (1) 
 
 
Group (2) 
 
 
Group (3) 
20 mg/kg 
 
20±0.1/
15 0.2 
15±0.01/
10± 0.02 
3.5± 0.1 
/4.5± 0.2 
3±0.01/
2±0.1 
3.5 
±0.01 
/2.5± 
0.02 
5 ±0.01 /5 
±0.04 
3 ±0.01 
/2.5± 
0.02 
5 ±0.01 
/2.5 
±0.02 
15 ±1.1 
/20 ±0.00 
15 ±0.7 
/10.5± 
0.7 
7 ±1.2 
/7.5 ±1.3 
0
/
3.5c 
±0.01 
105±2.2/  
140± 2.2 
130 ±0.3 
/110±0.2   
90±1.1/ 
95 ±1.4 
30±0.5/ 
40±0.7 
80± 
0.2/ 85 
±0.5 
75±0.2/ 
70± 2.5 
45±0.8/ 
40 ±0.3 
105±0.1
1/ 
40±0.6 
130±0.1/ 
120 ±0.2  
100 
±2.1 
/105± 
2.3 
50±0.3/ 
55 ±0.3 
30±1.4/ 
40± 1.1 
60±0.6/ 
75± 0.7 
50±0.
70± 0
3.00c 
±0.001 
100±2.4/
105± 2.3 
140±0.5/ 
155± 0.6 
160±0.
1/140± 
0.7 
85±1.2/ 
801.9 
120± 
0.1/120
± 0.2 
115±3.4/ 
180 ±3.5 
160±0.8/1
50 ±0.4 
200±3.0
/150 
±1.5  
180±0.4/ 
200± 0.5  
250±2.
3/300± 
2.0  
90±0.6/ 
100± 0.8  
110±1.3/
120 ±1.5 
120±0.3/ 
150± 0.4 
100±
110±
5.9d 
±0.03 250±1.9/
300±2.5  
300±1.7/  
305± 1.8 
250±2.
4/300± 
2.0 
120±1.1/
130± 
2.0 
350±2.
3/360± 
2.7 
350±3.1/ 
250 ±3.2 
150±0.1/1
60± 0.1 
305±1.1
/ 355± 
1.7 
450±0.1/ 
250 ±0.2 
300±2.
5/ 
250 
±2.2 
200±1.3/ 
250± 1.4 
150±1.1/ 
180± 1.7 
120±1.2/ 
200 ±1.5 
180±
200 ±
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Group (4) 
50mg/kg 
 
20±0.1/
15± 0.5 
15±0.00/
10 0.001 
1.5± 
0.01/ 
0.5± 0.4 
5±0.1/6
±0.2 
1.5±0.0
1/1.5 
±0.02 
5.5± 0.05 /7 
±0.03 
3.5± 0.05 
/3 0.07 
3.5 ±0.05 
/3 ±0.07 
25 ±1.2 
/20 ±1.3 
10 ±0.5 
/5 ±0.01 
5.5 ±1.0 
/5 ±1.1 
2
/
Group (5) 
100 mg/kg 
 
35±1.1/
30± 1.2 
15± 
1.7/10 
±1.1 
2.5± 0.1 
/3.5 ±0.2 
4±0.1/3
±0.2 
2 ±0.01 
/0.5±0.0
0 
10±0.01/15 
±0.04 
4.5±0.01/
5 ±0.01 
2.5 ±0.00 
/2.5 
±0.00 
30 ±1.0 
/30 ±1.1 
20 ±0.0 
/25 ±0.0 
10 ±1.1 
/8 ±1.2 
2
/
Group (6) 
20mg/kg  
twice/ 
weekly   
for 2weeks 
15±0.1/
15± 0.5 
5 ±0.04 
/5 ±0.07 
3.5± 0.1 
/5 ±0.2 
1.5±0.0
0/1.1±0.
01 
2.5± 
0.01 /2 
±0.07 
10 ±0.1 /15 
±0.3 
5.5 ±0.02 
/7.5 
±0.01 
5 ±0.04 
/7 ±0.05 
25 ±1.7 
/25 ±1.3 
15 ±1.1 
/20 ±0.5 
15 ±1.4 
/20 ±0.5 
3
/
Group (7) 
20mg/kg 
daily for 
8days 
40 ±1.3 
/50 ±1.5 
60±1.1/7
0± 1.3 
10± 0.1 
/15± 0.1 
2.5±0.1/
2±0.01 
5 ±0.01 
/5 ±0.02 
15 ±0.1 /20 
±0.2 
10± 0.01 
/15 ±0.02 
8 ±0.02 
/10 ±0.01 
30 ±1.5 
/25 ±1.4 
15 ±1.5 
/20 ±0.5 
25 ±1.2 
/30 ±1.1 
5
/
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(10) The concentration of Cymelarsan (Arsenic) in Different organs( µg/g )and serum, bile and urineµg/ml 
in Nubian goats infected with T. evansi and given single or multiple dosages of Cymelarsan  and Oxytetracycline 
combination(M±SE). 
Organs 
 
Dose 
Serum Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uteru
Group (1) 
 
≤0.07a 
Group (2) 
 
≤0.07a 
Group (3) 
 0.125 
mg/kgof 
MelCy+10mg
/kg ofOTC 
0.42b 
±0.04 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 0.4±0.
5/ 
≤0.07 
0.1±0.0
1/≤0.07 
≤0.07 ≤0.07
Group (4) 
0.125 mg/kg 
ofMelCy+50 
mg/kg of 
OTC 
0.55b 
±0.01 
0.5± 
1.22/ 
≤0.07 
0.1±0.00
/ 
≤0.07 
≤0.07 ≤0.07 0.1±0.
0 
≤0.07 
0.2±0.01
/≤0.07 
≤0.07 0.1±0.0
1/≤0.07 
≤0.07 ≤0.07 ≤0.07
Group (5) 
0.125 mg/kg 
ofMelCy+20 
mg/kg of 
OTC 
twice/week 
for 2weeks 
1.89c 
±0.14 
70±0.00/
90±0.00 
40±1.5/45± 
1.6 
30±1.
2/35±1.
1 
40 ±1.1 
/35 ±1.3 
15 ±1.4 
/18± 1.5 
7±1.01 
/10 ±1.03 
60±1.1/50
±1.3 
70±1.4
/80±1.
5 
45±1.1/
55±1.5 
30±1.0
/35±1.
9 
15±1.
20±1.
Gro
up (6) 0.125 
mg/kg 
3.1d 
±0.02 
110±1.5/
120±1.9 
120±1.1/ 
100±1.4 
85±1.7/ 
85±1.8 
75±2.5
/ 
70±1.5 
80±1.9/8
0 ±1.5 
75 ±1.7 
/70 ±1.8 
45±1.1/45 
±1.2 
100±1.4 
/110 
±1.5 
120±1.1 
/110±1.3 
105±2.0
100±1.1 
60±1.1
65  ±1
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
ofMelCy+ 
20m
g/kg of 
OTCdaily for 
8days 
The same letters in one column showed no significant changes p≤ 0.05. OTC = Ox tetracycline 
(RemacyclineR)          MelCy = CymelarsanRWeek1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, 
w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(10) the concentration of Quinapyramine  (%)  in Different organs in Nubian 
goats in Nubian goats infected with T. evansi and given single or multiple doses of   Quinapyramine 
(M±SE). 
Organs 
Dose 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uterus 
Group (1) 
 
nil 
Group (2) 
 
nil 
Group(3)  
5mg/kg 
10±0.05/2
±0.02/0.5
±0.01/nil 
13±1.5/10±
1.8/5±1.4/2
.5±0.1/0.5±
0.1 
0.5±0.5/0.1
±0.3/0.01±
0.2/0.05± 
0.01/nil 
nil 2±0.1/1.5±
0.2/0.5±0.1
/nil 
0.1±0.00/ 
0.2±0.5/0.0
5±0.3/ nil 
nil 3±0.5/0.5±
0.2/0.02± 
0.4/0.05± 
0.5/nil 
0.05±0.01/ 
0.01±0.02/nil 
0.01±0.0
1/nil 
0.05±0.05/ 
nil 
Group(4) 
12.5 mg/kg 
10±1.5/5±
0.5/2±0.1/
0.5±0.01/
0.1±0.01 
10±1.5/5±1
.1/5.5±0.5/
0.2±0.3/0.1
±0.2 
1.5±0.00/1
±0.1/0.5± 
0.1/0.5±0.0
0/0.1±0.1 
nil 1.0±0.00/ 
2.5±0.00/0.
5±0.00/0.1
±0.00/nil 
0.5±0.02/ 
0.2±0.00 
1/0.1± 
0.00/nil 
nil 5±1.5/2.5±
0.1/2±0.2/1
.5±0.5/0.5±
0.2 
0.5±0.00/nil nil 0.5±0.01/ 
0.1±0.00/ 
nil 
Group(5) 
25mg/kg 
10±1.5/ 
7.5±1.1/ 
5.5±1.3/5
±0.4/2.5± 
0.5 
15±0.5/10±
0.1/10.5±0.
02/8.5±0.05
/8±0.03 
2.5±0.00/2
±0.00/1.5±
0.00/1/0.5±
0.00 
nil 2±0.00/1±0
.01/1.5±0.0
2/0.5±1.1/0
.5±0.00 
1.5±0.00/ 
0.5±0.01/ 
nil 
nil 8±0.3/5± 
0.4/4±0.3/2
.5±0.2/2.5± 
0.2 
2.5±0.00/2±0
.1/1±0.2/0.5
±0.01/0.3± 
0.00 
1±0.01/0
.5±0.02/
0.2±0.01
/0.1±0.0
2/0.2± 
0.01 
1±0.00/0.5
±0.02/0.2±
0.1/0.1±0.0
1/0.2±0.2 
Group(6) 
50mg/k 
15±0.5/10
±0.6 
5±0.00/5.5
±0.00 
7.5±0.00/4.
5±0.01 
nil 5±1.2/3.5±
1.0 
2.5±0.01/2
±0.02 
nil 15±1.1/7.5
±1.4 
5±0.5/3±0.2 2.5±0.01
/ 
2.5±0.02 
1.5±0.04/1
±0.3 
Group(7)  
5 mg/kg 
weekly for 
10±0.1/ 
5.5±0.3 
5.5±1.0/5.5
±1.0 
3.5±0.1/2±
0.00 
nil 5±0.1/3.5±
0.2 
2±1.5/1.5± 
0.1 
nil 10±1.5/8.5
±1.0 
4.5±1.2/2.5±
0.1 
1.5±0.5/
2±0.1 
2.5±0.02/2
±0.23 
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3weeks 
Group(8) 
5mg/kg 
days for 8 
days 
30±1.5/35
±1.7 
25±1.5/20.5
±1.1 
10±0.1/8.5
±0.5 
nil 8.5±0.5/5.5
±0.4 
3.5±0.01/3.
0±0.02 
nil 12.5±/11± 10±/7.5± 8.5±0.01
/8±0.02 
5±0.01/2.5
±0.00 
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
able(10) The concentration of Oxytetracycline in organs, bile and urine(µg/g or/ml)  in Nubian goats infected with T. evansi and given 
single and multiple dosages  
of oxytetracycline (M+SE). 
Organs 
Dose 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg Muscle Uterus 
Group (1) 
 
nil 
Group (2) 
 
nil 
Group (3) 
20mg/kg 
 
0.3±0.00/0.05
±0.00 
0.4±0.01/0.3±
0.01 
0.1±0.01/0.2±
0.02 
0.5±0.01/0.01
±0.00 
0.5±0.01/0.00
1±0.02 
0.05±0.00/0.01±0
.00 
0.01±0.00/0.0
1±0.00 
1±0.1/0.05±0.
03 
0.3±0.04/0.05
±0.00 
0.01±0.02/0.0
1±0.01 
0.01±0.04/0.0
01±0.05 
0
0
Group (4) 
50mg/kg 
5±0.001/2±0.1
/0.5±0.1/0.1±0
.1/0.1±0.01 
5±0.1/1±0.01/
0.8±0.1/0.7± 
0.01/0.1±0.00 
1±0.1/0.5±0.0
1/0.3±0.01/0.5
±0.02/0.05± 
0.00 
0.1±0.01/0.00
5±0.00/0.005±
0.000/0.005±0
.000/0.005±0.
00 
0.5±0.00/0.3±
0.01/0.005± 
0.01/0.05±0.0
0/0.01±0.0 
0.5±0.00/0.3±0.0
0/0.2±0.00/0.5±0.
00/0.05±0.00 
0.5±0.00/0.3±
0.00/0.1±0.00/
0.5±0.00/0.2±
0.00 
10±0.00/0.7±0
.00/0.5±0.00/0
.3±0.00/0.005
±0.00 
5±0.1/5±0.2/3
±0.3/2±0.02/ 
0.5±0.01 
0.5±0.01/0.05
±0.01/0.05±0.
01/0.05±0.00/
0.05±0.03 
0.6±0.1/7±0.2/
2±0.00/1±0.01
/0.05±0.00 
1
0
0
0
Group (5) 
100 mg/kg 
 
 
 
18±0.1/1.5± 
0.01/1.0±0.00/
0.5±0.02/0.2± 
0.01 
2.0±0.01/1.9±
0.1/1.5±0.3/ 
1.0±0.01/0.5± 
0.00 
0.5±0.01/0.3±
0.02/0.5±0.01/
0.5±0.01/0.± 
0.01 
0.5±0.00/0.2±
0.00/0.5±0.01/
0.5±0.02/0.± 
0.02 
5±0.2/0.5±0.0
1/0.5±0.001/ 
0.50.03 
0.3±0.00/0.2±0.0
0/0.5±0.01/0.2±0.
02/0.01±0.00 
0
.2±0.0
1/0.1±
0.02/0
.1±0.0
0/0.5±
0.00/ 
0.1±0.00 
2±0.00/1±0.00
/1.5±0.1/1±0.2
/0.2±0.00 
5±0.1/5±0.2/3
±0.3/2±0.4/0.5
±0.1 
2±0.1/1±0.2/1.
5±0.1/0.5± 
0.01/0.1±0.00 
1±0.01/0.3±0.
00/0.5±0.01/ 
0.2±0.03/0.5± 
0.02 
1
0
0
0
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Group (6) 
20mg/kg 
weekly 
for3weeks 
10±1.2/5±0.5/
5±0.3/7±0.2/5
±0.01 
1.7±0.01/1.5±
0.01/1.5±0.02/
1.5±0.00/1.0±
0.01 
0.7±0.1/0.5±0.
2/0.3±/0.5±/ 
0.5± 
7±0.1/5±0.2/5
±0.3/7±0.02/7
±0.02 
10±0.1/7±0.2/
10±003/10± 
0.00/7±0.1 
0.3±0.00/0.2±0.0
1/0.2±0.01/0.2±0.
00/0.2±0.01 
0.5±0.01/0.3±
0.02/0.2±0.00/
0.2±0.01/0.2±
0.00 
10±1.5/10±1.2
/7±1.1/7±0.5/7
±0.5 
7±0.1/7±0.2/7
±0.2/5±0.1/7±
0.2 
5±1.5/5±0.1/7
±0.3/5±0.02/ 
5±0.3 
1.0±0.00/1.0±
0.3/0.5±0.2/ 
0.2±0.1/0.1± 
0.1 
2
0
0
.0
Group (7)  
20 mg/kg 
twice/week for 
2weeks 
15±1.3/20±1.5 1.8±1.2/20.5± 
.5 
2.3±0.1/2.8± 
0.1 
1.3±0.01/1.0±
0.05 
5.2±0.5/2.3± 
0.2 
1.5±0.1/2.5± 
0.2 
1.0±0.000/0.2
±0.000 
24.8±2.2/20± 
2.1 
30±1.5/25.5± 
1.5 
5±0.000/5.5±0
.01 
2.0±0.02/3.0±
0.3 
5
0
Group (8) 
20mg/kg daily 
for 8days 
10±1.5/5.5± 
1.1 
10±1.3/7±1.2 1.0±1.0/0.5± 
0.01 
0.5±0.2/0.2± 
0.1 
2.0±0.01/1.0±
0.01 
0.2±0.01/0.3±0.0
2 
0.01±0.01/0.0
1±0.01 
10.0±1.8/5.5±
1.5 
7.0±1.2/5.0± 
1.3 
2.0±0.01/1.0±
0.01 
0.1±0.1/0.02±
0.09 
2
0
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
Table(11) The concentration of Quinapyramine(%) in serum of Nubian goats infected with T. evansi and given 
single and multiple doasages of Quinapyramine  (M±SE). 
Dos
e 
Day
s 
Group
(1) 
 
 
Group
(2) 
 
Group(3) 
treatedwith5m
g/kg 
Group
(4) 
12.5 
mg/kg 
Group
(5) 
25mg/
kg 
Group
(6) 
50mg/
kg 
Group(7) 
5mg/kgwe
ekly for 
3weeks 
Group
(8) 5 
mg/kg 
daily 
for 
8days  
 
1 
hou
rs 
nil Nil 5±0.01 12±0.1 
 
13±0.0
5 
15±0.7 9±1.5 11±1.4 
3 
hou
rs 
nil Nil 8±0.02  
11±1.1 
14±0.2 20±0.5 9±1.3 10±1.1 
24 
hou
rs 
nil Nil 5±0.04  
13±1.2 
16±0.1 21±1.2 10±1.2 11±1.2 
3 
day
s 
nil Nil 5±0.01 15±1.0 
 
18±0.3 24±1.0 10±0.5 30±1.2 
7 
day
s 
nil Nil 5±0.01  
10±1.3 
22±0.1 15±0.5 13±0.4 35±1.5 
10 nil Nil 2±0.00  14±0.1 18±0.3 15±0.3 32±2.1 
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day
s 
5±0.5 
14 
day
s 
nil Nil 2±0.001  
5±0.2 
10±0.1 12±0.2 14±0..2 25±1.3 
21 
day
s 
nil Nil nil  
3±0.00
1 
8±0.01 10±0.5 10±0.1 20±1.5 
28 
day
s 
nil Nil nil  
2±0.00 
7± 0.03 40.02 8±0.5 15±0.0
2 
35 
day
s 
nil Nil nil  
3±0.00
1 
8±0.02 5±0.00 5±0.08 16±0.0
2 
42 
day
s 
nil nil nil  
nil 
5±0.02 30.01 nil nil 
49 
day
s 
nil nil nil  
nil 
3±0.00
1 
nil nil nil 
56 
day
s 
nil nil nil nil nil nil nil nil 
              Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(11) The concentration of Quinapyramine(%) in serum of Nubian goats infected with 
T. evansi and given single and multiple doasages of Quinapyramine and ethidium 
combination(M±SE). 
Groups 
Days 
Group(1) 
 
 
Group(2) *Group(3) 
5mg/kgof 
quina.+25mg/kg of 
eth. 
*Group(4) 
12.5mg/kgofquina.+1 
mg/kg of eth. 
**Group(5)  
5mg/kgofquina.+1mg/kg 
of eth. 
**Group(6) 
5mg/kgof 
quina.+2.5mg/kg 
of eth 
 hours nil nil 5±0.01 5±0.03 7±0.05 10±1.5 
 hours nil nil 5±0.02 3±0.01 6±0.01 8±1.1 
4 hours nil nil 6±0.03 3±0.00 7±0.02 9±0.5 
 days nil nil 8±0.04 4±0.00 5±0.01 10±1.0 
 days nil nil 5±0.03 3.5±0.02 5±0.02 10±1.0 
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0 days nil nil 4±0.02 nil 4±0.01 8±0.3 
4 days nil nil 5±0.01 nil 5±0.02 5±0.02 
1 days nil nil 3±0.01 nil 2±0.01 6±0.02 
8 days nil nil nil nil nil nil 
5 days nil nil nil nil nil nil 
2 days nil nil nil nil nil nil 
9 days nil nil nil nil nil nil 
56 days nil nil nil nil nil nil 
*      = Infection was done by T. evansi. **   = Infection was done by T. vivax. quina.= 
quinapyramine.     hom.  = homidium bromide. Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, 
w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
able(11) The concentration of Oxytetracycline in serum (µg/ml)  in Nubian goats infected with T. evansi and given single and multiple 
dosages 
 of Cymelarsan and oxytetracycline combination(M+SE). 
ys 
Group (1) 
 
Group (2) 
 
Group (3)  
20 mg/kg 
Group (4)  
50 mg/kg 
Group (5)  
100 mg/kg 
Group (6)  
20 mg/kg 
weekly/ 3weeks
Group (7)  
20 mg/kg 
twice/week for 
2weeksRDS 
G
20
d
rs nil nil 5±0.5 5±0.01 8±0.1 5±0.01 5±0.1 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
 
rs nil nil 6±0.08 5±0.03  
9±0.05 
6±0.01 6±0.5 
rs nil nil 2.5±0.01 4±0.01  
8±0.07 
5±0.01 7±0.4 
s nil nil nil 5±0.001  
10±0.1 
4±0.01 10±0.5 
s nil nil nil 6±0.02  
6±0.001 
5±0.02 8±0.2 
ys nil nil nil 5±0.02  
5±0.002 
5±0.00 12±0.3 
nil nil Died 4±0.001  
6±0.003 
5±0.00 8±1.0 
nil nil  3±0.01  
5±0.004 
3±0.01 5±0.00 
nil nil  nil  
6±0.005 
nil 4±0.02 
nil nil  nil  
Nil 
nil Nil 
nil nil  nil  
Nil 
nil Nil 
nil nil  nil Nil nil Nil 
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
 
 
 
 
 
 
 
 
 
 
 
 
Table(12) The concentration of Oxytetracycline in serum (µg/ml)  in Nubian goats infected with T. evansi and 
given single and multiple dosages of Cymelarsan followed by oxytetracycline combination (M±SE). 
Do
se 
Da
ys 
Gro
up 
(1) 
 
Gro
up 
(2) 
 
Group (3)  
1.25 mg/kg 
of 
MelCy+10
mg/kg of 
OTC 
 
Group (4)  
1.25 mg/kg 
of 
MelCy+50
mg/kg of 
OTC 
Group (5)  
1.25 mg/kg 
of 
MelCy+20m
g/kg 
ofOTCtwice
/week for 
Group (6)  
1.25 mg/kg 
of 
MelCy+20
mg/kg of 
OTC daily 
for 8days 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
2weeks 
1 
hou
rs 
Nil Nil 5±0.1 5±0.2 5±0.02 5±0.4 
3 
hou
rs 
Nil Nil 6±0.5 7±0.3 7±0.01 7±0.3 
24 
hou
rs 
Nil Nil 6±0.4 8±0.4 8±0.01 8±0.2 
3 
day
s 
Nil Nil 8±0.3 10±0.5 10±0.02 10±0.1 
7 
day
s 
Nil Nil 7±0.2 12±0.01 9±0.03 12±0.2 
10 
day
s 
Nil Nil 5±0.1 8±0.01 12±0.04 18±0.4 
14 
day
s 
Nil Nil 5±1.1 5±0.02 8±0.01 15±0.5 
21 
day
s 
Nil Nil Died 3.5±0.02 10.3±0.05 20±0.01 
28 
day
s 
Nil Nil  Nil Died Died 
35 
day
s 
Nil Nil  Nil   
42 
day
s 
Nil Nil  Nil   
49 
day
s 
Nil Nil  Nil   
MelCy = CymelarsanR           OTC = Ox tetracycline (RemacyclineR) ,Week1 (w1)=14day post treatment (d.p.t), 
w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
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Table(10) The concentration of Cymelarsan (Arsenic) in Different organs (µg/g) and serum, bile and 
urineµg/mlNubian goats infected with T. evansi and given single or multiple doses of Cymelarsan suplemented 
with zinc(Zn) and copper (Cu) (M±SE). 
Organs 
Dose 
Serum 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Group (1) 
 
≤0.07a 
Group (2) 
 
≤0.07a 
Group (3) 
0.25mg/kg+ 
Zn+ Cu 
0.41b 
±0.05 
0.2±0.05/ 
≤0.07 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 0.5± 
0.02/ 
≤0.07 
≤0.07 ≤0.07 
Group (4) 
0.25mg/dkg+Zn
+ Cu daily for 
8days 
3.2c 
±0.09 
25.40.20.07 25±0.01 30± 
0.21 
10.0± 
0.05 
1.50.05 ≤0.07 ≤0.07 ≤0.07 55.2± 
0.07 
≤0.07 
The same letters in one column showed  no significant changes p≤ 0.05.Week1 
(w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
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Table(11) the concentration of Oxytetracycline (µg/g) in Different organs in Nubian 
goats infected with T. evansi and given single or multiple doses of Cymelarsan and Oxytetracycline 
combination(M±SE). 
Organs 
Dose 
Liver Kidney Heart Lung Spleen Cerebellum Cerebrum Fat Site of 
injection 
Leg 
Muscle 
Uteru
Group (1) 
 
nil 
Group (2) nil 
Group (3) 
0.125 mg/kg of 
MelCy+10mg/
kg of OTC  
0.5±0.01 
0.3±0.02
/nil 
0.4±0.01 
0.3±0.01 
0.5±0.5/ 
0.4±0.00 
0.3±0.00/ 
0.02±0.01 
0.4±0.01 
0.2±0.02 
0.04±0.001      
/0.01±0.0 0 
0.03±0.00
0.01±0.00 
1±0.3/ 
0.05±0.2 
0.5±0.4 
0.05±0.5 
0.2±0.1 
0.01± 
0.00 
0.01± 
0.01/ 
0.01±0.
01 
Group (4) 
0.125 mg/kg of 
MelCy+50mg/
kg of OTC 
3.5±0.01 
1.5±0.00
/nil 
5±0.1/ 
1.2±0.01
/nil 
2.5±0.00 
0.5±0.01
/nil 
0.5±0.1/ 
0.5±0.2/ 
2.5±.0.02/ 
2ñ0.01/ 
1±0.00 
0.5±0.01 
0.3±0.02 
nil 
0.5±0.01/ 
0.3±0.02/ 
nil 
0.5±0.01/ 
0.3±0.00/ 
nil 
10±1.5/ 
7±1.00/ 
5±0.01/ 
3±0.02/ 
2.3±0.01 
5±0.5/ 
5.5±0.3/ 
3.5±0.01/
3±0.00/ 
2.1±0.00 
5±0.2/ 
5±0.1/ 
3.5±0.0
1/2±0.0
4/0.5±0
.07 
6±1.5 
/7±1.1/5
5±0.02/
.2±0.01
1.5±0.0
Group (5) 
0.125 mg/kg of 
MelCy+20 
mg/kg of 
OTCtwice/ 
week 
5±0.1/ 
10±0.2/1
.5±0.021
0.5±0.00 
0.3±0.01 
10.5±1.0 
15.0±1.1
/1±00.02
8.5±0.01 
5.5±0.00 
5±0.1/ 
3±0.2/ 
2±0.01/ 
2±0.03/ 
1.5±0.04 
5±0.1/ 
5±0.5/ 
3.5±0.06/ 
4±0.02/2.
5±0.04 
0.5±0.01 
0.3±0.02 
/nil 
0.3±0.01/ 
0.2±0.01/ 
nil 
0.1±0.00/ 
0.5±0.00 
/nil 
10±1.0/ 
7.5±0.5/ 
5.5±0.01 
3±0.03/ 
2±0.07 
5.5±0.2 
/5±0.4/ 
3±0.01/ 
2.5±0.02/ 
2±0.00 
0.5±0.2 
0.5±0.4
/nil 
1±0.5/
0.5±0.0
/nil 
Grou
p (6) 0.1.25 
mg/kg of 
MelCy+20mg/
kg of OTC 
daily for 
8days 
15±0.2/ 
20±0.1 
18±0.4/ 
20.5±0.5 
2.0±0.3/ 
2.5±0.2 
1.0±0.1/ 
1.0±0.2 
5.5±0.01 
5.5±0.02 
5.5±0.01/ 
3.5±0.01 
5.0±0.01/ 
5.2±0.3 
20.8±1.1 
20±1.2 
20.5±0.9/
30.5±0.8 
5±0.2/ 
7.5±0.3 
2.5±1.1
3.0±0.0
MelCy = CymelarsanR OTC = Ox tetracycline (Remacyclin), Week1 (w1)=14day post treatment 
(d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t. 
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Table(10) The concentration of Quinapyramine( % )in organs, bile and urine of Nubian goats infected with T. 
evansi and given single and multiple doasages of Quinapyramine and ethidium combination(M±SE). 
Dose 
Days 
Group 
(1) 
 
Group 
(2) 
 
*Group(3) 
5mg/kgof 
quina.+25mg/kg of eth. 
*Group(4) 
12.5mg/kgofquina.+1 
mg/kg of eth. 
**Group(5)  
5mg/kgofquina.+1mg/kg 
of eth. 
**Group(6) 5mg/kgof 
quina.+2.5mg/kg of eth
Liver 
 
Nil Nil 10±0.01/2±0.02/ 
0.5±0.03/nil 
10±1.5/5±0.5/2±0.1/0.5± 
0.01/0.1±0.01 
6.5±0.02/2.3±0.02/1 
±0.02 
10±0.01/5±0.02/4±0.03/ 
2.5±0.04 
Kidney 
 
Nil Nil 15±1.5/10±1.8/5±1.4/ 
2.5±0.1/0.5±0.1 
10±1.5/5±1.1/5.5±0.5/0.2± 
0.3/0.1±0.2 
10.2±0.01/7.3±0.02/nil 5.5±0.02/7.5±0.01/3.5±0.02/
2±0.00/1±0.05 
Heart 
 
Nil Nil 1±0.5/0.3±0.3/0.01±0.2/0.00± 
0.01/nil 
1.5±0.01/1±0.1/0.5± 
0.1/0.5±0.00/0.1±0.00 
10±0.00/6.5±0.02/7 
±0.00/5±0.02/3±0.01 
10.2±0.01/8±0.01/5.5±0.02/
2.5±0.01/1±0.03 
Lung 
 
Nil Nil Nil Nil 7±0.01/5±0.02/3.5±0.02 
/1.2±0.02/nil 
10.5±0.01/8.5±0.01/3.5±0.02/n
Spleen 
 
Nil Nil 3±0.1/2.5±0.2/0.5 
±0.1/nil 
1.5±0.00/4±0.00/0.5± 
0.00/0.1±0.00/nil 
0.5±0.02/1±0.03/nil 0.5±0.00/1±0.0/1.5±0.02/nil
erebellum Nil Nil 0.1±0.00/0.2±0.5/0.05 
±0.3/ nil 
0.5±0.02/0.2±0.001/0.1 
±0.00/nil 
2±0.03/3±0.00/1.5±0.01/nil 3±0.0.2/4.5±0.02/5.5±0.04/
4±0.02/0.5±0.02 
Cerebrum Nil Nil Nil Nil 1.5±0.02/1±0.02/nil 2±0.02/nil 
Fat Nil Nil 3±0.5/0.5±0.2/0.02±0.4/0.05 
±0.5/nil 
5±1.5/2.5±0.1/2±0.2/1.5 
0.5/0.5±0.2 
2.5±0.02/2±0.01/1.5± 
0.02/0.5±0.01/0.5±0.02 
3.5±0.02/2.50±.04/2±0.05/ 
1.5±0.05/nil 
Site of 
njection 
Nil Nil 0.05±0.01/0.01±0.02/nil 0.5±0.00/nil 1±0.03/1.5±0.02/0.5±0.03/ 
1±0.05/1±0.03 
15±0.00/10±0.02/7.5±0.02 
/5.5±0.02/3.5±0.02/ 
eg Muscle Nil Nil Nil  Nil 1.5±0.07/1±0.02/nil 0.5±0.03/nil 
Uterus 
 
Nil Nil 3±0.5/0.5±0.2/0.02±0.4/0.05 
±0.5/nil 
0.5±0.01/ 
0.1±0.00/nil 
1.5±0.02/1±0.02/0.5±0.001/ 
0.5±0.01/nil 
2.5±0.03/2±0.03/1.5±0.00 
/1±0.02/nil 
Ovary 
 
  0.051±0.03/nil 0.5±0.00/nil 1±0.03/0.5±0.03/0.5±0.01/nil 12±0.03/10±0.05/8±0.02 
/5.5±0.01/5±0.01 
Testis Nil Nil 0.05±0.05/ 
nil 
1.5±0.00/0.5±0.00/nil 2±0.03/1±0.05/1.5±0.03/ 
1±0.02/nil 
0.5±0.05/0.2±0.01/0.2± 
0.06/0.2±0.00/0.2±0.02 
Bile Nil Nil Nil 2.5±0.01/2±0.02/1.5± 
0.00/0.2±0.02/0.5±0.03 
1.50.03/20.00/30.01  7±0.00/3.5±0.01/2.0± 
0.00/2±0.02/0.5±0.00 
Urine Nil Nil 0.5±0.03/0.1±0.00/nil 
 
9±0.5/5±0.1/2.5±1.0/1.0 
±0.05/0.3±0.02 
1.5±0.00/0.5±0.00/nil /2 1.5±0.01/0.5±0.00/nil 
*      = Infection was done by T. evansi. **   = Infection was done by T. vivax. quina.= quinapyramine.     hom.  = 
homidium bromid 
Week1 (w1)=14day post treatment (d.p.t), w2=21d.p.t, w3=28d.p.t, w4= 35d.p.t and w5=42d.p.t.  
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Table(7) The concentration of Cymelarsan in different organs(µg/100g) and serum and urine (µg/ml) 
in camels infected naturally with T.evansi infected and given single and multiple dosages of 
Cymelarsan within the withdrawal period(M±SE).  
Groups 
Organs 
Group 
(1) 
Group (2) Group (3)  
0.25mg/kg 
Group (4) 
0.625mg/kg 
Group (5)  
0.125 mg/kg 
weekly/3weeks 
Serum ≤0.07 ≤0.07 2.3±0.01 8.3±0.02 5.6±0.00 
Liver 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Lung 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Kidney ≤0.07 ≤0.07 10 ±0.05 /3 ±0.01 
/≤0.07 
10 ±0.01 /5 ±0.02 
/≤0.07 
10 ±0.02 /4 ±0.00 
/≤0.07 
Heart ≤0.07 ≤0.07 0.5 ±0.01 
/0.6±0.00 /≤0.07 
0.5±0.01 
/0.5±0.00 /≤0.07 
0.8±0.00 /0.3±0.00 
/≤0.07 
Spleen 
 
≤0.07 ≤0.07 0.1 ±0.02 /≤0.07 0.5 ±0.00 /≤0.07 0.5 ±0.01 /≤0.07 
Cerebellum 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Cerebrum 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Fat 
 
≤0.07 ≤0.07 0.5 ±0.05 /≤0.07 0.5 ±0.00 /≤0.07 0.5 ±0.00/≤0.07 
Site of 
injection 
≤0.07 ≤0.07 5 ±0.2 /≤0.07 5 ±0.02 /≤0.07 5 ±0.02 /≤0.07 
Leg muscle 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Uterus 
 
≤0.07 ≤0.07 2.2 ±0.01 /≤0.07 2.5 ±0.02 /≤0.07 2.02 ±0.01 /≤0.07 
Ovary 
 
≤0.07 ≤0.07 0.5 ±0.02 /≤0.07 0.7 ±0.00 /≤0.07 0.8 ±0.00 /≤0.07 
Testis 
 
≤0.07 ≤0.07 0.2 ±0.01 /≤0.07 0.5 ±0.01 /≤0.07 0.9 ±0.01 /≤0.07 
Urine 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
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Table (7) the concentration of Oxytetracycline in Different organs (µg/g) and serum and urine (µg/ml)in camels 
infected naturally with T. evansi and given single and multiple dosages of Oxytetracycline within the withdrawal 
period (M±SE). 
Groups 
Organs 
Group 
(1) 
Group 
(2) 
Group (3) 
20 mg/kg 
Group (4) 
 50mg/kg 
Group (5)  
100 mg/kg 
Group (6)  
20mg/kg 
twice/week 
for 2 weeks 
Group (7)  
20mg/kg daily 
for 8days 
Liver 
 
 
Nil Nil 20±0.1/15 
±0.2 
20±0.1/15± 
0.5/10±0.02/5.5±
0.02/ nil 
35±1.1/30± 
0.02/20±0.1/1
5± 0.5/10± 
0.001/ nil 
35±1.1/30± 
1.2/20±0.02/1
5±0.02/5.5±0.
02 
35±1.1/30±1.2/ 
20±0.03/15±0.01/ 
5.5±0.02 
Kidney 
 
 
Nil Nil 15±0.01/10
± 0.02 
15±0.00/10 
±0.01/8±0.03/5±
0.02// nil 
15± 1.7/10 
±0.01/7.50.03/
50.02// nil 
5 ±0.04 /5 
±0.07/3.50.02/
1.50.02/20.00 
60±1.1/70±1.3/ 
55±0.02/40±0.03/ 
25±0.02 
Heart Nil Nil 3.5± 
0.1/4.5± 
0.2 
1.5± 0.01/ 0.5± 
0.4/0.2±0.02/0.5
±0.03/ nil 
2.5± 0.1/3.5 
±0.2/2.5±0.01
/1.5±0.02/ nil 
3.5± 0.1 /5 
±0.2/2.5±0.03/
2±0.03/1.5±0.
03 
10±0.1/15±0.1/ 
10±0.02/8±0.01/ 
5±0.02 
Lung 
 
 
Nil Nil 3±0.01/2±
0.1 
5±0.1/6±0.2/4±0
.02/2.5±0.02/ nil 
4±0.1/3±0.2/1
.5± 0.01/ 0.5± 
0.02/ nil 
1.5±0.00/1.1±
0.01/0.5±0.02/
1±0.01/0.6±0.
03 
2.5±0.1/2±0.01/ 
1.5±0.02/1±0.02/ 
0.5±0.00 
Spleen 
 
 
Nil Nil 3.5 ±0.01 
/2.5± 0.02 
1.5±0.01/1.5 
±0.02/10.02/0.50
.03// nil 
2 ±0.01 
/0.5±0.00/0.2
±0.01/0.3±0.0
0/ nil 
2.5± 0.01 /2 
±0.07/1.8±0.0
3/1.4±0.01/0.5
±0.02 
5±0.01/5±0.02/ 
3.5±0.02/2.5±0.02/
1.5±0.02 
Cerebellum 
 
 
Nil Nil 5 ±0.01 /5 
±0.04 
5.5± 0.05 /7 
±0.03/5.50.02/30
.06/ nil 
10±0.01/15 
±0.04/10±0.05
/5.5±0.03// nil 
10 ±0.1 /15 
±0.3/10±0.03/
5.5±0.02/2.5±
0.06 
15±0.1/20±0.2/ 
15±0.02/10±0.02/ 
5.5±0.00/ 
Cerebrum 
 
 
Nil Nil 3 ±0.01 
/2.5± 0.02 
3.5± 0.05 /3 
0.07/3 ±0.01 
/2.5± 0.02/ nil 
4.5±0.01/5 
±0.01/3.5 
±0.01 /2.5± 
0.01/ nil 
5.5 ±0.02 /7.5 
±0.01/5±0.01/
3.5±0.03/2±0.
02/ 
10±0.01/15±0.02/ 
10±0.00/5.5±0.05/ 
3.5±0.02/ 
Fat 
 
 
Nil Nil 5 ±0.01 
/2.5 ±0.02 
3.5 ±0.05 /3 
±0.07/1.5±0.02/1
.5 ±0.03/ nil 
2.5 ±0.00 /2.5 
±0.00/5 ±0.04 
/2.5 ±0.00/ nil 
5 ±0.04 /7 
±0.05/3.5±0.0
5/2±0.00/0.5±
0.02 
8±0.02/10±0.01/ 
5.5±0.00/3.5±0.02/
3±0.01 
Site of 
injection 
 
Nil Nil 15 ±1.1 /20 
±0.00 
25 ±1.2 /20 
±1.3/10 ±0.5/2.5 
±0.2 /1 ±0.01/ 
nil 
30 ±1.0 /30 
±1.1/25 ±0.02 
/20 ±0.03/ nil 
25 ±1.7 /25 
±1.3/15±0.06/
12±0.00/5.8±0
.02/ 
30±1.5/25±1.4/ 
2±0.00/15±0.02/ 
10±0.02 
Leg muscle 
 
 
Nil Nil 15 ±0.7 
/10.5± 0.7 
10 ±0.5 /5 
±0.012.5 ±0.2 /1 
±0.01/ nil 
20 ±0.0 /25 
±0.01/15 ±0.02 
/10± 0.01/ nil 
15 ±1.1 /20 
±0.5/15±0.02/10
±0.03/5.8±0.02 
15±1.5/20±0.5/ 
15±0.02/10±0.02/ 
5±0.00 
Uterus 
 
 
Nil Nil 7 ±1.2 /7.5 
±1.3 
5.5 ±1.0 /5 
±1.1/2.5 ±0.2 /1 
±0.05/ nil 
10 ±1.1 /8 
±0.02/7 ±0.02 
/7.5 ±0.03/ nil 
15 ±1.4 /20 
±0.5/18±0.02/10
±0.03/5±0.02 
25±1.2/30±1.1/ 
20±0.00/15±0.002/5.
5±0.02 
Ovary 
 
 
Nil Nil 0.5 ±0.1 /1 
±0.2 
2.5 ±0.2 /1 
±0.02/0.5±0.02/0.2
±0.01/ nil 
2.5 ±0.01 /2 
±0.02/1.5±0.02/
0.3±0.02/ nil 
3 ±0.1 /3.5 
±0.4/2.5±0.06/1.
5±0.03/0.5±0.04 
5±0.1/6.5±0.3/ 
2.5±0.00/1.5±0.01/0.
5±0.00 
Testis 
 
 
Nil Nil 7.5 ±0.07 
/8.5 ±0.08 
10 ±0.1 /10 
±0.5/8.5±0.02/3.5±
0.06/ nil 
5 ±0.2 /2.5 
±0.01/2±0.03/1
±0.02// nil 
8.5 ±0.1 /10 
±0.02/5 ±0.06 
/2.5 
±0.01/2±0.01 
8  ±0.1 /10.5 
±0.3/5.5±0.00/2.5±0.
00/1±0.02 
Urine 
 
Nil Nil 3.5 ±0.01 
/4 ±0.02 
5 ±0.1 /5.5 
±0.2/3.8 ±0.08 
/2.5 ±0.01// nil 
5.5 ±0.1 /4 
±0.2/3.5 
±0.01/2±0.01/
nil 
4.5 ±0.1 /4.5 
±0.01/3.5±0.0
2/2±0.02/1±0.
03 
5 ±0.01 /5 
±0.02/2.5±0.02/1.5
±0.03/1±0.00 
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Table (7) the concentration of Cymelarsan in different organs(µg/100g), serum and 
urine (µg /ml )in camels infected naturally with T. evansi and given single dosages of 
Cymelarsan and Oxytetracycline within the withdrawal period (M±SE). 
Groups 
Organs 
Group 
(1) 
Group 
(2) 
Group (3) 
0.25mg/kg of 
MelCY+20mg/kg 
of OTC 
Group (4) 
0.125mg/kgof 
MelCY+50mg/kg 
of OTC 
Group (5) 
0.125mg/kgof 
MelCY+100mg/kg 
of OTC 
Serum 
 
≤0.07 ≤0.07 1±0.02 2.5±0.02 0.5±0.03 
Liver 
 
≤0.07 ≤0.07 2.5 ±0.02 /≤0.07 2.5 ±0.01 /≤0.07 1.5±0.02/≤0.07 
Lung 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Kidney 
 
≤0.07 ≤0.07 2 ±0.001 /≤0.07 5 ±0.02 /2.5 ±0.03 
/0.5 ±0.00 /≤0.07 
0.3±0.01/≤0.07 
Heart 
 
≤0.07 ≤0.07 1.5 ±0.01 /≤0.07 0.2 ±0.02 /0.5 
±0.02 /0.7±0.001 
/≤0.07 
0.1±0.03/≤0.07 
Spleen 
 
≤0.07 ≤0.07 ≤0.07 0.1 ±0.001 /≤0.07 0.2±0.01/≤0.07 
Cerebellum 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 ≤0.07 
Cerebrum 
 
≤0.07 ≤0.07 ≤0.07 0.1 ±0.02 /≤0.07 ≤0.07 
Fat 
 
≤0.07 ≤0.07 ≤0.07 ≤0.07 0.6±0.01/≤0.07 
Site of 
injection 
≤0.07 ≤0.07 0.5 ±0.02 /≤0.07 0.5 ±0.03 /≤0.07 0.3±0.00/≤0.07 
Leg muscle 
 
≤0.07 ≤0.07 ≤0.07 0.2 ±0.001 /≤0.07 0.5±0.01/≤0.07 
Uterus 
 
≤0.07 ≤0.07 ≤0.07 0.2 ±0.05 /≤0.07 ≤0.07 
Ovary 
 
≤0.07 ≤0.07 ≤0.07 0.1 ±0.02 /0.1 
±0.03 /≤0.07 
≤0.07 
Testis 
 
Nil Nil ≤0.07 0.2 ±0.001 /≤0.07 /≤0.07 
Urine 
 
Nil Nil 0.5 ±0.001 /≤0.07 0.5 ±0.02 /≤0.07 ≤0.07 
MelCy = CymelarsanR       OTC = Oxtetracycline (RemacyclineR) 
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Table (8) the concentration of Oxytetracycline in different organs (µg/g) and serum 
and urine (µg /ml) in camels infected naturally with T. evansi and given Cymelarsan 
followed by Oxytetracycline within the withdrawal period(M±SE). 
Groups 
Organs 
Group 
(1) 
Group 
(2) 
Group (3) 0.25mg/kg of 
MelCY+20mg/kg of OTC 
Group (4) 0.125mg/kgof 
MelCY+50mg/kg of OTC 
Group (5) 0.125mg/kgof 
MelCY+100mg/kg of 
OTC 
Liver 
 
Nil Nil 10 ±0.5/5 ±0.2/3.5±0.02 
2±0.01/1±0.02 
60 ±1.7/55 ±1.8/40±0.01 
33±0.02/20±0.05 
70±0.03/35±0.02/20 ±0.08 
/15 ±0.02/5±0.02 
Lung 
 
Nil Nil 1.5±0.1/1.2±0.1/nil 2±0.1/2.5±1.5/ 
1±0.05/0.5±0.02/0.2±0.04 
40±0.03/20±0.04/15 ±0.02 
/15 ±0.07/10±0.02 
Kidney 
 
Nil Nil 10± 0.2/15 ±0.3/ 
10±0.01/3.5±0.02/1.5±0.03 
80 ±1.8 /60± 1.4/ 
45±0.02/30±0.03/25±0.02 
100±0.03/90±0.02/70±0.02/ 
55±0.01/40±0.02 
Heart 
 
Nil Nil 2± 0.2 /0.5± 0.02/nil 5 ±0.1 /3.5± 
0.02/1.5±0.03/nil 
15±0.08/20±0.03/15±0.03/ 
10±0.02/4.6±0.02 
Spleen 
 
Nil Nil 0.5± 0.01 /1 ±0.1/nil 3±0.01/3.5±0.02/2.5±0.01/ 
1.5±0.01/0.5±0.07 
10±0.00/5±0.05/1.5±0.02/ 
0.5±0.02/0.5±0.01 
Cerebellum 
 
Nil Nil 5 ±0.3 /5 ±0.5/3±0.01/ 
1.5±0.2/0.2±0.01 
15 ±1.1 /15 ±1.0/ 
10±0.03/5.5±0.04/4.5±0.02 
30±0.01/15±0.04/5±0.03 
/1.5±0.05/nil 
Cerebrum 
 
Nil Nil 3.5 ±0.01 /3 ±0.02/ 
1.5±0.04/nil 
20 ±0.01 /15 
±0.02/10.4±0.01/nil 
50±0.02/15±0.02/ 
11±0.05/5.5±0.02/0.5±0.02 
Fat Nil Nil 2.5 ±0.00 /2.5 ±0.00/ 
1.5±0.01/0.5±0.01/0.2±0.01
3.5 ±0.02 /2.5±0.05/ 
1.5±0.02/0.6±0.02/0.3±0.01 
50±0.000/40±0.02/ 
35 ±0.02 /25 ±0.01/20±0.01
Site of 
injection 
Nil Nil 15 ±0.0 /15 ±0.0/10.3±0.02 
/5.8±0.01/2.5±0.03 
25 ±1.02/25±1.01/20±0.03/ 
15±0.08/5.5±0.07 
15±0.02/10±0.00/10 ±0.02 
/10 ±0.01/5±0.2 
Leg muscle 
 
Nil Nil 10 ±0.5 /8 ±0.3/5±0.02/ 
1.5±0.03/0.5±0.06 
30 ±1.1 /25 ±1.2/15±0.03/ 
10.5±0.03/5±0.03 
50±0.01/45±0.07/ 
30 ±0.01 /25 ±0.02/15±0.03
Uterus 
 
Nil Nil 5.5 ±0.5 /5 ±0.3/ 
2.5±0.07/1±0.03/nil 
10 ±0.2 /10 ±0.1/ 
5.5±0.02/3.5±0.02/2±0.04 
7±0.00/5±0.01/3±0.03/ 
2±0.01/1±0.02 
Ovary Nil Nil 0.5 ±0.01 /0.5 ±0.01/nil 3 ±0.1 /2.5 ±0.2/100.05 
/0.5±0.02/0.2±0.03 
10±0.03/5±0.01/5.5 ±0.07 
/3.5 ±0.04/2±0.01 
Testis 
 
Nil Nil 4 ±0.05 /3 ±0.07/2±0.03/nil 5.5 ±0.01 /3 ±0.02/ 
1.5±0.02/1±0.05/0.5±0.02 
10±0.02/6±0.02/5.5 ±0.09 
/3  ±0.05/1.1±0.02 
Urine 
 
Nil Nil Nil Nil 0.5±0.02/0.5±0.02/0.2±0.03 
/nil 
MelCy = CymelarsanR       OTC = Oxtetracycline (RemacyclineR) 
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Table(9) The concentration of Oxytetracycline in serum (µg/ml)  in camels infected naturally with T. evansi and 
given single dosages Cymelarsan by Oxytetracycline within the withdrawal period(M±SE). 
Dose 
Days 
Group 
(1) 
 
Group 
(2) 
 
Group (3) 
0.25mg/kg of 
MelCY+20mg/kg 
of OTC 
Group (4) 
0.125mg/kgof 
MelCY+50mg/kg 
of OTC 
Group (5) 
0.125mg/kgof 
MelCY+100mg/kg 
of OTC 
1 hours 
 
Nil Nil 15±0.01 30±0.01 40±0.00 
3 hours 
 
Nil Nil 25±0.02 3±0.025 55±0.01 
24 hours 
 
Nil Nil 20±0.01 5±0.05 25±0.01 
3 days 
 
Nil Nil 6±0.00 3±0.00 15±0.01 
7 days 
 
Nil Nil Nil Nil 15±0.06 
10 days 
 
Nil Nil Nil Nil Nil 
14 days 
 
Nil Nil Nil Nil Nil 
21 days 
 
Nil Nil Nil Nil Nil 
28 days 
 
Nil Nil Nil Nil Nil 
35 days 
 
Nil Nil Nil Nil Nil 
42 days 
 
Nil Nil Nil Nil Nil 
49 days 
 
Nil Nil Nil Nil Nil 
MelCy = CymelarsanR       OTC = Oxtetracycline (RemacyclineR) 
 
 
 
 
 
 
 
 
 
 
Table(8) The concentration of Oxytetracycline in serum (µg/ml ) in camels infected naturally with T. evansi and 
given single and multiple dosages of Oxytetracycline within the withdrawal period(M±SE). 
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Dose 
Days 
Group(1) 
 
Group(2) 
 
Group (3) 
20mg/kg 
Group (4) 
50 mg/kg 
Group (5) 
100 mg/kg 
Group (6) 20 
mg/kg 
twice/week 
for weeks 
Group (7) 
20mg/kg 
daily for 
8days 
1 hours 
 
Nil Nil 20±0.05 35±0.02 40±0.02 20±0.05 20±0.01 
3 hours 
 
Nil Nil 25±0.02 3±0.020 50.5±0.02 25±0.02 25±0.02 
24 hours 
 
Nil Nil 15±0.01 5±0.02 20.5±0.01 15±0.00 30±0.02 
3 days 
 
Nil Nil 6±0.00 2.5±0.00 15±0.001 6.00±0.00 35±0.02 
7 days 
 
Nil Nil Nil Nil 10±0.02 20.3±0.02 45±0.01 
10 days 
 
Nil Nil Nil Nil Nil 15±0.01 30±0.04 
14 days 
 
Nil Nil Nil Nil Nil 15±0.02 5±0.01 
21 days 
 
Nil Nil Nil Nil Nil 10±0.02 Nil 
28 days 
 
Nil Nil Nil Nil Nil 10±0.03 Nil 
35 days 
 
Nil Nil Nil Nil Nil 12±0.00 Nil 
42 days 
 
Nil Nil Nil Nil Nil 10±0.02 Nil 
49 days 
 
Nil Nil Nil Nil Nil 10±0.01 Nil 
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Chapter four 
Discussion 
The study of the toxicity and efficacy of Cymelarsan in goats and camels infected 
with T. evansi experimentally or naturally respectively showed that the infection 
of T. evansi in Nubian goats needs more 3 days for parasitaemia to develop, 
reaching maximum at 7days and as the disease progresses, the parasitaemia 
continues very severe for 3 days, the goats dying on day 11and the camels dying 
on day 17. Mutayoba et al., (1980) found in infected goats the parasitaemia would 
appear on day5-9, reach the maximum on day 8-12, the death occurring 17weeks 
post-infection. Also Naylor, (1971b) and Fairouz, (2000) studied the parasitaemia 
in infected T. evansi goats, and found that the parasitaemia appeared on day3, in 
Fairouz study it reached maximum on day 7, death occurring on day 5. However, 
death occurred after 33-49days in Arowlo et al, (1988) study when they studied 
the parasitaemia in goats infected with T. evansi. Goats seem to be more 
susceptible than camels to T. evansi infection although, the end result was same as 
all animals died. This variation might be due to the difference in strains or method 
of storing the strains (activation), (Solusby, 1982), or to the age of the animals as 
from this study the younger animals were more susceptible than older. This is in 
agreement with Elmalik, (1983) who found that Nubian goats infected with T. 
evansi, the parasitaemia appeared 2-30 day post-infection, the death was10%, the 
variation might be due to the difference in species of the animals, agrees with the 
suggestion of (Elamin, 1980 and Elmalik, 1983).  However, no effects were 
observed ascribable to sex of the animals in this study. 
It is well known that Cymelarsan inhibits  the metabolism of the cells by an 
enzyme which is central to the regulation of the thiol/disulfide redox balance in 
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the parasite and absent from the host. Also the drug has a rapid trypanocidal 
activity where, trypanosomes are destroyed within a few hours (Bujon, 1990). All 
camels were parasite free post treatment. In the goats which received a single half 
therapeutic recommended dose 0.125 mg/kg, the parasitaemia is slight  (+ or ++), 
and the animals were dead, which may be attributed to the clinicopathological 
effects of the parasite. The therapeutic dose cleared the parasite from the 
peripheral blood within 4days post-treatment and the animals survived. When the 
drug is administered at two and a half the recommended therapeutic dose the 
blood was cleared immediately post dosing and the animals survived but, the 
animals died15 days post-treatment with five times the therapeutic recommended 
dose, in groups (7-10) the peripheral blood is cleared from the parasite and 
animals died, this might be due to the stress of the vital organs by the parasite and 
to the effect of the drug which contained arsenical molecules. The present study 
also showed that parasites detected by the liver impression smear completely 
disappeared in all camels, in goats (4-10) which agree with the results obtained in 
the peripheral blood or whole blood. Furthermore, results obtained by liver 
impression smears in group (3) agree with that of peripheral blood or whole blood 
indicating the existence of the parasite and support our belief that, the cause of 
death is due to the parasite, while the death in the other treated groups may be due 
to the clinicopathological effects of the drug on the stressed vital organs. The 
present study indicates therapeutic activity of Cymelarsan at doses of 0.25-
0.625mg/kg. Also, the half and the recommended therapeutic dose at twice/week 
for two weeks or at daily administered for 8days is toxic and fatal which believe 
that the drug has accumulative effect. This supported by Bujon, (1990) mentioned 
that the maximum tolerated dose is 3-5mg/kg in camels, but in this study the goats 
appear to be more sensitive to the drug toxicity that the maximum tolerated dose 
appeared to be >0.625 mg/kg.  
The clinical signs observed in camels infected naturally with T. evansi are similar 
to those observed by Musa et al., (1991). The clinical signs manifested by all 
infected groups reflected the intensity of parasites and were similar to those 
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described by Elamin, (1980) and Olaho et al., (1996). The swollen testes were also 
mentioned by Elamin, (1980) and the keratitis was observed by De-Villa et 
al,(1991). 
In the present study the signs of acute form of the disease had also been observed.  
Bujon, (1990) mentioned that Cymelarsan is a trivalent arsenical compound 
formed by conjugation of one equivalent of melarsenoxide and two equivalent of 
cystamine. Radositis et al, (2000) mentioned that the trivalent arsenical 
compounds cause severe syndrome and arsenic is a general tissue poison 
combining with and inactivating sulfahydryl groups in tissue enzymes. Although 
all tissues are affected, deposition and toxic effect are greatest in those tissues 
which are rich in oxidative enzymes system such as alimentary tract, liver, kidney, 
spleen and lungs leading to general depression of metabolic activity. The same 
author also mentioned that nervous signs caused by organic arsenic as a result of 
inhibition of dehydrogenase enzyme system, e.g. pyruvate, α keto glucourate 
system) causing degenerative changes while poisoning with arsenilic acid 
compounds the lesion are mostly in optical nerve causing blindness. In the 
poisoning with phenyl arsonic group, the nerves of the limbs appear to be affected 
most. Radositis et al, (2000) mentioned that local skin lesions include initial 
hyperaemia followed by necrosis and sloughing, leaving indolent lesions, which 
are extremely slow to heal, increase in the respiratory rate, heart rate, and the pulse 
small in amplitude. Also Blood and Henderson, (1974), Bentram and Anthony, 
(1993), and Joseph, (2001) mentioned that the trivalent As absorbed from 
gastrointestinal tract, skin, respiratory system, all mucous surfaces and the acute 
form causes gastroenteritis, nausea, vomiting, pain, colic, diarrhoea (rice water), 
capillary damage, dehydration, shock. Chronic form causes skin damage, loss of 
hair, bone marrow depression, anaemia, weak pulse, ruminal atony, prostration 
and high morbidity and mortality rate, while in the subacute form watery bloody 
diarrhea, depression, dehydration and anuria are prevalent.  
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The present study showed that following treatment signs become less severe and 
some disappeared mainly in goats in groups (3-5) but it is clear that the effect of 
the high dose of the drug was apparent especially in goats of groups (6-10).  
Additionally the parasitaemia in blood and liver supports our belief that the 
clinical signs appearing in groups (6-10), and the fatalities, are due to the toxic 
effect of the drug which contained arsenical molecule specially for the skin lesion, 
blindness, bloody urine, gastroenteritis manifested by colic, bloody diarrhoea, 
nervous signs, paralysis, in addition to the presence of fever, changes in 
respiratory and cardiovascular signs which have also been mentioned by  
Rubaiul et al, (2004). 
It is well known that cardiac muscle is rich in mitochondria (Bloom and Fawcett, 
1986 and Banks, 1992). Curtis and John (2003) mentioned that arsenic inhibits the 
energy -linked functions of mitochondria in two ways: competition with phosphate 
during oxidative phosphrylation and inhibition of energy- linked reduction of 
NAD, leading to inhibition of mitochondria respiration resulting in decreased 
cellular production of ATP, increased production of hydrogen peroxide, which 
might cause oxidative stress through the production of reactive oxygen species. In 
the light of this information and our results showing blood pressure decrease in 
groups (6-10) indicate weakness cardiac muscle of which terminally lead to 
cardiovascular failure. This belief is in agreement with the findings of Smith, 
(2001) and Rubaiul et al., (2004). These a single dose at 0.25-0.625mg/kg is 
toleratable, safe and can therefore be used with safety and efficacy in this animal 
species. 
In the present study most of the goats in group (2) showed moderate to severe 
congestion in vital organs such as brain, heart, liver, spleen and intestine. In 
addition, the carcass appeared pale, emaciated, body fat stores are depleted, severe 
swollen mucopurlent conjunctivitis, scattered foci of alopica 3-7cm diameter of 
irregular shape mostly at the abdomen and back of the animals. The buttock region 
was soiled by offensive watery faecal material, the testes were swollen, the lymph 
nodes were swollen and congested specially the prescapular, the heart is soft, 
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flabby and dilated, and the pericardial sac contains straw coulor fluids, the 
haemorrhagic lesion in the lungs were seen as petechial haemorrhage. These 
lesions resemble those observed by Elamin, (1980 and 1992), Damayanti et 
al.(1994), Olaho et al.,(1996), Dam  et al.(1998) and Fairouz, (2000). These signs 
did not change clearly in goats of group (3) but dramatic changes were observed in 
goats of group (4and 5) where they either disappeared or became slight.  
Also the present study showed that in goats of groups (6-10) lesions were 
moderate to severe and the cardiac lesions became more severe, site of injection 
swollen, inflamed, orchitis, the liver was significantly enlarged, abomasums  
approximately empty but, contained slight mucopurlent material, the intestines 
flatulent and appeared swollen and the blood vessels were congested and the 
alopica progressed towards normal. 
Our present results in trypanosome infected animals which showing diffuse 
vacculation round the neurons and glial cells proliferation, widening in 
prevascular spaces in both the brain and the spinal cord in addition to vacculation 
and irregular axon sheets, degeneration of neurons in spinal cord are in accord 
with clinical signs exhibited by the animals such as hypothermia (Agag et al., 
1993), constricted pupils, shivering, convulsion, muscle tremor in the limb and the 
neck.  Radositis et al., (2000), Moulton et al.,(1976) and Elamin, (1980) 
mentioned that under similar circumstances severe non suppurative 
menengioencephalitis or myocarditis may result, degenerative lesions in different 
organs may also be present. Thomas, et al., (1996/2003) mentioned that T. brucei, 
T. vivax, T. congolense, caused mononuclear inflammatory reaction in the brain, 
spinal cord and meningeal. The same author added that T. cruzi caused in the 
brain, oedema, congestion particularly in the meningeal and some prevascular 
lymphocytic infiltration and nodules of mononuclear and glial cells may occur 
throughout the brain in addition destruction of neuron may lead to chronic 
neurologic sequalae.  
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The pathological gross findings are similar to that described by Agag et al., (1993) 
and Charles, (2003) but, it is noticed that they are more oriented towards the lungs, 
heart, kidneys, spleen and intestines. The present study showed clear neural 
pathological changes in the nervous system especially in the cerebellum, cerebrum 
and spinal cord, where there are vacculation and glial cells proliferation in 
addition to congestion and haemorrhage. Also the haemorrhage found in the lungs 
and bronchioles, congestion and haemorrhage in the heart, kidney and liver in 
addition to lymphocytic infiltration all were indicative of neurocardiopathy, 
hepatitis and nephritis. The enteritis leads to diarrhoea and decrease of appetite, 
loss of appetite, emaciation, which all might expose the animals to secondary 
infections.  
Goats of groups (6-10) showed similar lesions as those of group (2) but, these 
groups were aparasitaemic which means that lesions are attributed to action of the 
drug containing arsenical molecules. Fever, depression, apathy, constriction of the 
pupil, muscle tremor and fasciculation, pressing the head and lips against objects, 
tonic paralysis of the forelimb, shivering, blindness might be due to degenerative 
changes in the peripheral nerves, cerebellum and spinal cord. Lorgue et al.,(1996), 
and Radositis et al.,(2000) mentioned that toxicity of arsenic results in lesions in 
the optic nerves, optic tract, peripheral nerves (sciatic nerve and brachial plexus), 
kidney, spleen (lymphoid hyperplasia), sensory loss of peripheral nervous system 
can appear one or two weeks after great exposures, consisting of wallerian 
degeneration of axons, fragmentation of myelin sheaths and axonal degeneration, 
in addition to enlargement in liver, bronchopneumonia, flabby heart, cachexia and 
generalized oedema.  
The pneumonic, cardiomyopathy observed in the present study is not surprising in 
infected goats and it has been mentioned before by Moulton et al., (1976) and 
Elamin, (1980) these two organs are also affected seriously by Cymelarsan 
containing arsenical molecule especially in goats of groups (6-10) where the heart 
becomes enlarged, myocardium yellow, myocardial sac containing fluids where 
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the right ventricle becomes extended, the ventricle wall is thin with an eventual 
cardiovascular failure. Curtis and Johon, (2003) mentioned that injection of large 
doses of arsenic may be fatal, result in cardiac arrhythmia are upper respiratory 
tract symptoms.  
The livers and kidneys in parasitaemic goats showed congestion, sinusoidal 
dilatation, degenerative and /or necrosis of hepatocyte, while the renal tubules 
were dilated with increase of glomerular cellularity.  These signs are in agreement 
with what was observed by Elamin, (1992), while the lesion observed in goats of 
groups (6-10) were more acute and in accord with that observed by Thomas et 
al.,(1996) and Radositis et al., (2000).  
The micro and macroscopic lesions, as well as the colic and the bloody diarrhoea 
indicate gastroenteritis where the mucous membrane of alimentary tract appeared 
swollen, epithelium readily coming away when gently rubbed. The inflammatory 
changes are probably due to the dilatation of the capillaries combined by increase 
in capillary permeability with passage of fluids in the tissues. In addition, there is 
direct action in the epithelial cells by arsenic while produce local effect on the 
alimentary tract mucosa identical to that caused by ingestion or when given 
through other routes. (Clarcke et al., 1981).  The gut contents are very fluid, 
contain mucous and shreds of mucosa and subendocardial haemorrahages, severe 
degeneration in liver, kidney, myocardium, optic and peripheral nerves such 
manifestation are  mentioned also in Blood and Henderson (1974). 
Horst et al., (1996) mentioned that the immunosuppressive action of trypanosome 
exceed the actual course of trypanosomosis, secondary infection from other 
pathogen are activated. Fore example Mwangi et al.,(1990) mentioned that cattle 
infected with T. congolense produce a decrease in immunosuppressive after the 
application of B. ancerasis  spores suspension than non infected animals. This 
information supports our belief that gastroenteritis in the trypanosome parasitic 
disease is due to immunosuppressive effect activating secondary infection. Curtis 
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and John (2003) mentioned that arsenic is one of the xenobiotics which are 
capable of immunosuppression.  
The RBC might have been destroyed by the parasite or its toxins. (Horst et 
al.,1996). Spleenomegaly, observed in the spleen of parasitaemic or treated 
animals, may be attributed to anaemia resulting from excessive destruction of the 
RBC by the parasite or toxins produced by the trypanosomes. (Horst et al., 1996).  
But spleenomegaly , observed in the treated goats might have been due to the 
mode of the action of the arsenical group such that the sulphahydryl groups in 
tissue enzymes are rich in oxidative enzyme system would promote production of 
hydrogen peroxide which in turn might produce reactive oxygen radicals 
(Radositis et al., (2000).  
High doses of inorganic arsenical compound given to pregnant experimental 
animals produced various malformations in fetus and offspring. However, such 
effects have not been noted in humans with excessive occupation exposure to 
arsenic compounds (Curtis and John, 2003). Radositis et al., (2000) mentioned 
that trypanosome caused regenerative changes in infected animals; also he 
mentioned that the mononuclear inflammation may occur in the uterus. Thomas 
and Rebecca, 2003) mentioned that the testis lesions caused by T. curzi may be 
severely elevated where the germinal cells become laden with the organism, 
intense lymphocytic infiltration occur in the interstitial stroma. Josef, 2001 
mentioned that arsenic produce pathological effect on the reproductive system, 
which is confirmed by our findings that the testis were inflamed and underwent 
pathological changes which might be attributed to the tendensy of As to 
accumulate in large quantities in this tissues. 
In the present study in goats the Hb concentration, PCV% and the RBC count 
were within the reference interval in goats of groups (4and 5), but they are 
decreased in goats of groups (2, 3 and6-10). It is well known that trypanosomosis 
causes anaemia attributed to erythrophagocytosis as a result of stimulation and 
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expansion of the mononuclear phagocytic system throughout the 
reticuloendothelium system and to the mechanical cell and tissue damage caused 
by the active mechanical invasion of the extraordinary strong and mobile 
pathogens; resulting in spleenomegaly (Horst et al.,1996).  This is in agreement 
with our result where the monocytes increased in the infected untreated group 
spleenomegaly were manifest. 
In the present study anaemia accompanied by reticulocytosis in parasitaemic goats 
was even more prominent in goats received high dosages of Cymelarsan. The 
slight increase in the MCV and the decrease in the MCHC indicate that the 
anaemia is macrocytic and hypochromic. These findings confirmed that the 
anaemia is regenerative and supported by (Kenneth et al.,2003) who mentioned 
that in regenerative anaemia the bone marrow is actively responding to anaemia by 
increased production of erythrocytes, reticulocytosis in addition to monocytosis 
and hypochromasia. In goats of group (3) anaemia changed to microcytic 
hypochromic and changes in the MCV values indicate defective erythrocytes 
maturation. The observation in group (3and 6) where the content of serum iron is 
decreased indicates also iron deficiency anaemia. 
In camels the decrease in the Hb concentration, PCV%, RBC count is indicative of 
anaemia, which is macrocytic, and hypochromic as the MCV increased while 
MCH and MCHC decreased, Anosa, (1988a) and Kenneth et al., (2003) 
mentioned that T. evansi caused regenerative haemolytic anaemia.  
In the present study dosages of Cymelarsan in goats of groups (4and 5) caused 
dramatic response and results were shifted towards normal values. In goats, which 
received multiple dosages of the drug, the reticulocytosis and the increased MCV, 
is more prominent indicating regenerative anaemia. However the hyperchromasia 
is surprising. Steven et al., (2002) mentioned that if there is an increase in MCHC 
value, the value is usually an erroneous value and the true value may be within 
reference interval or even decreased and the pathologic conditions that can cause 
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true increase in MCHC value are rare.  Steven et al.,(2002) and Kenneth et 
al.(2003)mentioned that trypanosome spp. causes haemolytic anaemia of unknown 
pathogenesis and caused spleenomegaly , monocytosis, thrombocytosis (platelet), 
hyperproteinaemia suggesting that the anaemia is of an extravascular type. But in 
goats which received the drug in high doses (five times the recommended dose or 
multiple dosages), the anaemia may be haemolytic and of intravascular type 
though it is mild to moderate. Where there is slight increase in the total bilirubin 
and the unconjugated bilirubin, this might mean that the liver is still capable of 
removing the bilirubin from plasma. In addition the increase of the MCV and 
MCHC indicate cell membrane deformity as glutathione reductase, one of the 
enzymes which contain thiol group, was possibly inactivated by the arsenic 
molecules present in the drug. Further toxic substances released when the parasite 
is destroyed within the circulatory system have been reported to damage the lining 
of the blood vessels. 
Platelets, also referred to as thrombocytes, increased mildly in the present study in 
parasitaemic groups. The present study showed that experimental animals express 
cellular defense mechanisms (through neutrophilia except group (4and 5) where 
they are within reference interval). Goats receiving high dosages of the drug 
showed immunosuppressive effects of humoral nature as the globulins were 
decreased significantly with concurrent decrease in the lymphocytes and 
monocytes. 
The present study showed that there are no changes in serum sodium, potassium 
and chloride concentrations and the slight decrease or increase in the experimental 
animals is within reference intervals. Also in the present study decrease in the 
PCV, high total proteinaemia and albuminaemia, and the loss of body weight are 
indicative of dehydration especially in parasitaemic group and those receiving 
high doses of Cymelarsan. Itazi and Inyaru, (1975)discussed the urinary change in 
rabbits chronically infected with T. brucei brucei they found that in the observed 
proteinurea, relatively were globulins than albumins were excreted and suggested 
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that renal malfunction might b one of the cause of death in rabbits infected with 
this trypanosomes species. 
The dehydration might be attributed to loss of appetite or inability of the animals 
to move towards water points as a result of recumbency and/or weakness of the 
hind limbs. Kenneth et al., (2003) mentioned that normonatraemia can occur when 
there is decreased extra cellular fluids (ECF) H2O (isotonic dehydration) in cases 
of diarrhoea, exudation, gut fluid sequestration, haemorrhage and renal diseases. 
He mentioned that hypernatraemia can occur when there is decreased ECF H2O 
(hypotonic dehydration) in cases of diarrhoea, loss of Na-rich fluids and renal 
diseases. Also Kenneth et al., (2003)mentioned that hyperkalaemia results from 
changes in internal balance (shifts of K ions from intra cellular fluids (ICF) to 
ECF) in cases of diarrohea, marked muscle exertion (mild K+ increase) and 
massive tissue necrosis in the one hand, and on the other, hand hypokalaemia can 
result due to changes in external balance(decreased K+ intake or increased K+ loss 
to environment) where there are anorexia (specially herbivores), loss of 
gastrointestinal fluids, abomasal stasis and diarrhoea or through increased renal 
loss (kaliuresis). 
The present study in goats showed that the serum Cl- concentration is increased in 
the experimental groups compared to control group but the slight increase 
observed in serum Cl- concentration is still within the reference intervals. Steven 
et al., (2002) mentioned that hyperchloraemia typically occurs when there is 
hypernatraemia or when there is a decreased (HCO-3). Generally changes in Cl- 
are related to attempts to main electrical neutrality and it is well seen in cases of 
water deficit, metabolic acidosis (alimentary loss of HCO-3-diarrhoea- and renal 
loss of HCO-3 and the respiratory alkalosis.)  
The present study showed that serum calcium and phosphorus follow a declining 
trend, though within the reference interval. But goats of group (6) which received 
a single five times the recommended dose showed severe decline in the value of 
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serum calcium and phosphorus and an increase in the serum magnesium. The 
serum calcium and phosphorus is decreased significantly in goats of groups (3and 
6), and we belief that this decrease can be attributed to the prolonged anorexia and 
recumbency in addition to the gastroenteritis which might hinder mineral 
absorption, or might be due to renal excretion. Respiratory alkalosis and metabolic 
acidosis might have played a role in the calcium- phosphorus picture. 
Also the present study showed no significant changes in the serum concentration 
of urea and creatinine, GPT activity while there are slight increases in the 
activities of serum GOT and SDH in most of experimental groups. The gross and 
histopathological findings indicate that the parasite and the high drug dosing levels 
have an effect in the liver (hepatocytic degeneration and/or necrosis) and in the 
kidneys (disappearance, lobulation and hypercellularity of some glomerular, renal 
tubules might be dilated and some of the epithelial cells have undergone 
degeneration and/or necrosis). Kenneth et al., (2003) mentioned that significant 
renal disease may be present in the absence of clinical signs or laboratory 
abnormalities due to the extensive reserve capacity of the kidney, and urea 
excretion in ruminants is governed by nitrogen intake where animals that are on a 
nitrogen –deficient diet or that have severe anorexia excrete almost all blood urea 
via the gastrointestinal tract and very little via the kidneys. Therefore urea can be 
within the reference intervals in some ruminants with severe renal disease. 
Decreased urea production via decrease hepatic urea cycle function occurs in cases 
of hepatic insufficiency. The same author mentioned that creatinine is freely 
filtered by glomerular and tubular reabsorption. Thus serum creatinine is a more 
accurate measurement of GFR and the creatinine concentration is a more sensitive 
indicator of renal diseases in cows and horses than BUN because in these species 
the potential for gastrointestinal excretion of creatinine is limited in contrast to 
urea.  
Steven et al, (2002) mentioned that hepatocyte of horses and cattle have so little 
ALT that ALT is not a useful marker of hypatocyte damage in these species. The 
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same author also mentioned that AST is a common marker of hepatocytes damage, 
but muscle damage, haemolysis and other processes also increase serum AST 
activity. Far away the SDH indicates hepatocytic damage and used primary in 
horses and cattle because other common hepatocytic cytosolic enzymes (AST and 
ALD) are not liver-specific. The slight increase in the serum activity of LDH and 
CK is attributed mostly to muscle damage (mostly skeletal, occasionally cardiac, 
rarely smooth). Also it is noticed that the fluctuation in the serum activity of AMS 
(amylase) and LBS (lipase) is within reference intervals and might be due to the 
dehydration.  
Generally we belief that trypanosome has a clear pathologic role on the kidney and 
the liver, which is indicative of the rise in the activities of serum GOT and SDH, 
in addition to the electrolytes imbalances. This phenomenon is more prominent in 
groups, receiving high doses of the drug and where the parasitaemia is treated. It is 
obvious that the drug also has a serious fatal role in the parasite-precipitated 
lesions. 
Post treatment with Cymelarsan and oxytetracycline alone or combined, camels 
were healthy full, regain their appetite, all the clinical signs pathological findings 
disappeared and blood chemistry, haematological parameters within reference 
interval. But serum concentration of total protein, albumin, globulin, cholesterol, 
glucose and triglyceride, are also improved but slowly. 
The present study showed that the thyroid gland in goats is exposed to 
pathological changes such as loss of thyroid tissue, although we did not measure 
the gland activity but we belief there is hypothyroidism (Mutayoba et al, 1992 and 
Abeb et al., 1996). The hypercholesterolaemia, hypercortisonaemia, 
hypertriglyceridaemia and hyperlipoaemia although mild, can be attributed to the 
hypothyroidism. Mutayoba et al, (1992) mentioned that trypanosome-induced 
hypothyroid status may play a role in the impairment of mitochondrial ATPase 
activity, a key enzyme in energy metabolism.  Also the present study showed that 
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slight hypoglycemia is observed in parasitaemic group and groups receiving high 
dosages of the drug. It is well known that trypanosomes consume glucose and 
essential nutrient, in addition the prolonged anorexia and starvation also leads to 
hypoglycemia. 
Ralph and Hung (1944) mentioned that the toxicity of arsenical compounds is 
primarily a function of the degree to which they are bound by tissues, and that the 
red blood cells form a valid model for the body tissues constitutes a reliable index 
of systemic toxicity, as the sequence of events in the blood stream reflect what 
occurs in body tissues. After leaving the blood, toxic compounds were firmly 
bound by the organs and relatively high levels were found in the liver and kidney 
48hrs. after the injection. This supports our findings that tissues such as liver, 
spleen, kidney, heart and lung, can accumulate considerable amounts of arsenic as 
these organs contain large quantities of the enzymes containing thiol groups. 
Bujon, (1990) mentioned that the general maximum tolerated dose at the range of 
3-5 mg/kg (12-20 times the recommended therapeutic dose) gives a large safety 
margin when therapeutic doses are used in camels. 
The nervous system contains large amounts of fats and repeated administration of 
the drug revealed a tendency of the drug to accumulate in the fat and nervous 
tissues which support our clinical and pathological findings in the nervous system 
agree with this phenomenon. 
Zweygarth et al., (1992) mentioned that Cymelarsan is partially effective at doses 
of 0.625 mg/kg, but the present study shows that doses higher than 0.625mg/kg 
can be effective in treatment of trypanosomes of the CNS but unfortunately such 
doses proved to be fatal. Drug accumulation might have taken place due to the fact 
that large and repeated doses are over the capacity of the vital organs responsible 
for the arsenic detoxification and excretion.  The accumulation of arsenic at high 
levels in the muscles and site of injection in parallel to our results where myositis 
at the site of injection took place due to the irritating effect of arsenic to tissues. 
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Many studies report that injection of the drug I/M caused swelling and 
inflammation but it disappeared gradually (Bujon, 1990 and Lun et al., 1991). 
Also Kenneth et al., (2003) mentioned that arsenic caused degeneration at various 
levels to muscular tissue thereby accounting for the weakness of the animals and 
their inability to move ending in a state of recumbency.  Tager-Kagan et al., 
(1989) reported that at a dose of 3.7mg/kg of the drug induced significant necrosis 
of tissue at a point of injection.  
It is noticed that in camels the serum, kidneys, site of injection recorded the 
highest values compared to the other organs. The minimum effect concentration of 
Cymelarsan to killed trypanosomes is 0.005-0.04 µg/ml this is supported by Zhang 
et al., (1992) who studied the sensitivity of trypanosoma evansi in vivo and in 
vitro. While Sones, (1991) mentioned that residues of total arsenic were noted in 
fat, liver and kidney all result of assay for total As were less than 2mg/kg, no 
residues were observed in plasma, no residues in one camel seven days after 
treatment when he studied the residues in seven infected camels in Kenya were 
treated with 0.25 mg/kg of Cymelarsan I/M and slaughter either 7days, 14 or 21. 
Toutain, (1989) mentioned that RM 110 was rapidly and completely absorbed 
after S/C injection 24h. when 0.1, 0.15, 0.2 or 0.3 mg/kg injected in Morocco 
dromedaries.  
In goats which received half recommended therapeutic dose twice a week for two 
weeks or once weekly for three weeks in camels the picture is surprising as goats 
recorded higher values of As than that recorded in camels. This may be due to 
species difference. Cymelarsan which has arsenical molecules, has a high affinity 
to pound to RBC compared to that of the camels this supported by the increase 
level of arsenic in goats especially goats that received the recommended dose 
twice a week for two weeks and also by the high concentration of As in kidney 
and urine in goats compare to that of camel. This might be attributed to that camel 
having other route of excretion of arsenic. It could be through saliva or faeces or it 
might be deposited in bones. Or the camels might have a high capacity to excrete 
arsenic throw the kidneys rapidly in less than 28days post treatment. The 
Pharmacotoxicity of some trypanocidal drugs in food animals (Nubian goats and camels)          
accumulative effect in goats is more evident than in camels which might explain 
why camels can tolerate five times the recommended therapeutic dose and also 
supports what was reported by Bujon, (1990) who mentioned that camels can 
tolerate 12-20 times the recommended therapeutic dose.  
The presence of trypanosomosis relapse after treatment is not a surprising as, 
Losos and Ikede et al., (1972), Baltz et al., (1989) and Payne et al.,(1994) 
mentioned that infection with brucei group of trypanosomes is usually associated 
with the presence of extravascular parasites sequestered in sites where the drug 
cannot penetrate. Trypanosomes in sites such as the brain and cerebrospinal fluids 
are protected from certain drugs by the blood brain barrier. Yet Cymelarsan was 
effective in the treatment of trypanosome infections involving the central nervous 
system suggesting that the drug can cross the blood- brain barrier.   
Treatment with OTC-LA at 100mg/kg, 20 mg/kg twice a week for two weeks and 
20mg/kg daily for 8days showed period of free parasitism in the peripheral blood 
followed by a relapse of mild parasitaemia. Dosages of daily 20mg/kg for 8days 
have fatal end 16days post treatment. This result is supported by liver impression 
smear where the livers were cleared 21 days post treatment and after cessation of 
the drug. Fairouz, (2000) found that the oxytetracycline decreased parasitaemia in 
Nubian goats by 75%, death occurring by 7days later. The relapse in 
trypanosomosis it might be attributed to maturation of immature stages of the 
trypanosome (Solusby, 1983). Relapse also depends upon the concentration of the 
drug or its metabolism in the blood circulation acting on certain stages of the 
parasite. The present study also indicates that the animals can tolerate single 
dosages up to 100mg/kg and also can tolerate multiple dosages of 20mg/kg weekly 
for 3weeks or twice a week for two weeks, but dosages of daily 20mg/kg for 8days 
result in fatal ends.  
When OTC-LA   is given to camels in recommended therapeutic dose it failed to 
clear peripheral blood or liver tissues from the parasite and the animals died 20 
day post treatment. However, when the drug is given at two and half and five fold 
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curative dose or the curative dose twice weekly for two weeks it was capable of 
freeing the parasite only from the peripheral blood approximately 21 days, mild 
relapse occurring. 
The clinical signs observed in T. evansi infection in goats or camels were 
generally similar.  
Goats which received the daily therapeutic dose for 8days didn't tolerate the drug, 
and the animals dying on day 18 this may be due to species-oriented phenomena.  
Sharp decrease in pulse rate, blood pressure and respiratory rate in goats which 
receiving the drug with fatal end may be attributed to the pneumocardiopathy 
which end with circulatory insufficiency.  
Macroscopic and microscopic changes observed in infected treated or untreated 
goats are indefinite. However, changes as observed in goats are dramatically 
reversed in camels infected with T. evansi and treated with OTC-LA   this may be 
attributed to a species difference.  
Increase in WBC counts might be due to the irritant effect of the drug at site of 
injection (Bywater et a., 1991). Decrease in the lymphocytes may be accounted for 
by the fact that trypanosomes have immunosuppressant (Hamnies et al., (1991) 
and Sellon et al., (1997)). But, the increase in platelet and reticulocyte counts may 
indicate of haematocrisis   stimulation (Schalm et al., (1985)). 
The slight increase in serum of potassium, chloride in addition to decrease of 
calcium, phosphorus as well as the decrease in the T3, T4 in addition to the 
pathological changes in some groups infected with T. evansi and treated with 
either single or repeated dosages indicate renal and/or metabolic disorders and 
acid-base imbalances.  
Similarly, serum potassium level was decreased in camels in infected with T. 
evansi (Anosa, 1988b) and also in infected T. evansi goats (Fairouz, 2000), serum 
calcium and serum phosphorus decrease in T. evansi infected goats (Elamin, 1980 
and Fairouz, 2000) while no changes were recorded in serum sodium level was 
seen post infection (Anosa, 1988b, Otsile et al., 1991 and Fairouz, 2000). 
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Both oxytetracycline and tetracycline are eliminated unchanged primarily via 
glomerular filtration. Patients with impaired renal function can have prolonged 
elimination half-lives and may accumulate the drug with repeated dosing. These 
drugs apparently are not metabolized, but are excreted into the GI tract via both 
biliary and nonbiliary routes and may become inactive after chelation with fecal 
material. (Pfizer, 2005). 
It is noticed that goats which received the daily program recorded least phosphorus 
value and recorded high manganese serum level and Melvin and Swenson, (1995) 
reported that higher level of manganese interfere with the retention, also Myra et 
al., (1981) mentioned that manganese ions antagonism has been observed in baby 
pigs and a level of 50-150ppm of manganese with a diet interfere with 
haemoglobin formation.  
Also it is noticed that slight decreases were observed in iron in repeating dosing 
program this may cause iron deficiency anaemia. The death may be due to 
anaemia or vital organs. Curtis and John, (2003) mentioned that tetracycline and 
chlortetracycline is a drug associated with the development of a plastic anaemia, 
also the same author mentioned that tetracyclines is one of cyanobiotic that 
developed specific coagulation factors inhibitor (Von willebrand) factor. Also the 
same author mentioned that OTC-LA   has cardiotoxicity manifested by negative 
entropic effect through decreasing Ca-ions. 
Amodu and Ige, (1975) elucidated the mechanism of development of anaemia in 
rabbits experimentally infected with T. brucei and concluded that the anaemia is 
possibly a  result of an auto reaction together with anaemia and specific organ 
damage, a wider range of immunological abnormalities appear to characterise the 
pathology of the disease. 
Slight increase were observed in GOT, which might be attributed to the 
degeneration in muscle, liver because it is not a liver specific enzyme, muscle, 
kidneys, heart….etc(Varley, 1965). 
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Also the present study indicates that camels which are T. evansi infected are 
responding and tolerating OTC-LA   at total doses ranged of 50-160 mg/kg where 
the serobiochemical improved when there is increase of dosages. 
The drug at single I/M 50-100mg/kg or 20mg/kg twice a week for two weeks 
reduced trypanosomosis in the blood, liver tissues 75% and kept the animals alive 
survived with mild parasitaemia for 49 days post treatment. This might justify the 
use of OTC by the Vets in the Sudan with a view to overcoming the 
immunosuppressant effect of trypanosomes concomitant with conventional 
trypanocides. 
The present study show for the first time that OTC-LA  at 20mg/kg daily for 8days 
is curative tolarable and not toxic in camels infected with T. evansi. This is 
remarkable as animals survived even after 49 days post treatment. 
It is noticed that in all groups, infected or infected treated, the body weight is not 
retain to that of group (1) until the end of experiment and its also noticed that most 
of these groups showed triglycerideaemia, phospholipidaemia and also an slight 
increase in cholesterol and glucose levels. In addition, liver and kidneys showed 
slight fatty changes. 
Like the findings of Benzo, (1987) OTC-LA increased hepatic lipids and 
depressed body weight. Soback et al., (1987) studied the pharmacokinetic changes 
of several antibiotics in children inducing fatty liver and found positive. 
The amount of the drug which absorbed from the site of injection was higher in 
camels than in goats approximately 5 folds. It is clear that the drug is cleared 
rapidly in camels than in goats which might be due to factors associated with the 
species differences in excretion and metabolism. (Bloom and Fawcett, (1982) and 
Banks, (1989)). 
The present study showed that the concentration of the drug in urine and bile is 
higher in camels than in goats and it released up to 5.5 µg/ml which is the 
therapeutic figure (Xia et al.1983). Oorgans such as testis, ovary, uterus, leg 
muscle, site of injection in camels recorded higher values than that of goats but the 
tendency of drug to accumulate in fat of goats was higher by 4 folds than that of 
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camels while, the drug accumulation in the cerebellum and was more in camels 
than in goats although the nervous tissues contained large amount of fat and this 
might be attributed to physiological barriers of the body.  
Similarly the residual concentration of the drug in the liver and kidneys was 
camels than in goats of these results generally indicate that the drug attains higher 
concentration in the body fluids and tissues of camels more than in those of goats. 
This might be due to the kidneys as this is a major route of excretion of OTC-LA 
after paraenteral administration. 
There is good correlation between the levels of OTC-LA   in the serum and in the 
liver, kidneys in camels while this correlation is not observed in goats. 
Luthman and Jacobson, (1982) mentioned that the plasma concentration of OTC-
LA   exceed 0.5 µg/ml therapeutically active concentration for about 60hr.  in 
calves. Bertzlaff, et al., (1982) mentioned that the concentration of OTC in plasma 
is 4.86+0.45 µg/ml, 5 µg/ml in uterine tissues when single I/V dose 22mg/kg of 
OTC was given to cows. a serum level of 12µg/ml cleared the parasites from the 
blood and liver tissues and terminated fatal. 
 The committee for veterinary medical products (CVMP) of the European agency 
for the evaluation of medicinal products (EAEMP, 1995) evaluated OTC-LA   in 
the past, and established an acceptable daily intake (ADI) of 0-0.003 mg/kg bw 
based on the human gut flora. Based on this ADI and taking into account the 
typical residue distribution of OTC-LA   in tissues, the following maximum 
residue limits (MRLs) established by 36th joint FAO/WHO expert committee on 
food additive (JECFA) were adopted: kidney 600  µg/kg, liver 300  µg/kg, eggs 
200  µg/kg, muscle 100  µg/kg, milk  µ100 g/kg. It was concluded that the 
antimicrobial potency of chlortetracycline and tetracycline is comparable to that of 
OTC-LA, the JECFA established a group ADI of 0-3 µg/kg b.w. for OTC-LA, 
tetracycline and chlortetracycline alone or in combination, the highest levels are in 
the kidney and liver, but they are not detectable in fat to any great extent. For the 
complete recovery compounds, the 4-epimers of OTC-LA, tetracycline and 
chlortetracycline, have to determine. The 4-empires of the compounds occur in 
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samples and are formed during sample preparation. The 4-empires are in 
equilibrium with the parent compound. Therefore, the marker residue is the sum of 
the parent drug and its 4-empires. (EAEMP, 1995). 
The present study showed that when Cymelarsan and OTC-LA combination was 
given at half recommended therapeutic dose of both in goats which infected   with 
T. evansi, the parasite is cleared from the peripheral blood by 50% and the animals 
were died at day 15 post treatment. The death is attributed to trypanosomosis. But 
when Cymelarsan administered at the half recommended therapeutic dose 
combined with OTC-LA either at two and half recommended therapeutic dose or 
at twice/week for two weeks or daily for 8days, the blood was completely free 
from the parasite. It is also noticed that the liver is free from the parasite in the 
repeated dosages program. In single dosages the parasite was found in the liver at 
25-50% after period of relapse for approximately two weeks post treatment, the 
combination cleared the blood and the liver from the parasite without death when 
given to camels naturally infected with T. evansi this seems to be in agreement 
with previous findings (Anosa, 1988a; Losos and Ikede et al., 1972, Baltz et al., 
1989 and Fairouz, (2000)).  The death in the daily treatment combination program 
is attributed to the toxic effects of these drugs although the blood and the liver are 
free of the parasites.  
A good health improvement as judged by clinical signs, pathological findings and 
haematological and serum biochemical result, was observed in goats which 
received the combination of the half recommended therapeutic dose of 
Cymelarsan with single or two and half recommended therapeutic dose of OTC-
LA. The same dose of Cymelarsan given with OTC-LA at the recommended 
therapeutic dose twice a week for two weeks or in treated camels, indicated that 
the combination was toleratable and successful to overcome the infection but 
when the combination was given at daily program the goats died although the 
blood and the liver were free of the parasite. Signs of Cymelarsan toxicity were 
noticed including hyperthermia, sharp decrease in the pulse rate, blood pressure 
with increase in the respiratory rate. All these indicate involvement of respiratory 
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and circulatory systems, in addition to the nervous system as indicated by the 
histopathological, lesions observed in the nervous tissue.  
The measurement of the concentrations of Cymelarsan and OTC-LA residues in 
tissues, urine, bile and serum of camels and goats confirm the previous results 
obtained clinically, pathologically, haematological and on serum biochemistry 
where most tissues recorded normal values by the end of slaughter program and it 
is noticed that as OTC-LA increased the accumulation of arsenic is decreased 
specially in camels and this is explained the tolerating capacity in this species. In 
the present study when we compared the serum concentration of OTC-LA which 
was capable to eliminate the trypanosomes from the blood and tissues, and that of 
the in vitro study, it is found that both results were in agreement, where 4µg/ml 
and above of OTC-LA is needed to eliminate the parasite. 
Combination preparation, may act by complementary mechanisms at different 
sites, or one of the drug may potentiate the clinical efficacy of the other by altering 
its distribution, biotransformation or excretion. (Baggot, 2001). Drugs are often 
given in combination with potentially   beneficial or adverse effect results. When 
two drugs are given together, their effects may be additives, the final being the 
sum of the individual effects. Alternatively, the interaction may be synergistic, the 
effect then being greater when two drugs are given together than one would expect 
from their effect when given alone (Girdwood, (1978) and Bentram and Anthony, 
(1993). 
This supported with Onyeyili et al., (1999) mentioned that the combined use of 
isometamidium chloride and difluromethylornithine in immunosuppressed rabbits, 
none of the treatments was effective in immunosuppressed rabbits at doses that 
were 100% effective in immunocompetent rabbits while, in Egwu et al., (1993) 
the combined use of isometamidium and difluorometyhylornithine(DFMO) in rats 
infected with T. brucei in late stage was successful. 
Mishra et al., (1983) mentioned that the treatment of infected cattle with Theileria 
annulata with three injection of Berenil with one injection of achromycin for 
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seven days with supportive administration of OTC, tetracycline, Belamyl, 
Novalgin, Mifex and Tonophosphan brought about the clinical recovery of the 
animals with marked reduction of parasitaemia and considerable rise of 
haemoglobin level. Treatment with Berenil- Oxysteclin combination for 6days 
also gave comparable results. The administration of Berenil alone (3 injection) 
with supportive therapy some relief but there was recurrence of the clinical 
symptoms witin 3-7 days. Dicrysticin administration was not found to be effective. 
Also Baggot, (2001) mentioned that the synergistic antimicrobial effect produced by trimethoprim-sulphonamide combinations is due 
to the sequential blockade in bacterial biosynthetic pathway for folic acid. Also, pyrethrin- piperonyl butoxide is potentiated 
insecticidal efficacy of pyrethrin, penicillin-probencid is increased the duration of effective penicillin concentration. 
Also it is agree with Wooly et al., (1984) who found a synergistic inhibitory acquired was observed with combination of EDTA- 
tromethamine plus penicillin, nalidixic acid, OTC, chloramphenicol,  polymyxin-B,  sulfamethazine, sulfapyridine, and sulfathiazo 
       le and a synergistic effect was notrecorded with combination of EDTA-tromethamine and streptomycin. 
The efficacy of Cymelarsan when given at single I/M of 0.125mg/kg b.w. once or 
daily for 8days resulted in complete clearance of the parasite from the peripheral 
blood and liver tissue and the animals survived until slaughter time or death. When 
the same dose was given to goats infected with T. evansi supported by the 
administration of 12 µmol/l zinc and copper once or daily for 8days, the peripheral 
blood and liver tissue were completely free from the parasites and death occurred 
in repeated dose. This is in agreement with Baqui et al, (2002) who studied the 
effect of Zn supplementation on morbidity and mortality in Bangladeshi children 
with diarrhoea and found that Zn supplementation in children in a dose of 
20mg/day for 14 days significantly decreased the incidence of diarrhoea and acute 
lower respiratory tract infection and attributed that to improved absorption of 
water and electrolyte by the intestine (Golden and Golden, 1985) and faster 
regeneration of gut epithelia (Bettger et al .,1981 ).  
The present result are in accord with those of Mir Misbahuddin and Kamaluddin, 
(2002); that goats which received daily Cymelarsan which contain As molecules 
caused the same signs and lesions of arsenicosis although goats which received Zn 
and Cu supplemented Cymelarsan in a daily program, but it is worth to mention 
that Cu, Zn slightly improved the clinicopathological findings and most of the 
haematological and serobiochemical parameter which were measured compared to 
that which is given Cymelarsan alone or for 8days program, that the 
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administration of Zn has adramatic response in treatment of As when given for 
short period, this is clear in goats which received half therapeutic dose 
supplemented by the improvement of Cymelarsan in treating trypanosomes within 
10days with out relapse or death until day 42 the end of the experiment also this in 
agree with Styblo and Thomas and Rebecca (2003) who observed that 
simultaneous administration of selenium and Zn may enhance the toxic effect of 
As, increasing its retention in tissues and suppressing its methylation, which may 
be a pathway of detoxification of arsenic. It is worth also to mention that this dose 
of Cymelarsan is weak for treating trypanosomosis and it is also worth to mention 
that clinical signs and pathological findings in addition to haematological and 
serobiochemical measurement were to worth the health goats. This is to enable the 
organs, tissues and the immunosystems to overcome the stress and damage cause 
by trypanosomosis. 
The high content of urine with As in the group which supplemented with Zn and 
Cu compared to that which was given Cymelarsan alone in the 8 days program of 
the treatment, means that supplemention with Zn and Cu improved the metabolism 
and the excretion of Cymelarsan which contain arsenical molecules. In the group 
which received single half the curative dose, the concentration of As in the serum 
increased by 4 folds which mean that supplementation of Zn and Cu improved the 
absorption of As and this is in accord with (2). The same phenomena was 
observed in the site of injection.  This is in agreement with Mir Misbahuddin and 
Kamaluddin, (2002) who found that oral administration of both zinc and arsenic 
when given for one 1month at a dose of 1mg/kg/day and 20 µg/kg respectively, is 
effective in the prevention of arsenic accumulation in different tissues such as 
spleen, lungs, kidneys, intestine and skin, but it is quite surprising that  
simultaneous administration of zinc and arsenic increase the accumulation of Zn in 
different tissues particularly kidneys and spleen. The mechanism by which Zn 
increases the accumulation of As is not known. 
It is well known that copper is an integral part of the cytochrome system. Such 
enzyme as tyrosinase, laccase, ascorbic acid oxidase, cytochrome oxidase, plasma 
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mono amine oxidase, erythrocuprin, urecase, superoxide dismutase contain Cu and 
their activity is dependant on this element. Zinc is a functional component of 
several enzymes systems such as carbonic anhydrose, carboxypeptidase, alkaline 
phosphatase, lactic dehydrogenase, glutamic dehydrogenase, also zinc is important 
in an enzymic system, necessary for synthesis of ribonucleic acid and is found in 
the pancreas, exhibit an active metabolic turnover and is important of maturation 
of spermatozoa (Melvin and William, 1993).  
The study of the toxicity and efficacy of quinapyramine in goats infected with T. 
evansi showed that the drug at 5-25 mg/kg cleared the parasite from peripheral 
blood and liver tissues without fatalities. Also, the drug at 5 mg/kg b.w. weekly for 
3 consequtive weeks cleared the peripheral blood and the liver tissue. But at 5 
mg/kg daily for 8 days the drug cleared the parasite from the peripheral blood and 
the liver tissue, followed by death 12-20 days post treatment. The results indicate 
that the drug has fatal accumulative properties at 25 mg/kg as a total dose. 
It is well known that trypanosomosis caused hypothermia, lacrimation, nasal 
discharges, depression, and diarrhoea, loss of appetite, loss of body weight, 
decrease of pulse and respiratory rates, emaciation then recumbency terminating in 
death (De-Villa et al., 1991 and Fairouz, 2000). Other sings such as keratitis, 
alopicea, orchitis, and hypothyroidism were also reported (Mutayoba, et al., 1992 
and Abebe and Eley, 1992). These signs appear mild or absent in treated groups, 
but signs such as loss of appetite emaciation, loss of body weight, diarrhoea, 
decrease in blood pressure, pulse rate, increase in respiratory rate might be 
attributed to high dosages of the drug. Clarcke et al., (1981), Alexander, (1985) 
and Girdwood, (1979) support our findings.  
It is clear from the present study that an effect has been observed on CNS 
exemplified by cerebellum, cerebrum and spinal cord especially in trypanosome 
infected groups and more in cases which received the drug at 50mg/kg r.t.d. and 5 
mg/kg r.t.d. repeated weekly for three weeks or daily for 8days. Also the later 
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groups showed an effect on thyroid gland, lungs, liver, kidneys, intestine and testis 
if compared to groups which received the drug at 5-25 mg/kg I/M.  
Drug detoxification may be reduced and the drug becomes more toxic in animals 
with damaged liver or kidneys. Clarcke et al., (1981) mentioned that post mortem 
findings include acute inflammation of gastro intestinal tract and nephrosis. Some 
toxins in drugs decrease the microsomal enzymes in the liver and so decrease 
serum enzymes activity (Ford et al, 1972). 
Our results show that the parasite might have stressed the vital organs. Death 
might be attributed to histamine release and /or anticholinergic effect on stressed 
organs. Clinicopathological effects such as decreased blood pressure and pulse 
rate may be related to hydroperitoneum and hydropericardium, cardiomyopathy, 
hepatitis, nephritis, pneumonitis, orchitis and thyroid gland insufficiency. 
The pathology of animal trypanosomosis was given in more details by Ikede, 
(1975)   although the disease caused by the various species of trypanosomes has 
certain features in common, the types and mechanisms of injury done to the host 
may vary considerably with the species. 
Haematological changes induced by trypanosomosis mostly returned to reference 
values although goats given 50 mg/kg b.w. needed more time to regain fully 
reference interval values. The increase in basophils and eosinophils in the infected 
group is well documented (Anosa, 1988b and De-Villa et al., 1991) but the 
presence of the eosenophils and basophiles in treated groups could be attributed to 
induced histamine release by the drug (Bentram ant Anthony, 1993). 
The increase in serum sodium and chloride, in addition, to decrease in calcium, 
phosphorus, copper, and zinc is a sign of nephritis. The increased potassium, total 
bilirubin, direct bilirubin serum concentrations are indicative of haemolytic 
anaemia which might be attributed to toxins resulting from the dead parasites 
(Clarcke et al., 1981) or might be due to the effect of the drug on RBC membrane 
(Bywater et al.,1991). 
The anaemia noticed in the eight days program is normochromic macrocytic, but 
there is evidence of iron, zinc and copper deficiency; these trace elements play a 
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role in the synthesis of haemoglobin and RBC (Varley, 1965). Or it might be 
attributed to loss of weight, loss of appetite and recumbency that the animals 
unable to reach the sources of food and water. Also increase in the creatinine in 
the eight day program is indicative of nephrosis. Non increase in urea in these 
groups (6and 8) is not surprising as nephritis occurred in these species without 
increase in urea. Consequently PCV decreased, hyperproteinaemia and 
albuminaemia thereby indicating haemoconcentration. The haemoconcentration 
can also be attributed to the drug inducing histamine release (hydroproteium and 
hydropericardium) (Bentram and Antohny, 1993).  
The increase in serum SDH activity is an indication of liver necrosis and the 
decrease in serum activity of amylase and lipase indicate an effect of the drug on 
the pancreas.  The increase in serum cholesterol concentration might be a 
consequence of hypothyroidism. Hypothyroidism and decrease of progesterone 
accompanying T. evansi infection is well known (Mutayoba et al., (1992) Osaer et 
al., (1998) and Fairouz, (2000)) but it is reverted to reference intervals when the is 
drug administered at a single dose of 5, 12.5 mg/kg, or at 5 mg/kg dose weekly for 
three weeks. The situation worsened in goats receiving single 50 mg/kg or 5 
mg/kg daily for 8 days.  This effect may be due to the action of the drug. The 
present study revealed increased globulin concentration at high doses the cellular 
defense mechanism might not have been affected seriously; Itazi and Inyaru, 
(1975) discussed the urinary change in rabbits chronically infected with T. brucei 
brucei they found that in the observed proteinurea, relatively were globulins than 
albumins were excreted and suggested that renal malfunction might be one of the 
causes of death in rabbits infected with this trypanosome species. 
The study of showed of the toxicity and efficacy of ethidium in goats infected with 
T. vivax that T. vivax caused death within 13-17 days while T .evansi caused the 
death of goats within 7-11 days. These results indicate that T. evansi is more 
pathogenic and goats are more susceptible to T. evansi when the same counts of 
trypanosomes were used. Goats receiving single 1 mg/kg doses the peripheral 
blood was not cleared of the parasite completely and the animals died within 16-
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20 days post treatment. This is supported by Elmalik, (1983) who studied the 
efficacy of the same dose of T. vivax infected in goats, relapse and death occurred. 
Variation in the time of death might be due to the strain used.   
Maxie, (1976) mentioned that in both goat and cattle infected with T. vivax 
parasitaemia was detected 6-7 days after inoculation with 1x105 but not in T. 
congolense infection. Mwambu, (1975) re-evaluated the value of ethidium for the 
treated of T. brucei subgroup infection in cattle and concluded that the use of this 
drug as a curative in T.  brucei infection of cattle should be restricted. Kalu, 1983 
observed complete disappearance of trypanosoma vivax from the blood 3days after 
treatment with homidium bromide, berenil and samorin. 
The clinical signs observed with T. evansi and T. vivax was not different, though 
they were more severe in T. evansi as observed by (Mubarak, 2002). Ethidium  at 
single I/M 2.5 I/M mg/kg or at 1 mg/kg weekly for three weeks  eliminate the 
parasite from the peripheral blood and liver tissue and the clinical signs are 
capable to the health status improved but doses such as single I/M 5 mg/kg or 1 
mg/kg daily for 8 days worsen the health of the status of the animal although they 
are free from the parasite while, the single I/M 1 mg/kg partially eliminates the 
parasite, but death occurred after 16-20 day for 60% of the goats. The relapse of T. 
vivax is an ordinary phenomena where in our present study it occurred in 35 days. 
The diarrhoea observed in infected or uninfected treated group may be a 
consequence of irritation of the intestine by the toxic metabolites of the parasite or 
toxic ingredients of the drug.  
The hyperthermia and hypothermia is controversial, Elmalik, (1983) and Elamin, 
(1980) observed hyperthermia in trypanosomosis, but Fairouz, (2000) and 
Mubark, (2002) observed hypothermia; which may due to the different strains 
used. 
Fever, increased in heart rate, anorexia, emaciation, and elevation of anaemia, 
body temperature were observed in T. vivax infected goat was also observed by 
Maxie et al., (1979) and Ugochukwu, (1986). So acute and chronic forms of 
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anaemia in trypanosomosis has been attributed to inhibition of haemopoiesis 
(Losos and Ikede, 1970).  
The pathological findings of Masake, (1980) in T. vivax in East African goats, 
Frisian cattle showed major changes in the lymph nodes, spleen, eyes, pituitary 
gland, testicles and heart, in infected Zebu cattle with T. vivax and T. congolense 
and treated 12th week post infection with Novidium and slaughtered for 
histological evidence of healing of the genital lesions in Sekoni, ( 1990) study, 
also in Isoun, (1975) observation T. vivax infected mice was generalized fibrin 
thrombus formation in the blood vessels of heart, lung, spleen and brain support 
our findings. 
With ethidium the health of animals free of the parasite deteriorated to a fatal end 
sometimes. This might have been due to adverse effects of the drug on neural 
structures both centrally and peripherally, supporting the findings of Curtis and 
John, (2003) who observed cellular basis of neurotoxicity which included 
intramyelinic oedema, status spongiosis of white matter. And, those of Riet-Correa 
et al., (2002) who observed demyelination on the sciatic nerves in adult Wister- 
rats; schwann cells showed vacculated cytoplasm and separation of the sheath 
from the axon. With increase doses of ethidium collagen fibers also increased in 
number and progressively involved swollen number of remyelination axons 
composing new fascicles. In the present study neurocardiopathy is evident which 
might be attributed to cholinesterase inhibition.  
Increase in blood plasma volumes and decrease in Hb, RBC, PCV, leukopeniaand 
thrombocytopenia, indicate that the drug has an effect on erythroypiosis as 
suggested by Anosa and Isoun, (1976). 
The slight increase in sodium, potassium, chloride, magnesium and creatinine 
decrease in phosphorus, calcium is indicative of renal insufficiency. In addition, 
the slight increase in serum GOT, SDH activity is indicative of hepatorenal effect. 
But the drug had no effect on the thyroid glands at doses used in this study. 
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The study of the effect of quinapyramine and homidium in goats infected with T. 
evansi or T. vivax showed that T. evansi is more fatal than T. vivax death occurring 
after 11days for T. evansi and after 17days for T. vivax.  
No apparent change was observed in the efficacy of quinapyramine and homidium 
bromide in goats infected with T. evansi at the level of dosages used compared to 
that of quinapyramine administered alone at the same dose level. Same was also 
observed in goats infected with T. vivax, where there are no changes observed in 
the efficacy of quinapyramine combined with ethidium at the two levels of 
combination when compared to that of ethidium administered alone and at the 
same dose level. In both infections (T. evansi and T. vivax) the presence of the 
parasite in the peripheral blood was more prevalent than when the drug was given 
alone. It is clear that combined effect of the drug is prominent. This is supported 
by Mubarak findings (2002). 
In the present study there are no clear changes in the efficacy of a combination of 
quinapyramine and ethidium but the health condition of goats improved.  
The present study with the combination revealed no prominent changes of efficacy 
at the peripheral blood level, but there appears to be is an unknown factor 
promoting the overall health of these animals.  
Recommendation: 
1/ In the light of the findings availed by the present study, we propose the 
following drug dosages regimen when treating trypanosomosis with Cymelarsan 
and /or oxytetracycline(OTC):  
a/in camels: 1/half of the conventionally recommended therapeutic dose of 
Cymelarsan plus two and half that of  dose of OTC. 2/ half of the conventionally 
recommended therapeutic dose of Cymelarsan plus five times of OTC in camels. 
3/half of the conventionally recommended therapeutic dose of Cymelarsan plus 
single recommended dose of OTC twice a week for 2 weeks. 4/a single dose of 
Cymelarsan plus a single dose of OTC or half the dose weekly for three weeks. 5/ 
single therapeutic dose. 6/ the two and half of therapeutic of Cymelarsan. 
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b/in goats: 1/a single dose of Cymelarsan plus a single dose of OTC.2/ half dose of 
Cymelarsan plus two and half dose of OTC.3/ half dose of Cymelarsan plus five 
times the dose of OTC.4/ the single dose or two and half the dose of Cymelarsan. 
c/ when OTC used goats: 1/the five times therapeutic.2/ the therapeutic dose 
weekly for three weeks.3/two and half of therapeutic.4/ the single therapeutic dose 
twice a week for two weeks of OTC. in camels 1/the two and half of therapeutic. 
2/ five times and the single therapeutic dose of OTC. 
d/ the half of the therapeutic dose of Cymelarsan plus zinc and copper. 
e/ the therapeutic dose plus the two and half of therapeutic of quinapyramine and 
ethidium. 
f/ the therapeutic dose weekly for three weeks, two and half of therapeutic dose of 
quinapyramine.  
g/ the therapeutic dose weekly for three weeks, two and half of therapeutic dose of 
ethidium. 
2/ the withdrawal periods of the drugs studied are more than mentioned by the 
manufacturers.                                                     
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